data_2kfw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' HE3' HG23 ' A' ' 139' ' ' ILE . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.478 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG21 HG13 ' A' ' 136' ' ' VAL . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 132' ' ' PHE . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.465 HG23 ' CG ' ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.445 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CD2' HG11 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.461 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' ILE . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 132' ' ' PHE . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.506 ' CD1' HD11 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.585 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 1.8 m-70 -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' HB1' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t-20 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' CG1' ' OD2' ' A' ' 120' ' ' ASP . 7.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.221 0.534 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH2' ' HB ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.499 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.452 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.46 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.403 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 110' ' ' THR . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.485 HG21 ' CG2' ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.525 HG11 ' N ' ' A' ' 118' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.525 ' N ' HG11 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.501 ' OD2' ' CG1' ' A' ' 76' ' ' VAL . 20.6 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' ASN . 17.1 p-10 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.237 0.542 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 130' ' ' LEU . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.446 HG12 HD12 ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' VAL . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.524 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.48 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.507 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.3 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 139' ' ' ILE . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 135' ' ' GLU . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG11 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.543 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HA ' HG11 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.434 ' H ' ' CG ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CE1' ' HB ' ' A' ' 134' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 48' ' ' ALA . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.455 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.472 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 129' ' ' ASN . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB1' ' CG ' ' A' ' 129' ' ' ASN . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 68' ' ' TYR . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 2.6 m-30 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 ' C ' ' HG3' ' A' ' 77' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.265 0.555 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.485 ' CB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.492 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.612 ' CG2' ' CZ ' ' A' ' 96' ' ' PHE . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.455 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.446 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 9.7 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.231 0.539 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 58' ' ' PHE . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.511 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 9' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.451 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.554 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 13.1 m170 -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 8' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.541 ' CG2' HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.52 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 26' ' ' SER . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.428 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 29' ' ' SER . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.506 ' N ' HG13 ' A' ' 28' ' ' VAL . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.451 ' HB2' HG23 ' A' ' 9' ' ' VAL . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.611 ' CE1' ' HG2' ' A' ' 5' ' ' LYS . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' CD1' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.631 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' CG2' HG12 ' A' ' 118' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.313 0.578 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 79' ' ' VAL . 2.1 tt0 -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.429 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.529 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' CD2' ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 105' ' ' VAL . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' PRO . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' GLY . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.58 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.58 ' NE2' ' CB ' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.244 0.545 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.509 ' CD1' ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.631 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.601 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.541 HD13 ' CG2' ' A' ' 3' ' ' VAL . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.469 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.46 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 146' ' ' GLU . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CB ' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 34' ' ' TYR . 5.5 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD1' HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 140' ' ' ARG . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 29' ' ' SER . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.508 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.617 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' CB ' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 136' ' ' VAL . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 ' CG2' ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' CB ' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' HA ' ' OD1' ' A' ' 120' ' ' ASP . 28.4 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.271 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.425 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HG2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.579 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.52 ' C ' ' O ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.5 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.449 ' O ' HG21 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' CG2' HG21 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 111' ' ' ALA . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.417 ' N ' HG23 ' A' ' 110' ' ' THR . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 118' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.506 ' N ' HG23 ' A' ' 117' ' ' VAL . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 108' ' ' GLU . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.439 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.9 t30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 129' ' ' ASN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' HG3' ' CB ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' CG2' HD12 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG3' ' CD2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 6' ' ' ASP . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.484 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD12 ' A' ' 7' ' ' LEU . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 139' ' ' ILE . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' GLU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.521 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 33' ' ' ASP . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.631 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' N ' ' OE1' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.631 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 37' ' ' GLY . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 138' ' ' ALA . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 62' ' ' VAL . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.536 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 61' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.524 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 12.6 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 84' ' ' PHE . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CZ ' ' CD2' ' A' ' 84' ' ' PHE . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG21 ' OE1' ' A' ' 102' ' ' GLN . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 94' ' ' MET . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.498 HG21 ' N ' ' A' ' 111' ' ' ALA . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.498 ' N ' HG21 ' A' ' 110' ' ' THR . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.443 ' HA ' HG11 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.578 ' NE2' ' CB ' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB1' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.492 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 4.9 t30 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.16 0.505 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 ' CG2' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.585 ' CE2' ' CG1' ' A' ' 134' ' ' VAL . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HA ' HG13 ' A' ' 54' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.539 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.541 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.465 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.533 ' CD1' HD22 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.475 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.5 ' CG1' ' CD2' ' A' ' 36' ' ' HIS . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' OD1' ' CE1' ' A' ' 38' ' ' HIS . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 140' ' ' ARG . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' HD21 ' A' ' 49' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.503 ' CB ' HG11 ' A' ' 134' ' ' VAL . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' VAL . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.546 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB3' HG12 ' A' ' 21' ' ' VAL . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.466 ' HB3' HD12 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.655 ' HG ' ' CG ' ' A' ' 38' ' ' HIS . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.5 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 ' CD2' HG12 ' A' ' 134' ' ' VAL . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 11' ' ' LEU . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 139' ' ' ILE . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.559 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.494 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.169 0.509 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 77' ' ' GLN . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.526 ' O ' ' CG2' ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 104' ' ' PRO . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.507 HG21 ' N ' ' A' ' 111' ' ' ALA . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 110' ' ' THR . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.467 ' CG1' HG11 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 118' ' ' VAL . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 108' ' ' GLU . 18.5 t70 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' A' ' 102' ' ' GLN . 1.8 m-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.523 ' CB ' ' CA ' ' A' ' 63' ' ' GLY . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 53' ' ' GLU . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 139' ' ' ILE . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HG3' HD11 ' A' ' 7' ' ' LEU . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.459 ' CA ' ' OE1' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.466 ' O ' HD21 ' A' ' 35' ' ' LEU . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.9 p-80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.539 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD3' ' NE2' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.529 ' HA ' ' CD1' ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' ARG . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.59 ' CD1' ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.496 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 29' ' ' SER . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.42 ' N ' HG11 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.462 ' O ' HG22 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 40' ' ' SER . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 67' ' ' ALA . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.512 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 61' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' CZ ' ' A' ' 132' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.271 0.557 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 119' ' ' VAL . 48.4 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' SD ' ' A' ' 94' ' ' MET . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.492 ' O ' ' CG1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.448 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HB3' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 ' O ' ' CA ' ' A' ' 93' ' ' GLY . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.52 ' CG2' HG21 ' A' ' 118' ' ' VAL . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.53 ' CB ' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 112' ' ' VAL . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.464 ' OD2' ' CB ' ' A' ' 108' ' ' GLU . 3.1 p30 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.494 ' CZ ' ' OH ' ' A' ' 68' ' ' TYR . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.59 ' CG1' ' CD1' ' A' ' 11' ' ' LEU . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.529 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 33' ' ' ASP . 16.0 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.516 ' CG2' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.527 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' OD1' ' HG ' ' A' ' 147' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' A' ' 134' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CB ' ' CG2' ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG1' ' CG2' ' A' ' 23' ' ' VAL . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 15' ' ' VAL . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 16' ' ' ARG . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD21 ' CG ' ' A' ' 38' ' ' HIS . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 35' ' ' LEU . 25.0 m-70 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 68' ' ' TYR . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.686 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CE2' ' CE1' ' A' ' 52' ' ' HIS . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.53 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.525 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.565 ' CE1' HD12 ' A' ' 42' ' ' ILE . 20.8 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 34.2 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.418 ' CG ' ' CG2' ' A' ' 119' ' ' VAL . 19.2 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.507 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 90' ' ' LEU . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.468 ' O ' HD13 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.507 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.418 ' CG2' ' CG ' ' A' ' 77' ' ' GLN . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.166 0.508 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.467 HD13 ' HA3' ' A' ' 63' ' ' GLY . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CZ ' HD23 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.3 t-20 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 57' ' ' LYS . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' VAL . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 145' ' ' GLU . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 38' ' ' HIS . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 p-80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.528 ' CG2' ' OE2' ' A' ' 146' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 49' ' ' LEU . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 132' ' ' PHE . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.468 ' OH ' HD11 ' A' ' 49' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.499 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 134' ' ' VAL . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 60' ' ' VAL . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 42' ' ' ILE . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.227 0.537 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' CG2' ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HG ' ' CE ' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.523 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.686 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 77' ' ' GLN . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.542 ' CD2' HG21 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 13' ' ' TYR . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 3' ' ' VAL . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.565 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.555 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 14.1 m170 -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 7.5 p . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 152' ' ' VAL . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 136' ' ' VAL . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CB ' HG11 ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 1.3 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.517 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG23 ' A' ' 17' ' ' THR . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 5' ' ' LYS . 66.2 t60 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.578 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 17.4 m-70 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CB ' HG21 ' A' ' 42' ' ' ILE . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.589 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.579 HG13 ' CE2' ' A' ' 132' ' ' PHE . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.578 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 ' CG1' ' HB2' ' A' ' 120' ' ' ASP . 4.2 m . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.262 0.554 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' O ' HG21 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 88' ' ' ASP . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 109' ' ' ILE . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' CG1' HG13 ' A' ' 112' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 109' ' ' ILE . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.407 HG21 ' CG ' ' A' ' 102' ' ' GLN . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.461 ' NE2' HG21 ' A' ' 23' ' ' VAL . 4.3 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.531 ' CD1' HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB2' ' CG1' ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.498 HG13 ' CG1' ' A' ' 92' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.579 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 110' ' ' THR . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 43.3 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.482 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 1.8 p-10 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 130' ' ' LEU . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.579 ' CE2' HG13 ' A' ' 62' ' ' VAL . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 7.7 t-20 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' HD22 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 10' ' ' SER . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 139' ' ' ILE . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.51 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 14.9 m170 -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.586 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' CD2' ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.533 ' CA ' HD23 ' A' ' 147' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 140' ' ' ARG . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 134' ' ' VAL . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.43 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' HG22 ' A' ' 15' ' ' VAL . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.641 ' CE2' ' CD2' ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.537 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.563 HD13 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 34' ' ' TYR . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 68' ' ' TYR . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 13.0 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 118' ' ' VAL . 10.5 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.302 0.572 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' O ' ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.463 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.466 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.456 HG21 HG22 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 117' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.484 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 111' ' ' ALA . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 2.0 p30 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.647 ' CE2' ' CG1' ' A' ' 62' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.506 ' C ' ' CG1' ' A' ' 139' ' ' ILE . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 3' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.477 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.49 ' CB ' ' HB2' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.0 m170 -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 152' ' ' VAL . 4.8 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CA ' HD13 ' A' ' 139' ' ' ILE . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.526 ' N ' ' NE2' ' A' ' 38' ' ' HIS . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 137' ' ' VAL . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.416 ' HB3' HG23 ' A' ' 21' ' ' VAL . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.63 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HG ' ' CE1' ' A' ' 38' ' ' HIS . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.758 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.577 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.63 ' CD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 68' ' ' TYR . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.519 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 42' ' ' ILE . 24.1 m-85 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 120' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.312 0.577 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.546 ' O ' ' CG2' ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 92' ' ' VAL . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.44 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.487 ' O ' HG21 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.218 0.532 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 58' ' ' PHE . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.468 ' C ' ' CG1' ' A' ' 139' ' ' ILE . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.54 HD13 ' CA ' ' A' ' 3' ' ' VAL . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.485 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.471 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.518 ' HA ' ' CG ' ' A' ' 146' ' ' GLU . 57.6 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' ' CD2' ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.498 HD11 ' CA ' ' A' ' 141' ' ' GLU . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' ARG . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.474 HG13 ' HB ' ' A' ' 23' ' ' VAL . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.529 HG23 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' HG13 ' A' ' 15' ' ' VAL . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.423 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.599 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.454 ' ND1' HG13 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' GLU . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 60' ' ' VAL . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 58' ' ' PHE . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.57 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 120' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.578 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.548 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 83' ' ' VAL . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.527 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.586 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.518 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 115' ' ' ASP . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.492 ' CG2' HG22 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.525 ' CG1' ' HG2' ' A' ' 78' ' ' ARG . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.527 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 15.8 p-10 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.242 0.544 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.529 ' CD2' HG23 ' A' ' 17' ' ' THR . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' GLY . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.478 ' HB2' ' NH1' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 3' ' ' VAL . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' CA ' HD11 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.473 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 1.8 m-70 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.511 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 8' ' ' VAL . 4.9 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.615 ' CA ' HD11 ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 38' ' ' HIS . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 139' ' ' ILE . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.637 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 23' ' ' VAL . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 17' ' ' THR . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CD1' HD11 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.561 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 47.9 t60 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.63 ' CE1' ' CD2' ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' OG1' ' A' ' 47' ' ' THR . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.449 HD23 HD11 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HA ' HG11 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' HG11 ' A' ' 136' ' ' VAL . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.466 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.466 ' CG2' ' C ' ' A' ' 61' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 68' ' ' TYR . 42.2 p90 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.357 0.598 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 78' ' ' ARG . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' HG11 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' CD2' HD12 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' HG23 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.514 ' O ' ' CG1' ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.546 ' O ' ' CG2' ' A' ' 119' ' ' VAL . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 111' ' ' ALA . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 110' ' ' THR . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 118' ' ' VAL . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 107' ' ' VAL . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.637 ' CE1' ' CG1' ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 58' ' ' PHE . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.531 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.615 HD11 ' CA ' ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' VAL . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 142' ' ' ALA . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CD2' ' O ' ' A' ' 151' ' ' HIS . 0.5 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 152' ' ' VAL . 2.3 p . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 54' ' ' VAL . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.551 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 26' ' ' SER . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 21' ' ' VAL . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' O ' ' OG1' ' A' ' 17' ' ' THR . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.622 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.552 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.633 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 9.6 t60 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.684 ' CG ' ' O ' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.633 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CE1' ' CB ' ' A' ' 136' ' ' VAL . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.458 HG21 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' C ' ' HB1' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' N ' ' HB1' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 42' ' ' ILE . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 120' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.221 0.534 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.526 ' CG1' ' CG1' ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' HG12 ' A' ' 79' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.533 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.492 ' N ' HG22 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 ' CG2' HG23 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 15.6 t0 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.639 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.584 HD13 ' CE1' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' CB ' HD13 ' A' ' 147' ' ' LEU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.481 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.528 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.55 HD13 ' CB ' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 15.7 m170 -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.416 ' HA ' HD11 ' A' ' 35' ' ' LEU . 1.5 p-80 -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 8' ' ' VAL . 25.3 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.601 ' HE2' ' CG ' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' CG ' ' A' ' 36' ' ' HIS . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.528 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 21' ' ' VAL . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.477 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.461 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' HG12 ' A' ' 15' ' ' VAL . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 25' ' ' GLU . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' CG ' ' O ' ' A' ' 38' ' ' HIS . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.601 ' CG ' ' HE2' ' A' ' 5' ' ' LYS . 2.1 t-160 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 42' ' ' ILE . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 138' ' ' ALA . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 61' ' ' ALA . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' C ' ' CG1' ' A' ' 62' ' ' VAL . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.545 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.26 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.472 ' O ' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' C ' ' CG1' ' A' ' 107' ' ' VAL . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.578 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.518 ' OD1' ' CG2' ' A' ' 110' ' ' THR . 30.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.411 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.258 0.551 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HG ' ' C ' ' A' ' 129' ' ' ASN . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.595 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' CG2' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' CG2' ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.424 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.527 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 151' ' ' HIS . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 11.0 m-70 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.435 ' CG2' ' HB ' ' A' ' 8' ' ' VAL . 32.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 7' ' ' LEU . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CD2' ' HB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.522 ' CB ' HG13 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' N ' HD11 ' A' ' 22' ' ' LEU . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE2' ' HG ' ' A' ' 32' ' ' LEU . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.648 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CG ' HG12 ' A' ' 136' ' ' VAL . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.462 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG23 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.22 0.534 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.545 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 90' ' ' LEU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.448 HG21 ' CG2' ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.482 ' O ' HD12 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.448 ' CG2' HG21 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.477 ' CG2' ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 119' ' ' VAL . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.332 0.586 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.461 HD12 ' HA3' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 45' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.518 ' N ' HD11 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.566 HG12 ' CG ' ' A' ' 52' ' ' HIS . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.496 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.503 ' HA ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.453 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.495 ' HA ' ' HG3' ' A' ' 146' ' ' GLU . 4.5 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.523 ' HE1' ' CG1' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CG2' HG22 ' A' ' 139' ' ' ILE . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.529 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CB ' HD22 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' A' ' 140' ' ' ARG . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.558 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 139' ' ' ILE . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.504 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.509 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' HIS . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD13 ' A' ' 42' ' ' ILE . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.471 HD13 ' CE1' ' A' ' 132' ' ' PHE . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.319 0.58 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.451 ' HG2' HG23 ' A' ' 119' ' ' VAL . 18.2 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 83' ' ' VAL . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.523 ' CD2' ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 111' ' ' ALA . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.46 ' HE3' ' CB ' ' A' ' 90' ' ' LEU . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.53 ' CB ' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.561 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.53 HG21 ' CB ' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.559 ' CG2' ' CG1' ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.277 0.561 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.594 ' CG1' ' CD1' ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.54 HG22 ' CG2' ' A' ' 3' ' ' VAL . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.9 m170 -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 8' ' ' VAL . 2.9 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.552 ' CA ' HD12 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.456 ' N ' ' CD2' ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.538 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG23 ' CG2' ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 2.4 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.578 ' HB ' ' CD1' ' A' ' 132' ' ' PHE . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD2' ' NE2' ' A' ' 38' ' ' HIS . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' NE2' ' CD2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 34' ' ' TYR . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' SER . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.592 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.584 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 134' ' ' VAL . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.522 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.529 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 76' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.193 0.52 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.525 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' C ' HG11 ' A' ' 107' ' ' VAL . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 119' ' ' VAL . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.505 ' N ' HG21 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.529 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' CG2' ' HG3' ' A' ' 113' ' ' GLU . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.326 0.584 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.515 ' CD1' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 7.5 m120 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 58' ' ' PHE . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.552 HD12 ' CA ' ' A' ' 3' ' ' VAL . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 141' ' ' GLU . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.583 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 79.5 m-70 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 16.7 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.473 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.507 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.558 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.515 ' CB ' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.532 ' CG1' ' CD2' ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.544 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.503 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.417 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.574 HD21 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 38.1 t60 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.574 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.509 ' N ' ' OG ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.54 ' CG ' HG22 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.638 ' CE2' ' CG2' ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.638 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 2.6 m-30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.517 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.559 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.628 ' CG2' ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.628 ' CD2' ' CG2' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.441 ' O ' HG21 ' A' ' 109' ' ' ILE . 2.4 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 91' ' ' GLN . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 111' ' ' ALA . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.512 ' N ' HG21 ' A' ' 110' ' ' THR . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.409 ' C ' HG11 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.409 HG11 ' C ' ' A' ' 116' ' ' HIS . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.311 0.577 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 13' ' ' TYR . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.54 HG22 ' CG ' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.589 ' CG2' ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.52 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.54 ' OE2' ' CG1' ' A' ' 152' ' ' VAL . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.515 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 1.9 p-80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.54 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 74.7 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HE3' HG23 ' A' ' 139' ' ' ILE . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.61 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.478 ' HA ' HD22 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.507 HG23 ' CG2' ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG21 HG13 ' A' ' 136' ' ' VAL . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 132' ' ' PHE . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.465 HG23 ' CG ' ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CD2' HG11 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.461 ' O ' ' OE1' ' A' ' 46' ' ' GLU . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 42' ' ' ILE . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' CG1' ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 132' ' ' PHE . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.506 ' CD1' HD11 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.585 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 1.8 m-70 -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' HB1' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.519 ' HB2' ' N ' ' A' ' 127' ' ' GLY . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t-20 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 42' ' ' ILE . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.76 -39.75 5.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 64' ' ' ALA . . . -76.17 -51.86 6.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 43.2 mt-30 61.34 43.84 10.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -1.151 . . . . 0.0 110.203 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' OH ' ' OD2' ' A' ' 120' ' ' ASP . 12.6 t80 -43.65 143.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.303 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.01 87.79 5.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.17 -11.72 43.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.245 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -84.45 0.53 49.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.232 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 tp -110.71 -14.37 14.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' CG1' ' OD2' ' A' ' 120' ' ' ASP . 7.0 m -91.37 123.85 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 110.2 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH2' ' HB ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.499 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.452 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.46 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.403 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 110' ' ' THR . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.485 HG21 ' CG2' ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.525 HG11 ' N ' ' A' ' 118' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.525 ' N ' HG11 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.501 ' OD2' ' CG1' ' A' ' 76' ' ' VAL . 20.6 t0 -167.56 171.68 10.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' N ' ' OD1' ' A' ' 120' ' ' ASP . . . -91.78 -131.64 5.37 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -114.79 132.44 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -102.38 -2.06 29.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -47.21 -32.43 4.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -3.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 -166.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.519 ' N ' ' HB2' ' A' ' 64' ' ' ALA . . . 63.66 21.49 65.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.458 ' N ' ' CB ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.23 72.92 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 110.237 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 129' ' ' ASN . 17.1 p-10 -73.2 120.15 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 130' ' ' LEU . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.446 HG12 HD12 ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.61 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' VAL . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.524 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.48 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.507 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.3 p -121.99 125.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.3 m170 45.76 60.29 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 156' ' ' HIS . . . -172.37 -77.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 52.33 -89.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.213 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 154' ' ' GLY . 3.4 t-80 -74.86 -37.75 62.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 157' ' ' ASP . 4.6 t0 -60.54 -28.94 68.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.29 149.63 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -58.14 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.423 ' N ' ' OD2' ' A' ' 163' ' ' ASP . 2.8 p-10 -162.98 80.97 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.32 59.33 3.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 161' ' ' ASP . 14.7 m-20 -121.77 -18.28 7.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -79.51 164.91 23.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.99 175.13 11.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.03 -21.91 43.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.21 150.63 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -1.12 . . . . 0.0 110.177 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.29 -81.5 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.61 -30.82 9.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.72 -166.75 42.79 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.56 160.25 25.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.35 -11.71 4.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.89 -73.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -1.186 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.7 143.68 48.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 5.2 p-80 -153.6 150.3 28.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.151 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.9 87.33 0.13 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -103.27 -65.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 180' ' ' GLY . 8.7 tt0 -119.38 37.53 4.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 64.08 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.151 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 178' ' ' GLU . . . -143.87 -131.37 2.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.26 -142.9 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -53.86 172.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 0.0 110.188 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 184' ' ' CYS . . . -52.94 -20.72 8.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER 64.13 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 110.259 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.5 95.99 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.216 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.81 -86.89 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 54.69 -131.74 47.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -130.6 169.34 15.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 110.224 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 161.97 40.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -57.54 -179.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.149 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 104.51 -56.67 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.8 -90.21 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 194' ' ' GLY . 0.1 OUTLIER 61.46 29.98 18.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 110.266 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 193' ' ' CYS . . . 56.42 102.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 179.52 6.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -1.082 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.209 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 139' ' ' ILE . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 135' ' ' GLU . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG11 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HB3' HD12 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.543 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HA ' HG11 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.434 ' H ' ' CG ' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CE1' ' HB ' ' A' ' 134' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 48' ' ' ALA . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.455 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.472 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 128' ' ' GLN . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 2.6 m-30 65.91 -61.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 126' ' ' ALA . . . -55.88 -64.4 4.42 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.8 mt-30 65.83 -143.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -1.156 . . . . 0.0 110.404 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -53.83 120.63 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 52.2 p-10 -137.35 74.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.148 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 71' ' ' TYR . 77.4 mt-10 -65.77 -18.65 65.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -92.27 3.96 54.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -49.69 -65.32 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 0.0 110.229 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 ' C ' ' HG3' ' A' ' 77' ' ' GLN . 12.3 m -129.26 155.63 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 ' CB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.492 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.612 ' CG2' ' CZ ' ' A' ' 96' ' ' PHE . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.455 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.61 170.96 12.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.58 65.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -81.18 176.61 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -1.119 . . . . 0.0 110.211 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -97.94 157.62 16.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 124' ' ' MET . 6.4 tmm? -61.47 -19.15 61.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.41 -70.1 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.661 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -109.31 -167.3 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.417 ' HA2' ' CD2' ' A' ' 75' ' ' LEU . . . 79.08 21.49 67.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.468 ' O ' ' HA3' ' A' ' 63' ' ' GLY . 23.5 mm100 -92.41 71.0 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -1.141 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 9.7 m120 -72.56 135.7 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 58' ' ' PHE . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.511 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 9' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 144' ' ' GLU . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.451 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.554 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 13.1 m170 -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 8' ' ' VAL . 1.5 p -130.45 111.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.2 t60 49.3 23.11 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.191 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 158' ' ' HIS . . . -110.85 30.61 7.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.38 -61.27 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.201 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.95 5.84 24.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.73 -13.0 60.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 154' ' ' GLY . 2.7 p80 -155.7 157.3 36.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.03 38.62 1.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -124.47 118.19 26.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 162' ' ' HIS . 3.3 m-20 -139.35 -107.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.203 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 161' ' ' ASP . 0.6 OUTLIER 176.22 56.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.103 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.95 -175.14 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -99.16 35.9 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.34 143.59 50.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.78 133.67 8.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.81 44.64 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -1.156 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.4 m 44.91 63.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.82 -87.54 0.21 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 153.07 52.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.409 ' C ' ' CD2' ' A' ' 171' ' ' HIS . 1.2 p-80 -84.38 -173.53 4.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.182 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 61.17 18.05 53.94 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.26 106.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -1.199 . . . . 0.0 110.248 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.2 137.44 48.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -102.01 -161.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.227 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.29 -83.17 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 177' ' ' HIS . 7.4 p80 -150.69 82.36 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -1.128 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -147.19 -164.23 1.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -65.01 155.63 34.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.53 142.02 3.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.88 149.03 0.99 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 15.3 mp0 -117.69 116.24 26.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -1.104 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.9 169.32 19.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 48.74 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -1.185 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.0 p -143.74 -38.58 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -125.91 157.87 20.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.19 -11.02 2.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 43.01 31.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.01 -121.3 6.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 49.49 -161.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -1.149 . . . . 0.0 110.12 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 62.77 70.52 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.32 1.52 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.1 m -122.87 143.91 49.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -1.163 . . . . 0.0 110.186 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.64 -126.62 0.07 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 27.1 p -162.54 177.74 9.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.204 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.541 ' CG2' HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.52 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 26' ' ' SER . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.428 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 29' ' ' SER . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.506 ' N ' HG13 ' A' ' 28' ' ' VAL . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' CD2' ' NE2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.451 ' HB2' HG23 ' A' ' 9' ' ' VAL . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.611 ' CE1' ' HG2' ' A' ' 5' ' ' LYS . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' CD1' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.631 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLY . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.531 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -109.35 52.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 64' ' ' ALA . . . -138.6 57.18 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -149.39 106.41 3.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -1.155 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.593 ' N ' ' CB ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -43.16 143.4 0.81 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 110.102 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 67.0 m-20 -83.53 69.82 10.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.15 -9.29 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.763 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 32.3 p-10 -55.6 -28.86 57.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.523 HD12 ' CG1' ' A' ' 76' ' ' VAL . 0.6 OUTLIER 173.27 -49.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.634 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 75' ' ' LEU . 6.2 p -144.21 155.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.682 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.629 ' NE2' ' CD2' ' A' ' 123' ' ' HIS . 2.1 tt0 -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.529 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' CD2' ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.502 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 105' ' ' VAL . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' PRO . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 93' ' ' GLY . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.58 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.58 ' NE2' ' CB ' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 -83.48 99.3 10.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -166.72 -144.13 4.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 4.5 m120 -118.62 155.58 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -1.159 . . . . 0.0 110.318 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -100.93 146.87 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.423 ' SD ' ' HG ' ' A' ' 125' ' ' LEU . 3.0 tmm? -67.37 -39.99 85.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.338 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.423 ' HG ' ' SD ' ' A' ' 124' ' ' MET . 42.5 mt -117.43 84.79 2.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 110.277 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.593 ' CB ' ' N ' ' A' ' 71' ' ' TYR . . . -144.88 124.79 13.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 71' ' ' TYR . . . 86.73 13.63 66.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -121.71 79.52 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.111 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -42.2 138.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.509 ' CD1' ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.631 ' CE1' ' CG1' ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.601 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.541 HD13 ' CG2' ' A' ' 3' ' ' VAL . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.469 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.46 ' OG1' ' OE1' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' OE2' ' A' ' 146' ' ' GLU . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CB ' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.584 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.541 ' CD2' ' HB1' ' A' ' 155' ' ' ALA . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 34' ' ' TYR . 5.5 p -114.51 121.3 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 153' ' ' HIS . 48.1 t60 56.75 64.58 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 151' ' ' HIS . . . 111.19 -140.55 16.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.541 ' HB1' ' CD2' ' A' ' 151' ' ' HIS . . . -172.01 125.96 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.51 -11.82 56.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 12.5 t70 -64.83 -42.42 94.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 2.1 m80 57.23 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -152.57 -41.42 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.183 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 159' ' ' HIS . 18.3 m-70 48.88 -174.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 163' ' ' ASP . 38.8 t70 -114.94 37.69 3.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.441 ' CB ' ' O ' ' A' ' 161' ' ' ASP . 0.5 OUTLIER 65.11 -70.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.189 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 161' ' ' ASP . 4.3 m-20 -100.41 65.57 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.32 119.93 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.93 . . . . 0.0 110.189 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.64 79.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.42 172.95 16.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 36.1 m -80.14 -58.85 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -1.144 . . . . 0.0 110.234 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.1 t -163.58 -47.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.78 167.24 32.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.94 -116.62 5.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 99.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.258 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.31 169.57 34.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.29 119.78 24.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -1.18 . . . . 0.0 110.289 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.53 167.58 30.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 178.58 5.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.137 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.82 40.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 179' ' ' HIS . 27.5 t-80 -112.12 -46.4 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -1.176 . . . . 0.0 110.186 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 179' ' ' HIS . 2.6 mt-10 56.21 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 177' ' ' HIS . 4.9 t60 43.56 68.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 110.165 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.41 138.32 6.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 182' ' ' GLU . . . -59.03 -166.29 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER -176.35 -141.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -1.168 . . . . 0.0 110.178 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLU . . . -44.18 -26.58 0.94 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -47.86 170.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 40.4 t -83.96 159.45 21.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.314 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.94 -135.01 5.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.34 -79.06 1.86 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.76 120.92 12.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -1.142 . . . . 0.0 110.149 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 190' ' ' ASN . . . -136.11 -110.23 1.03 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 189' ' ' GLY . 1.1 t-20 62.82 -161.28 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -46.97 103.84 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 162.98 168.85 25.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.2 t -55.76 144.74 26.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -1.177 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 160.07 -134.27 3.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 16.5 p -162.03 82.71 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 110.235 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.576 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.529 ' CD1' HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 140' ' ' ARG . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' CB ' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 29' ' ' SER . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.508 ' N ' HG22 ' A' ' 28' ' ' VAL . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.617 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.617 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.482 HG13 ' CB ' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' CG2' ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB3' HG23 ' A' ' 136' ' ' VAL . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 ' CG2' ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' CB ' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' CB ' ' HG3' ' A' ' 70' ' ' GLN . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.79 -11.9 57.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' GLN . . . 95.39 90.79 1.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.518 ' HG3' ' CB ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -46.69 170.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 110.153 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -72.71 129.31 37.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 110.152 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.21 104.02 8.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.13 -17.04 64.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -82.45 -10.26 59.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 122' ' ' ASN . 1.4 tp -88.58 -46.28 9.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' HA ' ' OD1' ' A' ' 120' ' ' ASP . 28.4 m -56.29 119.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.26 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.425 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HG2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' CG1' ' CG2' ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.579 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.52 ' C ' ' O ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.5 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.449 ' O ' HG21 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' CG2' HG21 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' N ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 111' ' ' ALA . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.417 ' N ' HG23 ' A' ' 110' ' ' THR . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 118' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.506 ' N ' HG23 ' A' ' 117' ' ' VAL . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 108' ' ' GLU . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 -133.48 139.0 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.45 66.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.416 ' HB2' HD21 ' A' ' 75' ' ' LEU . 7.2 t30 -81.35 146.55 30.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.164 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.73 140.54 29.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -18.86 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.72 -84.04 0.4 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 55.37 171.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.13 21.46 77.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 4.2 tt0 -145.64 98.3 3.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -1.167 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.9 t30 -54.89 159.45 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 128' ' ' GLN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' HG3' ' CB ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' CG2' HD12 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG3' ' CD2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 6' ' ' ASP . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.484 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m -122.93 127.53 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.4 m170 46.29 71.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.88 -171.38 13.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.81 137.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.198 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -66.79 -23.45 66.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.279 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -40.86 29.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.07 19.21 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 111.23 22.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -115.85 -51.18 2.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 162' ' ' HIS . 16.3 t0 45.93 49.97 11.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 52.52 161.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 164' ' ' HIS . 27.3 t70 -116.3 -70.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 163' ' ' ASP . 10.5 m170 -155.44 94.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.18 -75.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 167' ' ' CYS . . . -136.34 -177.82 15.3 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 166' ' ' GLY . 1.2 m 59.46 22.72 11.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -1.107 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.0 m -65.39 -158.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.95 -105.64 1.27 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 165.85 144.2 4.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.61 19.59 8.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.85 83.01 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -124.02 14.63 9.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -1.192 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.41 123.64 47.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -112.2 -30.82 7.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.91 136.49 0.19 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -174.41 168.27 3.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.167 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 179' ' ' HIS . 33.9 tp10 -174.52 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.413 ' N ' ' HG3' ' A' ' 178' ' ' GLU . 6.1 p-80 -74.65 -161.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.18 -49.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -128.01 -157.64 9.44 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -149.25 29.92 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 110.242 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.74 47.68 0.05 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.88 -55.83 2.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 62.21 -149.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.188 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.38 2.95 60.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 188' ' ' LYS . . . -92.54 -136.41 7.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER 63.45 -178.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.155 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.19 115.86 0.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -45.41 100.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.68 -35.4 1.88 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.89 38.43 0.5 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.71 74.41 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 195' ' ' CYS . . . 170.65 55.36 0.04 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 194' ' ' GLY . 60.4 m 57.31 -160.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -1.16 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.238 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD12 ' A' ' 7' ' ' LEU . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 139' ' ' ILE . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 141' ' ' GLU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.521 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' HG11 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 33' ' ' ASP . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.631 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' N ' ' OE1' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.631 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 37' ' ' GLY . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 138' ' ' ALA . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 62' ' ' VAL . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.536 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 61' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.524 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' GLY . 38.8 m-85 -135.56 10.93 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' TYR . . . 44.27 89.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.512 ' HB3' ' CB ' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -64.63 126.52 28.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -84.6 130.92 34.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 110.357 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 4.5 t0 -126.24 69.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . 2.0 mt-10 -69.02 -7.1 32.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.461 ' OD1' HD23 ' A' ' 125' ' ' LEU . 1.3 m120 -61.75 -25.84 67.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.49 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' C ' ' CD1' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -169.36 31.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 110.595 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 76' ' ' VAL . 12.6 p -95.14 95.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.428 ' NH1' ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.521 HD13 ' CE2' ' A' ' 84' ' ' PHE . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CZ ' ' CD2' ' A' ' 84' ' ' PHE . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG21 ' OE1' ' A' ' 102' ' ' GLN . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 94' ' ' MET . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 HG21 ' N ' ' A' ' 111' ' ' ALA . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.498 ' N ' HG21 ' A' ' 110' ' ' THR . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.443 ' HA ' HG11 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.578 ' NE2' ' CB ' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB1' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.492 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 -159.52 113.68 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.462 ' CA ' ' HA ' ' A' ' 107' ' ' VAL . . . -62.14 119.36 17.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -59.03 122.8 14.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -1.116 . . . . 0.0 110.198 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -102.07 -170.15 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -77.38 -45.04 27.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.461 HD23 ' OD1' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -59.69 -30.54 68.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -150.41 145.31 26.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.72 21.51 6.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -123.18 84.84 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -1.166 . . . . 0.0 110.236 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 128' ' ' GLN . 4.9 t30 -42.45 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 ' CG2' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.585 ' CE2' ' CG1' ' A' ' 134' ' ' VAL . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.441 ' HA ' HG13 ' A' ' 54' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.539 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.541 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.465 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.533 ' CD1' HD22 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p -65.93 142.88 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.42 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 63.7 -158.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.853 . . . . 0.0 110.235 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.7 -173.85 17.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.49 ' O ' ' ND1' ' A' ' 158' ' ' HIS . . . -78.33 4.19 13.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -1.141 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -56.31 -26.99 54.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -76.97 -58.28 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 60.91 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -110.38 -21.59 12.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.215 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -178.84 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -74.06 -179.6 3.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.64 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -68.21 125.21 25.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.281 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.92 163.89 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 110.17 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.06 107.18 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.22 109.84 2.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.05 -47.59 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -1.177 . . . . 0.0 110.215 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.2 p -125.14 20.37 8.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.14 -110.08 3.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.27 67.46 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -45.16 -28.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -168.42 -157.24 11.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -124.25 134.25 53.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -1.18 . . . . 0.0 110.259 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.49 60.69 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.93 . . . . 0.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 177' ' ' HIS . 0.3 OUTLIER -78.92 5.16 12.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.03 -19.29 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.506 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 4.9 t60 -108.73 125.01 51.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -1.154 . . . . 0.0 110.189 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.34 147.94 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -0.945 . . . . 0.0 110.279 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -71.43 96.47 1.49 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.57 -95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.75 177.23 30.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.85 126.82 15.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -1.185 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.65 43.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.497 ' O ' ' C ' ' A' ' 185' ' ' CYS . 95.1 m -90.09 77.2 6.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -1.181 . . . . 0.0 110.245 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 184' ' ' CYS . 14.5 p 33.8 45.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.584 -0.698 . . . . 0.0 110.518 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.34 52.14 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 188' ' ' LYS . . . -102.6 133.69 11.5 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 187' ' ' GLY . 37.3 mtpt 43.51 -153.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.82 -174.2 25.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -162.97 148.94 12.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.133 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.99 127.6 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 193' ' ' CYS . . . -110.18 15.52 30.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 192' ' ' GLY . 0.1 OUTLIER 173.05 131.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -1.15 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 159.66 -35.34 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 11.3 t -138.03 114.31 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 110.179 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.412 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 7.7 p-80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.21 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HG2' ' CD1' ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.5 ' CG1' ' CD2' ' A' ' 36' ' ' HIS . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.508 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' OD1' ' CE1' ' A' ' 38' ' ' HIS . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 140' ' ' ARG . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.521 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' HD21 ' A' ' 49' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.503 ' CB ' HG11 ' A' ' 134' ' ' VAL . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 23' ' ' VAL . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.546 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB3' HG12 ' A' ' 21' ' ' VAL . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.466 ' HB3' HD12 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.484 ' HB3' ' CB ' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HG2' ' CB ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.6 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.655 ' HG ' ' CG ' ' A' ' 38' ' ' HIS . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.5 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.486 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 ' CD2' HG12 ' A' ' 134' ' ' VAL . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 48' ' ' ALA . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 11' ' ' LEU . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG21 HD13 ' A' ' 139' ' ' ILE . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.559 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 128' ' ' GLN . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.494 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -80.36 -18.15 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.07 114.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' O ' ' CA ' ' A' ' 127' ' ' GLY . 1.3 pp0? -128.96 151.65 49.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.461 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HA ' ' HB1' ' A' ' 126' ' ' ALA . 9.2 t80 -60.22 123.63 17.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.413 ' HB2' ' HA2' ' A' ' 127' ' ' GLY . 48.8 t0 -137.11 118.71 14.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.433 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 5.5 mm-40 -68.68 -33.31 73.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -58.37 -15.63 11.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.47 -16.72 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.0 136.46 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.308 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 77' ' ' GLN . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.526 ' O ' ' CG2' ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 104' ' ' PRO . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.507 HG21 ' N ' ' A' ' 111' ' ' ALA . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 110' ' ' THR . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.467 ' CG1' HG11 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 118' ' ' VAL . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CD2' ' A' ' 123' ' ' HIS . 18.5 t70 -108.73 165.93 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -99.17 177.98 30.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -63.63 99.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -1.157 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.56 ' CD2' ' OD2' ' A' ' 120' ' ' ASP . 42.9 m170 -44.04 -32.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 ttp -57.64 -23.98 54.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.228 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 mp -124.63 39.54 3.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 71' ' ' TYR . . . -69.81 166.42 19.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.247 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ASN . . . 91.48 21.77 33.63 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.562 ' O ' ' CB ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -62.95 70.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -1.163 . . . . 0.0 110.09 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 128' ' ' GLN . 1.8 m-20 164.63 71.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.397 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.523 ' CB ' ' CA ' ' A' ' 63' ' ' GLY . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 53' ' ' GLU . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 139' ' ' ILE . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HG3' HD11 ' A' ' 7' ' ' LEU . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.48 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.459 ' CA ' ' OE1' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.466 ' O ' HD21 ' A' ' 35' ' ' LEU . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.9 p-80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.539 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 1.6 p -121.54 111.47 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 154' ' ' GLY . 69.2 t60 -169.47 -88.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.533 ' N ' ' CD2' ' A' ' 153' ' ' HIS . . . -55.0 -103.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 48.17 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 110.287 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -61.21 -13.16 16.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.05 -42.52 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.883 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.81 -161.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 110.236 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.25 74.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -62.08 104.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 -168.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 162' ' ' HIS . 7.2 p80 -166.76 137.16 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.228 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' OD2' ' SG ' ' A' ' 167' ' ' CYS . 1.8 m-20 -113.29 79.62 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 3.8 t60 -51.84 96.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 164' ' ' HIS . 78.4 m-20 54.93 36.55 27.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 116.94 -158.49 14.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.401 ' SG ' ' OD2' ' A' ' 163' ' ' ASP . 0.1 OUTLIER -129.48 -50.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -1.14 . . . . 0.0 110.254 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 41.2 t -163.99 160.26 21.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 120.8 67.36 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.4 -69.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.91 176.64 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 110.208 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.34 -114.05 3.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 50.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 64.9 m-20 -138.22 174.95 10.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.263 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 19.8 m80 -159.59 -178.9 7.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.05 132.37 12.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 179' ' ' HIS . 1.3 t60 -111.86 65.65 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -1.155 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 177' ' ' HIS . 11.6 tt0 54.42 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.164 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -130.79 -170.77 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.188 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.21 179.48 38.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 140.12 -88.73 0.19 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -99.46 -3.22 34.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . 142.88 -168.29 26.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.35 76.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.127 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 183' ' ' GLY . 63.8 m -79.97 -86.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.81 -109.71 3.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -169.1 106.56 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 106.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -121.72 117.25 3.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.61 8.53 10.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.244 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -60.56 -106.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.509 ' O ' ' C ' ' A' ' 193' ' ' CYS . . . -59.95 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.509 ' C ' ' O ' ' A' ' 192' ' ' GLY . 14.9 p 33.48 -150.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.994 . . . . 0.0 110.578 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 126.74 -54.97 0.75 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' A' ' 196' ' ' HIS . 26.7 t -93.35 -87.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.458 ' CE1' ' SG ' ' A' ' 195' ' ' CYS . 5.6 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.14 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HD3' ' NE2' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' HA ' ' CD1' ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' ARG . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 ' CD1' ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.504 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 15' ' ' VAL . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.496 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 29' ' ' SER . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.42 ' N ' HG11 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' O ' HG22 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 40' ' ' SER . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 67' ' ' ALA . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.512 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 61' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' CZ ' ' A' ' 132' ' ' PHE . 0.8 OUTLIER -98.32 4.62 48.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.51 -65.25 0.83 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 50.84 86.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.152 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 73' ' ' GLU . 1.9 t80 -74.48 126.88 31.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -123.51 80.7 1.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 71' ' ' TYR . 1.5 mt-10 -69.26 -7.09 33.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.2 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' C ' ' HG ' ' A' ' 75' ' ' LEU . 54.4 t-20 -64.54 -46.61 82.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 0.0 110.342 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.535 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 1.2 pp 177.98 52.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.413 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG11 ' CD2' ' A' ' 123' ' ' HIS . 70.0 t -139.2 110.33 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' A' ' 119' ' ' VAL . 48.4 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 79' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD11 ' SD ' ' A' ' 94' ' ' MET . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.492 ' O ' ' CG1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.448 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HB3' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 ' O ' ' CA ' ' A' ' 93' ' ' GLY . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.52 ' CG2' HG21 ' A' ' 118' ' ' VAL . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.53 ' CB ' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 112' ' ' VAL . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.464 ' OD2' ' CB ' ' A' ' 108' ' ' GLU . 3.1 p30 -85.14 119.82 25.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 177.28 -97.77 0.11 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 122' ' ' ASN . 9.1 p30 -118.68 120.77 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.125 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.528 ' CD2' HG11 ' A' ' 76' ' ' VAL . 1.7 t-80 -44.99 147.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.3 tpt -77.22 -38.07 52.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.6 tt -125.67 78.11 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.185 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . . . -164.33 166.4 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' CA ' ' CD2' ' A' ' 71' ' ' TYR . . . 103.47 9.15 39.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 129' ' ' ASN . 1.3 mt-30 -146.38 88.99 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.8 p-10 -42.08 152.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.494 ' CZ ' ' OH ' ' A' ' 68' ' ' TYR . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.59 ' CG1' ' CD1' ' A' ' 11' ' ' LEU . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.477 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.529 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 154' ' ' GLY . 16.0 m -128.47 142.39 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 1.6 m-70 58.55 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.23 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -109.03 149.79 17.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.05 13.91 10.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.279 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -15.44 63.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -71.09 -60.61 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 t60 62.88 164.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.165 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.515 ' C ' ' CD2' ' A' ' 159' ' ' HIS . 0.7 OUTLIER -171.99 -161.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -139.25 164.83 28.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.64 145.25 48.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER 178.65 -34.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 5.2 m-20 64.15 33.01 12.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.44 75.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.73 176.88 8.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -152.8 57.42 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.63 71.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.3 m -138.85 -44.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 110.218 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.96 66.17 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.75 8.64 59.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -1.159 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.82 66.6 1.91 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.41 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.52 170.67 15.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -50.83 177.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -122.28 141.58 14.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 33.8 p80 -122.86 -162.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -1.161 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER 63.58 57.9 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.237 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 46.38 -172.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.52 -85.98 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 173.24 41.78 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.44 -163.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.24 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . 152.61 -19.63 0.79 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 183' ' ' GLY . 31.8 p -47.25 174.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 68.6 m -93.14 -15.06 26.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.67 68.79 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.42 146.93 14.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -63.77 -61.89 2.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -1.191 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.9 70.36 0.03 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -121.85 140.83 51.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -1.19 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 55.42 -104.17 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.26 -131.39 10.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 194' ' ' GLY . 19.9 p -171.28 -144.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 193' ' ' CYS . . . -132.21 -80.55 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.08 102.71 5.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -1.117 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.132 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.516 ' CG2' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' OD1' ' HG ' ' A' ' 147' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB3' ' CG1' ' A' ' 134' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CB ' ' CG2' ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' CG1' ' CG2' ' A' ' 23' ' ' VAL . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 15' ' ' VAL . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 16' ' ' ARG . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.477 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD21 ' CG ' ' A' ' 38' ' ' HIS . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.553 ' CG ' HD21 ' A' ' 35' ' ' LEU . 25.0 m-70 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.565 HD12 ' CE1' ' A' ' 68' ' ' TYR . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.686 ' CE1' ' CE2' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CE2' ' CE1' ' A' ' 52' ' ' HIS . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.53 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' CB ' ' HG2' ' A' ' 70' ' ' GLN . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.525 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.595 ' HA ' ' CG ' ' A' ' 123' ' ' HIS . 20.8 m-85 -116.48 -7.08 11.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 70' ' ' GLN . . . 55.76 17.96 16.09 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HG2' ' CB ' ' A' ' 64' ' ' ALA . 24.8 mt-30 60.51 81.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.234 -1.157 . . . . 0.0 110.466 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.617 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 2.9 p90 -84.5 121.64 27.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.33 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 4.3 t0 -83.48 126.93 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -51.92 -20.14 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.0 4.01 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.978 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 2.0 tt -75.71 -44.41 42.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 34.2 m -67.93 95.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' LEU . 19.2 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.507 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 90' ' ' LEU . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.468 ' O ' HD13 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.507 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.418 ' CG2' ' CG ' ' A' ' 77' ' ' GLN . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 -153.25 171.68 18.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 145.22 75.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 25.6 p-10 -108.66 107.36 17.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 0.0 110.202 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 68' ' ' TYR . 44.4 m-70 -68.9 -167.22 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.56 ' HB2' ' CZ ' ' A' ' 68' ' ' TYR . 1.6 mmt -77.58 -15.23 59.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.516 HD13 ' CB ' ' A' ' 128' ' ' GLN . 0.1 OUTLIER 178.86 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.012 -1.055 . . . . 0.0 110.313 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.602 ' HB2' ' CD2' ' A' ' 71' ' ' TYR . . . -94.01 150.46 20.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.298 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.54 52.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.518 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -126.6 73.33 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.9 t-20 -41.34 142.91 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 128' ' ' GLN . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CZ ' HD23 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.3 t-20 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 57' ' ' LYS . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' VAL . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.539 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' OE2' ' NE2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 35' ' ' LEU . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.486 ' NE2' ' OE2' ' A' ' 145' ' ' GLU . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 38' ' ' HIS . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 p-80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.528 ' CG2' ' OE2' ' A' ' 146' ' ' GLU . 2.7 p -79.8 119.01 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t60 48.82 -151.83 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 48.92 66.69 2.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.66 144.71 36.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.159 . . . . 0.0 110.233 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.1 -56.29 4.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.5 -48.73 7.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 55.21 50.32 15.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' CE1' ' OD1' ' A' ' 161' ' ' ASP . 3.7 t-160 -115.55 128.67 56.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.209 -0.932 . . . . 0.0 110.238 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -94.4 52.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 159' ' ' HIS . 13.5 m-20 -69.95 157.13 38.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -173.54 56.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.196 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -165.49 -48.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.155 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -73.29 70.61 1.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.06 105.01 3.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 110.24 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.0 125.89 1.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.94 70.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.238 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 170' ' ' GLY . 0.8 OUTLIER -62.21 -13.51 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.257 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.7 95.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 168' ' ' CYS . . . -152.72 -126.72 1.2 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -76.92 85.14 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -1.156 . . . . 0.0 110.216 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.67 3.74 32.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.25 147.58 14.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 p-10 -63.45 -170.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 9.9 p-80 -172.07 103.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.225 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.94 136.53 6.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -97.44 114.36 26.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.46 60.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -83.65 1.02 44.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.06 -98.13 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.73 -160.82 34.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -104.5 138.88 40.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.185 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -100.45 103.6 2.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.8 t -104.62 23.49 13.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.234 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.55 74.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.75 146.56 4.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 52.43 -107.37 0.5 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -46.17 151.32 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -1.184 . . . . 0.0 110.175 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.4 151.37 5.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.75 -154.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -1.14 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 124.85 -47.67 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 161.68 -92.53 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.0 m 44.98 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 110.169 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.98 -69.88 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.97 -69.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.189 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 49' ' ' LEU . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 132' ' ' PHE . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.468 ' OH ' HD11 ' A' ' 49' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.499 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 134' ' ' VAL . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 60' ' ' VAL . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 42' ' ' ILE . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' CB ' ' HA2' ' A' ' 127' ' ' GLY . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 -94.55 -37.95 11.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 64' ' ' ALA . . . 54.77 74.24 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.574 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 53.8 mt-30 -87.59 -146.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 110.316 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 27.2 p90 -81.99 125.87 31.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.06 -1.025 . . . . 0.0 110.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 145.42 29.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.911 -1.118 . . . . 0.0 110.04 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.83 -6.84 9.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.63 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -48.77 -21.79 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.535 ' O ' ' CG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -108.81 57.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p -93.62 155.72 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' CG2' ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.492 ' HG ' ' CE ' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.523 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.686 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 105' ' ' VAL . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 77' ' ' GLN . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' HB2' ' OD1' ' A' ' 122' ' ' ASN . 7.9 p-10 -132.26 106.41 7.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -70.87 79.28 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.652 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 29.8 m120 -118.68 178.29 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -1.125 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 122' ' ' ASN . 1.6 t-160 -56.74 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 110.788 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.489 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.2 ttm -77.53 -45.29 25.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.909 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 124' ' ' MET . 8.1 tp -178.21 115.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.013 . . . . 0.0 110.385 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.679 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -122.58 176.73 5.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 110.131 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.492 ' HA2' ' CB ' ' A' ' 64' ' ' ALA . . . 58.94 16.47 32.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -120.23 85.95 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -1.16 . . . . 0.0 110.254 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 -42.65 140.21 1.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.542 ' CD2' HG21 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 13' ' ' TYR . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 3' ' ' VAL . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.565 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.547 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.555 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 14.1 m170 -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.53 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' HIS . 7.5 p -103.15 139.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 152' ' ' VAL . 16.9 t60 57.35 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.272 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 151' ' ' HIS . . . 93.14 130.19 5.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.512 ' HA ' ' NE2' ' A' ' 151' ' ' HIS . . . -125.97 155.82 40.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -1.1 . . . . 0.0 110.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -66.31 -48.89 68.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.28 -18.62 41.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' CB ' ' HB2' ' A' ' 155' ' ' ALA . 0.2 OUTLIER -108.19 176.98 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER 61.29 140.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -102.34 88.69 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.9 67.04 1.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.27 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -136.14 -67.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 31.5 p30 -176.32 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 166' ' ' GLY . 31.3 m80 -127.17 -5.48 6.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.1 t70 65.85 -67.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.23 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 164' ' ' HIS . . . 106.55 -164.22 13.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 166' ' ' GLY . 2.6 t 66.41 -60.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -1.175 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 166' ' ' GLY . 1.7 m -152.77 43.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.14 -167.78 7.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 172' ' ' GLY . . . -88.61 42.79 3.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.91 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 170' ' ' GLY . . . -177.71 145.55 7.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -47.01 113.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.1 t70 -98.78 -63.1 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -44.96 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 177' ' ' HIS . . . -144.95 38.12 1.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 177' ' ' HIS . 0.3 OUTLIER 179.07 116.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -1.155 . . . . 0.0 110.228 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.89 39.5 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 21.1 m170 -80.72 -39.81 26.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.38 116.48 0.42 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 182' ' ' GLU . . . -157.18 26.7 0.49 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' GLY . 4.6 tm-20 54.27 104.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -1.108 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.86 31.92 4.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 151.7 49.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.7 p -120.57 -179.12 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.96 108.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -166.09 -47.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.73 118.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -1.145 . . . . 0.0 110.194 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.92 165.57 19.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.68 122.4 38.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -1.134 . . . . 0.0 110.194 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 54.42 33.94 54.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.17 -165.03 1.33 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.7 p -167.24 38.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -1.124 . . . . 0.0 110.167 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 195' ' ' CYS . . . -165.94 -140.25 2.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 194' ' ' GLY . 37.6 t 58.0 160.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.19 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 152' ' ' VAL . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 136' ' ' VAL . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CB ' HG11 ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 1.3 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.517 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG23 ' A' ' 17' ' ' THR . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.547 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 5' ' ' LYS . 66.2 t60 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.578 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 17.4 m-70 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.578 HG22 ' CB ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' CB ' HG21 ' A' ' 42' ' ' ILE . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.589 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.579 HG13 ' CE2' ' A' ' 132' ' ' PHE . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.493 ' O ' ' HA2' ' A' ' 69' ' ' GLY . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.578 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 -100.3 -11.17 20.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 39.4 41.5 1.6 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.606 ' HA ' ' N ' ' A' ' 127' ' ' GLY . 1.3 mt-30 63.64 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -1.156 . . . . 0.0 109.846 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.652 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.1 p90 -81.51 122.6 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 110.571 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.49 148.05 22.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 122' ' ' ASN . 0.4 OUTLIER -66.24 -7.07 16.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 110.49 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -70.98 -30.04 66.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 79.24 1.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 ' CG1' ' HB2' ' A' ' 120' ' ' ASP . 4.2 m -52.98 155.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' O ' HG21 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' VAL . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 88' ' ' ASP . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 109' ' ' ILE . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' CG1' HG13 ' A' ' 112' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' HB2' HD12 ' A' ' 109' ' ' ILE . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.407 HG21 ' CG ' ' A' ' 102' ' ' GLN . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.461 ' NE2' HG21 ' A' ' 23' ' ' VAL . 4.3 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.508 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.531 ' CD1' HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.476 ' HB2' ' CG1' ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.498 HG13 ' CG1' ' A' ' 92' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.579 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 110' ' ' THR . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.536 ' HB2' ' CG1' ' A' ' 76' ' ' VAL . 43.3 t0 -117.28 102.17 9.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -119.09 160.81 14.03 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 3.9 t30 -117.86 142.63 47.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -1.097 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.55 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 5.7 m170 -102.37 177.62 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.971 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' CD2' ' A' ' 125' ' ' LEU . 3.6 ttt -47.11 -28.79 1.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.993 . . . . 0.0 109.851 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER 174.23 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -40.48 131.69 2.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 70' ' ' GLN . . . 113.1 21.82 5.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 129' ' ' ASN . 20.8 mm-40 -87.24 75.18 9.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -1.095 . . . . 0.0 109.825 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.8 p-10 -26.27 139.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.803 -0.561 . . . . 0.0 111.261 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 128' ' ' GLN . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.579 ' CE2' HG13 ' A' ' 62' ' ' VAL . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 7.7 t-20 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' HD22 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 10' ' ' SER . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.48 HD13 HG23 ' A' ' 139' ' ' ILE . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.468 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.51 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 14.9 m170 -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.586 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 7.5 p -130.6 139.29 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 65.01 80.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.927 . . . . 0.0 110.202 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.57 -44.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -48.59 124.46 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -1.126 . . . . 0.0 110.143 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.65 -34.36 76.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.06 -60.45 2.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.1 67.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.225 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 161' ' ' ASP . 53.9 p-80 -96.34 158.61 15.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' HIS . 11.6 m-70 42.33 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.173 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 41.46 -155.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 162' ' ' HIS . 7.3 t60 -115.11 64.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.4 t0 -119.21 50.17 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 166' ' ' GLY . 10.2 p80 178.05 -39.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.4 t70 65.86 -65.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 164' ' ' HIS . . . 143.56 -123.81 2.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 166' ' ' GLY . 26.6 t 58.47 87.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -1.132 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.68 -65.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.13 137.45 3.74 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -168.75 71.26 0.15 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' HIS . 0.5 OUTLIER -49.04 158.49 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.172 . . . . 0.0 110.176 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.4 151.47 35.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -78.61 -154.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -1.152 . . . . 0.0 110.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 175' ' ' HIS . 1.6 t70 -151.69 158.44 43.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.161 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.405 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 58.2 m-70 -138.34 -88.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.3 128.51 1.94 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -132.05 160.31 36.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.28 90.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -146.28 -49.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.2 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.86 -107.54 2.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -160.96 172.94 37.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.06 123.6 4.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.97 83.58 1.63 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 28.54 6.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.241 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.92 44.31 2.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.41 -80.51 1.32 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.2 69.6 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 50.86 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.147 . . . . 0.0 110.287 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.63 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -172.63 38.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -1.157 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.54 -21.75 2.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.08 174.54 51.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.8 m -150.79 57.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.13 . . . . 0.0 110.196 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 130.3 57.94 0.1 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 21.6 p -115.89 4.2 13.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -1.122 . . . . 0.0 110.232 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.056 -0.974 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' CD2' ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' CA ' HD23 ' A' ' 147' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 140' ' ' ARG . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 134' ' ' VAL . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.497 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.43 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' HG22 ' A' ' 15' ' ' VAL . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.641 ' CE2' ' CD2' ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.537 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.63 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.641 ' CD2' ' CE2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.563 HD13 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' CD1' ' HB3' ' A' ' 34' ' ' TYR . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 68' ' ' TYR . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 13.0 m-85 -135.79 13.86 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 64' ' ' ALA . . . -93.58 -19.5 34.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.59 -25.15 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.31 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 5.7 t80 -43.26 143.32 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 110.161 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 1.2 t70 -130.8 148.26 52.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -24.14 64.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.223 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -50.8 -20.94 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 59.35 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 118' ' ' VAL . 10.5 p -56.69 153.82 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.405 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' O ' ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.463 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.466 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.456 HG21 HG22 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.472 ' O ' HG13 ' A' ' 117' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.484 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 111' ' ' ALA . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG22 HG21 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 2.0 p30 -88.23 155.8 19.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.36 96.74 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -62.96 137.93 58.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -1.123 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.27 164.57 14.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.17 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mtm -71.4 -12.92 61.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.269 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 125' ' ' LEU . 1.4 mm? -89.22 -66.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 71' ' ' TYR . . . -47.82 117.89 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -136.99 81.2 1.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -1.155 . . . . 0.0 110.19 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -58.44 172.0 0.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.647 ' CE2' ' CG1' ' A' ' 62' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.506 ' C ' ' CG1' ' A' ' 139' ' ' ILE . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 3' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.477 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.535 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.466 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.49 ' CB ' ' HB2' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.0 m170 -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 152' ' ' VAL . 4.8 m -130.56 119.67 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 81.6 t60 57.93 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 75.61 158.78 7.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 158' ' ' HIS . . . -175.89 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -1.166 . . . . 0.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -83.98 5.46 25.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.269 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.53 -31.51 57.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.413 ' O ' ' CB ' ' A' ' 159' ' ' HIS . 1.9 p80 -118.84 170.36 9.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 158' ' ' HIS . 0.5 OUTLIER 63.27 77.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.175 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -157.99 48.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.193 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.32 45.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -99.48 -52.01 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.267 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -44.62 123.98 3.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.475 ' CE1' ' OD1' ' A' ' 165' ' ' ASP . 26.8 t-80 -151.97 152.99 33.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' OD1' ' CE1' ' A' ' 164' ' ' HIS . 9.6 p-10 -60.55 -177.56 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.09 135.83 1.89 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.481 ' SG ' ' NE2' ' A' ' 173' ' ' HIS . 0.5 OUTLIER -151.83 41.14 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -1.149 . . . . 0.0 110.144 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 22.2 p -62.07 178.8 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.47 41.17 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 174.86 37.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -91.08 67.4 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -1.157 . . . . 0.0 110.152 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -62.04 -31.26 78.08 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.481 ' NE2' ' SG ' ' A' ' 167' ' ' CYS . 4.6 m-70 -60.58 -128.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 110.133 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 173' ' ' HIS . 1.9 t70 -41.66 136.57 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 110.264 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.46 152.47 21.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.44 80.63 0.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -63.16 -69.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.1 114.58 2.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -171.96 169.14 5.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 107.59 -15.2 38.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 182' ' ' GLU . . . 64.12 173.06 2.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 181' ' ' GLY . 10.6 pt-20 38.0 35.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.44 -1.036 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.72 -31.58 2.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.6 t -101.46 -5.91 24.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -1.143 . . . . 0.0 110.11 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -138.54 104.55 5.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -172.45 70.56 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.45 -31.68 29.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 162.92 6.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 110.188 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -98.72 -159.16 29.67 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -90.44 -43.78 10.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -177.75 134.08 2.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.19 24.77 3.95 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 49.1 t -110.06 59.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 110.173 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -108.91 -10.62 24.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.88 -15.06 11.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -1.135 . . . . 0.0 110.192 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CA ' HD13 ' A' ' 139' ' ' ILE . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.526 ' N ' ' NE2' ' A' ' 38' ' ' HIS . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.466 ' O ' HG21 ' A' ' 137' ' ' VAL . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD23 ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.521 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' HB3' HG23 ' A' ' 21' ' ' VAL . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.63 ' CZ ' ' CD2' ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.758 ' HG ' ' CE1' ' A' ' 38' ' ' HIS . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.758 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.577 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.63 ' CD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 68' ' ' TYR . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 72' ' ' ASP . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.519 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 42' ' ' ILE . 24.1 m-85 -106.95 35.88 2.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.16 -113.35 0.97 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 71' ' ' TYR . 8.6 pt20 -157.23 -114.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 110.137 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CZ ' ' NE2' ' A' ' 70' ' ' GLN . 12.1 p90 -84.73 143.91 28.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 25.7 p30 -104.93 69.76 0.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 123' ' ' HIS . 43.7 mt-10 -67.33 -6.62 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 2.5 p-10 -67.3 4.05 1.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.872 . . . . 0.0 110.761 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 ' H ' ' C ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -53.74 -10.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.995 . . . . 0.0 110.548 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 120' ' ' ASP . 1.4 p -53.14 153.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.546 ' O ' ' CG2' ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 92' ' ' VAL . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.44 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' HB3' ' CG2' ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 105' ' ' VAL . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.487 ' O ' HG21 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 -148.81 146.75 28.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.74 -20.17 8.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 8.3 m120 -118.71 177.52 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.184 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 26.1 m80 -71.19 142.13 50.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.6 mtm -77.44 -11.21 59.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.078 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 126' ' ' ALA . 0.3 OUTLIER -51.92 -68.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 110.533 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . . . -47.14 176.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 74' ' ' ASN . . . 100.01 -34.12 5.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 127' ' ' GLY . 6.6 mt-30 -135.23 71.55 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.042 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -94.34 -21.33 19.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.441 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.457 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 58' ' ' PHE . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.468 ' C ' ' CG1' ' A' ' 139' ' ' ILE . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.54 HD13 ' CA ' ' A' ' 3' ' ' VAL . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.485 ' N ' HD13 ' A' ' 7' ' ' LEU . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.471 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.518 ' HA ' ' CG ' ' A' ' 146' ' ' GLU . 57.6 t -123.63 142.45 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.44 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 65.75 13.23 8.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.231 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . 89.92 78.45 1.33 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . 54.14 106.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.46 -72.14 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.27 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -92.02 -58.2 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 176.7 -60.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.444 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 26.5 p80 -176.94 -165.31 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 63.04 104.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 160' ' ' HIS . 3.7 t0 63.84 -146.51 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.26 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -91.18 -67.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -174.46 149.26 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.32 101.47 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.53 107.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.65 -164.36 1.8 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 1.7 t -122.75 57.25 1.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 46.22 -166.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.02 -162.57 11.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.89 140.31 14.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -165.79 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -1.138 . . . . 0.0 110.183 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.89 -71.1 2.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.37 -47.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -1.119 . . . . 0.0 110.217 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -113.53 101.83 9.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.231 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 53.5 -153.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.14 -133.52 6.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -163.21 55.87 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.24 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.11 13.63 4.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -95.19 -30.88 13.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.15 45.44 73.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 152.6 115.63 0.63 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.47 117.22 4.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 184' ' ' CYS . . . 160.7 125.32 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 1.1 m 59.04 57.46 3.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.239 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 149.36 1.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 178.24 93.61 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.55 -129.66 3.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.57 -2.59 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -1.196 . . . . 0.0 110.18 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.9 -53.71 1.09 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 12.2 m120 51.42 46.14 26.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -1.168 . . . . 0.0 110.183 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.69 116.43 3.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 152.24 61.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 61.5 m -85.03 114.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 117.09 136.48 5.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 9.6 p -139.35 158.22 44.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -1.113 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.151 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' ' CD2' ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.498 HD11 ' CA ' ' A' ' 141' ' ' GLU . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' ARG . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 HG13 ' HB ' ' A' ' 23' ' ' VAL . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.529 HG23 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' HG13 ' A' ' 15' ' ' VAL . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.423 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 38' ' ' HIS . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.454 ' ND1' HG13 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 53' ' ' GLU . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD2' HG21 ' A' ' 60' ' ' VAL . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 58' ' ' PHE . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' CB ' ' HA2' ' A' ' 127' ' ' GLY . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.57 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 -144.88 -38.97 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.586 ' HA2' ' CD2' ' A' ' 123' ' ' HIS . . . -83.81 -80.16 1.04 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER 68.68 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -1.137 . . . . 0.0 110.436 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -43.44 144.36 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' CB ' HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -82.75 79.14 9.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 75' ' ' LEU . 2.2 mt-10 -69.35 -26.87 64.9 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.025 -1.047 . . . . 0.0 109.646 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 2.6 t-20 -63.12 -3.95 2.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 74' ' ' ASN . 33.4 mt 61.32 65.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.891 0.853 . . . . 0.0 109.778 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG13 ' CB ' ' A' ' 72' ' ' ASP . 1.4 p -52.75 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.77 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' LEU . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.548 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.462 ' HG2' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 83' ' ' VAL . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.53 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.527 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.586 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.518 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.474 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 115' ' ' ASP . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.492 ' CG2' HG22 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.525 ' CG1' ' HG2' ' A' ' 78' ' ' ARG . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.527 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 15.8 p-10 -137.39 171.76 14.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.74 34.01 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.5 ' CB ' ' CG ' ' A' ' 72' ' ' ASP . 2.5 p-10 -115.0 171.89 7.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 110.325 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.586 ' CD2' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-70 -102.44 176.86 5.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.121 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.46 ' O ' HD11 ' A' ' 125' ' ' LEU . 2.6 ptp -49.13 -22.08 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 124' ' ' MET . 7.8 tp -174.11 104.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.9 52.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 64' ' ' ALA . . . 112.57 14.71 10.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.509 ' O ' ' CD1' ' A' ' 130' ' ' LEU . 30.6 tt0 -96.29 71.03 2.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -1.153 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -44.88 128.95 7.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.529 ' CD2' HG23 ' A' ' 17' ' ' THR . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' GLY . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.478 ' HB2' ' NH1' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 3' ' ' VAL . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' CA ' HD11 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.473 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.559 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.511 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 1.8 m-70 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.511 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 8' ' ' VAL . 4.9 p -128.02 127.31 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 53.9 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 154.22 -103.12 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.524 ' HB1' ' CB ' ' A' ' 158' ' ' HIS . . . 56.24 79.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -1.164 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -66.73 -39.59 88.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.57 -25.95 57.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.524 ' CB ' ' HB1' ' A' ' 155' ' ' ALA . 15.9 t60 -46.78 -62.47 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -47.22 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 45.6 t60 43.49 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.267 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.02 -44.73 13.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.4 26.96 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.69 -56.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -112.62 93.33 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -151.73 129.61 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 110.225 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.71 42.96 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 168' ' ' CYS . 26.0 t -85.88 164.45 17.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.207 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 4.2 t 64.94 169.17 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.88 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.12 47.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -132.63 121.48 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -1.176 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.52 -144.99 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.9 56.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -1.145 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -146.23 36.6 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -126.46 151.29 47.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.78 12.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -91.32 121.28 32.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.203 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.8 116.25 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.62 144.27 31.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.14 -153.95 20.97 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.82 11.24 5.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -49.62 157.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -1.149 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . -174.77 49.72 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' CYS . 53.3 m 54.32 -86.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER 65.53 154.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 174.12 -108.33 0.27 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.98 -144.18 10.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.75 -15.64 10.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -1.161 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.07 -80.69 0.09 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.99 176.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 110.195 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.38 -124.57 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 -102.89 0.56 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.1 m -64.62 171.1 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -1.094 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.85 9.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 115.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.163 . . . . 0.0 110.206 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.615 ' CA ' HD11 ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 38' ' ' HIS . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' A' ' 140' ' ' ARG . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 139' ' ' ILE . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.637 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 23' ' ' VAL . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 17' ' ' THR . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG21 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CD1' HD11 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.561 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 47.9 t60 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.63 ' CE1' ' CD2' ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' OG1' ' A' ' 47' ' ' THR . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.449 HD23 HD11 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HA ' HG11 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' HG11 ' A' ' 136' ' ' VAL . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.466 ' C ' ' CG2' ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.466 ' CG2' ' C ' ' A' ' 61' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.511 ' O ' ' O ' ' A' ' 69' ' ' GLY . 42.2 p90 -110.94 48.82 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 68' ' ' TYR . . . -46.64 -99.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.559 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 6.2 mt-30 -141.7 -106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.232 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.671 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.77 120.31 21.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 110.405 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.23 113.6 10.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 2.5 mm-40 -66.2 -8.63 25.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.264 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.97 -14.49 54.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.24 33.19 5.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 73' ' ' GLU . 18.4 m -66.64 149.95 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 ' CG2' ' C ' ' A' ' 78' ' ' ARG . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' HG11 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' CD2' HD12 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' HG23 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.437 HD12 ' CD2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.514 ' O ' ' CG1' ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.576 ' CG2' HG21 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' O ' ' CG2' ' A' ' 119' ' ' VAL . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 111' ' ' ALA . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' N ' HG22 ' A' ' 110' ' ' THR . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 118' ' ' VAL . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG21 ' CG2' ' A' ' 107' ' ' VAL . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -135.95 130.13 33.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -73.26 137.12 23.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 122' ' ' ASN . 19.2 p30 -118.5 121.67 40.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -1.177 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.477 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 16.5 m-70 -76.45 -162.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 ttp -62.98 -41.02 99.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 17.3 tp 174.4 109.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.671 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -96.39 -167.52 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.52 53.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' ASN . 24.4 tt0 -105.96 79.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -1.114 . . . . 0.0 110.104 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 128' ' ' GLN . 15.3 p30 -41.23 149.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.321 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.637 ' CE1' ' CG1' ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.495 ' HB ' ' CE1' ' A' ' 58' ' ' PHE . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.531 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.615 HD11 ' CA ' ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' VAL . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 142' ' ' ALA . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.49 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CD2' ' O ' ' A' ' 151' ' ' HIS . 0.5 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 152' ' ' VAL . 2.3 p -64.91 114.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.519 ' CD2' ' HB2' ' A' ' 156' ' ' HIS . 57.3 t60 -158.04 -66.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.66 37.75 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 46.41 41.2 9.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -1.129 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.519 ' HB2' ' CD2' ' A' ' 153' ' ' HIS . 1.4 t-80 -82.65 -63.25 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -32.53 73.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 51.03 -143.61 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -148.68 0.34 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -87.05 179.95 6.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 48.95 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 48.13 54.91 9.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -130.16 125.93 36.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.06 5.79 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.92 2.8 53.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -120.05 60.36 0.52 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 28.1 p -131.58 7.26 4.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 24.8 p -167.02 132.66 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.234 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.22 -81.23 0.22 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 171' ' ' HIS . . . 88.31 178.93 46.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' GLY . 0.1 OUTLIER 63.07 61.48 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.172 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -103.61 -32.34 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 172' ' ' GLY . 5.7 m-70 55.03 165.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.256 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -70.75 -60.75 2.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 48.04 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 63.38 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.406 ' ND1' ' C ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -71.34 -153.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 179' ' ' HIS . 1.5 tm-20 -103.5 140.13 37.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.449 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -67.14 -158.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.02 -135.77 3.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 182' ' ' GLU . . . 114.57 -62.61 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 181' ' ' GLY . 17.4 tt0 62.75 38.6 11.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -1.14 . . . . 0.0 110.225 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.11 171.61 42.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 48.8 t -108.74 -32.89 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -1.192 . . . . 0.0 110.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 184' ' ' CYS . 8.7 t 61.12 164.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.6 52.0 2.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.54 -152.71 14.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -60.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.3 33.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -175.56 168.32 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 110.196 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 130.96 87.76 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 97.98 82.51 1.66 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.1 t -173.98 149.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -1.121 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -152.36 69.22 0.31 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 46.9 m -130.88 7.4 4.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 110.207 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.243 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 54' ' ' VAL . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.551 ' HA ' ' CD2' ' A' ' 35' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 26' ' ' SER . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 21' ' ' VAL . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' O ' ' OG1' ' A' ' 17' ' ' THR . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.622 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.552 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.633 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 9.6 t60 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.684 ' CG ' ' O ' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.633 ' CD1' ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CE1' ' CB ' ' A' ' 136' ' ' VAL . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.458 HG21 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' C ' ' HB1' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' N ' ' HB1' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 42' ' ' ILE . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 69' ' ' GLY . 22.6 p90 -104.48 45.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 68' ' ' TYR . . . -42.97 -90.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -177.65 58.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.448 ' HB3' ' OE2' ' A' ' 73' ' ' GLU . 6.6 t80 -78.74 134.79 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.462 ' OD1' ' OD1' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -83.88 74.09 10.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.269 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 22.3 mp0 -69.31 -16.39 63.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.173 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' OD1' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p-10 -56.5 -16.53 6.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.64 -25.44 19.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.197 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 73' ' ' GLU . 7.2 p -55.53 140.3 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.161 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.526 ' CG1' ' CG1' ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.43 ' HD2' HG12 ' A' ' 79' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.526 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.667 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.533 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.492 ' N ' HG22 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.509 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 79' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 ' CG2' HG23 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 15.6 t0 -150.02 165.86 31.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.99 -162.54 23.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 37.1 p-10 -118.11 96.02 5.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.412 ' HB3' ' CD2' ' A' ' 125' ' ' LEU . 8.0 m-70 -74.48 151.75 39.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.422 ' O ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -75.49 -39.32 58.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 72' ' ' ASP . 3.0 pp -42.98 -29.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 71' ' ' TYR . . . -98.15 157.39 16.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.95 -6.83 29.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.438 ' O ' HD12 ' A' ' 130' ' ' LEU . 15.8 mm100 -97.91 76.17 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -1.13 . . . . 0.0 110.225 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -44.05 150.88 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.211 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 128' ' ' GLN . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.553 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.639 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.584 HD13 ' CE1' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' CB ' HD13 ' A' ' 147' ' ' LEU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.481 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.528 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.55 HD13 ' CB ' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 15.7 m170 -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.422 ' CD2' ' O ' ' A' ' 153' ' ' HIS . 1.5 p-80 -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 8' ' ' VAL . 25.3 t -85.4 136.32 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 12.6 t60 58.4 154.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.82 32.38 2.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.57 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -1.195 . . . . 0.0 110.25 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.99 -16.76 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.73 -18.84 13.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -103.37 132.66 49.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.13 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 4.1 t60 -140.58 19.56 2.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 50.88 75.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 1.2 m-20 -125.16 172.07 9.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 163' ' ' ASP . 79.4 m80 -58.27 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 162' ' ' HIS . 1.3 t0 59.56 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.23 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 165' ' ' ASP . 32.9 m80 -91.25 -4.31 56.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 164' ' ' HIS . 0.9 OUTLIER 42.53 -163.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 170.13 116.06 0.36 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.53 53.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.255 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 15.9 m -79.43 135.82 36.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.61 -76.28 1.08 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.48 145.62 26.65 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -129.71 128.16 41.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -1.181 . . . . 0.0 110.229 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.24 166.89 0.64 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 0.0 OUTLIER -165.83 140.46 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.223 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -167.33 69.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.172 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.63 63.62 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -56.07 -38.07 74.4 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.26 69.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -1.152 . . . . 0.0 110.216 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -78.11 137.06 38.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 0.5 OUTLIER -69.27 -158.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.91 170.91 0.31 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.96 -33.2 0.17 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 46.16 26.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 74.34 154.2 3.54 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.7 t -142.36 -52.19 0.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 94.5 m -133.82 167.99 19.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.21 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.33 89.53 1.22 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -134.24 -51.12 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 -168.21 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.397 -1.061 . . . . 0.0 110.259 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 144.13 145.84 4.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.96 -173.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -1.18 . . . . 0.0 110.255 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -129.82 157.76 21.99 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.43 102.24 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.48 134.97 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -1.184 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.92 111.01 1.61 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.5 t -95.58 -5.4 42.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.222 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.252 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.601 ' HE2' ' CG ' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 ' CG ' ' A' ' 36' ' ' HIS . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD12 ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.528 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 21' ' ' VAL . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.477 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.461 ' HB3' ' OE2' ' A' ' 25' ' ' GLU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' HG12 ' A' ' 15' ' ' VAL . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 25' ' ' GLU . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' CG ' ' O ' ' A' ' 38' ' ' HIS . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CG ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.601 ' CG ' ' HE2' ' A' ' 5' ' ' LYS . 2.1 t-160 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' HG13 ' A' ' 42' ' ' ILE . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 3' ' ' VAL . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 138' ' ' ALA . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 61' ' ' ALA . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' C ' ' CG1' ' A' ' 62' ' ' VAL . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 70' ' ' GLN . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 -110.16 -29.06 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.23 -121.45 0.91 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.483 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 4.4 mm-40 54.94 68.09 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -1.182 . . . . 0.0 110.148 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' HB3' ' CB ' ' A' ' 126' ' ' ALA . 1.4 p90 -43.39 143.39 0.91 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.59 90.51 3.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.31 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -52.09 -21.07 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.962 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -78.63 4.26 14.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.121 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' C ' ' O ' ' A' ' 74' ' ' ASN . 1.3 tt -31.4 -58.66 0.25 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.52 -0.738 . . . . 0.0 110.578 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t -83.62 95.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 110.108 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.404 ' O ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.472 ' O ' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.473 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.578 ' CG2' ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.518 ' OD1' ' CG2' ' A' ' 110' ' ' THR . 30.7 p-10 -167.63 99.18 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -165.97 68.04 0.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.534 ' CB ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -118.61 177.45 4.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 122' ' ' ASN . 1.2 m-70 -43.89 128.49 5.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.1 mtp -76.58 -19.85 57.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 100.1 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' A' ' 71' ' ' TYR . . . -98.03 -176.12 3.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 64' ' ' ALA . . . 98.38 18.0 27.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.421 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.7 OUTLIER -110.55 81.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 110.244 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.411 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 -60.69 157.41 14.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.147 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 128' ' ' GLN . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' CG2' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' CG2' ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.54 HD12 ' CG2' ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 141' ' ' GLU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.424 ' OG1' ' CD ' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.527 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.551 ' O ' ' CD2' ' A' ' 151' ' ' HIS . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 11.0 m-70 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 153' ' ' HIS . 32.8 t -130.23 111.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 67.22 -58.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 110.206 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -73.08 150.6 44.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.6 114.5 4.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -1.113 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -83.14 -32.44 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -78.85 -15.13 58.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.548 ' CD2' ' NE2' ' A' ' 162' ' ' HIS . 16.3 t-80 -108.75 15.5 23.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -127.17 -66.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 161' ' ' ASP . 0.3 OUTLIER -66.97 101.83 0.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 61.89 124.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.283 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.548 ' NE2' ' CD2' ' A' ' 158' ' ' HIS . 1.1 t-160 -114.69 -21.09 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -167.58 -158.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -97.67 99.01 10.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.38 40.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.73 -47.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.5 m 50.19 85.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -1.127 . . . . 0.0 110.204 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 26.3 p -81.91 5.89 17.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.173 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.37 170.64 1.73 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.9 -24.5 20.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 14.1 32.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -1.154 . . . . 0.0 110.18 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.01 -177.32 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 175' ' ' HIS . 2.2 t-80 -106.79 -3.36 20.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -1.151 . . . . 0.0 110.226 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 173' ' ' HIS . 11.5 t0 66.28 -63.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 21.4 p-80 -149.47 132.58 16.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 178' ' ' GLU . . . 178.55 52.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.419 ' HB2' ' OE2' ' A' ' 178' ' ' GLU . 31.5 m-70 54.54 -87.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.154 . . . . 0.0 110.158 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -125.05 152.7 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 179' ' ' HIS . 20.2 m170 -74.72 -8.51 56.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.213 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.88 130.11 2.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.23 -97.55 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.67 159.76 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.07 -99.66 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 185' ' ' CYS . 53.9 t -75.11 116.51 15.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 110.214 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 184' ' ' CYS . 8.2 m 54.91 -171.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.78 -160.85 24.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.0 157.2 35.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 146.33 27.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.35 95.07 0.94 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -129.06 105.75 8.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.35 -48.63 85.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.27 131.85 5.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.09 -51.0 2.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.233 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.02 46.7 0.66 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 20.2 p -176.18 154.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -1.111 . . . . 0.0 110.275 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.226 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 7' ' ' LEU . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CD2' ' HB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.522 ' CB ' HG13 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' N ' HD11 ' A' ' 22' ' ' LEU . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE2' ' HG ' ' A' ' 32' ' ' LEU . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.648 ' CD2' ' CD2' ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CG ' HG12 ' A' ' 136' ' ' VAL . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.462 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG23 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' A' ' 70' ' ' GLN . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 -112.6 10.17 19.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' GLN . . . 72.3 2.49 54.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 8.0 mm100 41.61 77.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.631 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.3 p90 -54.13 124.28 15.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.259 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -83.28 126.4 32.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 110.13 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' HG3' ' CA ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -52.16 -19.78 2.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 110.308 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -76.14 2.75 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' CD1' ' ND2' ' A' ' 122' ' ' ASN . 2.7 pp -88.2 -7.83 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.4 m -53.67 122.97 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' O ' HG22 ' A' ' 119' ' ' VAL . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG21 ' CD1' ' A' ' 90' ' ' LEU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.448 HG21 ' CG2' ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.482 ' O ' HD12 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.448 ' CG2' HG21 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.551 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.477 ' CG2' ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 119' ' ' VAL . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -167.72 171.81 9.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.82 60.66 0.84 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.496 ' ND2' ' CD1' ' A' ' 75' ' ' LEU . 74.4 m-20 -118.79 144.22 46.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -1.202 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 2.3 m-70 -76.24 139.5 41.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.259 -0.901 . . . . 0.0 110.277 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.539 ' CA ' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -77.45 -11.35 59.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 110.051 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 126' ' ' ALA . 10.0 tp -54.39 -36.63 64.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 110.349 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -42.1 143.53 0.57 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.76 21.68 5.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 129' ' ' ASN . 68.2 mt-30 -148.47 101.81 3.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.103 . . . . 0.0 109.994 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 128' ' ' GLN . 2.8 p30 -37.85 140.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.381 -0.824 . . . . 0.0 110.354 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.461 HD12 ' HA3' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 45' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.518 ' N ' HD11 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.566 HG12 ' CG ' ' A' ' 52' ' ' HIS . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.496 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.503 ' HA ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.453 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.561 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.561 ' CE1' ' O ' ' A' ' 153' ' ' HIS . 0.6 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.495 ' HA ' ' HG3' ' A' ' 146' ' ' GLU . 4.5 m -99.85 123.67 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.561 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 0.2 OUTLIER 47.77 -163.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.306 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.19 -52.95 4.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 54.73 72.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 110.207 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -53.77 -29.59 40.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 158' ' ' HIS . 19.0 p-10 -75.51 -32.72 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 52.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.166 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -114.12 23.59 12.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.551 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -76.58 -170.14 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 163' ' ' ASP . 3.6 m-20 -150.71 103.09 3.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.178 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 80.4 m-70 55.31 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 161' ' ' ASP . 11.6 t0 -111.0 -145.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -121.25 2.61 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.83 146.89 29.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.26 53.07 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 30.3 p -78.77 1.74 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -1.117 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.26 127.87 55.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.02 -164.67 13.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.45 147.56 22.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.68 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 0.0 110.142 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.85 -178.36 50.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -164.75 62.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.5 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 92.11 1.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 157.93 -74.85 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.82 83.88 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -1.179 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 179' ' ' HIS . 1.3 tp10 -66.24 -63.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 178' ' ' GLU . 2.8 m80 47.49 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -129.85 148.27 18.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.86 -107.05 3.17 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.66 168.34 2.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -1.094 . . . . 0.0 110.238 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 46.18 -124.6 7.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 52.9 t -100.36 126.76 46.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.172 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 61.44 0.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.154 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -135.7 10.9 4.29 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -151.73 58.26 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -25.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -1.199 . . . . 0.0 110.192 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.81 125.46 3.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.57 135.24 54.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.167 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.91 75.57 1.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.22 173.66 3.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.99 169.93 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -1.176 . . . . 0.0 110.202 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 195' ' ' CYS . . . -126.81 -33.92 0.62 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 36.4 m 58.71 153.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -1.174 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 195' ' ' CYS . 73.9 m80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.214 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HE1' ' CG1' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' CG2' HG22 ' A' ' 139' ' ' ILE . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' CB ' HD11 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CB ' HD22 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' A' ' 140' ' ' ARG . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.558 ' CG2' ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 139' ' ' ILE . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.515 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.527 ' OG ' ' CB ' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.509 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.479 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.509 ' CB ' ' HA ' ' A' ' 36' ' ' HIS . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG23 HD13 ' A' ' 42' ' ' ILE . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.471 HD13 ' CE1' ' A' ' 132' ' ' PHE . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' N ' ' HA3' ' A' ' 69' ' ' GLY . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -110.52 34.5 3.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' HA3' ' N ' ' A' ' 64' ' ' ALA . . . -78.97 -33.7 36.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 69' ' ' GLY . 3.1 mm-40 -41.6 163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -1.089 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' CA ' ' HB2' ' A' ' 126' ' ' ALA . 1.8 t80 -84.68 120.47 26.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.121 -0.987 . . . . 0.0 110.576 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -137.75 122.45 18.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 122' ' ' ASN . 44.0 mt-10 -69.5 -6.42 30.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 111.162 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' C ' ' A' ' 75' ' ' LEU . 5.1 m-80 -82.3 -46.98 12.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.875 -1.14 . . . . 0.0 112.146 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' CD1' ' CG ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -40.56 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 122' ' ' ASN . 1.6 m -146.06 156.3 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 110.991 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HB2' ' CA ' ' A' ' 121' ' ' GLY . 18.2 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 83' ' ' VAL . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HB ' ' CD2' ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.523 ' CD2' ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 111' ' ' ALA . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.46 ' HE3' ' CB ' ' A' ' 90' ' ' LEU . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.53 ' CB ' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.561 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.53 HG21 ' CB ' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.559 ' CG2' ' CG1' ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 -97.59 105.61 17.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.593 ' CA ' ' HB2' ' A' ' 77' ' ' GLN . . . -160.88 -141.08 3.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 40.8 p30 -53.76 168.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.151 . . . . 0.0 110.248 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.646 ' CG ' ' CD1' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -102.0 -161.3 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.432 ' H ' ' CG ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -77.47 -29.14 52.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.299 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 124' ' ' MET . 0.5 OUTLIER 179.14 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.423 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.552 ' HB2' ' CA ' ' A' ' 71' ' ' TYR . . . 61.64 174.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.8 21.61 69.46 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' ASN . 7.7 tp-100 -125.2 89.58 3.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -1.119 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -39.34 129.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 110.285 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 128' ' ' GLN . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.594 ' CG1' ' CD1' ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.533 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.54 HG22 ' CG2' ' A' ' 3' ' ' VAL . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.538 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.9 m170 -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.428 ' ND1' ' HA ' ' A' ' 155' ' ' ALA . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 8' ' ' VAL . 2.9 p -130.1 116.49 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 52.12 41.06 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.62 41.34 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.428 ' HA ' ' ND1' ' A' ' 151' ' ' HIS . . . -179.79 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -1.099 . . . . 0.0 110.242 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -63.29 -23.59 67.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.06 4.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 102.14 4.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.98 54.33 1.92 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.51 78.8 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.66 5.67 2.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -81.49 141.92 33.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.7 t70 -175.01 121.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.578 ' O ' ' CG ' ' A' ' 164' ' ' HIS . 0.4 OUTLIER -178.27 95.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 30.4 p30 -44.77 157.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.68 -76.5 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 58.63 74.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.15 -79.77 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -148.95 119.62 1.08 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -91.77 -86.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 173' ' ' HIS . . . -155.67 -160.22 9.84 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.485 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 3.4 t60 63.75 130.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.36 127.82 18.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 173' ' ' HIS . 55.8 m-70 -103.73 164.95 11.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.12 144.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -173.92 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.125 . . . . 0.0 110.12 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 179' ' ' HIS . 2.1 tm-20 65.15 136.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 180' ' ' GLY . 19.5 p-80 -59.21 -146.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' ' CG ' ' A' ' 179' ' ' HIS . . . -123.77 88.46 0.39 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.14 143.85 47.2 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -150.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.096 . . . . 0.0 110.241 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.13 -143.19 0.42 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.89 130.72 36.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.36 26.11 6.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 126.16 106.4 1.5 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.43 49.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 90.98 -179.89 42.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.67 -175.22 4.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -1.16 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.12 -148.18 7.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 164.38 21.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.12 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -1.14 . . . . 0.0 110.215 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -121.95 -63.18 0.22 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 196' ' ' HIS . 31.2 p -127.52 151.15 49.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 18.9 t60 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.552 ' CA ' HD12 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' N ' ' CD2' ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.538 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG23 ' CG2' ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.589 HD22 ' CZ ' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 2.4 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.578 ' HB ' ' CD1' ' A' ' 132' ' ' PHE . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 10' ' ' SER . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.598 ' CD2' ' NE2' ' A' ' 38' ' ' HIS . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.548 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.539 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' NE2' ' CD2' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 34' ' ' TYR . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 40' ' ' SER . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.592 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.584 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 134' ' ' VAL . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.522 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.529 ' CB ' ' HA2' ' A' ' 63' ' ' GLY . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.34 56.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -150.9 87.08 0.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.531 ' CA ' ' HA ' ' A' ' 126' ' ' ALA . 88.1 mm-40 57.08 47.71 16.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -1.095 . . . . 0.0 110.171 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -70.18 127.19 31.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.0 110.388 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -135.41 69.36 1.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.85 -34.14 73.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.895 . . . . 0.0 110.396 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' CG ' ' CG1' ' A' ' 105' ' ' VAL . 63.7 t30 -79.24 -15.48 57.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -44.07 -30.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.027 . . . . 0.0 110.086 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.568 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.4 p -144.02 126.66 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.525 ' O ' ' CG2' ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' O ' HG21 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG1' ' CG ' ' A' ' 74' ' ' ASN . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' C ' HG11 ' A' ' 107' ' ' VAL . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 119' ' ' VAL . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.505 ' N ' HG21 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.529 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.487 ' CG1' HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' CG2' ' HG3' ' A' ' 113' ' ' GLU . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.22 171.67 7.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.459 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . -167.66 63.08 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.35 162.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.24 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.424 ' CE1' ' OH ' ' A' ' 71' ' ' TYR . 1.9 t-80 -102.28 -140.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 3.4 mtm -63.97 -45.12 90.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.47 ' O ' ' OE1' ' A' ' 70' ' ' GLN . 0.2 OUTLIER 176.64 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.531 ' HA ' ' CA ' ' A' ' 70' ' ' GLN . . . -66.93 -177.31 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.57 21.76 6.0 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.525 ' CB ' ' HG3' ' A' ' 70' ' ' GLN . 6.0 tt0 -121.18 87.06 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -72.19 142.7 49.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.383 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' CD1' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 7.5 m120 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 58' ' ' PHE . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.552 HD12 ' CA ' ' A' ' 3' ' ' VAL . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 141' ' ' GLU . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.544 ' CB ' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.452 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.583 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 79.5 m-70 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 16.7 t -130.48 111.08 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' C ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 39.03 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 155' ' ' ALA . . . 148.31 -61.66 0.44 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.529 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.31 115.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -1.108 . . . . 0.0 110.215 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 151' ' ' HIS . 11.0 m170 -64.22 -26.5 68.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -78.54 -24.4 45.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 110.257 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 1.4 t60 60.07 145.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 2.1 p80 -178.49 156.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.506 ' CD2' ' C ' ' A' ' 160' ' ' HIS . 3.4 p-80 -53.02 -175.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -155.3 -178.49 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 162' ' ' HIS . 2.1 p-80 -135.09 -158.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -146.87 -176.8 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.881 . . . . 0.0 110.208 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 165' ' ' ASP . 8.6 m80 -57.29 -168.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 164' ' ' HIS . 11.5 m-20 -156.81 -52.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 167' ' ' CYS . . . 161.59 -37.0 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.522 ' C ' ' O ' ' A' ' 166' ' ' GLY . 15.2 p 33.45 44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -1.0 . . . . 0.0 110.562 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.4 t -113.2 89.88 3.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.48 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 87.79 1.81 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.23 56.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.157 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.47 -71.48 0.72 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -172.73 133.11 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 176' ' ' GLY . 28.4 t0 -100.79 150.34 22.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.448 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 19.0 t-80 -103.58 -15.23 15.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 174' ' ' ASP . . . -168.8 -169.01 31.67 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 177' ' ' HIS . 6.3 p80 -148.1 18.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -1.148 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.48 139.53 39.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -70.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.72 135.43 3.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 182' ' ' GLU . . . -45.97 -81.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' GLY . 14.6 mt-10 43.49 -148.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -1.142 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . -101.59 -22.76 10.0 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' GLY . 0.8 OUTLIER 60.24 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 29.9 m 44.84 -145.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 127.62 114.69 1.86 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.71 -49.81 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -176.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 98.12 -116.43 5.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -173.13 171.04 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.183 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.81 176.48 6.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.26 15.8 57.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -179.48 8.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.209 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.439 ' O ' ' SG ' ' A' ' 195' ' ' CYS . . . -93.84 41.92 2.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 194' ' ' GLY . 1.7 m -160.61 173.62 15.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -1.154 . . . . 0.0 110.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.558 ' CG2' ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.515 ' CB ' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.589 ' CD2' ' CG2' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.532 ' CG1' ' CD2' ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.544 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 21' ' ' VAL . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.503 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.417 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.574 HD21 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 38.1 t60 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.574 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.509 ' N ' ' OG ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.523 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.54 ' CG ' HG22 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.638 ' CE2' ' CG2' ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.638 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 66' ' ' ASP . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' HA2' ' CB ' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 2.6 m-30 -65.44 -36.03 82.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.07 105.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.489 ' HB2' ' CD2' ' A' ' 125' ' ' LEU . 0.8 OUTLIER -106.15 -45.26 4.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -1.114 . . . . 0.0 110.096 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.721 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 1.5 p90 -43.16 144.89 0.59 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 70' ' ' GLN . 0.6 OUTLIER -125.75 116.97 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.614 -0.679 . . . . 0.0 110.181 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -53.03 -21.84 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -15.17 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 pp -46.99 -27.19 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.82 136.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.517 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.559 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.628 ' CG2' ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.628 ' CD2' ' CG2' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.441 ' O ' HG21 ' A' ' 109' ' ' ILE . 2.4 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 91' ' ' GLN . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 111' ' ' ALA . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.512 ' N ' HG21 ' A' ' 110' ' ' THR . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 112' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.409 ' C ' HG11 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.409 HG11 ' C ' ' A' ' 116' ' ' HIS . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 -120.98 162.87 19.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.36 -174.38 33.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.61 133.25 54.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -171.62 0.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -28.91 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 70' ' ' GLN . 3.7 tp -110.88 -125.47 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 0.0 110.007 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.721 ' CB ' ' HB2' ' A' ' 71' ' ' TYR . . . 45.86 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.14 -5.28 27.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 81.36 1.9 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -51.07 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 13' ' ' TYR . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.54 HG22 ' CG ' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.589 ' CG2' ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.52 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.54 ' OE2' ' CG1' ' A' ' 152' ' ' VAL . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.515 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 144' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 1.9 p-80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.54 ' CG1' ' OE2' ' A' ' 146' ' ' GLU . 74.7 t -70.8 140.8 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' GLY . 0.1 OUTLIER 61.01 129.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 153' ' ' HIS . . . -48.57 175.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.12 15.7 11.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -1.183 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -83.93 -7.06 59.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.121 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.7 m-20 -44.18 -58.55 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -167.09 -70.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.483 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 19.7 t-160 58.58 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.285 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' HIS . 43.8 p-80 -133.27 176.39 8.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 162' ' ' HIS . 23.2 m-20 -70.9 137.58 49.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.237 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 161' ' ' ASP . 4.2 t-160 58.24 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -84.3 56.41 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -120.06 -0.22 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.87 -172.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 167' ' ' CYS . . . 87.18 -143.14 18.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER 176.97 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -1.153 . . . . 0.0 110.186 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 168' ' ' CYS . 24.7 p -144.27 110.85 5.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.78 -40.75 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 158.8 -136.41 4.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.23 111.73 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.98 -136.97 7.97 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.54 -65.43 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.138 . . . . 0.0 110.227 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -175.63 -68.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 179.05 4.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 136.43 108.13 0.89 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.31 -159.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -1.163 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.51 -28.94 7.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.223 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.91 94.53 7.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.2 147.49 16.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -56.28 120.72 21.03 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -151.67 113.23 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.166 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.65 135.58 9.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 11.8 p -168.05 101.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 12.5 t -133.02 101.44 5.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.86 0.84 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.41 0.94 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.64 107.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -1.096 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.78 160.86 27.87 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -45.9 115.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.161 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.79 -165.38 0.24 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 166.38 129.97 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.0 t -102.85 -3.66 25.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -1.069 . . . . 0.0 110.126 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 169.5 169.16 32.45 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.8 t 46.91 54.97 8.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.151 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 7' ' ' LEU . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.055 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 138' ' ' ALA . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE1' HD21 ' A' ' 41' ' ' LEU . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 24' ' ' ASP . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 25' ' ' GLU . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.92 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 8' ' ' VAL . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.043 HD23 ' CE1' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.736 ' CD2' HG13 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 1.043 ' CE1' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 45' ' ' LEU . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 45' ' ' LEU . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 45' ' ' LEU . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' HG23 ' A' ' 47' ' ' THR . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.809 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 139' ' ' ILE . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CE2' ' CG2' ' A' ' 60' ' ' VAL . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 67' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.0 t30 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.839 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 120' ' ' ASP . 7.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.221 0.534 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.756 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HG2' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 90' ' ' LEU . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.747 ' HB3' HG23 ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.469 ' OG1' HG21 ' A' ' 105' ' ' VAL . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 105' ' ' VAL . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' OG1' ' A' ' 100' ' ' THR . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.747 HG23 ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 92' ' ' VAL . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.022 HG23 HG22 ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 112' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.604 ' N ' HG12 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 76' ' ' VAL . 20.6 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.955 HD21 ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.237 0.542 . . . . 0.0 110.286 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 17' ' ' THR . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' CD1' ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.055 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.719 ' C ' HD23 ' A' ' 7' ' ' LEU . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.992 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.491 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.415 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.992 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.758 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 8' ' ' VAL . 3.3 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG11 ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 3' ' ' VAL . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.647 HD12 ' CG1' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.97 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 24' ' ' ASP . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 25' ' ' GLU . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.691 ' HB3' HD11 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.97 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.853 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.853 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.953 HD11 ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HA ' HG12 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' HD1' HG23 ' A' ' 60' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG23 ' HD1' ' A' ' 58' ' ' PHE . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 131' ' ' LYS . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 60' ' ' VAL . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 129' ' ' ASN . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.953 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' C ' ' HG3' ' A' ' 77' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.265 0.555 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.591 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.491 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.707 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HD3' ' A' ' 78' ' ' ARG . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.707 HG22 ' HB ' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' A' ' 64' ' ' ALA . 8.4 m-80 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.231 0.539 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 132' ' ' PHE . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 130' ' ' LEU . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' A' ' 13' ' ' TYR . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 3' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.074 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 144' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.681 ' H ' HG22 ' A' ' 143' ' ' THR . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.458 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.074 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.694 ' HB ' HG11 ' A' ' 8' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.86 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.619 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 1.03 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.03 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' ILE . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.809 HG11 ' CG2' ' A' ' 3' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.015 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.558 ' O ' HG11 ' A' ' 152' ' ' VAL . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.843 ' CD2' HD23 ' A' ' 35' ' ' LEU . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.72 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 HG21 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HA ' HG12 ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 12.6 t-160 -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.103 HG22 ' HB2' ' A' ' 67' ' ' ALA . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 ' CG1' ' A' ' 118' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.313 0.578 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.04 HG23 HD23 ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.04 HD23 HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.786 ' O ' HG22 ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' THR . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 96' ' ' PHE . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.244 0.545 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.975 ' CE1' HG12 ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.619 ' HB1' HH11 ' A' ' 140' ' ' ARG . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.737 HG22 HD23 ' A' ' 7' ' ' LEU . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.619 HH11 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.97 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.967 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 33' ' ' ASP . 5.5 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.002 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.736 ' CB ' HD21 ' A' ' 147' ' ' LEU . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.797 HG21 HG21 ' A' ' 3' ' ' VAL . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.749 HD12 HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' HD22 ' A' ' 22' ' ' LEU . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.839 HD13 ' O ' ' A' ' 15' ' ' VAL . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 22' ' ' LEU . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.75 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.112 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 1.112 ' CD2' HD23 ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.708 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.816 HD11 HG21 ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 137' ' ' VAL . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.088 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 1.029 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.088 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.271 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.808 HG21 ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' C ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.648 ' O ' HG22 ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.636 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 97' ' ' LEU . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' C ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 109' ' ' ILE . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 79' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 111' ' ' ALA . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.778 ' O ' HD22 ' A' ' 130' ' ' LEU . 17.2 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 129' ' ' ASN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.816 HG21 HD11 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.002 ' CD1' HG23 ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.77 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.76 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.984 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.984 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.93 HD12 ' HB3' ' A' ' 142' ' ' ALA . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.519 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.953 ' HA ' HG21 ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 HG23 ' A' ' 139' ' ' ILE . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 137' ' ' VAL . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.917 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CB ' HG12 ' A' ' 134' ' ' VAL . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.5 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' C ' HD22 ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.71 ' O ' HG12 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.917 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 9' ' ' VAL . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.129 HD23 ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.726 ' CD2' HG12 ' A' ' 3' ' ' VAL . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' C ' ' OE2' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 1.129 ' CD2' HD23 ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.642 ' CD2' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD13 ' HZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 139' ' ' ILE . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.693 ' O ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.798 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 76' ' ' VAL . 12.6 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 83' ' ' VAL . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 HD13 ' A' ' 90' ' ' LEU . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD13 HG23 ' A' ' 87' ' ' VAL . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.679 ' O ' HG22 ' A' ' 107' ' ' VAL . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.788 ' C ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HA ' HG13 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 112' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.58 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 4.9 t30 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.16 0.505 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.882 ' HZ ' HD13 ' A' ' 45' ' ' LEU . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 56' ' ' ASP . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 11' ' ' LEU . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.953 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.901 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.025 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.025 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.014 HD22 HD21 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.499 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.513 ' HA ' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.473 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 1.037 ' HG2' HD11 ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.754 ' C ' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 HG21 ' A' ' 9' ' ' VAL . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.9 ' HA ' HD11 ' A' ' 35' ' ' LEU . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 HG13 ' A' ' 3' ' ' VAL . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.88 ' O ' HG22 ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' HD11 ' A' ' 22' ' ' LEU . 2.0 mp0 -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.882 ' CG1' HD21 ' A' ' 130' ' ' LEU . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.7 HG22 HD12 ' A' ' 130' ' ' LEU . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 14' ' ' GLN . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' VAL . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE1' HD13 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 1.008 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.008 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.076 HD12 ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 1.076 ' CD2' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 6' ' ' ASP . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.56 ' CD2' HG11 ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.833 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.945 HD11 ' CZ ' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.793 HG21 ' HA ' ' A' ' 67' ' ' ALA . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD13 ' HE1' ' A' ' 132' ' ' PHE . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 44' ' ' GLY . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 3' ' ' VAL . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.695 ' HA ' HG13 ' A' ' 136' ' ' VAL . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 1.028 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.028 ' HB3' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.169 0.509 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.462 HE21 HG11 ' A' ' 79' ' ' VAL . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.656 ' CB ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' VAL . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 96' ' ' PHE . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 109' ' ' ILE . 5.6 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 112' ' ' VAL . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.663 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.073 HG13 HG12 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.073 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.656 HG12 ' CB ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 108' ' ' GLU . 18.5 t70 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' A' ' 102' ' ' GLN . 1.8 m-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.882 HD21 ' CG1' ' A' ' 15' ' ' VAL . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.788 ' HE1' HD13 ' A' ' 45' ' ' LEU . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.649 HG11 HD21 ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 1' ' ' MET . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.925 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.925 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 38' ' ' HIS . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.7 p80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 146' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.836 ' HA ' HG21 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.753 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 1.02 ' HA ' HD11 ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 152' ' ' VAL . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD13 ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.787 ' HB3' HG13 ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG2' ' OE1' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.531 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.815 ' C ' HD12 ' A' ' 22' ' ' LEU . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 21' ' ' VAL . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.742 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 41' ' ' LEU . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.683 ' O ' HG21 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.02 HD11 ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HB3' HD21 ' A' ' 45' ' ' LEU . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 68' ' ' TYR . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 47' ' ' THR . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 43' ' ' SER . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.557 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 62' ' ' VAL . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HE1' HD11 ' A' ' 42' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.271 0.557 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' VAL . 48.4 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 83' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.669 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 89' ' ' GLU . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 92' ' ' VAL . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HG3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.852 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.706 ' HA ' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.75 HD13 HG12 ' A' ' 119' ' ' VAL . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.02 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 118' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.02 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 109' ' ' ILE . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 3.1 p30 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.687 ' HD1' HG23 ' A' ' 15' ' ' VAL . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' TYR . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.836 HG21 ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.972 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.954 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 33' ' ' ASP . 16.0 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 35' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.911 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.911 ' CD1' HG12 ' A' ' 9' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.657 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 1.025 ' CB ' HG22 ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 24' ' ' ASP . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' HD12 ' A' ' 22' ' ' LEU . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD21 ' OE2' ' A' ' 25' ' ' GLU . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.558 ' OE2' HD21 ' A' ' 22' ' ' LEU . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.657 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.468 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 150' ' ' GLY . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' GLY . 31.1 m80 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.624 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.866 HG21 ' HA ' ' A' ' 67' ' ' ALA . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.039 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.727 ' ND1' HG23 ' A' ' 136' ' ' VAL . 19.0 t-160 -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.039 ' CZ ' ' HB1' ' A' ' 48' ' ' ALA . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.747 HG12 ' HB2' ' A' ' 67' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.797 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.866 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' CE2' HD13 ' A' ' 130' ' ' LEU . 20.8 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 76' ' ' VAL . 34.2 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.418 ' CG ' ' CG2' ' A' ' 119' ' ' VAL . 10.8 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' C ' HG13 ' A' ' 79' ' ' VAL . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.817 ' O ' HG22 ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.526 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HE2' HG11 ' A' ' 117' ' ' VAL . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 92' ' ' VAL . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.624 ' HB3' HD11 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 117' ' ' VAL . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.526 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' H ' HG22 ' A' ' 119' ' ' VAL . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.166 0.508 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.676 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HD22 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 6.2 t30 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 1.025 HG22 ' CB ' ' A' ' 13' ' ' TYR . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.727 HG23 ' ND1' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.874 HG22 HD22 ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.049 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 145' ' ' GLU . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.006 ' OE2' HG23 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.049 HD23 ' HB3' ' A' ' 142' ' ' ALA . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.698 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 2.0 p80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.006 HG23 ' OE2' ' A' ' 146' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HE3' ' N ' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.944 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.032 HD13 HG13 ' A' ' 134' ' ' VAL . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.831 HG12 ' O ' ' A' ' 24' ' ' ASP . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.127 HG22 HD23 ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.831 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' HE2' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.616 ' OH ' HD21 ' A' ' 11' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 147' ' ' LEU . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.457 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.646 HD12 ' CG1' ' A' ' 62' ' ' VAL . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.753 HD11 ' HD2' ' A' ' 132' ' ' PHE . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.96 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.476 ' N ' ' HE3' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 15.6 t-160 -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 132' ' ' PHE . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 67' ' ' ALA . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.227 0.537 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.534 ' C ' HG23 ' A' ' 79' ' ' VAL . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 83' ' ' VAL . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 92' ' ' VAL . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.883 ' O ' HG22 ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.899 ' HB3' HG23 ' A' ' 107' ' ' VAL . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 97' ' ' LEU . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 98' ' ' ALA . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 110' ' ' THR . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 109' ' ' ILE . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' HB3' HG23 ' A' ' 76' ' ' VAL . 7.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.127 HD23 HG22 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.773 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 1.032 HG13 HD13 ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 139' ' ' ILE . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.033 HG22 HD23 ' A' ' 7' ' ' LEU . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD13 HD21 ' A' ' 35' ' ' LEU . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.653 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.455 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 7.5 p . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.911 ' O ' HD12 ' A' ' 7' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.035 HD23 HG22 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' OD1' ' A' ' 33' ' ' ASP . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' CD ' HD21 ' A' ' 22' ' ' LEU . 3.1 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' OE1' ' A' ' 102' ' ' GLN . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.619 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' HG22 ' A' ' 8' ' ' VAL . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 41.5 t-80 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LEU . 5.1 m80 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG21 ' A' ' 62' ' ' VAL . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.957 HD21 HG21 ' A' ' 134' ' ' VAL . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' A' ' 3' ' ' VAL . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 12.1 t-160 -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.673 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 67' ' ' ALA . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 129' ' ' ASN . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 17.2 t-20 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.933 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 120' ' ' ASP . 4.2 m . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.262 0.554 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 90' ' ' LEU . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.764 ' N ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.771 ' HG ' HG23 ' A' ' 87' ' ' VAL . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 92' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' VAL . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.411 ' OE1' HG22 ' A' ' 23' ' ' VAL . 12.0 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.858 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 117' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.756 HG12 HG23 ' A' ' 112' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 76' ' ' VAL . 43.3 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 12.9 p30 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 130' ' ' LEU . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.3 t30 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.957 HG21 HD21 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.532 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 54' ' ' VAL . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.035 HG22 HD23 ' A' ' 7' ' ' LEU . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 147' ' ' LEU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 144' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 143' ' ' THR . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.007 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.012 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.67 ' HB2' ' CE1' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.67 ' CE1' ' HB2' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.637 ' CG1' HG21 ' A' ' 8' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.946 ' HA ' HG21 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.851 ' HA ' HD11 ' A' ' 35' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 8' ' ' VAL . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.037 ' CG2' HG23 ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.954 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.985 ' CD2' HD21 ' A' ' 49' ' ' LEU . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.568 ' HB3' HG22 ' A' ' 134' ' ' VAL . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 24' ' ' ASP . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG2' HG23 ' A' ' 17' ' ' THR . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.841 ' O ' HG22 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 1.131 ' CD2' HD13 ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.851 HD11 ' HA ' ' A' ' 6' ' ' ASP . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.642 ' CG ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.131 HD13 ' CD2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.971 HD11 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.985 HD21 ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 67' ' ' ALA . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.94 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.94 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.971 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 13.0 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.302 0.572 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.594 HG23 HD23 ' A' ' 90' ' ' LEU . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD23 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' HG21 ' A' ' 109' ' ' ILE . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' ILE . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.843 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.751 HG23 HG13 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 109' ' ' ILE . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 HG23 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p30 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.821 ' CB ' HG12 ' A' ' 15' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.938 ' CG1' HD13 ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 9' ' ' VAL . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.037 HG23 ' CG2' ' A' ' 9' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.055 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 144' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 143' ' ' THR . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.985 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.055 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 152' ' ' VAL . 4.8 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 HG21 ' A' ' 9' ' ' VAL . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.863 ' O ' HD22 ' A' ' 7' ' ' LEU . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 6' ' ' ASP . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 152' ' ' VAL . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.079 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 31' ' ' PRO . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.77 HD21 ' OH ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CB ' HG12 ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.031 HG12 ' O ' ' A' ' 24' ' ' ASP . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.031 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.83 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 28' ' ' VAL . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.83 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.834 ' CZ ' HD23 ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.899 HD21 ' HG ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.661 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.834 HD23 ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.899 HG21 ' HA ' ' A' ' 67' ' ' ALA . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.527 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.568 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' HG23 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG11 ' HA3' ' A' ' 44' ' ' GLY . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.899 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HE2' HD11 ' A' ' 42' ' ' ILE . 24.1 m-85 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 119' ' ' VAL . 1.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.312 0.577 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 83' ' ' VAL . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.43 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.764 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.69 HG13 HG22 ' A' ' 117' ' ' VAL . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG22 HG13 ' A' ' 112' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' VAL . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.218 0.532 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.592 HG12 ' CB ' ' A' ' 13' ' ' TYR . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 52' ' ' HIS . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 54' ' ' VAL . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 7' ' ' LEU . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.854 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 144' ' ' GLU . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.872 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.899 ' HG ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 8' ' ' VAL . 57.6 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.976 ' CB ' HD21 ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.795 HD22 ' HB3' ' A' ' 4' ' ' ALA . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 152' ' ' VAL . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' HG23 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.004 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.555 ' CB ' HG12 ' A' ' 134' ' ' VAL . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' N ' HD23 ' A' ' 22' ' ' LEU . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 1.004 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 28' ' ' VAL . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.703 ' O ' HD23 ' A' ' 35' ' ' LEU . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.91 HG21 ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD21 HG11 ' A' ' 134' ' ' VAL . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.538 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.938 HG21 ' HB1' ' A' ' 48' ' ' ALA . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 120' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.578 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.676 HG23 ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.719 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.719 ' H ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 1.028 ' O ' HD11 ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.883 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 98' ' ' ALA . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' C ' HD13 ' A' ' 109' ' ' ILE . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.028 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.639 ' O ' HG23 ' A' ' 112' ' ' VAL . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 117' ' ' VAL . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.639 HG21 ' HB ' ' A' ' 107' ' ' VAL . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.913 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.8 p-10 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.242 0.544 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 17' ' ' THR . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.568 HG11 HD21 ' A' ' 45' ' ' LEU . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LYS . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 9' ' ' VAL . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB1' ' NE ' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.781 HG22 HD23 ' A' ' 7' ' ' LEU . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.67 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.063 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.487 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.063 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 1.3 m170 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 8' ' ' VAL . 4.9 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 139' ' ' ILE . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.928 HG23 ' CD1' ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 7' ' ' LEU . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.844 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 6' ' ' ASP . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 3' ' ' VAL . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.848 HD21 ' HE1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.902 HG13 ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 131' ' ' LYS . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.829 HG22 HD23 ' A' ' 130' ' ' LEU . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' HB ' ' CG1' ' A' ' 15' ' ' VAL . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.958 ' CD1' HD13 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.785 HD23 ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.76 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 27.9 t-80 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.785 ' CE1' HD23 ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB1' ' HZ ' ' A' ' 58' ' ' PHE . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 139' ' ' ILE . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.858 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.685 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.858 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HH ' ' HE1' ' A' ' 132' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.357 0.598 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 83' ' ' VAL . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' HB ' HG12 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' HD2' HD11 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.744 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.524 ' O ' HD11 ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.477 ' OE1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG21 ' OE1' ' A' ' 102' ' ' GLN . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.846 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.872 ' C ' HD13 ' A' ' 109' ' ' ILE . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 110' ' ' THR . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.598 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.468 ' NE2' ' HB2' ' A' ' 78' ' ' ARG . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 111' ' ' ALA . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 108' ' ' GLU . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.829 HD23 HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.902 ' CE1' HG13 ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 49' ' ' LEU . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.542 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.928 ' CD1' HG23 ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.684 ' O ' HD13 ' A' ' 7' ' ' LEU . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.969 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.969 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 143' ' ' THR . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.733 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 2.3 p . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.686 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.946 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 7' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.975 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 HD22 ' A' ' 11' ' ' LEU . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CB ' HG12 ' A' ' 134' ' ' VAL . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.106 HD13 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.039 ' N ' HD22 ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 28' ' ' VAL . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 1.025 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.2 t-80 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD13 ' HE1' ' A' ' 132' ' ' PHE . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 52' ' ' HIS . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.575 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 1.034 ' NE2' HD11 ' A' ' 139' ' ' ILE . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.839 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.108 HG12 ' HB2' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.108 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.045 HG23 ' HB2' ' A' ' 120' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.221 0.534 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.701 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.834 ' CG1' HG11 ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 83' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.834 HG11 ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.917 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.909 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' ' N ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' N ' ' HE3' ' A' ' 94' ' ' MET . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 107' ' ' VAL . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.907 ' HA ' HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.716 HG12 HG23 ' A' ' 112' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 1.045 ' HB2' HG23 ' A' ' 76' ' ' VAL . 15.6 t0 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 130' ' ' LEU . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.556 ' HE1' HD13 ' A' ' 45' ' ' LEU . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.877 HG12 ' CB ' ' A' ' 13' ' ' TYR . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.987 HG21 ' ND1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.034 HD11 ' NE2' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.616 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.032 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.032 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 39' ' ' GLY . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 146' ' ' GLU . 25.3 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.862 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.702 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.953 ' HA ' HD11 ' A' ' 35' ' ' LEU . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.863 HD21 ' OE2' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.672 HG13 ' HB3' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 138' ' ' ALA . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.876 HD13 HD21 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.725 ' HB3' HG12 ' A' ' 134' ' ' VAL . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 24' ' ' ASP . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.486 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HD12 ' A' ' 22' ' ' LEU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 130' ' ' LEU . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.858 ' O ' HG12 ' A' ' 15' ' ' VAL . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.791 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 6' ' ' ASP . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.792 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HE2' ' A' ' 5' ' ' LYS . 1.7 t-80 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 62' ' ' VAL . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' THR . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.876 HD21 HD13 ' A' ' 11' ' ' LEU . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 54' ' ' VAL . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 134' ' ' VAL . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG12 HG13 ' A' ' 62' ' ' VAL . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.768 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.682 HG13 HG12 ' A' ' 60' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 1.021 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.26 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.845 ' CE2' HD11 ' A' ' 90' ' ' LEU . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD11 ' CE2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.675 ' HG3' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 106' ' ' PRO . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' C ' ' CG1' ' A' ' 107' ' ' VAL . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.675 HD11 ' HG3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.705 HG21 ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.053 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.646 ' OE1' HG13 ' A' ' 118' ' ' VAL . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.705 ' OD1' HG21 ' A' ' 110' ' ' THR . 30.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.414 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.258 0.551 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 130' ' ' LEU . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.768 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.753 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.66 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.672 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.863 ' OE2' HD21 ' A' ' 7' ' ' LEU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.583 HG23 ' OE1' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.921 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.563 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.635 HG21 ' HB ' ' A' ' 8' ' ' VAL . 32.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.918 ' HA ' HG21 ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.613 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.869 ' O ' HD22 ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.896 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 HG23 ' A' ' 139' ' ' ILE . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.774 HD21 ' CB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HB3' HG12 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 HG23 ' A' ' 23' ' ' VAL . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' THR . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.921 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 9' ' ' VAL . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.152 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 1.152 ' CD2' HD23 ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.854 HD11 ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 52' ' ' HIS . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.924 ' CA ' HD12 ' A' ' 130' ' ' LEU . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.22 0.534 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.945 ' HG2' HG23 ' A' ' 118' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.882 HG22 ' H ' ' A' ' 89' ' ' GLU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.617 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.882 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 105' ' ' VAL . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 118' ' ' VAL . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.798 ' HB3' ' CG1' ' A' ' 118' ' ' VAL . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.945 HG23 ' HG2' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.332 0.586 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.924 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.854 ' CE1' HD11 ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.774 ' CB ' HD21 ' A' ' 11' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.552 ' C ' HD12 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.748 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.94 HG23 HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.896 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.031 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.031 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.903 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.63 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 139' ' ' ILE . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 HD22 ' A' ' 49' ' ' LEU . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.932 ' CB ' HD21 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 4' ' ' ALA . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 3' ' ' VAL . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.986 HD13 ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.886 ' OG ' ' HB1' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HA ' HG11 ' A' ' 152' ' ' VAL . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD21 ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.492 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.603 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 40' ' ' SER . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG13 ' CB ' ' A' ' 45' ' ' LEU . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 134' ' ' VAL . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.88 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.897 ' O ' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 62' ' ' VAL . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.552 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.319 0.58 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 119' ' ' VAL . 4.1 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 79' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.009 ' HB ' HD23 ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.009 HD23 ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.905 HG12 ' HB ' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.905 ' HB ' HG12 ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.277 0.561 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.552 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.508 ' HB3' ' CB ' ' A' ' 15' ' ' VAL . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.986 ' CG1' HD13 ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 56' ' ' ASP . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 2' ' ' LYS . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 1.01 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.932 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 34' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.653 ' HE2' HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.904 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.868 ' N ' HD21 ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.877 HG21 HG22 ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.907 HD12 HG13 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 5.5 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.884 HG12 ' O ' ' A' ' 24' ' ' ASP . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.884 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' CD ' ' N ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 1.035 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.835 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.739 HD22 ' HA2' ' A' ' 150' ' ' GLY . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.675 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' LEU . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 41' ' ' LEU . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' HE1' ' HD1' ' A' ' 58' ' ' PHE . 7.9 t-160 -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' HD1' ' HE1' ' A' ' 52' ' ' HIS . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.054 HG12 ' HB2' ' A' ' 67' ' ' ALA . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.98 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' CG ' ' A' ' 129' ' ' ASN . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 1.054 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 76' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.193 0.52 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' HG21 ' A' ' 87' ' ' VAL . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.651 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 96' ' ' PHE . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.636 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' THR . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.548 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.548 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 78' ' ' ARG . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.654 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 64' ' ' ALA . 8.7 m120 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.326 0.584 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.838 HD12 HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.547 ' C ' HG23 ' A' ' 134' ' ' VAL . 37.6 m-20 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.907 HG13 HD12 ' A' ' 11' ' ' LEU . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.999 HG23 HD13 ' A' ' 7' ' ' LEU . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 8' ' ' VAL . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.996 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.996 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.818 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.739 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 44.4 m80 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.881 ' CG2' HG11 ' A' ' 8' ' ' VAL . 16.7 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.614 ' HE2' HG22 ' A' ' 139' ' ' ILE . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.511 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.994 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HG2' ' HA3' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.886 ' HB3' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.101 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.927 ' CG1' HD23 ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 1.5 tt0 -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.906 HG22 HD22 ' A' ' 130' ' ' LEU . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG22 ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.789 ' O ' HG12 ' A' ' 15' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.622 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 43.0 t-80 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.809 ' CD2' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.592 ' C ' HD12 ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.906 HG21 ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 134' ' ' VAL . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 1.029 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.972 HG21 ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.678 ' H ' HG22 ' A' ' 87' ' ' VAL . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.972 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' VAL . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 96' ' ' PHE . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 92' ' ' VAL . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 117' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 112' ' ' VAL . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.777 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.517 HG13 ' C ' ' A' ' 118' ' ' VAL . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HB2' ' N ' ' A' ' 63' ' ' GLY . 3.4 p30 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.311 0.577 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.906 HD22 HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 HD21 ' A' ' 45' ' ' LEU . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 1.029 HG21 ' HB3' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.101 HG23 ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.988 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.988 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 4.6 p80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.938 HG13 ' OE2' ' A' ' 146' ' ' GLU . 74.7 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 7' ' ' LEU . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.055 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 138' ' ' ALA . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE1' HD21 ' A' ' 41' ' ' LEU . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 24' ' ' ASP . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 25' ' ' GLU . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.92 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 8' ' ' VAL . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.043 HD23 ' CE1' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.736 ' CD2' HG13 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 1.043 ' CE1' HD23 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 45' ' ' LEU . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 45' ' ' LEU . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 45' ' ' LEU . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' HG23 ' A' ' 47' ' ' THR . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.809 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 139' ' ' ILE . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CE2' ' CG2' ' A' ' 60' ' ' VAL . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 67' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB2' ' N ' ' A' ' 128' ' ' GLN . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.0 t30 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.839 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.76 -39.75 5.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' GLN . . . -76.17 -51.86 6.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 43.2 mt-30 61.34 43.84 10.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -1.151 . . . . 0.0 110.203 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' OH ' ' OD2' ' A' ' 120' ' ' ASP . 12.6 t80 -43.65 143.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.303 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.01 87.79 5.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 tt0 -65.17 -11.72 43.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -84.45 0.53 49.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.232 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 tp -110.71 -14.37 14.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 120' ' ' ASP . 7.0 m -91.37 123.85 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 110.2 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.756 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HG2' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 90' ' ' LEU . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.747 ' HB3' HG23 ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.469 ' OG1' HG21 ' A' ' 105' ' ' VAL . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 105' ' ' VAL . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' OG1' ' A' ' 100' ' ' THR . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.747 HG23 ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 92' ' ' VAL . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.022 HG23 HG22 ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 112' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.604 ' N ' HG12 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 76' ' ' VAL . 20.6 t0 -167.56 171.68 10.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . . . -91.78 -131.64 5.37 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -114.79 132.44 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -102.38 -2.06 29.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -47.21 -32.43 4.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -3.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 -166.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' ' 64' ' ' ALA . . . 63.66 21.49 65.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.911 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.23 72.92 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 110.237 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 17.1 p-10 -73.2 120.15 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 17' ' ' THR . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' CD1' ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.055 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.719 ' C ' HD23 ' A' ' 7' ' ' LEU . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.992 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.491 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.415 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.992 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.758 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 8' ' ' VAL . 3.3 p -121.99 125.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 45.76 60.29 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 156' ' ' HIS . . . -172.37 -77.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 52.33 -89.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.213 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 154' ' ' GLY . 3.4 t-80 -74.86 -37.75 62.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 157' ' ' ASP . 4.6 t0 -60.54 -28.94 68.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.29 149.63 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -58.14 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.423 ' N ' ' OD2' ' A' ' 163' ' ' ASP . 2.8 p-10 -162.98 80.97 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.32 59.33 3.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 161' ' ' ASP . 14.7 m-20 -121.77 -18.28 7.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -79.51 164.91 23.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.99 175.13 11.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.03 -21.91 43.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.21 150.63 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -1.12 . . . . 0.0 110.177 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.29 -81.5 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.61 -30.82 9.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.72 -166.75 42.79 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.56 160.25 25.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.35 -11.71 4.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.89 -73.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -1.186 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.7 143.68 48.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -153.6 150.3 28.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.151 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.9 87.33 0.13 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -103.27 -65.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 180' ' ' GLY . 8.7 tt0 -119.38 37.53 4.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 64.08 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.151 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 178' ' ' GLU . . . -143.87 -131.37 2.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.26 -142.9 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -53.86 172.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 0.0 110.188 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 184' ' ' CYS . . . -52.94 -20.72 8.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER 64.13 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 110.259 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.5 95.99 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.216 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.81 -86.89 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 54.69 -131.74 47.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -130.6 169.34 15.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 110.224 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 161.97 40.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -57.54 -179.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.149 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 104.51 -56.67 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.8 -90.21 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 194' ' ' GLY . 0.1 OUTLIER 61.46 29.98 18.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 110.266 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 193' ' ' CYS . . . 56.42 102.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 179.52 6.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -1.082 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.209 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG11 ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 3' ' ' VAL . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD12 ' CG1' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.97 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 24' ' ' ASP . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 25' ' ' GLU . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.691 ' HB3' HD11 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.97 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.853 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.853 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.953 HD11 ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HA ' HG12 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' HD1' HG23 ' A' ' 60' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG23 ' HD1' ' A' ' 58' ' ' PHE . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 131' ' ' LYS . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 60' ' ' VAL . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.695 ' HB1' ' OD2' ' A' ' 72' ' ' ASP . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.953 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 65.91 -61.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 126' ' ' ALA . . . -55.88 -64.4 4.42 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 38.8 mt-30 65.83 -143.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -1.156 . . . . 0.0 110.404 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -53.83 120.63 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.695 ' OD2' ' HB1' ' A' ' 64' ' ' ALA . 52.2 p-10 -137.35 74.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.148 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' A' ' 71' ' ' TYR . 77.4 mt-10 -65.77 -18.65 65.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -92.27 3.96 54.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -49.69 -65.32 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 0.0 110.229 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 75' ' ' LEU . 12.3 m -129.26 155.63 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.591 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.491 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.707 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HD3' ' A' ' 78' ' ' ARG . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.707 HG22 ' HB ' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 121' ' ' GLY . 25.6 t0 -85.61 170.96 12.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 120' ' ' ASP . . . 155.58 65.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -81.18 176.61 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -1.119 . . . . 0.0 110.211 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -97.94 157.62 16.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 124' ' ' MET . 6.4 tmm? -61.47 -19.15 61.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.41 -70.1 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.661 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -109.31 -167.3 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 75' ' ' LEU . . . 79.08 21.49 67.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' A' ' 63' ' ' GLY . 23.5 mm100 -92.41 71.0 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -1.141 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.645 ' ND2' ' HB3' ' A' ' 64' ' ' ALA . 9.7 m120 -72.56 135.7 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 132' ' ' PHE . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 130' ' ' LEU . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' A' ' 13' ' ' TYR . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 3' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.074 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 144' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.681 ' H ' HG22 ' A' ' 143' ' ' THR . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.074 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.694 ' HB ' HG11 ' A' ' 8' ' ' VAL . 1.5 p -130.45 111.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 49.3 23.11 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.191 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 158' ' ' HIS . . . -110.85 30.61 7.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.38 -61.27 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.201 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.95 5.84 24.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.73 -13.0 60.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 154' ' ' GLY . 2.7 p80 -155.7 157.3 36.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.03 38.62 1.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -124.47 118.19 26.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 162' ' ' HIS . 3.3 m-20 -139.35 -107.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.203 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 176.22 56.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.103 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.95 -175.14 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -99.16 35.9 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.34 143.59 50.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.78 133.67 8.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.81 44.64 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -1.156 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.4 m 44.91 63.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.82 -87.54 0.21 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 153.07 52.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.38 -173.53 4.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.182 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 61.17 18.05 53.94 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.26 106.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -1.199 . . . . 0.0 110.248 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.2 137.44 48.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -102.01 -161.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.227 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.29 -83.17 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 177' ' ' HIS . 7.4 p80 -150.69 82.36 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -1.128 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -147.19 -164.23 1.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -65.01 155.63 34.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.53 142.02 3.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.88 149.03 0.99 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 15.3 mp0 -117.69 116.24 26.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -1.104 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.9 169.32 19.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 48.74 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -1.185 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.0 p -143.74 -38.58 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -125.91 157.87 20.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.19 -11.02 2.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 43.01 31.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.01 -121.3 6.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 49.49 -161.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -1.149 . . . . 0.0 110.12 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 62.77 70.52 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.32 1.52 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.1 m -122.87 143.91 49.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -1.163 . . . . 0.0 110.186 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.64 -126.62 0.07 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 27.1 p -162.54 177.74 9.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.204 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.86 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.619 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.03 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.03 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' ILE . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.809 HG11 ' CG2' ' A' ' 3' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.015 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.558 ' O ' HG11 ' A' ' 152' ' ' VAL . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.843 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.843 ' CD2' HD23 ' A' ' 35' ' ' LEU . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.72 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 HG21 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HA ' HG12 ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 12.6 t-160 -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.103 HG22 ' HB2' ' A' ' 67' ' ' ALA . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -109.35 52.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.691 ' O ' ' HB2' ' A' ' 64' ' ' ALA . . . -138.6 57.18 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -149.39 106.41 3.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -1.155 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.088 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -43.16 143.4 0.81 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 110.102 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 77' ' ' GLN . 67.0 m-20 -83.53 69.82 10.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.15 -9.29 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.763 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 32.3 p-10 -55.6 -28.86 57.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD12 HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER 173.27 -49.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.634 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HD12 ' A' ' 75' ' ' LEU . 6.2 p -144.21 155.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.682 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.582 ' NE2' ' C ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.04 HG23 HD23 ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.04 HD23 HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.786 ' O ' HG22 ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' THR . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 96' ' ' PHE . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 -83.48 99.3 10.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -166.72 -144.13 4.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' C ' ' NE2' ' A' ' 77' ' ' GLN . 4.5 m120 -118.62 155.58 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -1.159 . . . . 0.0 110.318 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' ND1' ' CG ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -100.93 146.87 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' ' HG ' ' A' ' 125' ' ' LEU . 3.0 tmm? -67.37 -39.99 85.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.338 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.428 ' HG ' ' SD ' ' A' ' 124' ' ' MET . 42.5 mt -117.43 84.79 2.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 110.277 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.088 ' HB1' ' N ' ' A' ' 71' ' ' TYR . . . -144.88 124.79 13.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 71' ' ' TYR . . . 86.73 13.63 66.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -121.71 79.52 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.111 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' GLN . 8.9 p-10 -42.2 138.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.975 ' CE1' HG12 ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.619 ' HB1' HH11 ' A' ' 140' ' ' ARG . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.737 HG22 HD23 ' A' ' 7' ' ' LEU . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.619 HH11 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.97 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.967 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 155' ' ' ALA . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 33' ' ' ASP . 5.5 p -114.51 121.3 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 54.7 t-80 56.75 64.58 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 151' ' ' HIS . . . 111.19 -140.55 16.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . -172.01 125.96 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.51 -11.82 56.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 12.5 t70 -64.83 -42.42 94.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 2.1 m80 57.23 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -152.57 -41.42 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.183 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 159' ' ' HIS . 18.3 m-70 48.88 -174.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 163' ' ' ASP . 38.8 t70 -114.94 37.69 3.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.441 ' CB ' ' O ' ' A' ' 161' ' ' ASP . 0.5 OUTLIER 65.11 -70.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.189 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 161' ' ' ASP . 4.3 m-20 -100.41 65.57 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.32 119.93 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.93 . . . . 0.0 110.189 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.64 79.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.42 172.95 16.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 36.1 m -80.14 -58.85 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -1.144 . . . . 0.0 110.234 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.1 t -163.58 -47.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.78 167.24 32.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.94 -116.62 5.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 99.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.258 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.31 169.57 34.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.29 119.78 24.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -1.18 . . . . 0.0 110.289 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.53 167.58 30.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 178.58 5.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.137 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.82 40.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 179' ' ' HIS . 27.5 t-80 -112.12 -46.4 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -1.176 . . . . 0.0 110.186 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 179' ' ' HIS . 2.6 mt-10 56.21 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 177' ' ' HIS . 4.9 t60 43.56 68.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 110.165 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.41 138.32 6.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 182' ' ' GLU . . . -59.03 -166.29 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER -176.35 -141.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -1.168 . . . . 0.0 110.178 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLU . . . -44.18 -26.58 0.94 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -47.86 170.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 40.4 t -83.96 159.45 21.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.314 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.94 -135.01 5.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.34 -79.06 1.86 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.76 120.92 12.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -1.142 . . . . 0.0 110.149 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 190' ' ' ASN . . . -136.11 -110.23 1.03 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 189' ' ' GLY . 1.1 t-20 62.82 -161.28 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -46.97 103.84 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 162.98 168.85 25.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.2 t -55.76 144.74 26.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -1.177 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 160.07 -134.27 3.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 16.5 p -162.03 82.71 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 110.235 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.002 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.736 ' CB ' HD21 ' A' ' 147' ' ' LEU . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.797 HG21 HG21 ' A' ' 3' ' ' VAL . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.749 HD12 HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' HD22 ' A' ' 22' ' ' LEU . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.839 HD13 ' O ' ' A' ' 15' ' ' VAL . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 22' ' ' LEU . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.75 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.112 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 1.112 ' CD2' HD23 ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.708 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.816 HD11 HG21 ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 137' ' ' VAL . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.088 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 1.029 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.946 ' HB1' ' HG3' ' A' ' 70' ' ' GLN . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.088 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.79 -11.9 57.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' GLN . . . 95.39 90.79 1.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.946 ' HG3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -46.69 170.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 110.153 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 126' ' ' ALA . 2.6 t80 -72.71 129.31 37.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.21 104.02 8.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.13 -17.04 64.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -82.45 -10.26 59.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 122' ' ' ASN . 1.4 tp -88.58 -46.28 9.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 76' ' ' VAL . 28.4 m -56.29 119.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.26 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.808 HG21 ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' C ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.648 ' O ' HG22 ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.636 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 97' ' ' LEU . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' C ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 109' ' ' ILE . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 79' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 111' ' ' ALA . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 -133.48 139.0 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.45 66.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.42 ' H ' HD23 ' A' ' 75' ' ' LEU . 7.2 t30 -81.35 146.55 30.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.164 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.73 140.54 29.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -18.86 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 1.2 mp -98.72 -84.04 0.4 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . 55.37 171.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.13 21.46 77.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 4.2 tt0 -145.64 98.3 3.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -1.167 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.778 ' O ' HD22 ' A' ' 130' ' ' LEU . 17.2 t-20 -54.89 159.45 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 129' ' ' ASN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.816 HG21 HD11 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.002 ' CD1' HG23 ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.77 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.76 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.984 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.984 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.93 HD12 ' HB3' ' A' ' 142' ' ' ALA . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.519 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m -122.93 127.53 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.4 m170 46.29 71.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.88 -171.38 13.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.81 137.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.198 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -66.79 -23.45 66.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.279 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -40.86 29.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.07 19.21 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 111.23 22.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -115.85 -51.18 2.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 162' ' ' HIS . 16.3 t0 45.93 49.97 11.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 52.52 161.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.3 -70.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -155.44 94.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.18 -75.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 167' ' ' CYS . . . -136.34 -177.82 15.3 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 166' ' ' GLY . 1.2 m 59.46 22.72 11.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -1.107 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.0 m -65.39 -158.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.95 -105.64 1.27 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 165.85 144.2 4.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.61 19.59 8.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.85 83.01 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -124.02 14.63 9.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -1.192 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.41 123.64 47.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -112.2 -30.82 7.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.91 136.49 0.19 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -174.41 168.27 3.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.167 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 179' ' ' HIS . 33.9 tp10 -174.52 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' A' ' 178' ' ' GLU . 6.1 p-80 -74.65 -161.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.18 -49.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -128.01 -157.64 9.44 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -149.25 29.92 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 110.242 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.74 47.68 0.05 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.88 -55.83 2.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 62.21 -149.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.188 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.38 2.95 60.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 188' ' ' LYS . . . -92.54 -136.41 7.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER 63.45 -178.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.155 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.19 115.86 0.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -45.41 100.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.68 -35.4 1.88 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.89 38.43 0.5 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.71 74.41 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 195' ' ' CYS . . . 170.65 55.36 0.04 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 194' ' ' GLY . 60.4 m 57.31 -160.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -1.16 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 196' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.238 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.953 ' HA ' HG21 ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 HG23 ' A' ' 139' ' ' ILE . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 137' ' ' VAL . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.917 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CB ' HG12 ' A' ' 134' ' ' VAL . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.5 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' C ' HD22 ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.71 ' O ' HG12 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.917 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 9' ' ' VAL . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.129 HD23 ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.726 ' CD2' HG12 ' A' ' 3' ' ' VAL . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' C ' ' OE2' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 1.129 ' CD2' HD23 ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.642 ' CD2' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD13 ' HZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 139' ' ' ILE . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.693 ' O ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.798 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.698 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' GLY . 38.8 m-85 -135.56 10.93 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' TYR . . . 44.27 89.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.698 ' HG3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -64.63 126.52 28.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -84.6 130.92 34.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 110.357 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 4.5 t0 -126.24 69.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.691 ' HA ' HG12 ' A' ' 76' ' ' VAL . 2.0 mt-10 -69.02 -7.1 32.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.403 ' OD1' HD21 ' A' ' 125' ' ' LEU . 1.3 m120 -61.75 -25.84 67.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.49 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.654 HD13 ' N ' ' A' ' 121' ' ' GLY . 0.3 OUTLIER -169.36 31.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 110.595 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 76' ' ' VAL . 12.6 p -95.14 95.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 83' ' ' VAL . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 HD13 ' A' ' 90' ' ' LEU . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD13 HG23 ' A' ' 87' ' ' VAL . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.679 ' O ' HG22 ' A' ' 107' ' ' VAL . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.788 ' C ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HA ' HG13 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 112' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.58 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 -159.52 113.68 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.654 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -62.14 119.36 17.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 24.4 p-10 -59.03 122.8 14.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -1.116 . . . . 0.0 110.198 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -102.07 -170.15 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -77.38 -45.04 27.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.403 HD21 ' OD1' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -59.69 -30.54 68.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 70' ' ' GLN . . . -150.41 145.31 26.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.72 21.51 6.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 129' ' ' ASN . 2.4 mt-30 -123.18 84.84 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -1.166 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 128' ' ' GLN . 4.9 t30 -42.45 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.882 ' HZ ' HD13 ' A' ' 45' ' ' LEU . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 56' ' ' ASP . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 11' ' ' LEU . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.953 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.901 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.025 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.025 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.014 HD22 HD21 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.499 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.513 ' HA ' HD13 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.473 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p -65.93 142.88 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.42 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 63.7 -158.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.853 . . . . 0.0 110.235 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.7 -173.85 17.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.49 ' O ' ' ND1' ' A' ' 158' ' ' HIS . . . -78.33 4.19 13.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -1.141 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -56.31 -26.99 54.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -76.97 -58.28 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 60.91 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -110.38 -21.59 12.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.215 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -178.84 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -74.06 -179.6 3.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.64 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -68.21 125.21 25.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.281 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.92 163.89 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 110.17 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.06 107.18 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.22 109.84 2.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.05 -47.59 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -1.177 . . . . 0.0 110.215 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.2 p -125.14 20.37 8.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.14 -110.08 3.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.27 67.46 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -45.16 -28.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -168.42 -157.24 11.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -124.25 134.25 53.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -1.18 . . . . 0.0 110.259 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.49 60.69 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.93 . . . . 0.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 177' ' ' HIS . 0.3 OUTLIER -78.92 5.16 12.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.03 -19.29 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.531 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 4.9 t60 -108.73 125.01 51.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -1.154 . . . . 0.0 110.189 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.34 147.94 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -0.945 . . . . 0.0 110.279 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -71.43 96.47 1.49 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.57 -95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.75 177.23 30.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.85 126.82 15.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -1.185 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.65 43.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.497 ' O ' ' C ' ' A' ' 185' ' ' CYS . 95.1 m -90.09 77.2 6.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -1.181 . . . . 0.0 110.245 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 184' ' ' CYS . 14.5 p 33.8 45.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.584 -0.698 . . . . 0.0 110.518 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.34 52.14 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 188' ' ' LYS . . . -102.6 133.69 11.5 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 187' ' ' GLY . 37.3 mtpt 43.51 -153.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.82 -174.2 25.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -162.97 148.94 12.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.133 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.99 127.6 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 193' ' ' CYS . . . -110.18 15.52 30.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 192' ' ' GLY . 0.1 OUTLIER 173.05 131.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -1.15 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 159.66 -35.34 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 11.3 t -138.03 114.31 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 110.179 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.3 p80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.21 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.037 ' HG2' HD11 ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.754 ' C ' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 HG21 ' A' ' 9' ' ' VAL . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.9 ' HA ' HD11 ' A' ' 35' ' ' LEU . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 HG13 ' A' ' 3' ' ' VAL . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.88 ' O ' HG22 ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' HD11 ' A' ' 22' ' ' LEU . 2.0 mp0 -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.882 ' CG1' HD21 ' A' ' 130' ' ' LEU . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.7 HG22 HD12 ' A' ' 130' ' ' LEU . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 14' ' ' GLN . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' VAL . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE1' HD13 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 1.008 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.008 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.076 HD12 ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 1.076 ' CD2' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 6' ' ' ASP . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.56 ' CD2' HG11 ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.833 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.945 HD11 ' CZ ' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.793 HG21 ' HA ' ' A' ' 67' ' ' ALA . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD13 ' HE1' ' A' ' 132' ' ' PHE . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 44' ' ' GLY . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 3' ' ' VAL . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.695 ' HA ' HG13 ' A' ' 136' ' ' VAL . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 1.028 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 128' ' ' GLN . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.028 ' HB3' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -80.36 -18.15 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.07 114.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' O ' ' CA ' ' A' ' 127' ' ' GLY . 1.3 pp0? -128.96 151.65 49.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.461 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 126' ' ' ALA . 9.2 t80 -60.22 123.63 17.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' HB2' ' HA2' ' A' ' 127' ' ' GLY . 48.8 t0 -137.11 118.71 14.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 5.5 mm-40 -68.68 -33.31 73.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -58.37 -15.63 11.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 128' ' ' GLN . 0.2 OUTLIER -65.47 -16.72 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.0 136.46 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.308 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.462 HE21 HG11 ' A' ' 79' ' ' VAL . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.656 ' CB ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' VAL . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 96' ' ' PHE . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 109' ' ' ILE . 5.6 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 112' ' ' VAL . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.663 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG21 ' CD ' ' A' ' 128' ' ' GLN . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.073 HG13 HG12 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.073 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.656 HG12 ' CB ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CD2' ' A' ' 123' ' ' HIS . 18.5 t70 -108.73 165.93 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -99.17 177.98 30.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -63.63 99.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -1.157 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.56 ' CD2' ' OD2' ' A' ' 120' ' ' ASP . 42.9 m170 -44.04 -32.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.737 ' O ' HD12 ' A' ' 125' ' ' LEU . 5.1 ttp -57.64 -23.98 54.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.228 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 124' ' ' MET . 7.4 mp -124.63 39.54 3.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLN . . . -69.81 166.42 19.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.247 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' ASN . . . 91.48 21.77 33.63 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.95 70.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -1.163 . . . . 0.0 110.09 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 128' ' ' GLN . 1.8 m-20 164.63 71.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.397 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.882 HD21 ' CG1' ' A' ' 15' ' ' VAL . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.788 ' HE1' HD13 ' A' ' 45' ' ' LEU . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.649 HG11 HD21 ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 1' ' ' MET . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.925 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.925 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 38' ' ' HIS . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.7 p80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 146' ' ' GLU . 1.6 p -121.54 111.47 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 154' ' ' GLY . 69.2 t60 -169.47 -88.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.533 ' N ' ' CD2' ' A' ' 153' ' ' HIS . . . -55.0 -103.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 48.17 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 110.287 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -61.21 -13.16 16.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.05 -42.52 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.883 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.81 -161.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 110.236 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.25 74.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -62.08 104.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 -168.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -166.76 137.16 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.228 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -113.29 79.62 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 3.8 t60 -51.84 96.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 164' ' ' HIS . 78.4 m-20 54.93 36.55 27.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 116.94 -158.49 14.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -50.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -1.14 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 41.2 t -163.99 160.26 21.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 120.8 67.36 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.4 -69.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.91 176.64 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 110.208 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.34 -114.05 3.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 50.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 64.9 m-20 -138.22 174.95 10.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.263 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 19.8 m80 -159.59 -178.9 7.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.05 132.37 12.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 179' ' ' HIS . 1.3 t60 -111.86 65.65 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -1.155 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 177' ' ' HIS . 11.6 tt0 54.42 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.164 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -130.79 -170.77 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.188 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.21 179.48 38.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 140.12 -88.73 0.19 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -99.46 -3.22 34.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . 142.88 -168.29 26.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.35 76.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.127 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 183' ' ' GLY . 63.8 m -79.97 -86.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.81 -109.71 3.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -169.1 106.56 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 106.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -121.72 117.25 3.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.61 8.53 10.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.244 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -60.56 -106.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.509 ' O ' ' C ' ' A' ' 193' ' ' CYS . . . -59.95 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.509 ' C ' ' O ' ' A' ' 192' ' ' GLY . 14.9 p 33.48 -150.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.994 . . . . 0.0 110.578 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 126.74 -54.97 0.75 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.521 ' HG ' ' CE1' ' A' ' 196' ' ' HIS . 26.7 t -93.35 -87.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 195' ' ' CYS . 5.6 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.14 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.836 ' HA ' HG21 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.753 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.02 ' HA ' HD11 ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 152' ' ' VAL . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 9' ' ' VAL . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD13 ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.787 ' HB3' HG13 ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG2' ' OE1' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.531 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.815 ' C ' HD12 ' A' ' 22' ' ' LEU . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 21' ' ' VAL . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.742 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 41' ' ' LEU . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.683 ' O ' HG21 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.02 HD11 ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HB3' HD21 ' A' ' 45' ' ' LEU . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 68' ' ' TYR . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 47' ' ' THR . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 43' ' ' SER . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.557 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 62' ' ' VAL . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HE1' HD11 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -98.32 4.62 48.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.51 -65.25 0.83 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 50.84 86.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.152 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 73' ' ' GLU . 1.9 t80 -74.48 126.88 31.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -123.51 80.7 1.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 71' ' ' TYR . 1.5 mt-10 -69.26 -7.09 33.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.2 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' C ' ' HG ' ' A' ' 75' ' ' LEU . 54.4 t-20 -64.54 -46.61 82.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 0.0 110.342 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.825 HD12 HG23 ' A' ' 76' ' ' VAL . 1.2 pp 177.98 52.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.413 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.825 HG23 HD12 ' A' ' 75' ' ' LEU . 70.0 t -139.2 110.33 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' CD ' ' ND2' ' A' ' 122' ' ' ASN . 7.2 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 83' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.669 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 89' ' ' GLU . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 92' ' ' VAL . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HG3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.852 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.706 ' HA ' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.75 HD13 HG12 ' A' ' 119' ' ' VAL . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.02 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 118' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.02 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 109' ' ' ILE . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 3.1 p30 -85.14 119.82 25.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 177.28 -97.77 0.11 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 0.4 OUTLIER -118.68 120.77 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.125 . . . . 0.0 110.177 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 1.7 t-80 -44.99 147.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.3 tpt -77.22 -38.07 52.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.6 tt -125.67 78.11 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.185 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 123' ' ' HIS . . . -164.33 166.4 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' CA ' ' CD2' ' A' ' 71' ' ' TYR . . . 103.47 9.15 39.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.4 OUTLIER -146.38 88.99 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.221 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 128' ' ' GLN . 10.2 p30 -42.08 152.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.687 ' HD1' HG23 ' A' ' 15' ' ' VAL . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' TYR . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.836 HG21 ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.972 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.954 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 33' ' ' ASP . 16.0 m -128.47 142.39 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 1.6 m-70 58.55 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.23 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -109.03 149.79 17.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.05 13.91 10.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.279 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -15.44 63.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -71.09 -60.61 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 t60 62.88 164.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.165 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -161.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -139.25 164.83 28.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.64 145.25 48.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER 178.65 -34.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 5.2 m-20 64.15 33.01 12.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.44 75.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.73 176.88 8.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -152.8 57.42 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.63 71.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.3 m -138.85 -44.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 110.218 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.96 66.17 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.75 8.64 59.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -1.159 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.82 66.6 1.91 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.41 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.52 170.67 15.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -50.83 177.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -122.28 141.58 14.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 33.8 p80 -122.86 -162.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -1.161 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER 63.58 57.9 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.237 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 46.38 -172.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.52 -85.98 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 173.24 41.78 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.44 -163.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.24 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . 152.61 -19.63 0.79 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 183' ' ' GLY . 31.8 p -47.25 174.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 68.6 m -93.14 -15.06 26.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.67 68.79 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.42 146.93 14.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -63.77 -61.89 2.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -1.191 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.9 70.36 0.03 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -121.85 140.83 51.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -1.19 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 55.42 -104.17 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.26 -131.39 10.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 194' ' ' GLY . 19.9 p -171.28 -144.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 193' ' ' CYS . . . -132.21 -80.55 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.08 102.71 5.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -1.117 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.132 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 35' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.911 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.911 ' CD1' HG12 ' A' ' 9' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.657 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 1.025 ' CB ' HG22 ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 24' ' ' ASP . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' HD12 ' A' ' 22' ' ' LEU . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD21 ' OE2' ' A' ' 25' ' ' GLU . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.558 ' OE2' HD21 ' A' ' 22' ' ' LEU . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.657 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.468 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 150' ' ' GLY . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' GLY . 31.1 m80 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.624 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.866 HG21 ' HA ' ' A' ' 67' ' ' ALA . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.039 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.727 ' ND1' HG23 ' A' ' 136' ' ' VAL . 19.0 t-160 -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.039 ' CZ ' ' HB1' ' A' ' 48' ' ' ALA . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.747 HG12 ' HB2' ' A' ' 67' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.797 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' CG ' ' A' ' 70' ' ' GLN . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.866 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 123' ' ' HIS . 20.8 m-85 -116.48 -7.08 11.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' GLN . . . 55.76 17.96 16.09 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.642 ' CG ' ' HB1' ' A' ' 64' ' ' ALA . 24.8 mt-30 60.51 81.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.234 -1.157 . . . . 0.0 110.466 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.617 ' N ' ' HB2' ' A' ' 126' ' ' ALA . 2.9 p90 -84.5 121.64 27.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.33 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 4.3 t0 -83.48 126.93 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -51.92 -20.14 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.0 4.01 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.978 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 2.0 tt -75.71 -44.41 42.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 76' ' ' VAL . 34.2 m -67.93 95.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 75' ' ' LEU . 10.8 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' C ' HG13 ' A' ' 79' ' ' VAL . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.817 ' O ' HG22 ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.526 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HE2' HG11 ' A' ' 117' ' ' VAL . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 92' ' ' VAL . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.624 ' HB3' HD11 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 117' ' ' VAL . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.526 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' H ' HG22 ' A' ' 119' ' ' VAL . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 -153.25 171.68 18.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 145.22 75.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.595 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 25.6 p-10 -108.66 107.36 17.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 0.0 110.202 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.617 ' CG ' ' HA ' ' A' ' 68' ' ' TYR . 17.3 m80 -68.9 -167.22 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 68' ' ' TYR . 1.6 mmt -77.58 -15.23 59.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 128' ' ' GLN . 0.1 OUTLIER 178.86 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.012 -1.055 . . . . 0.0 110.313 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.617 ' HB2' ' N ' ' A' ' 71' ' ' TYR . . . -94.01 150.46 20.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.298 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.54 52.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.936 ' CB ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -126.6 73.33 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.9 t-20 -41.34 142.91 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.676 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HD22 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 6.2 t30 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 1.025 HG22 ' CB ' ' A' ' 13' ' ' TYR . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.727 HG23 ' ND1' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.874 HG22 HD22 ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.049 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 145' ' ' GLU . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.006 ' OE2' HG23 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.049 HD23 ' HB3' ' A' ' 142' ' ' ALA . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.698 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 2.0 p80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.006 HG23 ' OE2' ' A' ' 146' ' ' GLU . 2.7 p -79.8 119.01 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t60 48.82 -151.83 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 48.92 66.69 2.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.66 144.71 36.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.159 . . . . 0.0 110.233 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.1 -56.29 4.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.5 -48.73 7.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 55.21 50.32 15.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' CE1' ' OD1' ' A' ' 161' ' ' ASP . 3.7 t-160 -115.55 128.67 56.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.209 -0.932 . . . . 0.0 110.238 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -94.4 52.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 159' ' ' HIS . 13.5 m-20 -69.95 157.13 38.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -173.54 56.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.196 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -165.49 -48.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.155 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -73.29 70.61 1.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.06 105.01 3.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 110.24 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.0 125.89 1.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.94 70.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.238 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 170' ' ' GLY . 0.8 OUTLIER -62.21 -13.51 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.257 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.7 95.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 168' ' ' CYS . . . -152.72 -126.72 1.2 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -76.92 85.14 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -1.156 . . . . 0.0 110.216 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.67 3.74 32.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.25 147.58 14.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 p-10 -63.45 -170.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -172.07 103.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.94 136.53 6.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -97.44 114.36 26.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.46 60.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -83.65 1.02 44.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.06 -98.13 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.73 -160.82 34.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -104.5 138.88 40.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.185 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -100.45 103.6 2.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.8 t -104.62 23.49 13.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.234 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.55 74.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.75 146.56 4.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 52.43 -107.37 0.5 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -46.17 151.32 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -1.184 . . . . 0.0 110.175 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.4 151.37 5.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.75 -154.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -1.14 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 124.85 -47.67 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 161.68 -92.53 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.0 m 44.98 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 110.169 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.98 -69.88 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.97 -69.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.189 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HE3' ' N ' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.944 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.032 HD13 HG13 ' A' ' 134' ' ' VAL . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.831 HG12 ' O ' ' A' ' 24' ' ' ASP . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.127 HG22 HD23 ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.831 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' HE2' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.616 ' OH ' HD21 ' A' ' 11' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 147' ' ' LEU . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.646 HD12 ' CG1' ' A' ' 62' ' ' VAL . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.753 HD11 ' HD2' ' A' ' 132' ' ' PHE . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.96 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' N ' ' HE3' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.548 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 15.6 t-160 -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 132' ' ' PHE . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 67' ' ' ALA . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 127' ' ' GLY . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 -94.55 -37.95 11.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 64' ' ' ALA . . . 54.77 74.24 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.598 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 53.8 mt-30 -87.59 -146.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 110.316 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.909 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 27.2 p90 -81.99 125.87 31.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.06 -1.025 . . . . 0.0 110.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -82.98 145.42 29.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.911 -1.118 . . . . 0.0 110.04 179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.83 -6.84 9.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.63 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.412 ' OD1' ' HB3' ' A' ' 72' ' ' ASP . 11.4 p-10 -48.77 -21.79 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -108.81 57.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p -93.62 155.72 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.534 ' C ' HG23 ' A' ' 79' ' ' VAL . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 83' ' ' VAL . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 92' ' ' VAL . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.883 ' O ' HG22 ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.899 ' HB3' HG23 ' A' ' 107' ' ' VAL . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 97' ' ' LEU . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 98' ' ' ALA . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 110' ' ' THR . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 109' ' ' ILE . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.62 ' HB2' ' ND2' ' A' ' 122' ' ' ASN . 7.9 p-10 -132.26 106.41 7.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -70.87 79.28 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.676 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 69.2 m-80 -118.68 178.29 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -1.125 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 122' ' ' ASN . 1.6 t-160 -56.74 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 110.788 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.2 ttm -77.53 -45.29 25.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.909 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.49 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 8.1 tp -178.21 115.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.013 . . . . 0.0 110.385 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . -122.58 176.73 5.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 110.131 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 64' ' ' ALA . . . 58.94 16.47 32.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASN . 1.9 mp0 -120.23 85.95 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -1.16 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 -42.65 140.21 1.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.127 HD23 HG22 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.773 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 1.032 HG13 HD13 ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 139' ' ' ILE . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.033 HG22 HD23 ' A' ' 7' ' ' LEU . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD13 HD21 ' A' ' 35' ' ' LEU . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.653 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 153' ' ' HIS . 7.5 p -103.15 139.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 28.2 t-80 57.35 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.272 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 151' ' ' HIS . . . 93.14 130.19 5.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 158' ' ' HIS . . . -125.97 155.82 40.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -1.1 . . . . 0.0 110.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -66.31 -48.89 68.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.28 -18.62 41.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 155' ' ' ALA . 0.2 OUTLIER -108.19 176.98 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER 61.29 140.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -102.34 88.69 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.9 67.04 1.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.27 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -136.14 -67.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 31.5 p30 -176.32 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 166' ' ' GLY . 31.3 m80 -127.17 -5.48 6.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.1 t70 65.85 -67.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.23 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 168' ' ' CYS . . . 106.55 -164.22 13.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 166' ' ' GLY . 2.6 t 66.41 -60.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -1.175 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 166' ' ' GLY . 1.7 m -152.77 43.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.14 -167.78 7.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 172' ' ' GLY . . . -88.61 42.79 3.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.91 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 170' ' ' GLY . . . -177.71 145.55 7.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -47.01 113.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.1 t70 -98.78 -63.1 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -44.96 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 177' ' ' HIS . . . -144.95 38.12 1.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER 179.07 116.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -1.155 . . . . 0.0 110.228 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.89 39.5 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -80.72 -39.81 26.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.38 116.48 0.42 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 182' ' ' GLU . . . -157.18 26.7 0.49 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' GLY . 4.6 tm-20 54.27 104.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -1.108 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.86 31.92 4.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 151.7 49.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.7 p -120.57 -179.12 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.96 108.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -166.09 -47.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.73 118.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -1.145 . . . . 0.0 110.194 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.92 165.57 19.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.68 122.4 38.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -1.134 . . . . 0.0 110.194 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 54.42 33.94 54.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.17 -165.03 1.33 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.7 p -167.24 38.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -1.124 . . . . 0.0 110.167 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 195' ' ' CYS . . . -165.94 -140.25 2.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 194' ' ' GLY . 37.6 t 58.0 160.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.19 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.911 ' O ' HD12 ' A' ' 7' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.035 HD23 HG22 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' OD1' ' A' ' 33' ' ' ASP . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' CD ' HD21 ' A' ' 22' ' ' LEU . 3.1 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' OE1' ' A' ' 102' ' ' GLN . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.619 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' HG22 ' A' ' 8' ' ' VAL . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 41.5 t-80 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 35' ' ' LEU . 5.1 m80 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG21 ' A' ' 62' ' ' VAL . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.957 HD21 HG21 ' A' ' 134' ' ' VAL . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' A' ' 3' ' ' VAL . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CE1' ' HB2' ' A' ' 58' ' ' PHE . 12.1 t-160 -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.673 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 67' ' ' ALA . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 129' ' ' ASN . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' O ' ' HA2' ' A' ' 69' ' ' GLY . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 17.2 t-20 -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.933 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 -100.3 -11.17 20.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 39.4 41.5 1.6 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.598 ' HA ' ' N ' ' A' ' 127' ' ' GLY . 1.3 mt-30 63.64 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -1.156 . . . . 0.0 109.846 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.652 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.1 p90 -81.51 122.6 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 110.571 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -94.49 148.05 22.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HB2' ' A' ' 122' ' ' ASN . 0.4 OUTLIER -66.24 -7.07 16.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 110.49 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -70.98 -30.04 66.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD21 ' H ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -108.82 79.24 1.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 120' ' ' ASP . 4.2 m -52.98 155.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 90' ' ' LEU . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.764 ' N ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.771 ' HG ' HG23 ' A' ' 87' ' ' VAL . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 92' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' VAL . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.411 ' OE1' HG22 ' A' ' 23' ' ' VAL . 12.0 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.858 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 117' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.756 HG12 HG23 ' A' ' 112' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 76' ' ' VAL . 43.3 t0 -117.28 102.17 9.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -119.09 160.81 14.03 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 3.9 t30 -117.86 142.63 47.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -1.097 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.55 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -102.37 177.62 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.971 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' CD2' ' A' ' 125' ' ' LEU . 3.6 ttt -47.11 -28.79 1.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.993 . . . . 0.0 109.851 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER 174.23 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -40.48 131.69 2.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.598 ' N ' ' HA ' ' A' ' 70' ' ' GLN . . . 113.1 21.82 5.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 129' ' ' ASN . 20.8 mm-40 -87.24 75.18 9.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -1.095 . . . . 0.0 109.825 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' A' ' 128' ' ' GLN . 12.9 p30 -26.27 139.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.803 -0.561 . . . . 0.0 111.261 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 130' ' ' LEU . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.3 t30 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.957 HG21 HD21 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.532 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 54' ' ' VAL . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.035 HG22 HD23 ' A' ' 7' ' ' LEU . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 147' ' ' LEU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 144' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 143' ' ' THR . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.007 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.012 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.67 ' HB2' ' CE1' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.67 ' CE1' ' HB2' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.637 ' CG1' HG21 ' A' ' 8' ' ' VAL . 7.5 p -130.6 139.29 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 65.01 80.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.927 . . . . 0.0 110.202 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.57 -44.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -48.59 124.46 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -1.126 . . . . 0.0 110.143 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.65 -34.36 76.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' HB2' ' OE1' ' A' ' 145' ' ' GLU . 5.0 m-20 -48.06 -60.45 2.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.1 67.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.225 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 161' ' ' ASP . 53.9 p-80 -96.34 158.61 15.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' HIS . 11.6 m-70 42.33 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.173 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 41.46 -155.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 162' ' ' HIS . 7.3 t60 -115.11 64.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.4 t0 -119.21 50.17 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 166' ' ' GLY . 19.3 p-80 178.05 -39.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.4 t70 65.86 -65.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 164' ' ' HIS . . . 143.56 -123.81 2.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 166' ' ' GLY . 26.6 t 58.47 87.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -1.132 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.68 -65.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.13 137.45 3.74 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -168.75 71.26 0.15 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 158.49 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.172 . . . . 0.0 110.176 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.4 151.47 35.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -78.61 -154.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -1.152 . . . . 0.0 110.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 175' ' ' HIS . 1.6 t70 -151.69 158.44 43.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.161 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.405 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 58.2 m-70 -138.34 -88.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.3 128.51 1.94 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -132.05 160.31 36.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.28 90.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -146.28 -49.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.2 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.86 -107.54 2.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -160.96 172.94 37.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.06 123.6 4.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.97 83.58 1.63 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 28.54 6.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.241 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.92 44.31 2.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.41 -80.51 1.32 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.2 69.6 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 50.86 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.147 . . . . 0.0 110.287 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.63 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -172.63 38.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -1.157 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.54 -21.75 2.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.08 174.54 51.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.8 m -150.79 57.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.13 . . . . 0.0 110.196 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 130.3 57.94 0.1 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 21.6 p -115.89 4.2 13.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -1.122 . . . . 0.0 110.232 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.056 -0.974 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.946 ' HA ' HG21 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.851 ' HA ' HD11 ' A' ' 35' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 8' ' ' VAL . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.037 ' CG2' HG23 ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.954 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.985 ' CD2' HD21 ' A' ' 49' ' ' LEU . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.568 ' HB3' HG22 ' A' ' 134' ' ' VAL . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 24' ' ' ASP . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG2' HG23 ' A' ' 17' ' ' THR . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.841 ' O ' HG22 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 1.131 ' CD2' HD13 ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.851 HD11 ' HA ' ' A' ' 6' ' ' ASP . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.642 ' CG ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.131 HD13 ' CD2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.971 HD11 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.985 HD21 ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 67' ' ' ALA . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.94 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' C ' ' A' ' 69' ' ' GLY . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.94 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.971 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 13.0 m-85 -135.79 13.86 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' HA ' ' A' ' 64' ' ' ALA . . . -93.58 -19.5 34.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.59 -25.15 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.31 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 5.7 t80 -43.26 143.32 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 110.161 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 1.2 t70 -130.8 148.26 52.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -24.14 64.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.223 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -50.8 -20.94 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 59.35 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 p -56.69 153.82 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.594 HG23 HD23 ' A' ' 90' ' ' LEU . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD23 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' HG21 ' A' ' 109' ' ' ILE . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' ILE . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.843 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.751 HG23 HG13 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 109' ' ' ILE . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 HG23 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p30 -88.23 155.8 19.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.36 96.74 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -62.96 137.93 58.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -1.123 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.27 164.57 14.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.17 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mtm -71.4 -12.92 61.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.269 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 130' ' ' LEU . 1.4 mm? -89.22 -66.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -47.82 117.89 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -136.99 81.2 1.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -1.155 . . . . 0.0 110.19 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -58.44 172.0 0.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.821 ' CB ' HG12 ' A' ' 15' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.938 ' CG1' HD13 ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 9' ' ' VAL . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.037 HG23 ' CG2' ' A' ' 9' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.055 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 144' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 143' ' ' THR . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.985 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.055 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 152' ' ' VAL . 4.8 m -130.56 119.67 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 81.6 t60 57.93 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 155' ' ' ALA . . . 75.61 158.78 7.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 158' ' ' HIS . . . -175.89 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -1.166 . . . . 0.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -83.98 5.46 25.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.269 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.53 -31.51 57.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.413 ' O ' ' CB ' ' A' ' 159' ' ' HIS . 1.9 p80 -118.84 170.36 9.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 158' ' ' HIS . 0.5 OUTLIER 63.27 77.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.175 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -157.99 48.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.193 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.32 45.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -99.48 -52.01 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.267 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -44.62 123.98 3.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.475 ' CE1' ' OD1' ' A' ' 165' ' ' ASP . 26.8 t-80 -151.97 152.99 33.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' OD1' ' CE1' ' A' ' 164' ' ' HIS . 9.6 p-10 -60.55 -177.56 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.09 135.83 1.89 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.447 ' HG ' ' CE1' ' A' ' 173' ' ' HIS . 0.5 OUTLIER -151.83 41.14 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -1.149 . . . . 0.0 110.144 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 22.2 p -62.07 178.8 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.47 41.17 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 174.86 37.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -91.08 67.4 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -1.157 . . . . 0.0 110.152 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -62.04 -31.26 78.08 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-70 -60.58 -128.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 110.133 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 173' ' ' HIS . 1.9 t70 -41.66 136.57 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 110.264 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.46 152.47 21.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.44 80.63 0.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -63.16 -69.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.1 114.58 2.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -171.96 169.14 5.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 107.59 -15.2 38.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 182' ' ' GLU . . . 64.12 173.06 2.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 181' ' ' GLY . 10.6 pt-20 38.0 35.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.44 -1.036 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.72 -31.58 2.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.6 t -101.46 -5.91 24.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -1.143 . . . . 0.0 110.11 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -138.54 104.55 5.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -172.45 70.56 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.45 -31.68 29.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 162.92 6.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 110.188 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -98.72 -159.16 29.67 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -90.44 -43.78 10.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -177.75 134.08 2.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.19 24.77 3.95 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 49.1 t -110.06 59.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 110.173 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -108.91 -10.62 24.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.88 -15.06 11.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -1.135 . . . . 0.0 110.192 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 HG21 ' A' ' 9' ' ' VAL . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.863 ' O ' HD22 ' A' ' 7' ' ' LEU . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 6' ' ' ASP . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 152' ' ' VAL . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.079 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 31' ' ' PRO . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.77 HD21 ' OH ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CB ' HG12 ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.031 HG12 ' O ' ' A' ' 24' ' ' ASP . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.031 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.83 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 28' ' ' VAL . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.83 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.834 ' CZ ' HD23 ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.899 HD21 ' HG ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.661 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.834 HD23 ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.899 HG21 ' HA ' ' A' ' 67' ' ' ALA . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.527 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.568 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' HG23 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG11 ' HA3' ' A' ' 44' ' ' GLY . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.822 ' HB3' ' H ' ' A' ' 127' ' ' GLY . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.899 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HE2' HD11 ' A' ' 42' ' ' ILE . 24.1 m-85 -106.95 35.88 2.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.16 -113.35 0.97 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 71' ' ' TYR . 8.6 pt20 -157.23 -114.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 110.137 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.907 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 12.1 p90 -84.73 143.91 28.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 25.7 p30 -104.93 69.76 0.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 43.7 mt-10 -67.33 -6.62 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 2.5 p-10 -67.3 4.05 1.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.872 . . . . 0.0 110.761 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -10.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.995 . . . . 0.0 110.548 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 119' ' ' VAL . 1.4 p -53.14 153.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 83' ' ' VAL . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.43 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.764 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.69 HG13 HG22 ' A' ' 117' ' ' VAL . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG22 HG13 ' A' ' 112' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' VAL . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 -148.81 146.75 28.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.74 -20.17 8.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 8.3 m120 -118.71 177.52 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.184 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 26.1 m80 -71.19 142.13 50.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.6 mtm -77.44 -11.21 59.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.078 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 126' ' ' ALA . 0.3 OUTLIER -51.92 -68.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 110.533 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 71' ' ' TYR . . . -47.14 176.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.822 ' H ' ' HB3' ' A' ' 64' ' ' ALA . . . 100.01 -34.12 5.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' ' C ' ' A' ' 127' ' ' GLY . 6.6 mt-30 -135.23 71.55 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.042 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -94.34 -21.33 19.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.441 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.592 HG12 ' CB ' ' A' ' 13' ' ' TYR . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 52' ' ' HIS . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 54' ' ' VAL . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 7' ' ' LEU . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.854 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 144' ' ' GLU . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.872 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.899 ' HG ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 8' ' ' VAL . 57.6 t -123.63 142.45 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.44 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 65.75 13.23 8.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.231 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . 89.92 78.45 1.33 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . 54.14 106.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.46 -72.14 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.27 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -92.02 -58.2 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 176.7 -60.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 26.5 p80 -176.94 -165.31 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 63.04 104.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 160' ' ' HIS . 3.7 t0 63.84 -146.51 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.26 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -91.18 -67.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -174.46 149.26 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.32 101.47 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.53 107.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.65 -164.36 1.8 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 1.7 t -122.75 57.25 1.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 46.22 -166.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.02 -162.57 11.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.89 140.31 14.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -165.79 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -1.138 . . . . 0.0 110.183 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.89 -71.1 2.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.37 -47.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -1.119 . . . . 0.0 110.217 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -113.53 101.83 9.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.231 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 53.5 -153.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.14 -133.52 6.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -163.21 55.87 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.24 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.11 13.63 4.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -95.19 -30.88 13.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.15 45.44 73.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 152.6 115.63 0.63 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.47 117.22 4.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' CYS . . . 160.7 125.32 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 1.1 m 59.04 57.46 3.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.239 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 149.36 1.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 178.24 93.61 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.55 -129.66 3.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.57 -2.59 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -1.196 . . . . 0.0 110.18 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.9 -53.71 1.09 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 12.2 m120 51.42 46.14 26.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -1.168 . . . . 0.0 110.183 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.69 116.43 3.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 152.24 61.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 61.5 m -85.03 114.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 117.09 136.48 5.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 9.6 p -139.35 158.22 44.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -1.113 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.151 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.976 ' CB ' HD21 ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.795 HD22 ' HB3' ' A' ' 4' ' ' ALA . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 152' ' ' VAL . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' HG23 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.004 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' CB ' HG12 ' A' ' 134' ' ' VAL . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' N ' HD23 ' A' ' 22' ' ' LEU . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 1.004 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 28' ' ' VAL . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.703 ' O ' HD23 ' A' ' 35' ' ' LEU . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.91 HG21 ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD21 HG11 ' A' ' 134' ' ' VAL . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.538 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.938 HG21 ' HB1' ' A' ' 48' ' ' ALA . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' CB ' ' HA2' ' A' ' 127' ' ' GLY . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 -144.88 -38.97 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' ' 70' ' ' GLN . . . -83.81 -80.16 1.04 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER 68.68 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -1.137 . . . . 0.0 110.436 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -43.44 144.36 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CG ' ' CB ' ' A' ' 122' ' ' ASN . 1.0 OUTLIER -82.75 79.14 9.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 2.2 mt-10 -69.35 -26.87 64.9 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.025 -1.047 . . . . 0.0 109.646 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -63.12 -3.95 2.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 74' ' ' ASN . 33.4 mt 61.32 65.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.891 0.853 . . . . 0.0 109.778 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 120' ' ' ASP . 1.4 p -52.75 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.77 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' LEU . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.676 HG23 ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.719 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.719 ' H ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 1.028 ' O ' HD11 ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.883 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 98' ' ' ALA . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' C ' HD13 ' A' ' 109' ' ' ILE . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.028 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.639 ' O ' HG23 ' A' ' 112' ' ' VAL . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 117' ' ' VAL . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.639 HG21 ' HB ' ' A' ' 107' ' ' VAL . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.913 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.8 p-10 -137.39 171.76 14.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.74 34.01 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.65 ' OD1' HG21 ' A' ' 76' ' ' VAL . 2.5 p-10 -115.0 171.89 7.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 110.325 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.4 ' ND1' ' HA2' ' A' ' 69' ' ' GLY . 50.1 m80 -102.44 176.86 5.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.121 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.6 ptp -49.13 -22.08 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 125' ' ' LEU . 7.8 tp -174.11 104.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.9 52.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.404 ' HA2' ' CB ' ' A' ' 64' ' ' ALA . . . 112.57 14.71 10.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.611 ' O ' HD12 ' A' ' 130' ' ' LEU . 30.6 tt0 -96.29 71.03 2.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -1.153 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -44.88 128.95 7.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 128' ' ' GLN . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.568 HG11 HD21 ' A' ' 45' ' ' LEU . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LYS . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 9' ' ' VAL . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB1' ' NE ' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.781 HG22 HD23 ' A' ' 7' ' ' LEU . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.67 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.063 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.487 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.063 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 1.3 m170 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 8' ' ' VAL . 4.9 p -128.02 127.31 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 53.9 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 154.22 -103.12 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' A' ' 158' ' ' HIS . . . 56.24 79.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -1.164 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -66.73 -39.59 88.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 160' ' ' HIS . 0.2 OUTLIER -75.57 -25.95 57.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.867 ' HB2' ' HB1' ' A' ' 155' ' ' ALA . 15.9 t60 -46.78 -62.47 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -47.22 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 59.8 t-80 43.49 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.02 -44.73 13.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.4 26.96 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.69 -56.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -112.62 93.33 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -151.73 129.61 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 110.225 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.71 42.96 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 168' ' ' CYS . 26.0 t -85.88 164.45 17.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.207 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 4.2 t 64.94 169.17 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.88 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.12 47.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -132.63 121.48 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -1.176 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.52 -144.99 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.9 56.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -1.145 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -146.23 36.6 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -126.46 151.29 47.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.78 12.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -91.32 121.28 32.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.203 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.8 116.25 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -143.62 144.27 31.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.14 -153.95 20.97 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.82 11.24 5.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -49.62 157.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -1.149 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . -174.77 49.72 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' CYS . 53.3 m 54.32 -86.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER 65.53 154.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 174.12 -108.33 0.27 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.98 -144.18 10.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.75 -15.64 10.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -1.161 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.07 -80.69 0.09 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.99 176.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 110.195 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.38 -124.57 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 -102.89 0.56 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.1 m -64.62 171.1 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -1.094 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.85 9.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 115.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.163 . . . . 0.0 110.206 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 139' ' ' ILE . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.928 HG23 ' CD1' ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 7' ' ' LEU . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.844 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 6' ' ' ASP . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 3' ' ' VAL . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.848 HD21 ' HE1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.902 HG13 ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 131' ' ' LYS . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.829 HG22 HD23 ' A' ' 130' ' ' LEU . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' HB ' ' CG1' ' A' ' 15' ' ' VAL . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.958 ' CD1' HD13 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.785 HD23 ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.76 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 27.9 t-80 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.785 ' CE1' HD23 ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB1' ' HZ ' ' A' ' 58' ' ' PHE . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 139' ' ' ILE . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.858 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.685 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.858 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HH ' ' HE1' ' A' ' 132' ' ' PHE . 42.2 p90 -110.94 48.82 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 70' ' ' GLN . . . -46.64 -99.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.566 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 6.2 mt-30 -141.7 -106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.232 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.084 ' N ' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.77 120.31 21.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 110.405 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.23 113.6 10.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.954 ' O ' HG13 ' A' ' 76' ' ' VAL . 2.5 mm-40 -66.2 -8.63 25.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.264 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.97 -14.49 54.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -124.24 33.19 5.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.954 HG13 ' O ' ' A' ' 73' ' ' GLU . 18.4 m -66.64 149.95 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 83' ' ' VAL . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' HB ' HG12 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' HD2' HD11 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.744 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.524 ' O ' HD11 ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.477 ' OE1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG21 ' OE1' ' A' ' 102' ' ' GLN . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.846 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.872 ' C ' HD13 ' A' ' 109' ' ' ILE . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 110' ' ' THR . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.598 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' NE2' ' HB2' ' A' ' 78' ' ' ARG . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 111' ' ' ALA . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 108' ' ' GLU . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -135.95 130.13 33.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -73.26 137.12 23.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 122' ' ' ASN . 19.2 p30 -118.5 121.67 40.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -1.177 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.473 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 16.5 m-70 -76.45 -162.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 ttp -62.98 -41.02 99.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 17.3 tp 174.4 109.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.084 ' HB2' ' N ' ' A' ' 71' ' ' TYR . . . -96.39 -167.52 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.52 53.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' ASN . 24.4 tt0 -105.96 79.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -1.114 . . . . 0.0 110.104 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 128' ' ' GLN . 15.3 p30 -41.23 149.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.321 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.829 HD23 HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.902 ' CE1' HG13 ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 49' ' ' LEU . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.542 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.928 ' CD1' HG23 ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.684 ' O ' HD13 ' A' ' 7' ' ' LEU . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.969 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.969 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 143' ' ' THR . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 155' ' ' ALA . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.733 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CD2' ' O ' ' A' ' 151' ' ' HIS . 0.5 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 2.3 p -64.91 114.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 156' ' ' HIS . 57.3 t60 -158.04 -66.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.66 37.75 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . 46.41 41.2 9.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -1.129 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 153' ' ' HIS . 1.4 t-80 -82.65 -63.25 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -32.53 73.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 51.03 -143.61 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -148.68 0.34 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -87.05 179.95 6.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 48.95 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 48.13 54.91 9.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -130.16 125.93 36.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -132.06 5.79 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.92 2.8 53.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -120.05 60.36 0.52 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 28.1 p -131.58 7.26 4.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 24.8 p -167.02 132.66 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.234 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.22 -81.23 0.22 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 171' ' ' HIS . . . 88.31 178.93 46.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' GLY . 0.1 OUTLIER 63.07 61.48 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.172 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -103.61 -32.34 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 172' ' ' GLY . 5.7 m-70 55.03 165.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.256 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -70.75 -60.75 2.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 48.04 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 63.38 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.406 ' ND1' ' C ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -71.34 -153.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 179' ' ' HIS . 1.5 tm-20 -103.5 140.13 37.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.449 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -67.14 -158.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.02 -135.77 3.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 182' ' ' GLU . . . 114.57 -62.61 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 181' ' ' GLY . 17.4 tt0 62.75 38.6 11.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -1.14 . . . . 0.0 110.225 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.11 171.61 42.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 48.8 t -108.74 -32.89 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -1.192 . . . . 0.0 110.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 184' ' ' CYS . 8.7 t 61.12 164.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.6 52.0 2.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.54 -152.71 14.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -60.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.3 33.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -175.56 168.32 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 110.196 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 130.96 87.76 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 97.98 82.51 1.66 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.1 t -173.98 149.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -1.121 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -152.36 69.22 0.31 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 46.9 m -130.88 7.4 4.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 110.207 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.243 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.686 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.946 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 7' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.975 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 HD22 ' A' ' 11' ' ' LEU . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CB ' HG12 ' A' ' 134' ' ' VAL . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.106 HD13 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.039 ' N ' HD22 ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 28' ' ' VAL . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 1.025 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.754 HD13 ' CE1' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.2 t-80 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.754 ' CE1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD13 ' HE1' ' A' ' 132' ' ' PHE . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 52' ' ' HIS . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.575 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 1.034 ' NE2' HD11 ' A' ' 139' ' ' ILE . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.839 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.108 HG12 ' HB2' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.108 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 69' ' ' GLY . 22.6 p90 -104.48 45.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.667 ' HA2' HD13 ' A' ' 130' ' ' LEU . . . -42.97 -90.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -177.65 58.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 6.6 t80 -78.74 134.79 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB2' HD21 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.88 74.09 10.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.269 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.946 ' O ' HG12 ' A' ' 76' ' ' VAL . 22.3 mp0 -69.31 -16.39 63.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.173 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' OD1' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p-10 -56.5 -16.53 6.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -91.64 -25.44 19.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.197 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.045 HG23 ' HB2' ' A' ' 120' ' ' ASP . 7.2 p -55.53 140.3 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.161 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.701 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.834 ' CG1' HG11 ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 83' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.834 HG11 ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.917 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.909 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' MET . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' ' N ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' N ' ' HE3' ' A' ' 94' ' ' MET . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 107' ' ' VAL . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.907 ' HA ' HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.716 HG12 HG23 ' A' ' 112' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 1.045 ' HB2' HG23 ' A' ' 76' ' ' VAL . 15.6 t0 -150.02 165.86 31.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.99 -162.54 23.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 37.1 p-10 -118.11 96.02 5.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 125' ' ' LEU . 8.0 m-70 -74.48 151.75 39.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.422 ' O ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -75.49 -39.32 58.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 72' ' ' ASP . 3.0 pp -42.98 -29.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 71' ' ' TYR . . . -98.15 157.39 16.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.95 -6.83 29.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -97.91 76.17 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -1.13 . . . . 0.0 110.225 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -44.05 150.88 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.211 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.667 HD13 ' HA2' ' A' ' 69' ' ' GLY . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.556 ' HE1' HD13 ' A' ' 45' ' ' LEU . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.877 HG12 ' CB ' ' A' ' 13' ' ' TYR . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.987 HG21 ' ND1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.034 HD11 ' NE2' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.616 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.032 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.032 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.427 ' O ' ' HA2' ' A' ' 39' ' ' GLY . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.7 OUTLIER -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 146' ' ' GLU . 25.3 t -85.4 136.32 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 12.6 t60 58.4 154.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.82 32.38 2.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.57 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -1.195 . . . . 0.0 110.25 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.99 -16.76 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.73 -18.84 13.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -103.37 132.66 49.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.13 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.449 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 41.6 t-80 -140.58 19.56 2.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 50.88 75.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 1.2 m-20 -125.16 172.07 9.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 163' ' ' ASP . 79.4 m80 -58.27 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 162' ' ' HIS . 1.3 t0 59.56 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.23 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 165' ' ' ASP . 32.9 m80 -91.25 -4.31 56.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 164' ' ' HIS . 0.9 OUTLIER 42.53 -163.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 170.13 116.06 0.36 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.53 53.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.255 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 15.9 m -79.43 135.82 36.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.61 -76.28 1.08 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.48 145.62 26.65 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -129.71 128.16 41.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -1.181 . . . . 0.0 110.229 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.24 166.89 0.64 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 0.0 OUTLIER -165.83 140.46 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.223 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -167.33 69.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.172 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.63 63.62 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -56.07 -38.07 74.4 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.26 69.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -1.152 . . . . 0.0 110.216 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -78.11 137.06 38.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -158.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.91 170.91 0.31 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.96 -33.2 0.17 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 46.16 26.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 74.34 154.2 3.54 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.7 t -142.36 -52.19 0.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 94.5 m -133.82 167.99 19.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.21 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.33 89.53 1.22 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -134.24 -51.12 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 -168.21 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.397 -1.061 . . . . 0.0 110.259 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 144.13 145.84 4.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.96 -173.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -1.18 . . . . 0.0 110.255 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -129.82 157.76 21.99 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.43 102.24 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.48 134.97 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -1.184 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.92 111.01 1.61 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.5 t -95.58 -5.4 42.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.222 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.252 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.862 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.702 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.953 ' HA ' HD11 ' A' ' 35' ' ' LEU . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.863 HD21 ' OE2' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.672 HG13 ' HB3' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 138' ' ' ALA . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.876 HD13 HD21 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' HB3' HG12 ' A' ' 134' ' ' VAL . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 24' ' ' ASP . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.486 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HD12 ' A' ' 22' ' ' LEU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 130' ' ' LEU . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.858 ' O ' HG12 ' A' ' 15' ' ' VAL . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.791 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 6' ' ' ASP . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.792 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.702 ' CD2' ' HE2' ' A' ' 5' ' ' LYS . 1.7 t-80 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 62' ' ' VAL . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' THR . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.876 HD21 HD13 ' A' ' 11' ' ' LEU . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 54' ' ' VAL . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 134' ' ' VAL . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG12 HG13 ' A' ' 62' ' ' VAL . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.768 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.682 HG13 HG12 ' A' ' 60' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 1.021 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' GLN . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 -110.16 -29.06 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.23 -121.45 0.91 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 4.4 mm-40 54.94 68.09 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -1.182 . . . . 0.0 110.148 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 1.4 p90 -43.39 143.39 0.91 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.59 90.51 3.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.31 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -52.09 -21.07 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.962 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -78.63 4.26 14.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.121 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' C ' ' O ' ' A' ' 74' ' ' ASN . 1.3 tt -31.4 -58.66 0.25 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.52 -0.738 . . . . 0.0 110.578 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t -83.62 95.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 110.108 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.845 ' CE2' HD11 ' A' ' 90' ' ' LEU . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD11 ' CE2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.675 ' HG3' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 106' ' ' PRO . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.675 HD11 ' HG3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.705 HG21 ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.053 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.646 ' OE1' HG13 ' A' ' 118' ' ' VAL . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.705 ' OD1' HG21 ' A' ' 110' ' ' THR . 30.7 p-10 -167.63 99.18 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -165.97 68.04 0.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -118.61 177.45 4.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 122' ' ' ASN . 1.2 m-70 -43.89 128.49 5.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.463 ' O ' HD12 ' A' ' 125' ' ' LEU . 6.1 mtp -76.58 -19.85 57.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -147.93 100.1 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . . . -98.03 -176.12 3.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.38 18.0 27.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.55 81.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 110.244 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.414 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 -60.69 157.41 14.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.147 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 130' ' ' LEU . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.768 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.753 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.66 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.672 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.863 ' OE2' HD21 ' A' ' 7' ' ' LEU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.583 HG23 ' OE1' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.921 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.563 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.635 HG21 ' HB ' ' A' ' 8' ' ' VAL . 32.8 t -130.23 111.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 67.22 -58.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 110.206 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -73.08 150.6 44.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.6 114.5 4.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -1.113 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -83.14 -32.44 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -78.85 -15.13 58.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -108.75 15.5 23.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.156 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -127.17 -66.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 161' ' ' ASP . 0.3 OUTLIER -66.97 101.83 0.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 61.89 124.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.283 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -114.69 -21.09 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.142 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -167.58 -158.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -97.67 99.01 10.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.38 40.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.73 -47.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.5 m 50.19 85.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -1.127 . . . . 0.0 110.204 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 26.3 p -81.91 5.89 17.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.173 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.37 170.64 1.73 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.9 -24.5 20.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 14.1 32.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -1.154 . . . . 0.0 110.18 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.01 -177.32 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 175' ' ' HIS . 2.2 t-80 -106.79 -3.36 20.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -1.151 . . . . 0.0 110.226 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 173' ' ' HIS . 11.5 t0 66.28 -63.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 173' ' ' HIS . 28.9 p80 -149.47 132.58 16.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 178' ' ' GLU . . . 178.55 52.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.446 ' HB2' ' OE2' ' A' ' 178' ' ' GLU . 31.5 m-70 54.54 -87.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.154 . . . . 0.0 110.158 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -125.05 152.7 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.72 -8.51 56.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.213 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.88 130.11 2.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.23 -97.55 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.67 159.76 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.07 -99.66 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 185' ' ' CYS . 53.9 t -75.11 116.51 15.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 110.214 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 184' ' ' CYS . 8.2 m 54.91 -171.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.78 -160.85 24.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.0 157.2 35.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 146.33 27.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.35 95.07 0.94 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -129.06 105.75 8.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.35 -48.63 85.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.27 131.85 5.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.09 -51.0 2.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.233 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.02 46.7 0.66 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 20.2 p -176.18 154.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -1.111 . . . . 0.0 110.275 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.226 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.918 ' HA ' HG21 ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.613 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.869 ' O ' HD22 ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.896 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 HG23 ' A' ' 139' ' ' ILE . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.774 HD21 ' CB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HB3' HG12 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.583 HG21 HD21 ' A' ' 125' ' ' LEU . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' THR . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.921 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 9' ' ' VAL . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.152 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 1.152 ' CD2' HD23 ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.854 HD11 ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 52' ' ' HIS . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.924 ' CA ' HD12 ' A' ' 130' ' ' LEU . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 -112.6 10.17 19.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' GLN . . . 72.3 2.49 54.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 8.0 mm100 41.61 77.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.631 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.3 p90 -54.13 124.28 15.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.259 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.665 ' O ' HD23 ' A' ' 75' ' ' LEU . 15.8 m-20 -83.28 126.4 32.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -52.16 -19.78 2.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 110.308 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -76.14 2.75 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.746 HD11 ' OD1' ' A' ' 122' ' ' ASN . 2.7 pp -88.2 -7.83 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 73' ' ' GLU . 28.4 m -53.67 122.97 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.945 ' HG2' HG23 ' A' ' 118' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.882 HG22 ' H ' ' A' ' 89' ' ' GLU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.617 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.882 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 105' ' ' VAL . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 118' ' ' VAL . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.798 ' HB3' ' CG1' ' A' ' 118' ' ' VAL . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.945 HG23 ' HG2' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -167.72 171.81 9.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.82 60.66 0.84 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.746 ' OD1' HD11 ' A' ' 75' ' ' LEU . 9.4 m120 -118.79 144.22 46.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -1.202 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.683 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 5.9 m170 -76.24 139.5 41.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.259 -0.901 . . . . 0.0 110.277 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.554 ' CA ' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -77.45 -11.35 59.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 110.051 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 17' ' ' THR . 10.0 tp -54.39 -36.63 64.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 110.349 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -42.1 143.53 0.57 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.76 21.68 5.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 129' ' ' ASN . 68.2 mt-30 -148.47 101.81 3.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.103 . . . . 0.0 109.994 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 128' ' ' GLN . 8.4 p-10 -37.85 140.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.381 -0.824 . . . . 0.0 110.354 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.924 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.854 ' CE1' HD11 ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.774 ' CB ' HD21 ' A' ' 11' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.552 ' C ' HD12 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.748 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.94 HG23 HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.896 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.031 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.031 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.903 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.63 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.561 ' CE1' ' O ' ' A' ' 153' ' ' HIS . 0.6 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -99.85 123.67 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.561 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 0.2 OUTLIER 47.77 -163.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.306 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 85.19 -52.95 4.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 154' ' ' GLY . . . 54.73 72.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -53.77 -29.59 40.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 158' ' ' HIS . 19.0 p-10 -75.51 -32.72 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 52.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.166 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -114.12 23.59 12.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -76.58 -170.14 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 163' ' ' ASP . 3.6 m-20 -150.71 103.09 3.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.178 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 80.4 m-70 55.31 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 161' ' ' ASP . 11.6 t0 -111.0 -145.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -121.25 2.61 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.83 146.89 29.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.26 53.07 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 30.3 p -78.77 1.74 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -1.117 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.26 127.87 55.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.02 -164.67 13.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.45 147.56 22.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.68 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 0.0 110.142 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.85 -178.36 50.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -164.75 62.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.5 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 92.11 1.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 157.93 -74.85 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.82 83.88 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -1.179 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 179' ' ' HIS . 1.3 tp10 -66.24 -63.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 178' ' ' GLU . 2.8 m80 47.49 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -129.85 148.27 18.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.86 -107.05 3.17 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.66 168.34 2.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -1.094 . . . . 0.0 110.238 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 46.18 -124.6 7.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 52.9 t -100.36 126.76 46.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.172 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 61.44 0.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.154 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -135.7 10.9 4.29 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -151.73 58.26 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -25.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -1.199 . . . . 0.0 110.192 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.81 125.46 3.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.57 135.24 54.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.167 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.91 75.57 1.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.22 173.66 3.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.99 169.93 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -1.176 . . . . 0.0 110.202 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 195' ' ' CYS . . . -126.81 -33.92 0.62 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 36.4 m 58.71 153.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -1.174 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 195' ' ' CYS . 73.9 m80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.214 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 139' ' ' ILE . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 HD22 ' A' ' 49' ' ' LEU . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.932 ' CB ' HD21 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 4' ' ' ALA . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 3' ' ' VAL . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.986 HD13 ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.886 ' OG ' ' HB1' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HA ' HG11 ' A' ' 152' ' ' VAL . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD21 ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.492 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.603 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 40' ' ' SER . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG13 ' CB ' ' A' ' 45' ' ' LEU . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 134' ' ' VAL . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.88 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.897 ' O ' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 62' ' ' VAL . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.552 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' N ' ' HA3' ' A' ' 69' ' ' GLY . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -110.52 34.5 3.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' HA3' ' N ' ' A' ' 64' ' ' ALA . . . -78.97 -33.7 36.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 69' ' ' GLY . 3.1 mm-40 -41.6 163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -1.089 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.675 ' CD2' ' HB3' ' A' ' 126' ' ' ALA . 1.8 t80 -84.68 120.47 26.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.121 -0.987 . . . . 0.0 110.576 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -137.75 122.45 18.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 44.0 mt-10 -69.5 -6.42 30.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 111.162 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' C ' ' A' ' 75' ' ' LEU . 5.1 m-80 -82.3 -46.98 12.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.875 -1.14 . . . . 0.0 112.146 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -40.56 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.698 ' H ' HD12 ' A' ' 75' ' ' LEU . 1.6 m -146.06 156.3 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 110.991 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HB2' ' CA ' ' A' ' 121' ' ' GLY . 18.2 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 79' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.009 ' HB ' HD23 ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.009 HD23 ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.905 HG12 ' HB ' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.905 ' HB ' HG12 ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 -97.59 105.61 17.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.619 ' CA ' ' HB2' ' A' ' 77' ' ' GLN . . . -160.88 -141.08 3.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 40.8 p30 -53.76 168.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.151 . . . . 0.0 110.248 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.814 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -102.0 -161.3 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.431 ' O ' ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -77.47 -29.14 52.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.299 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.5 OUTLIER 179.14 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.423 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . 61.64 174.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.8 21.61 69.46 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' ASN . 48.9 tp60 -125.2 89.58 3.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -1.119 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -39.34 129.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 110.285 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.552 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.508 ' HB3' ' CB ' ' A' ' 15' ' ' VAL . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.986 ' CG1' HD13 ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 56' ' ' ASP . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 2' ' ' LYS . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.01 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.932 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 155' ' ' ALA . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 34' ' ' TYR . 2.9 p -130.1 116.49 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 52.12 41.06 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 155' ' ' ALA . . . -174.42 -174.62 41.34 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 154' ' ' GLY . . . -179.79 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -1.099 . . . . 0.0 110.242 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -63.29 -23.59 67.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.06 4.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 102.14 4.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.98 54.33 1.92 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.51 78.8 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.66 5.67 2.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -81.49 141.92 33.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.7 t70 -175.01 121.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.578 ' O ' ' CG ' ' A' ' 164' ' ' HIS . 0.0 OUTLIER -178.27 95.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 30.4 p30 -44.77 157.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.68 -76.5 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 58.63 74.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.15 -79.77 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -148.95 119.62 1.08 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -91.77 -86.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 173' ' ' HIS . . . -155.67 -160.22 9.84 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.485 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 3.4 t60 63.75 130.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.36 127.82 18.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 173' ' ' HIS . 55.8 m-70 -103.73 164.95 11.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.12 144.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -173.92 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.125 . . . . 0.0 110.12 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 179' ' ' HIS . 2.1 tm-20 65.15 136.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 180' ' ' GLY . 19.5 p-80 -59.21 -146.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' ' CG ' ' A' ' 179' ' ' HIS . . . -123.77 88.46 0.39 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.14 143.85 47.2 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -150.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.096 . . . . 0.0 110.241 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.13 -143.19 0.42 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.89 130.72 36.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.36 26.11 6.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 126.16 106.4 1.5 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.43 49.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 90.98 -179.89 42.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.67 -175.22 4.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -1.16 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.12 -148.18 7.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 164.38 21.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.12 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -1.14 . . . . 0.0 110.215 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -121.95 -63.18 0.22 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 196' ' ' HIS . 31.2 p -127.52 151.15 49.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 18.9 t60 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HE2' HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.904 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.868 ' N ' HD21 ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.043 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.877 HG21 HG22 ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.907 HD12 HG13 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 5.5 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.884 HG12 ' O ' ' A' ' 24' ' ' ASP . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.884 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 1.035 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.835 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.739 HD22 ' HA2' ' A' ' 150' ' ' GLY . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.675 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' LEU . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 41' ' ' LEU . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' HE1' ' HD1' ' A' ' 58' ' ' PHE . 7.9 t-160 -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' HD1' ' HE1' ' A' ' 52' ' ' HIS . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.054 HG12 ' HB2' ' A' ' 67' ' ' ALA . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.98 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 1.054 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.34 56.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -150.9 87.08 0.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.809 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 88.1 mm-40 57.08 47.71 16.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -1.095 . . . . 0.0 110.171 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -70.18 127.19 31.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.0 110.388 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.813 ' CG ' ' HB3' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -135.41 69.36 1.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.85 -34.14 73.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.895 . . . . 0.0 110.396 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' CG ' ' CG1' ' A' ' 105' ' ' VAL . 63.7 t30 -79.24 -15.48 57.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -44.07 -30.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.027 . . . . 0.0 110.086 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.4 p -144.02 126.66 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' HG21 ' A' ' 87' ' ' VAL . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.651 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG1' ' CG ' ' A' ' 74' ' ' ASN . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 96' ' ' PHE . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.636 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' THR . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.548 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.548 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 78' ' ' ARG . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.654 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.22 171.67 7.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . -167.66 63.08 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.35 162.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.24 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.459 ' CD2' ' H ' ' A' ' 124' ' ' MET . 5.5 t60 -102.28 -140.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -63.97 -45.12 90.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER 176.64 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.813 ' HB3' ' CG ' ' A' ' 72' ' ' ASP . . . -66.93 -177.31 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.57 21.76 6.0 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.536 ' CB ' ' HG3' ' A' ' 70' ' ' GLN . 31.1 tt0 -121.18 87.06 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 64' ' ' ALA . 8.7 m120 -72.19 142.7 49.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.383 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.838 HD12 HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.547 ' C ' HG23 ' A' ' 134' ' ' VAL . 37.6 m-20 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.907 HG13 HD12 ' A' ' 11' ' ' LEU . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.999 HG23 HD13 ' A' ' 7' ' ' LEU . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 8' ' ' VAL . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.996 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.996 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.818 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.739 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 44.4 m80 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.881 ' CG2' HG11 ' A' ' 8' ' ' VAL . 16.7 t -130.48 111.08 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' C ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 39.03 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 148.31 -61.66 0.44 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 154' ' ' GLY . . . 66.31 115.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -1.108 . . . . 0.0 110.215 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.423 ' H ' ' CD2' ' A' ' 151' ' ' HIS . 2.2 m80 -64.22 -26.5 68.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -78.54 -24.4 45.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 110.257 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 1.4 t60 60.07 145.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 9.3 p-80 -178.49 156.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -53.02 -175.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.229 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -155.3 -178.49 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -135.09 -158.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -146.87 -176.8 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.881 . . . . 0.0 110.208 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 165' ' ' ASP . 8.6 m80 -57.29 -168.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 164' ' ' HIS . 11.5 m-20 -156.81 -52.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 167' ' ' CYS . . . 161.59 -37.0 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.522 ' C ' ' O ' ' A' ' 166' ' ' GLY . 15.2 p 33.45 44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -1.0 . . . . 0.0 110.562 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.4 t -113.2 89.88 3.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.48 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 87.79 1.81 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.23 56.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.157 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.47 -71.48 0.72 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -172.73 133.11 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 176' ' ' GLY . 28.4 t0 -100.79 150.34 22.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.448 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 19.0 t-80 -103.58 -15.23 15.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 174' ' ' ASP . . . -168.8 -169.01 31.67 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -148.1 18.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -1.148 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.48 139.53 39.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -70.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.72 135.43 3.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 182' ' ' GLU . . . -45.97 -81.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' GLY . 14.6 mt-10 43.49 -148.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -1.142 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . -101.59 -22.76 10.0 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' GLY . 0.8 OUTLIER 60.24 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 29.9 m 44.84 -145.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 127.62 114.69 1.86 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.71 -49.81 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -176.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 98.12 -116.43 5.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -173.13 171.04 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.183 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.81 176.48 6.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.26 15.8 57.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -179.48 8.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.209 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.439 ' O ' ' SG ' ' A' ' 195' ' ' CYS . . . -93.84 41.92 2.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 194' ' ' GLY . 1.7 m -160.61 173.62 15.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -1.154 . . . . 0.0 110.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.614 ' HE2' HG22 ' A' ' 139' ' ' ILE . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.994 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HG2' ' HA3' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.886 ' HB3' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.101 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.927 ' CG1' HD23 ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 1.5 tt0 -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.906 HG22 HD22 ' A' ' 130' ' ' LEU . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG22 ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.789 ' O ' HG12 ' A' ' 15' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.622 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 43.0 t-80 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.809 ' CD2' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.592 ' C ' HD12 ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.906 HG21 ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 134' ' ' VAL . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 1.029 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 -65.44 -36.03 82.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.07 105.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.849 ' HB2' HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -106.15 -45.26 4.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -1.114 . . . . 0.0 110.096 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.147 ' CB ' ' HB2' ' A' ' 126' ' ' ALA . 1.5 p90 -43.16 144.89 0.59 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -125.75 116.97 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.614 -0.679 . . . . 0.0 110.181 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -53.03 -21.84 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -15.17 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 72' ' ' ASP . 2.6 pp -46.99 -27.19 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -55.82 136.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.972 HG21 ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.678 ' H ' HG22 ' A' ' 87' ' ' VAL . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.972 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' VAL . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 96' ' ' PHE . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 92' ' ' VAL . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 117' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 112' ' ' VAL . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.777 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.517 HG13 ' C ' ' A' ' 118' ' ' VAL . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 -120.98 162.87 19.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.36 -174.38 33.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.61 133.25 54.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -171.62 0.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -28.91 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB2' ' A' ' 70' ' ' GLN . 3.7 tp -110.88 -125.47 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 0.0 110.007 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.147 ' HB2' ' CB ' ' A' ' 71' ' ' TYR . . . 45.86 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.14 -5.28 27.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 81.36 1.9 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HB2' ' N ' ' A' ' 63' ' ' GLY . 1.4 p-10 -51.07 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.906 HD22 HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 HD21 ' A' ' 45' ' ' LEU . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 1.029 HG21 ' HB3' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.101 HG23 ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.988 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.988 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 4.6 p80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.938 HG13 ' OE2' ' A' ' 146' ' ' GLU . 74.7 t -70.8 140.8 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' GLY . 0.1 OUTLIER 61.01 129.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 153' ' ' HIS . . . -48.57 175.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.12 15.7 11.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -1.183 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -83.93 -7.06 59.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.121 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.7 m-20 -44.18 -58.55 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -167.09 -70.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 19.7 t-160 58.58 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.285 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' HIS . 43.8 p-80 -133.27 176.39 8.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 162' ' ' HIS . 23.2 m-20 -70.9 137.58 49.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.237 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 161' ' ' ASP . 4.2 t-160 58.24 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -84.3 56.41 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -120.06 -0.22 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.87 -172.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 167' ' ' CYS . . . 87.18 -143.14 18.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER 176.97 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -1.153 . . . . 0.0 110.186 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 168' ' ' CYS . 24.7 p -144.27 110.85 5.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.78 -40.75 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 158.8 -136.41 4.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.23 111.73 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.98 -136.97 7.97 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.54 -65.43 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.138 . . . . 0.0 110.227 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -175.63 -68.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 179.05 4.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 136.43 108.13 0.89 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.31 -159.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -1.163 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.51 -28.94 7.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.223 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.91 94.53 7.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.2 147.49 16.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -56.28 120.72 21.03 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -151.67 113.23 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.166 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.65 135.58 9.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 11.8 p -168.05 101.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 12.5 t -133.02 101.44 5.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.86 0.84 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.41 0.94 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.64 107.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -1.096 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.78 160.86 27.87 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -45.9 115.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.161 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.79 -165.38 0.24 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 166.38 129.97 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.0 t -102.85 -3.66 25.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -1.069 . . . . 0.0 110.126 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 169.5 169.16 32.45 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.8 t 46.91 54.97 8.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.151 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 7' ' ' LEU . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.055 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 138' ' ' ALA . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE1' HD21 ' A' ' 41' ' ' LEU . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 24' ' ' ASP . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 25' ' ' GLU . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.92 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 8' ' ' VAL . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.849 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.736 ' CD2' HG13 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 45' ' ' LEU . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 45' ' ' LEU . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 45' ' ' LEU . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' HG23 ' A' ' 47' ' ' THR . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.809 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 1.8 m-70 -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 139' ' ' ILE . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 67' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t-20 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.839 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 120' ' ' ASP . 7.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.221 0.534 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.756 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HG2' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 90' ' ' LEU . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.747 ' HB3' HG23 ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.469 ' OG1' HG21 ' A' ' 105' ' ' VAL . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 105' ' ' VAL . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' OG1' ' A' ' 100' ' ' THR . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.747 HG23 ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 92' ' ' VAL . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.022 HG23 HG22 ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 112' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.604 ' N ' HG12 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 76' ' ' VAL . 20.6 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 17.1 p-10 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.237 0.542 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 17' ' ' THR . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' CD1' ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.055 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.719 ' C ' HD23 ' A' ' 7' ' ' LEU . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.992 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.491 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.415 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.992 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.758 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 8' ' ' VAL . 3.3 p . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.694 HG11 ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 3' ' ' VAL . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.647 HD12 ' CG1' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.97 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 24' ' ' ASP . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 25' ' ' GLU . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.691 ' HB3' HD11 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.97 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.853 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.853 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.953 HD11 ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HA ' HG12 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' HD1' HG23 ' A' ' 60' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG23 ' HD1' ' A' ' 58' ' ' PHE . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 131' ' ' LYS . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 60' ' ' VAL . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.645 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.953 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' C ' ' HG3' ' A' ' 77' ' ' GLN . 12.3 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.265 0.555 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.591 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.491 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.707 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HD3' ' A' ' 78' ' ' ARG . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.707 HG22 ' HB ' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.645 ' ND2' ' HB3' ' A' ' 64' ' ' ALA . 9.7 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.231 0.539 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 132' ' ' PHE . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 130' ' ' LEU . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' A' ' 13' ' ' TYR . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 3' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.074 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 144' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.681 ' H ' HG22 ' A' ' 143' ' ' THR . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.458 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.074 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 13.1 m170 -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.694 ' HB ' HG11 ' A' ' 8' ' ' VAL . 1.5 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.86 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.619 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 1.03 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.03 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' ILE . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.809 HG11 ' CG2' ' A' ' 3' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.015 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.558 ' O ' HG11 ' A' ' 152' ' ' VAL . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.843 ' CD2' HD23 ' A' ' 35' ' ' LEU . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.72 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 HG21 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HA ' HG12 ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.103 HG22 ' HB2' ' A' ' 67' ' ' ALA . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.562 HG21 ' CG1' ' A' ' 118' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.313 0.578 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.528 ' NE2' ' HB ' ' A' ' 79' ' ' VAL . 2.1 tt0 -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' N ' ' HG2' ' A' ' 77' ' ' GLN . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.04 HG23 HD23 ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.04 HD23 HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.786 ' O ' HG22 ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' THR . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 96' ' ' PHE . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.244 0.545 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.975 ' CE1' HG12 ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.619 ' HB1' HH11 ' A' ' 140' ' ' ARG . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.737 HG22 HD23 ' A' ' 7' ' ' LEU . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.619 HH11 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.97 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.967 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 33' ' ' ASP . 5.5 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.002 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.736 ' CB ' HD21 ' A' ' 147' ' ' LEU . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.797 HG21 HG21 ' A' ' 3' ' ' VAL . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.749 HD12 HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' HD22 ' A' ' 22' ' ' LEU . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.839 HD13 ' O ' ' A' ' 15' ' ' VAL . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 22' ' ' LEU . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.75 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.112 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 1.112 ' CD2' HD23 ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.708 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.816 HD11 HG21 ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 137' ' ' VAL . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.552 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.088 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 1.029 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.088 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 76' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.271 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.808 HG21 ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' C ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.648 ' O ' HG22 ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.636 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 97' ' ' LEU . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' C ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 109' ' ' ILE . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 79' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 111' ' ' ALA . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.778 ' O ' HD22 ' A' ' 130' ' ' LEU . 9.9 t30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 129' ' ' ASN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.816 HG21 HD11 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.002 ' CD1' HG23 ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.77 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.76 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.984 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.984 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.93 HD12 ' HB3' ' A' ' 142' ' ' ALA . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.519 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.953 ' HA ' HG21 ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 HG23 ' A' ' 139' ' ' ILE . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 137' ' ' VAL . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.917 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CB ' HG12 ' A' ' 134' ' ' VAL . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.5 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' C ' HD22 ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.71 ' O ' HG12 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.917 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 9' ' ' VAL . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.129 HD23 ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.726 ' CD2' HG12 ' A' ' 3' ' ' VAL . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' C ' ' OE2' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 1.129 ' CD2' HD23 ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.642 ' CD2' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.882 HD13 ' HZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 139' ' ' ILE . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.693 ' O ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.798 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 76' ' ' VAL . 12.6 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 83' ' ' VAL . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 HD13 ' A' ' 90' ' ' LEU . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD13 HG23 ' A' ' 87' ' ' VAL . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.679 ' O ' HG22 ' A' ' 107' ' ' VAL . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.788 ' C ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HA ' HG13 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 112' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.58 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 4.9 t30 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.16 0.505 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.882 ' HZ ' HD13 ' A' ' 45' ' ' LEU . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 56' ' ' ASP . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 11' ' ' LEU . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.953 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.901 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.025 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.025 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.014 HD22 HD21 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.499 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.513 ' HA ' HD13 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.473 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 1.037 ' HG2' HD11 ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.754 ' C ' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 HG21 ' A' ' 9' ' ' VAL . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.9 ' HA ' HD11 ' A' ' 35' ' ' LEU . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 HG13 ' A' ' 3' ' ' VAL . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.88 ' O ' HG22 ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.882 ' CG1' HD21 ' A' ' 130' ' ' LEU . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.7 HG22 HD12 ' A' ' 130' ' ' LEU . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 14' ' ' GLN . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' VAL . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE1' HD13 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 1.008 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.008 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.076 HD12 ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 1.076 ' CD2' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 6' ' ' ASP . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.56 ' CD2' HG11 ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.833 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.945 HD11 ' CZ ' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.793 HG21 ' HA ' ' A' ' 67' ' ' ALA . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD13 ' HE1' ' A' ' 132' ' ' PHE . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 44' ' ' GLY . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 3' ' ' VAL . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.695 ' HA ' HG13 ' A' ' 136' ' ' VAL . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 1.028 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.028 ' HB3' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.169 0.509 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.462 HE21 HG11 ' A' ' 79' ' ' VAL . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.656 ' CB ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' VAL . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 96' ' ' PHE . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 109' ' ' ILE . 2.5 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 112' ' ' VAL . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.663 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.073 HG13 HG12 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.073 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.656 HG12 ' CB ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 108' ' ' GLU . 18.5 t70 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' A' ' 102' ' ' GLN . 1.8 m-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.882 HD21 ' CG1' ' A' ' 15' ' ' VAL . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.788 ' HE1' HD13 ' A' ' 45' ' ' LEU . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.649 HG11 HD21 ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 1' ' ' MET . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.925 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.925 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 38' ' ' HIS . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.9 p-80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 146' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.836 ' HA ' HG21 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.753 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 1.02 ' HA ' HD11 ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 152' ' ' VAL . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD13 ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.787 ' HB3' HG13 ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG2' ' OE1' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.531 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.815 ' C ' HD12 ' A' ' 22' ' ' LEU . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 21' ' ' VAL . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.742 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 41' ' ' LEU . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.683 ' O ' HG21 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.02 HD11 ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HB3' HD21 ' A' ' 45' ' ' LEU . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 68' ' ' TYR . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 47' ' ' THR . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 43' ' ' SER . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.557 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 62' ' ' VAL . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HE1' HD11 ' A' ' 42' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.271 0.557 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' VAL . 48.4 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 83' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.669 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 89' ' ' GLU . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 92' ' ' VAL . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HG3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.852 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.706 ' HA ' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.75 HD13 HG12 ' A' ' 119' ' ' VAL . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.02 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 118' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.02 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 109' ' ' ILE . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 3.1 p30 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.687 ' HD1' HG23 ' A' ' 15' ' ' VAL . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' TYR . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.836 HG21 ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.972 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.954 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 33' ' ' ASP . 16.0 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 35' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.911 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.911 ' CD1' HG12 ' A' ' 9' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.657 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 1.025 ' CB ' HG22 ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 24' ' ' ASP . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' HD12 ' A' ' 22' ' ' LEU . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.558 HD21 ' OE2' ' A' ' 25' ' ' GLU . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.558 ' OE2' HD21 ' A' ' 22' ' ' LEU . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.657 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.468 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 150' ' ' GLY . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' GLY . 25.0 m-70 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.624 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.866 HG21 ' HA ' ' A' ' 67' ' ' ALA . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.039 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.94 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.039 ' CZ ' ' HB1' ' A' ' 48' ' ' ALA . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.747 HG12 ' HB2' ' A' ' 67' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.797 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.866 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' CE2' HD13 ' A' ' 130' ' ' LEU . 20.8 m-85 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 76' ' ' VAL . 34.2 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.463 HE21 HG11 ' A' ' 79' ' ' VAL . 19.2 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' C ' HG13 ' A' ' 79' ' ' VAL . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.817 ' O ' HG22 ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.526 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HE2' HG11 ' A' ' 117' ' ' VAL . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 92' ' ' VAL . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.624 ' HB3' HD11 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 117' ' ' VAL . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.526 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' H ' HG22 ' A' ' 119' ' ' VAL . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.166 0.508 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.676 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HD22 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.3 t-20 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 1.025 HG22 ' CB ' ' A' ' 13' ' ' TYR . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.94 HG23 ' CD2' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.874 HG22 HD22 ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.049 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 145' ' ' GLU . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.006 ' OE2' HG23 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.049 HD23 ' HB3' ' A' ' 142' ' ' ALA . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.698 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.7 p-80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.006 HG23 ' OE2' ' A' ' 146' ' ' GLU . 2.7 p . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HE3' ' N ' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.944 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.032 HD13 HG13 ' A' ' 134' ' ' VAL . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.831 HG12 ' O ' ' A' ' 24' ' ' ASP . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.127 HG22 HD23 ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.831 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' HE2' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.616 ' OH ' HD21 ' A' ' 11' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 147' ' ' LEU . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.457 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.646 HD12 ' CG1' ' A' ' 62' ' ' VAL . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.753 HD11 ' HD2' ' A' ' 132' ' ' PHE . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.96 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.476 ' N ' ' HE3' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.508 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 132' ' ' PHE . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 67' ' ' ALA . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.227 0.537 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.534 ' C ' HG23 ' A' ' 79' ' ' VAL . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 83' ' ' VAL . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 92' ' ' VAL . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.883 ' O ' HG22 ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.899 ' HB3' HG23 ' A' ' 107' ' ' VAL . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 97' ' ' LEU . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 98' ' ' ALA . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 110' ' ' THR . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 109' ' ' ILE . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' HB3' HG23 ' A' ' 76' ' ' VAL . 7.9 p-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.274 0.559 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.127 HD23 HG22 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.773 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 1.032 HG13 HD13 ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 139' ' ' ILE . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.033 HG22 HD23 ' A' ' 7' ' ' LEU . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD13 HD21 ' A' ' 35' ' ' LEU . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.555 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 14.1 m170 -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.653 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.455 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 7.5 p . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.911 ' O ' HD12 ' A' ' 7' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.035 HD23 HG22 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' OD1' ' A' ' 33' ' ' ASP . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' CD ' HD21 ' A' ' 22' ' ' LEU . 1.3 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' NE2' ' A' ' 102' ' ' GLN . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.619 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' HG22 ' A' ' 8' ' ' VAL . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 66.2 t60 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 17.4 m-70 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG21 ' A' ' 62' ' ' VAL . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.957 HD21 HG21 ' A' ' 134' ' ' VAL . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' A' ' 3' ' ' VAL . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.589 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 134' ' ' VAL . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 67' ' ' ALA . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 129' ' ' ASN . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.933 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 120' ' ' ASP . 4.2 m . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.262 0.554 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 90' ' ' LEU . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.764 ' N ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.771 ' HG ' HG23 ' A' ' 87' ' ' VAL . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 92' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' VAL . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.561 ' NE2' HG22 ' A' ' 23' ' ' VAL . 4.3 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.858 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 117' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.756 HG12 HG23 ' A' ' 112' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 76' ' ' VAL . 43.3 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 1.8 p-10 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 130' ' ' LEU . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 7.7 t-20 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.957 HG21 HD21 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 54' ' ' VAL . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.035 HG22 HD23 ' A' ' 7' ' ' LEU . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 147' ' ' LEU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 144' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 143' ' ' THR . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.007 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.012 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 14.9 m170 -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.637 ' CG1' HG21 ' A' ' 8' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.946 ' HA ' HG21 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.851 ' HA ' HD11 ' A' ' 35' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 8' ' ' VAL . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.037 ' CG2' HG23 ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.954 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.985 ' CD2' HD21 ' A' ' 49' ' ' LEU . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.568 ' HB3' HG22 ' A' ' 134' ' ' VAL . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 24' ' ' ASP . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG2' HG23 ' A' ' 17' ' ' THR . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.841 ' O ' HG22 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 1.131 ' CD2' HD13 ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.851 HD11 ' HA ' ' A' ' 6' ' ' ASP . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.642 ' CG ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.131 HD13 ' CD2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.971 HD11 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.985 HD21 ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 67' ' ' ALA . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.94 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.94 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.971 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 13.0 m-85 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.302 0.572 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.594 HG23 HD23 ' A' ' 90' ' ' LEU . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD23 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' HG21 ' A' ' 109' ' ' ILE . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' ILE . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.843 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.751 HG23 HG13 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.492 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 109' ' ' ILE . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 HG23 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p30 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.821 ' CB ' HG12 ' A' ' 15' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.938 ' CG1' HD13 ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 9' ' ' VAL . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.037 HG23 ' CG2' ' A' ' 9' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.055 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 144' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 143' ' ' THR . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.985 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.055 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.0 m170 -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 152' ' ' VAL . 4.8 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 HG21 ' A' ' 9' ' ' VAL . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.863 ' O ' HD22 ' A' ' 7' ' ' LEU . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 6' ' ' ASP . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 152' ' ' VAL . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.079 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 31' ' ' PRO . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.77 HD21 ' OH ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CB ' HG12 ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.031 HG12 ' O ' ' A' ' 24' ' ' ASP . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.031 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.83 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 28' ' ' VAL . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.83 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.834 ' CZ ' HD23 ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.899 HD21 ' HG ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.661 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.834 HD23 ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.899 HG21 ' HA ' ' A' ' 67' ' ' ALA . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.527 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.568 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' HG23 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.425 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.572 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG11 ' HA3' ' A' ' 44' ' ' GLY . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.899 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HE2' HD11 ' A' ' 42' ' ' ILE . 24.1 m-85 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 119' ' ' VAL . 1.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.312 0.577 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 83' ' ' VAL . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.43 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.764 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.69 HG13 HG22 ' A' ' 117' ' ' VAL . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.69 HG22 HG13 ' A' ' 112' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' VAL . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.218 0.532 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.592 HG12 ' CB ' ' A' ' 13' ' ' TYR . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 52' ' ' HIS . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 54' ' ' VAL . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 7' ' ' LEU . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.854 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 144' ' ' GLU . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.872 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.899 ' HG ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 8' ' ' VAL . 57.6 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.976 ' CB ' HD21 ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.795 HD22 ' HB3' ' A' ' 4' ' ' ALA . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 152' ' ' VAL . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' HG23 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.004 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.555 ' CB ' HG12 ' A' ' 134' ' ' VAL . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' N ' HD23 ' A' ' 22' ' ' LEU . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 1.004 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 28' ' ' VAL . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.703 ' O ' HD23 ' A' ' 35' ' ' LEU . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.91 HG21 ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD21 HG11 ' A' ' 134' ' ' VAL . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.538 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.938 HG21 ' HB1' ' A' ' 48' ' ' ALA . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 120' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.578 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.676 HG23 ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.719 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.719 ' H ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 1.028 ' O ' HD11 ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.883 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 98' ' ' ALA . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' C ' HD13 ' A' ' 109' ' ' ILE . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.028 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.639 ' O ' HG23 ' A' ' 112' ' ' VAL . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 117' ' ' VAL . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.639 HG21 ' HB ' ' A' ' 107' ' ' VAL . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.913 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.8 p-10 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.242 0.544 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 17' ' ' THR . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.568 HG11 HD21 ' A' ' 45' ' ' LEU . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LYS . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 9' ' ' VAL . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB1' ' NE ' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.781 HG22 HD23 ' A' ' 7' ' ' LEU . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.67 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.063 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.487 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.063 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 1.8 m-70 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 8' ' ' VAL . 4.9 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 139' ' ' ILE . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.928 HG23 ' CD1' ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 7' ' ' LEU . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.844 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 6' ' ' ASP . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 3' ' ' VAL . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.848 HD21 ' HE1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.902 HG13 ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 131' ' ' LYS . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.829 HG22 HD23 ' A' ' 130' ' ' LEU . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' HB ' ' CG1' ' A' ' 15' ' ' VAL . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.958 ' CD1' HD13 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.785 HD23 ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.561 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 47.9 t60 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.785 ' CE1' HD23 ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB1' ' HZ ' ' A' ' 58' ' ' PHE . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 139' ' ' ILE . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.858 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.685 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.858 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HH ' ' HE1' ' A' ' 132' ' ' PHE . 42.2 p90 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.357 0.598 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 83' ' ' VAL . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' HB ' HG12 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' HD2' HD11 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.744 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.524 ' O ' HD11 ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.477 ' OE1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG21 ' OE1' ' A' ' 102' ' ' GLN . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.846 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.872 ' C ' HD13 ' A' ' 109' ' ' ILE . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 110' ' ' THR . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.598 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.468 ' NE2' ' HB2' ' A' ' 78' ' ' ARG . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 111' ' ' ALA . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 108' ' ' GLU . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 p30 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.829 HD23 HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.902 ' CE1' HG13 ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 49' ' ' LEU . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.542 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.928 ' CD1' HG23 ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.684 ' O ' HD13 ' A' ' 7' ' ' LEU . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.969 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.969 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 143' ' ' THR . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.733 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CD2' ' O ' ' A' ' 151' ' ' HIS . 0.5 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 2.3 p . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.686 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.946 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 7' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.975 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 HD22 ' A' ' 11' ' ' LEU . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CB ' HG12 ' A' ' 134' ' ' VAL . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.106 HD13 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.039 ' N ' HD22 ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 28' ' ' VAL . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 1.025 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.728 HD22 ' HD2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 9.6 t60 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.728 ' HD2' HD22 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD13 ' HE1' ' A' ' 132' ' ' PHE . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 52' ' ' HIS . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.575 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 1.034 ' NE2' HD11 ' A' ' 139' ' ' ILE . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.839 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.108 HG12 ' HB2' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.108 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.045 HG23 ' HB2' ' A' ' 120' ' ' ASP . 7.2 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.221 0.534 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.701 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.834 ' CG1' HG11 ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 83' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.834 HG11 ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.917 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.909 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' ' N ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' N ' ' HE3' ' A' ' 94' ' ' MET . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 107' ' ' VAL . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.907 ' HA ' HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.716 HG12 HG23 ' A' ' 112' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 1.045 ' HB2' HG23 ' A' ' 76' ' ' VAL . 15.6 t0 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 130' ' ' LEU . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.556 ' HE1' HD13 ' A' ' 45' ' ' LEU . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.877 HG12 ' CB ' ' A' ' 13' ' ' TYR . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.987 HG21 ' ND1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.034 HD11 ' NE2' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.616 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.032 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.032 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 15.7 m170 -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 35' ' ' LEU . 1.5 p-80 -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 146' ' ' GLU . 25.3 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.862 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HE2' ' CG ' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.953 ' HA ' HD11 ' A' ' 35' ' ' LEU . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.863 HD21 ' OE2' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.672 HG13 ' HB3' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 138' ' ' ALA . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.876 HD13 HD21 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.725 ' HB3' HG12 ' A' ' 134' ' ' VAL . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 24' ' ' ASP . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.486 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HD12 ' A' ' 22' ' ' LEU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 130' ' ' LEU . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.858 ' O ' HG12 ' A' ' 15' ' ' VAL . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.791 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 6' ' ' ASP . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.792 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.621 ' CG ' ' HE2' ' A' ' 5' ' ' LYS . 2.1 t-160 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 62' ' ' VAL . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' THR . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.876 HD21 HD13 ' A' ' 11' ' ' LEU . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 54' ' ' VAL . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 134' ' ' VAL . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG12 HG13 ' A' ' 62' ' ' VAL . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.768 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.682 HG13 HG12 ' A' ' 60' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 1.021 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.26 0.552 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.845 ' CE2' HD11 ' A' ' 90' ' ' LEU . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD11 ' CE2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.675 ' HG3' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 106' ' ' PRO . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' C ' ' CG1' ' A' ' 107' ' ' VAL . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.675 HD11 ' HG3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.705 HG21 ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.053 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.646 ' OE1' HG13 ' A' ' 118' ' ' VAL . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.705 ' OD1' HG21 ' A' ' 110' ' ' THR . 30.7 p-10 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.414 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.258 0.551 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 130' ' ' LEU . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.768 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.753 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.66 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.672 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.863 ' OE2' HD21 ' A' ' 7' ' ' LEU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.583 HG23 ' OE1' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.921 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.563 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 11.0 m-70 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.635 HG21 ' HB ' ' A' ' 8' ' ' VAL . 32.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.918 ' HA ' HG21 ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.613 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.869 ' O ' HD22 ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.896 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 HG23 ' A' ' 139' ' ' ILE . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.774 HD21 ' CB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HB3' HG12 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.544 HG23 HG23 ' A' ' 23' ' ' VAL . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' THR . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.921 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 9' ' ' VAL . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.152 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 1.152 ' CD2' HD23 ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.854 HD11 ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 52' ' ' HIS . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.924 ' CA ' HD12 ' A' ' 130' ' ' LEU . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 28.4 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.22 0.534 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.945 ' HG2' HG23 ' A' ' 118' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.882 HG22 ' H ' ' A' ' 89' ' ' GLU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.617 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.882 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 105' ' ' VAL . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 118' ' ' VAL . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.798 ' HB3' ' CG1' ' A' ' 118' ' ' VAL . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.945 HG23 ' HG2' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.332 0.586 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.924 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.854 ' CE1' HD11 ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.774 ' CB ' HD21 ' A' ' 11' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.552 ' C ' HD12 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.748 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.94 HG23 HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.896 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.031 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.031 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.903 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.63 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 139' ' ' ILE . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 HD22 ' A' ' 49' ' ' LEU . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.932 ' CB ' HD21 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 4' ' ' ALA . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 3' ' ' VAL . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.986 HD13 ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.886 ' OG ' ' HB1' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HA ' HG11 ' A' ' 152' ' ' VAL . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.73 HD21 ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.492 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.603 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 40' ' ' SER . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG13 ' CB ' ' A' ' 45' ' ' LEU . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 134' ' ' VAL . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.88 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.897 ' O ' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 62' ' ' VAL . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.552 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.319 0.58 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 119' ' ' VAL . 18.2 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 79' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.009 ' HB ' HD23 ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.009 HD23 ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.905 HG12 ' HB ' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.905 ' HB ' HG12 ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.277 0.561 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.552 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.508 ' HB3' ' CB ' ' A' ' 15' ' ' VAL . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.986 ' CG1' HD13 ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 56' ' ' ASP . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 2' ' ' LYS . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 1.01 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.932 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.9 m170 -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 34' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.653 ' HE2' HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.904 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.868 ' N ' HD21 ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.877 HG21 HG22 ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.907 HD12 HG13 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 2.4 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.884 HG12 ' O ' ' A' ' 24' ' ' ASP . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.884 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' CD ' ' N ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 1.035 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.835 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.739 HD22 ' HA2' ' A' ' 150' ' ' GLY . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.675 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' LEU . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 41' ' ' LEU . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.443 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.592 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 134' ' ' VAL . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.054 HG12 ' HB2' ' A' ' 67' ' ' ALA . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.98 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' CG ' ' A' ' 129' ' ' ASN . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 1.054 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 76' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.193 0.52 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' HG21 ' A' ' 87' ' ' VAL . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.651 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 96' ' ' PHE . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.636 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' THR . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.719 ' O ' HG13 ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.548 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.548 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 78' ' ' ARG . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.654 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 64' ' ' ALA . 8.7 m120 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.326 0.584 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.838 HD12 HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.547 ' C ' HG23 ' A' ' 134' ' ' VAL . 7.5 m120 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.907 HG13 HD12 ' A' ' 11' ' ' LEU . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.999 HG23 HD13 ' A' ' 7' ' ' LEU . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 8' ' ' VAL . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.996 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.996 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.818 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.739 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 79.5 m-70 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.881 ' CG2' HG11 ' A' ' 8' ' ' VAL . 16.7 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.614 ' HE2' HG22 ' A' ' 139' ' ' ILE . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.511 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.994 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HG2' ' HA3' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.886 ' HB3' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.101 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.927 ' CG1' HD23 ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.906 HG22 HD22 ' A' ' 130' ' ' LEU . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.573 HG22 ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.789 ' O ' HG12 ' A' ' 15' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.622 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 38.1 t60 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.809 ' CD2' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.592 ' C ' HD12 ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.906 HG21 ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 134' ' ' VAL . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 1.029 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.972 HG21 ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.678 ' H ' HG22 ' A' ' 87' ' ' VAL . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.972 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' VAL . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 96' ' ' PHE . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 92' ' ' VAL . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 117' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 112' ' ' VAL . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.777 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.517 HG13 ' C ' ' A' ' 118' ' ' VAL . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HB2' ' N ' ' A' ' 63' ' ' GLY . 3.4 p30 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.311 0.577 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.906 HD22 HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 HD21 ' A' ' 45' ' ' LEU . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 1.029 HG21 ' HB3' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.101 HG23 ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.988 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.988 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 1.9 p-80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.938 HG13 ' OE2' ' A' ' 146' ' ' GLU . 74.7 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HE1' HD21 ' A' ' 7' ' ' LEU . 4.0 ttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.317 0.58 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 3.0 mmtm -125.83 139.71 53.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.055 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -54.99 138.92 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.0 109.957 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -156.71 -179.21 7.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.368 -0.833 . . . . 0.0 110.384 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -61.52 161.11 10.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.074 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 6.4 m-20 56.17 46.41 21.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.922 . . . . 0.0 110.173 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -152.95 96.68 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 152' ' ' VAL . 9.8 p -51.59 129.93 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 109.94 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 138' ' ' ALA . 3.7 p -143.84 122.19 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.155 -0.966 . . . . 0.0 110.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.3 t -89.37 106.03 18.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -130.65 114.59 15.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 110.483 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.31 149.15 35.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.0 109.635 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE1' HD21 ' A' ' 41' ' ' LEU . 52.3 p90 -155.85 139.88 16.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.643 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 36.3 tt0 -104.98 128.04 53.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 24' ' ' ASP . 5.9 p -111.48 142.18 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.39 135.83 27.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.93 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 130' ' ' LEU . 31.6 p -85.37 151.89 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.212 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -30.57 30.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.834 . . . . 0.0 110.276 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -61.75 -11.19 11.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 110.145 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.87 7.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.4 t -121.22 150.55 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -1.125 . . . . 0.0 110.335 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 25' ' ' GLU . 2.6 tt -107.13 110.65 22.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.175 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.15 -34.36 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 110.157 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.92 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -170.05 150.16 3.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 22' ' ' LEU . 24.5 tt0 -149.06 131.16 15.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.324 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -108.67 123.36 37.45 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.132 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.8 Cg_endo -72.99 156.22 52.31 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.871 1.459 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.72 -28.48 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -4.92 36.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -149.25 73.44 10.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.133 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.95 143.07 35.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.958 1.504 . . . . 0.0 110.474 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.37 108.25 18.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 8' ' ' VAL . 26.6 t0 -83.04 131.41 35.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -161.09 168.02 25.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.303 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.849 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.5 tp -72.71 125.56 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.736 ' CD2' HG13 ' A' ' 3' ' ' VAL . 13.9 t-80 -67.87 145.31 54.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 110.168 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 81.35 -59.58 4.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.02 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -1.199 . . . . 0.0 110.358 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.77 -48.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER 177.78 -63.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -1.126 . . . . 0.0 110.133 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 45' ' ' LEU . 9.9 mp -43.83 141.71 1.51 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 45' ' ' LEU . 14.5 pt -43.49 142.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -58.18 -45.32 87.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.266 -0.896 . . . . 0.0 110.165 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -43.68 -33.8 2.51 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 45' ' ' LEU . 2.3 tt -82.55 -41.14 20.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -1.113 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' GLY . 58.0 mt-10 -60.22 -57.74 11.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.159 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.557 HG23 ' N ' ' A' ' 48' ' ' ALA . 11.5 t -55.43 -40.95 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.318 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' HG23 ' A' ' 47' ' ' THR . . . -63.99 -23.88 67.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.295 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 11' ' ' LEU . 6.0 mt -79.99 -26.59 39.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.389 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.809 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.4 tm-20 -51.5 131.53 29.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 2' ' ' LYS . . . 67.16 88.05 0.07 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CE1' ' CD2' ' A' ' 58' ' ' PHE . 1.8 m-70 -155.17 -88.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER 167.31 143.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.274 -0.891 . . . . 0.0 110.086 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.6 HG22 HG13 ' A' ' 139' ' ' ILE . 24.5 t -84.22 119.11 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 110.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 96.34 2.94 60.21 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 57' ' ' LYS . 8.2 t0 -100.49 146.31 27.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 110.252 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 1.8 ttpm? -104.18 140.56 37.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 22.3 t80 -147.23 153.34 39.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 74.4 m-20 -105.97 132.34 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.597 ' CG2' ' CE2' ' A' ' 58' ' ' PHE . 19.6 t -134.04 130.63 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.94 . . . . 0.0 110.22 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -92.22 123.49 35.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.261 -0.899 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.8 HG12 ' HB2' ' A' ' 67' ' ' ALA . 75.9 t -157.24 109.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 110.24 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.839 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -149.52 -78.82 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.911 ' HB2' ' N ' ' A' ' 128' ' ' GLN . . . -78.21 -24.42 47.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.298 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t-20 -75.72 -20.73 58.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 110.169 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.57 73.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 110.028 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.839 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -171.85 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.384 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.76 -39.75 5.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.355 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' GLN . . . -76.17 -51.86 6.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 43.2 mt-30 61.34 43.84 10.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -1.151 . . . . 0.0 110.203 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' OH ' ' OD2' ' A' ' 120' ' ' ASP . 12.6 t80 -43.65 143.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.303 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.01 87.79 5.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 tt0 -65.17 -11.72 43.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -84.45 0.53 49.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.927 . . . . 0.0 110.232 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 tp -110.71 -14.37 14.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.831 HG12 ' OD2' ' A' ' 120' ' ' ASP . 7.0 m -91.37 123.85 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 110.2 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.756 ' O ' HG12 ' A' ' 119' ' ' VAL . 2.0 tt0 -140.29 126.54 19.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.246 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HG2' HG22 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -105.28 119.42 39.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.166 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 m -147.13 147.26 28.41 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.19 163.45 38.01 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.993 1.523 . . . . 0.0 110.399 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 84' ' ' PHE . 4.5 pttt -71.49 -2.96 18.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.3 m-20 -57.51 -19.19 23.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 110.303 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' PHE . 7.9 p -96.28 -3.59 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 84' ' ' PHE . 1.3 p90 -177.51 115.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 110.222 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.496 ' CG ' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -141.33 22.31 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.18 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.01 48.39 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 90' ' ' LEU . 13.4 t -90.27 32.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.133 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 5.4 t0 70.82 1.09 3.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 2.7 mt-10 166.64 104.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.259 -0.901 . . . . 0.0 109.973 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -106.67 104.99 14.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 109' ' ' ILE . 36.7 tt0 -147.09 154.23 40.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.155 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 111' ' ' ALA . 45.8 t -64.14 137.82 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 101.3 -36.46 4.19 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 109' ' ' ILE . 26.3 ttp -46.54 155.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.142 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' N ' ' HG2' ' A' ' 94' ' ' MET . 0.7 OUTLIER -98.13 127.48 44.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 110.153 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.747 ' HB3' HG23 ' A' ' 107' ' ' VAL . 41.9 t80 -118.55 164.13 15.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -122.25 110.36 15.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.164 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 131.66 50.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.266 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -99.71 80.54 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.164 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.469 ' OG1' HG21 ' A' ' 105' ' ' VAL . 19.5 p -75.43 173.37 11.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.155 -0.966 . . . . 0.0 110.232 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.83 -31.58 66.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.46 -8.41 33.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 105' ' ' VAL . . . 122.66 -160.26 17.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.92 117.78 5.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.946 1.498 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 ' OG1' ' A' ' 100' ' ' THR . 6.5 t -120.46 109.91 36.18 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.87 . . . . 0.0 110.336 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.31 128.54 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.987 1.52 . . . . 0.0 110.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.747 HG23 ' HB3' ' A' ' 96' ' ' PHE . 27.1 m -124.68 172.17 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 28.6 tt0 -152.06 107.72 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.48 134.47 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 9.4 t -118.16 -19.08 9.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 0.0 110.149 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 92' ' ' VAL . . . 179.28 112.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.022 HG23 HG22 ' A' ' 117' ' ' VAL . 9.1 p -65.39 146.78 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.368 -0.832 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 116' ' ' HIS . 3.1 tt0 -137.51 154.1 49.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 2.1 t70 -47.12 157.26 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 110.256 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 3.0 m-20 73.49 -56.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.393 -0.817 . . . . 0.0 110.385 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' GLU . 11.8 p80 -156.87 165.08 37.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.488 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 112' ' ' VAL . 91.3 t -84.16 173.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.404 -0.81 . . . . 0.0 110.276 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.604 ' N ' HG12 ' A' ' 117' ' ' VAL . 39.3 t -123.05 121.25 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -119.82 138.83 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 110.095 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.831 ' OD2' HG12 ' A' ' 76' ' ' VAL . 20.6 t0 -167.56 171.68 10.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.991 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . . . -91.78 -131.64 5.37 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -114.79 132.44 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -102.38 -2.06 29.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -47.21 -32.43 4.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 -3.59 32.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 -166.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.852 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.445 ' C ' ' HB2' ' A' ' 64' ' ' ALA . . . 63.66 21.49 65.06 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.911 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -89.23 72.92 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.338 -1.095 . . . . 0.0 110.237 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 129' ' ' ASN . 17.1 p-10 -73.2 120.15 18.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 17' ' ' THR . 7.5 mp -107.43 153.54 22.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -116.05 130.35 56.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 20.4 p90 -146.71 144.95 29.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.935 . . . . 0.0 110.356 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 21.1 m-20 -92.13 142.77 27.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.686 HG13 ' CD1' ' A' ' 11' ' ' LEU . 25.5 t -124.77 149.68 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.175 -0.953 . . . . 0.0 110.463 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 29.5 mt-10 -139.6 112.26 7.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.019 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLY . 72.9 t -75.27 136.88 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -0.92 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 10' ' ' SER . 16.1 t -111.69 -35.43 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 0.0 110.306 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -150.55 161.66 42.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.145 -0.972 . . . . 0.0 110.464 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.055 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.9 mt -143.39 102.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.312 -0.867 . . . . 0.0 110.087 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.719 ' C ' HD23 ' A' ' 7' ' ' LEU . 37.1 mtp85 -132.69 158.66 41.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.151 -0.968 . . . . 0.0 110.428 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -94.86 146.43 24.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.992 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -91.43 158.0 16.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.491 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.93 -175.63 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.157 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.415 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -58.84 -45.7 89.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.122 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -71.21 -34.79 71.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.992 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -61.86 -43.82 98.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.938 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.758 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.3 OUTLIER -82.07 -13.65 56.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.924 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.6 13.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -90.42 -3.24 57.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.413 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.508 ' O ' ' ND1' ' A' ' 151' ' ' HIS . . . 74.71 44.23 26.35 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 150' ' ' GLY . 29.1 m-70 -137.67 160.92 37.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.322 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.069 HG21 HG21 ' A' ' 8' ' ' VAL . 3.3 p -121.99 125.91 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 110.191 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.3 m170 45.76 60.29 3.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 156' ' ' HIS . . . -172.37 -77.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 52.33 -89.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.213 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 154' ' ' GLY . 3.4 t-80 -74.86 -37.75 62.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 157' ' ' ASP . 4.6 t0 -60.54 -28.94 68.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.29 149.63 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.152 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -58.14 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.423 ' N ' ' OD2' ' A' ' 163' ' ' ASP . 2.8 p-10 -162.98 80.97 0.48 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.32 59.33 3.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 161' ' ' ASP . 14.7 m-20 -121.77 -18.28 7.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -79.51 164.91 23.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.211 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -162.99 175.13 11.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.169 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.03 -21.91 43.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.21 150.63 33.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -1.12 . . . . 0.0 110.177 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.29 -81.5 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.61 -30.82 9.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.72 -166.75 42.79 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.56 160.25 25.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.221 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 134.35 -11.71 4.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.89 -73.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -1.186 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.7 143.68 48.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 5.2 p-80 -153.6 150.3 28.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.151 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.9 87.33 0.13 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -103.27 -65.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 180' ' ' GLY . 8.7 tt0 -119.38 37.53 4.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.246 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 64.08 -74.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.151 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 178' ' ' GLU . . . -143.87 -131.37 2.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.26 -142.9 0.13 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -53.86 172.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -1.143 . . . . 0.0 110.188 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 184' ' ' CYS . . . -52.94 -20.72 8.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER 64.13 148.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 110.259 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 36.4 t -90.5 95.99 10.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.216 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -140.81 -86.89 0.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 54.69 -131.74 47.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -130.6 169.34 15.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 110.224 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 161.97 40.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -57.54 -179.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.149 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 104.51 -56.67 0.55 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.8 -90.21 0.08 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 194' ' ' GLY . 0.1 OUTLIER 61.46 29.98 18.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 110.266 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 193' ' ' CYS . . . 56.42 102.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 179.52 6.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -1.082 . . . . 0.0 110.22 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 31.4 m80 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.209 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' CG ' ' N ' ' A' ' 2' ' ' LYS . 14.7 ttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -170.84 173.39 5.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 110.257 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.924 HG22 HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -57.15 141.64 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -152.29 165.75 33.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.206 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -62.7 162.2 11.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 110.184 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' OD1' ' HG2' ' A' ' 5' ' ' LYS . 1.0 OUTLIER 57.17 20.36 5.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -0.87 . . . . 0.0 110.184 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD13 ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -131.59 113.82 14.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 110.257 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.694 HG11 ' HB ' ' A' ' 152' ' ' VAL . 3.4 m -63.62 137.0 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.123 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG22 ' A' ' 3' ' ' VAL . 55.0 t -139.96 120.48 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 110.386 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 4.5 p -93.51 128.2 39.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 109.823 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD12 ' CG1' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -149.14 112.23 4.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.975 . . . . 0.0 110.574 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.97 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.07 142.12 38.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.95 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' A' ' 134' ' ' VAL . 36.9 p90 -156.49 148.44 22.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.072 -1.018 . . . . 0.0 110.703 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -111.92 147.26 36.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.545 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.66 HG12 ' O ' ' A' ' 24' ' ' ASP . 2.1 p -132.23 152.89 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 11.4 mtm180 -144.42 135.81 25.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.537 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -85.08 151.82 23.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 110.305 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' THR . 4.6 tt0 -41.65 -27.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 110.327 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -59.18 -11.65 4.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.069 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.87 23.07 43.25 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG2' ' OG1' ' A' ' 17' ' ' THR . 15.0 m -121.41 151.54 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.42 -1.047 . . . . 0.0 110.314 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.691 HD11 ' HB3' ' A' ' 25' ' ' GLU . 1.2 tt -92.28 120.93 33.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.879 . . . . 0.0 110.158 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' A' ' 17' ' ' THR . 91.3 t -75.99 -58.69 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.112 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.66 ' O ' HG12 ' A' ' 15' ' ' VAL . 25.4 t0 -139.84 153.91 47.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.913 . . . . 0.0 110.208 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.691 ' HB3' HD11 ' A' ' 22' ' ' LEU . 14.8 pt-20 -149.03 138.23 21.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.97 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.2 t -125.5 117.47 24.86 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 110.126 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.91 165.21 33.41 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.962 1.506 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 12.7 p -62.47 -24.25 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 110.243 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.49 -9.92 59.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.177 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -144.66 57.27 4.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 45.3 Cg_endo -72.91 147.84 44.59 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.051 1.553 . . . . 0.0 110.398 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.61 97.2 7.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 -83.12 110.51 18.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.305 -0.872 . . . . 0.0 109.996 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.7 p90 -132.76 167.49 20.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -0.974 . . . . 0.0 110.339 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.853 HD23 ' NE2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -81.7 136.13 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.352 -0.842 . . . . 0.0 110.169 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -75.19 148.77 39.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.56 -57.12 2.95 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.853 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -130.04 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.249 -1.148 . . . . 0.0 110.305 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.67 -54.48 0.02 OUTLIER Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.3 OUTLIER 169.56 -43.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.226 -1.161 . . . . 0.0 110.254 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -43.68 168.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.209 -0.932 . . . . 0.0 110.172 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.953 HD11 ' CE1' ' A' ' 68' ' ' TYR . 9.4 mt -80.16 137.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -69.88 -23.5 63.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 0.0 110.378 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -64.86 -50.66 57.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.5 pp -81.95 -25.28 34.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -1.122 . . . . 0.0 110.093 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.4 OUTLIER -43.66 -37.33 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.905 . . . . 0.0 110.08 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.2 p -52.53 -42.76 64.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.126 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -63.2 -35.27 79.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.097 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -70.73 -24.21 62.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.146 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.596 ' HA ' HG12 ' A' ' 3' ' ' VAL . 5.3 tt0 -69.29 130.6 43.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 50.42 25.27 8.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -59.3 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -1.124 . . . . 0.0 110.16 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.41 99.6 3.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 110.214 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.81 119.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 110.44 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.0 61.57 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 -170.66 2.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.24 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' A' ' 135' ' ' GLU . 32.0 mtmt -127.35 157.39 40.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.138 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' HD1' HG23 ' A' ' 60' ' ' VAL . 43.7 p90 -152.15 132.31 13.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -84.15 125.07 31.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 110.214 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG23 ' HD1' ' A' ' 58' ' ' PHE . 28.0 t -131.45 105.01 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.19 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.578 ' HB2' ' HG2' ' A' ' 131' ' ' LYS . . . -84.17 120.33 26.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.053 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.568 HG23 HG12 ' A' ' 60' ' ' VAL . 4.8 t -147.72 105.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.586 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -73.46 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.695 ' HB1' ' OD2' ' A' ' 72' ' ' ASP . . . -81.66 -20.67 39.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -1.132 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 65' ' ' ASN . 3.3 m120 -81.12 -31.18 34.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 1.0 OUTLIER -175.22 66.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.247 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HA ' HD13 ' A' ' 42' ' ' ILE . . . 175.56 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.953 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 65.91 -61.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.294 -0.879 . . . . 0.0 110.311 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 126' ' ' ALA . . . -55.88 -64.4 4.42 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 19.8 mt-30 65.83 -143.7 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -1.156 . . . . 0.0 110.404 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' O ' ' CB ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -53.83 120.63 6.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.367 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.695 ' OD2' ' HB1' ' A' ' 64' ' ' ALA . 52.2 p-10 -137.35 74.35 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.148 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' A' ' 71' ' ' TYR . 77.4 mt-10 -65.77 -18.65 65.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -92.27 3.96 54.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -49.69 -65.32 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 0.0 110.229 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 75' ' ' LEU . 12.3 m -129.26 155.63 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.268 -0.895 . . . . 0.0 110.203 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 31.5 mt-30 -144.85 154.49 42.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 110.216 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.591 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -122.95 124.93 44.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.203 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 78' ' ' ARG . 6.2 m -156.25 124.59 2.9 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.935 . . . . 0.0 110.15 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 44.9 Cg_endo -73.18 159.84 46.5 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.896 1.472 . . . . 0.0 110.361 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -63.09 -16.95 61.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.96 -14.74 10.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.2 -14.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -75.84 -79.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.29 89.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.153 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.13 74.1 0.65 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 90' ' ' LEU . 13.1 m -127.81 -33.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -1.141 . . . . 0.0 110.272 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 5.4 t0 61.0 13.86 4.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 170.94 107.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 87' ' ' VAL . 1.9 tp -141.15 101.54 4.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 110.306 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 46.3 tt0 -126.66 134.41 50.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.042 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' GLN . 26.9 t -41.56 128.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 88.15 -20.6 28.7 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.519 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 8.5 ttp -63.85 155.34 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.307 -1.114 . . . . 0.0 110.236 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.491 ' N ' ' HG2' ' A' ' 94' ' ' MET . 5.0 ptm180 -116.76 140.93 48.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.612 ' CZ ' ' CG2' ' A' ' 107' ' ' VAL . 27.7 p90 -139.01 153.58 48.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 106.34 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.25 -0.906 . . . . 0.0 110.261 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -73.3 151.27 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.335 -0.853 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.51 64.57 1.55 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.187 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -175.48 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.171 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -19.38 52.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -91.08 16.84 8.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.24 163.86 19.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 46.8 Cg_endo -73.02 131.67 17.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.058 1.557 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 70.7 t -126.9 129.36 24.03 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 110.177 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.33 113.65 3.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.909 1.478 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.707 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.8 m -127.52 169.86 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.179 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.468 ' CG ' ' C ' ' A' ' 107' ' ' VAL . 15.6 mt-10 -148.53 118.08 7.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 110.252 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.5 132.02 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -124.78 -10.71 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.27 -178.77 7.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.185 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -145.78 139.74 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.69 175.39 9.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 110.188 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 115' ' ' ASP . 1.2 m-20 -69.41 128.88 38.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 110.228 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 43.93 38.03 1.99 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.157 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -172.38 151.43 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.294 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 t -140.19 151.57 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 110.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HD3' ' A' ' 78' ' ' ARG . 5.8 t -105.55 150.41 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.251 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.707 HG22 ' HB ' ' A' ' 107' ' ' VAL . 5.6 p -152.29 135.21 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 121' ' ' GLY . 25.6 t0 -85.61 170.96 12.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 120' ' ' ASP . . . 155.58 65.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -81.18 176.61 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -1.119 . . . . 0.0 110.211 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -97.94 157.62 16.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 110.181 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 124' ' ' MET . 6.4 tmm? -61.47 -19.15 61.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.177 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -73.41 -70.1 0.39 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.29 -0.881 . . . . 0.0 110.217 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.661 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -109.31 -167.3 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.297 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 75' ' ' LEU . . . 79.08 21.49 67.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' A' ' 63' ' ' GLY . 23.5 mm100 -92.41 71.0 5.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -1.141 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.645 ' ND2' ' HB3' ' A' ' 64' ' ' ALA . 9.7 m120 -72.56 135.7 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.847 . . . . 0.0 110.083 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 132' ' ' PHE . 1.9 pp -148.51 139.85 23.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -107.13 134.78 49.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.959 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HD2' HD12 ' A' ' 130' ' ' LEU . 47.6 p90 -148.56 126.52 11.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -80.17 137.13 36.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 109.792 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' A' ' 13' ' ' TYR . 16.4 t -125.77 148.37 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.036 . . . . 0.0 110.766 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 11' ' ' LEU . 20.4 pt-20 -131.2 143.13 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.735 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG21 ' NE2' ' A' ' 52' ' ' HIS . 54.7 t -91.19 140.17 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.487 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 10' ' ' SER . 92.2 t -111.64 -44.42 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.2 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -155.15 162.91 40.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -1.0 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 3' ' ' VAL . 7.0 mt -152.46 102.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 110.09 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.451 ' HG2' ' N ' ' A' ' 141' ' ' GLU . 30.1 ttp180 -142.15 163.95 31.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 110.342 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 140' ' ' ARG . 38.5 mt-10 -76.1 157.62 32.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.074 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -111.67 161.16 16.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.681 HG22 ' H ' ' A' ' 144' ' ' GLU . 3.6 m -74.46 -175.57 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 110.061 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.681 ' H ' HG22 ' A' ' 143' ' ' THR . 30.6 tp10 -59.04 -43.93 91.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.359 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' HB3' ' OE1' ' A' ' 146' ' ' GLU . 0.9 OUTLIER -69.39 -45.37 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.157 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.074 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -54.93 -41.91 71.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -0.964 . . . . 0.0 109.687 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -79.19 -19.69 50.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.48 -53.46 10.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.984 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 13.1 m170 -86.25 -3.67 59.02 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.797 . . . . 0.0 109.239 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 66.17 55.44 18.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 73.5 m-70 -158.05 165.74 34.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -1.161 . . . . 0.0 110.281 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.694 ' HB ' HG11 ' A' ' 8' ' ' VAL . 1.5 p -130.45 111.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.2 t60 49.3 23.11 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.191 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.442 ' O ' ' NE2' ' A' ' 158' ' ' HIS . . . -110.85 30.61 7.93 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -95.38 -61.27 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.201 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -83.95 5.84 24.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.19 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.73 -13.0 60.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.196 -0.94 . . . . 0.0 110.199 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' NE2' ' O ' ' A' ' 154' ' ' GLY . 2.7 p80 -155.7 157.3 36.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.03 38.62 1.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -124.47 118.19 26.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 162' ' ' HIS . 3.3 m-20 -139.35 -107.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.203 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.449 ' HB3' ' O ' ' A' ' 161' ' ' ASP . 0.6 OUTLIER 176.22 56.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.072 -1.018 . . . . 0.0 110.103 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.95 -175.14 4.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.88 . . . . 0.0 110.176 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -99.16 35.9 1.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 110.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.34 143.59 50.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.78 133.67 8.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.81 44.64 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -1.156 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 84.4 m 44.91 63.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.82 -87.54 0.21 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 153.07 52.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.409 ' C ' ' CD2' ' A' ' 171' ' ' HIS . 1.2 p-80 -84.38 -173.53 4.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.182 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 61.17 18.05 53.94 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.26 106.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -1.199 . . . . 0.0 110.248 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.2 137.44 48.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -102.01 -161.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.227 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.29 -83.17 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 177' ' ' HIS . 7.4 p80 -150.69 82.36 1.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -1.128 . . . . 0.0 110.135 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -147.19 -164.23 1.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -65.01 155.63 34.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.53 142.02 3.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.88 149.03 0.99 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 15.3 mp0 -117.69 116.24 26.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -1.104 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.9 169.32 19.94 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 48.74 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.185 -1.185 . . . . 0.0 110.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.0 p -143.74 -38.58 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 110.226 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -125.91 157.87 20.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.19 -11.02 2.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mttt 43.01 31.7 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.173 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.01 -121.3 6.76 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 49.49 -161.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -1.149 . . . . 0.0 110.12 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 62.77 70.52 1.02 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.23 -112.32 1.52 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.1 m -122.87 143.91 49.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -1.163 . . . . 0.0 110.186 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -71.64 -126.62 0.07 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 27.1 p -162.54 177.74 9.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.204 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 10.7 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.27 0.557 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 3' ' ' VAL . 1.2 pttm -161.39 -175.64 4.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.86 HG21 HD22 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -80.82 154.86 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.844 . . . . 0.0 110.278 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -158.03 161.72 38.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 110.31 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.619 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -66.19 62.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.114 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.03 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 167.38 35.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 110.144 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.03 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.4 mp -150.13 134.6 17.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.241 -0.912 . . . . 0.0 110.342 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' ILE . 3.6 m -67.98 134.75 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 0.0 109.871 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.809 HG11 ' CG2' ' A' ' 3' ' ' VAL . 6.4 m -133.68 114.33 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 110.64 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -96.57 120.84 37.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.577 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER -147.39 130.02 15.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.013 . . . . 0.0 110.684 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.18 155.09 16.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.637 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 54.8 p90 -156.47 142.24 17.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.108 -0.995 . . . . 0.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -98.62 141.86 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.917 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.8 t -111.31 142.46 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.442 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 3.3 ttm180 -151.54 142.47 23.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.333 -0.854 . . . . 0.0 110.007 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.484 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 32.9 p -101.93 152.01 21.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.147 -0.97 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.7 -18.91 2.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.3 5.83 7.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.22 29.59 58.28 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 25.3 t -121.23 151.53 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -1.104 . . . . 0.0 110.252 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -105.24 136.99 43.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.6 t -103.39 -21.97 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.305 -0.872 . . . . 0.0 110.178 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -176.35 150.28 0.9 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 44.8 tt0 -149.04 125.12 10.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 110.293 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.48 131.03 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.12 145.9 40.15 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.942 1.496 . . . . 0.0 110.475 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.86 -23.04 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.8 m -84.88 -6.71 59.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 110.203 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.015 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.99 66.92 15.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.161 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 156.97 52.16 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.007 1.53 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.56 94.98 9.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 110.188 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.558 ' O ' HG11 ' A' ' 152' ' ' VAL . 13.9 p-10 -83.03 124.97 30.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.02 168.01 27.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.909 . . . . 0.0 110.397 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.843 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.5 tp -67.83 112.99 5.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.898 . . . . 0.0 110.121 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -63.86 140.78 58.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.422 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' CA ' ' OE2' ' A' ' 46' ' ' GLU . . . 88.61 -55.59 4.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.843 ' CD2' HD23 ' A' ' 35' ' ' LEU . 23.2 p-80 -130.27 87.26 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -1.162 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 40' ' ' SER . . . -156.29 -66.26 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER 177.27 35.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -1.149 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.34 -168.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.165 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.72 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -116.44 148.12 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.414 ' CB ' ' OD2' ' A' ' 66' ' ' ASP . 1.7 m -49.7 -47.32 50.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.202 -0.936 . . . . 0.0 110.258 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 62' ' ' VAL . . . -54.94 -32.2 55.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -86.69 -63.88 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -1.157 . . . . 0.0 110.341 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' OE2' ' CA ' ' A' ' 37' ' ' GLY . 40.5 mt-10 -42.43 -48.07 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.268 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -51.86 -39.94 59.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 110.255 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.11 66.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 110.245 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 HG21 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -80.64 -35.29 34.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HA ' HG12 ' A' ' 3' ' ' VAL . 25.5 tt0 -47.9 129.99 14.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.227 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' GLU . . . 44.59 70.54 0.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -115.16 -126.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 110.099 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -165.7 128.45 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.076 -1.015 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 54' ' ' VAL . 28.5 m -81.84 118.99 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.882 . . . . 0.0 110.371 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.83 34.36 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -123.5 169.23 11.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.226 . . . . 0.0 110.262 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 157.49 40.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 60' ' ' VAL . 76.0 t80 -149.38 146.69 27.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.8 t70 -85.37 139.53 31.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 110.174 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 50.3 t -147.29 130.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.244 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -106.35 120.41 41.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.103 HG22 ' HB2' ' A' ' 67' ' ' ALA . 10.0 p -138.54 118.8 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -163.79 -76.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 69' ' ' GLY . . . -92.24 -25.35 18.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.382 -1.069 . . . . 0.0 110.133 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 3.8 t-20 -81.01 -14.41 57.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.9 . . . . 0.0 110.398 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER 174.67 70.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.103 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . 177.32 -143.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -109.35 52.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.691 ' O ' ' HB2' ' A' ' 64' ' ' ALA . . . -138.6 57.18 0.64 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -149.39 106.41 3.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -1.155 . . . . 0.0 110.212 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.088 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -43.16 143.4 0.81 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.226 -0.921 . . . . 0.0 110.102 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 77' ' ' GLN . 67.0 m-20 -83.53 69.82 10.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.15 -9.29 21.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.763 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 32.3 p-10 -55.6 -28.86 57.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 110.235 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.943 HD12 HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER 173.27 -49.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 110.634 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.943 HG12 HD12 ' A' ' 75' ' ' LEU . 6.2 p -144.21 155.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.919 . . . . 0.0 110.682 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.629 ' NE2' ' CD2' ' A' ' 123' ' ' HIS . 2.1 tt0 -103.01 142.67 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.408 -0.807 . . . . 0.0 110.015 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 3.4 mtt85 -88.95 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.313 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 117' ' ' VAL . 13.3 p -163.14 120.34 1.23 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.927 . . . . 0.0 110.198 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -73.12 162.23 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 0.0 110.424 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HG3' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.44 -5.45 32.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 110.304 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -21.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 83' ' ' VAL . 70.5 t -101.88 4.74 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 4.0 m-85 -82.72 -7.91 59.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.249 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.5 tpp 51.35 59.2 4.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.205 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.4 105.8 3.05 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.04 HG23 HD23 ' A' ' 90' ' ' LEU . 2.4 p -127.48 89.44 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -1.129 . . . . 0.0 110.247 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.36 7.76 10.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.03 39.57 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.04 HD23 HG23 ' A' ' 87' ' ' VAL . 1.1 mm? -72.86 114.37 10.92 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.658 -0.651 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 94' ' ' MET . 21.7 tt0 -118.38 125.86 50.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 0.0 110.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 p -60.06 132.44 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.231 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 109' ' ' ILE . . . 92.72 -4.8 76.23 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 5.7 ttp -91.06 151.95 20.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -1.183 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.09 126.3 39.23 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.229 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.786 ' O ' HG22 ' A' ' 107' ' ' VAL . 61.8 t80 -107.42 143.08 36.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.879 . . . . 0.0 110.2 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.57 125.57 43.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.3 120.75 42.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.213 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.46 70.91 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 0.0 110.155 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 102' ' ' GLN . 15.4 t -79.87 158.71 26.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.62 -29.06 10.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' THR . 10.8 tp60 -65.84 -8.73 23.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.217 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.77 175.67 15.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.14 127.04 11.65 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.033 1.544 . . . . 0.0 110.389 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -137.95 119.07 10.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.198 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.99 129.88 14.8 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.957 1.504 . . . . 0.0 110.402 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 96' ' ' PHE . 5.0 m -118.37 153.25 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.257 -0.902 . . . . 0.0 110.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 119' ' ' VAL . 55.3 mm-40 -110.7 165.26 11.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 96' ' ' PHE . 5.1 mt -135.04 102.14 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 t -127.04 -8.55 5.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.355 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -141.87 160.34 40.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.974 . . . . 0.0 110.335 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.8 t -143.75 106.0 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 7.2 mm-40 -93.7 173.28 7.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 110.289 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 12.4 t0 -78.76 136.61 37.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.233 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 2.7 m-20 71.83 -1.21 2.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.377 -0.827 . . . . 0.0 110.493 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.605 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 45.9 p-80 -175.19 145.82 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.117 -0.989 . . . . 0.0 110.338 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.4 m -100.56 176.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.27 -0.894 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 25.4 t -119.65 127.65 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 110.22 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.527 ' CB ' ' O ' ' A' ' 108' ' ' GLU . 27.5 m -139.09 142.39 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 110.115 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 49.4 t0 -83.48 99.3 10.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -166.72 -144.13 4.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.436 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 4.5 m120 -118.62 155.58 30.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -1.159 . . . . 0.0 110.318 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -100.93 146.87 26.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 110.13 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' ' HG ' ' A' ' 125' ' ' LEU . 3.0 tmm? -67.37 -39.99 85.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.338 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.428 ' HG ' ' SD ' ' A' ' 124' ' ' MET . 42.5 mt -117.43 84.79 2.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 110.277 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.088 ' HB1' ' N ' ' A' ' 71' ' ' TYR . . . -144.88 124.79 13.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.953 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 71' ' ' TYR . . . 86.73 13.63 66.79 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -121.71 79.52 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.255 -1.144 . . . . 0.0 110.111 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -42.2 138.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 63' ' ' GLY . 4.3 mp -105.87 138.39 42.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.189 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' ARG . 1.2 ptmt -101.45 132.13 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.056 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.975 ' CE1' HG12 ' A' ' 62' ' ' VAL . 24.2 p90 -148.41 125.89 11.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 110.319 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 68.1 m-20 -72.04 139.12 48.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.937 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 13' ' ' TYR . 20.0 t -119.43 152.59 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.182 -0.948 . . . . 0.0 110.429 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.3 tm-20 -139.88 128.65 23.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.054 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 4.8 t -83.59 143.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.235 -0.916 . . . . 0.0 110.239 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 10' ' ' SER . 21.5 t -111.43 -42.51 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.362 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.619 ' HB1' HH11 ' A' ' 140' ' ' ARG . . . -166.23 157.84 13.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.737 HG22 HD23 ' A' ' 7' ' ' LEU . 5.7 mt -137.26 102.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.619 HH11 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -116.54 171.54 7.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HG3' ' HG ' ' A' ' 7' ' ' LEU . 1.6 mp0 -100.54 122.37 43.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.212 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.97 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -66.89 160.75 25.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.228 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -175.75 2.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 110.215 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.151 -0.968 . . . . 0.0 110.307 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.8 tt0 -71.16 -42.56 68.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.967 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.65 -47.02 83.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 142' ' ' ALA . 2.7 mm? -77.34 -18.79 57.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.885 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -55.36 -53.09 60.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 -11.12 15.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.506 -0.746 . . . . 0.0 109.687 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 35' ' ' LEU . . . 88.17 58.52 1.76 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 155' ' ' ALA . 24.3 m-70 -137.28 150.84 48.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -1.114 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 33' ' ' ASP . 5.5 p -114.51 121.3 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 153' ' ' HIS . 48.1 t60 56.75 64.58 1.62 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 151' ' ' HIS . . . 111.19 -140.55 16.11 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . -172.01 125.96 0.56 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -83.51 -11.82 56.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 12.5 t70 -64.83 -42.42 94.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 2.1 m80 57.23 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -152.57 -41.42 0.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.887 . . . . 0.0 110.183 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 159' ' ' HIS . 18.3 m-70 48.88 -174.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 163' ' ' ASP . 38.8 t70 -114.94 37.69 3.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.441 ' CB ' ' O ' ' A' ' 161' ' ' ASP . 0.5 OUTLIER 65.11 -70.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.189 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 161' ' ' ASP . 4.3 m-20 -100.41 65.57 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.15 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -86.32 119.93 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.93 . . . . 0.0 110.189 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.64 79.72 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.205 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -124.42 172.95 16.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 36.1 m -80.14 -58.85 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -1.144 . . . . 0.0 110.234 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.1 t -163.58 -47.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.78 167.24 32.08 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.94 -116.62 5.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.91 99.71 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.258 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.31 169.57 34.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.29 119.78 24.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -1.18 . . . . 0.0 110.289 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -156.53 167.58 30.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 178.58 5.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.905 . . . . 0.0 110.137 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.82 40.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 179' ' ' HIS . 27.5 t-80 -112.12 -46.4 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -1.176 . . . . 0.0 110.186 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 179' ' ' HIS . 2.6 mt-10 56.21 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 177' ' ' HIS . 4.9 t60 43.56 68.53 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 110.165 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 116.41 138.32 6.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 182' ' ' GLU . . . -59.03 -166.29 0.15 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 183' ' ' GLY . 0.0 OUTLIER -176.35 -141.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -1.168 . . . . 0.0 110.178 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 182' ' ' GLU . . . -44.18 -26.58 0.94 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -47.86 170.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 40.4 t -83.96 159.45 21.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.314 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 149.94 -135.01 5.09 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.34 -79.06 1.86 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.76 120.92 12.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -1.142 . . . . 0.0 110.149 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 190' ' ' ASN . . . -136.11 -110.23 1.03 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 189' ' ' GLY . 1.1 t-20 62.82 -161.28 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -1.165 . . . . 0.0 110.19 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -46.97 103.84 0.06 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 162.98 168.85 25.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 3.2 t -55.76 144.74 26.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -1.177 . . . . 0.0 110.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 160.07 -134.27 3.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 16.5 p -162.03 82.71 0.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -1.136 . . . . 0.0 110.235 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.296 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.205 0.526 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.525 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 8.0 mmtt -124.46 151.81 44.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 110.193 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.002 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 152.84 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.179 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -175.31 -172.71 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 110.299 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' ' CE1' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -60.72 160.86 8.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.736 ' CB ' HD21 ' A' ' 147' ' ' LEU . 9.0 t70 57.52 16.75 3.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.206 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.933 HD12 HG22 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -128.41 97.47 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.304 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 8' ' ' VAL . 7.7 p -58.0 123.48 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.154 -0.966 . . . . 0.0 109.917 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.797 HG21 HG21 ' A' ' 3' ' ' VAL . 8.5 p -126.72 117.19 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.323 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -94.12 115.68 28.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.767 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.749 HD12 HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -137.8 116.3 12.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 110.512 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -77.27 156.24 31.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 51.4 p90 -156.4 137.16 13.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.077 -1.015 . . . . 0.0 110.409 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 27.2 mm-40 -93.09 137.36 32.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.7 t -111.23 143.53 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 110.498 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -161.02 138.26 9.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.372 -0.83 . . . . 0.0 109.964 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 38.4 p -102.6 151.81 21.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -0.955 . . . . 0.0 110.244 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -52.3 -36.25 52.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.459 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.2 -12.89 5.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.961 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.36 39.07 5.17 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' C ' HD22 ' A' ' 22' ' ' LEU . 2.9 t -121.28 151.67 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.839 HD13 ' O ' ' A' ' 15' ' ' VAL . 3.9 mm? -109.3 112.75 25.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 50.7 t -85.97 -21.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.229 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.1 t70 177.04 150.35 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 22' ' ' LEU . 1.3 mt-10 -149.13 116.03 5.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.75 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -102.98 114.38 65.27 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 110.128 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.7 164.75 34.7 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.531 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.9 m -68.95 -25.66 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -73.28 -1.98 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.131 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.3 72.26 3.93 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.564 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.8 Cg_endo -72.57 164.34 35.9 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.029 1.542 . . . . 0.0 110.415 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.8 tp -95.71 108.72 21.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 110.298 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 3.2 p30 -91.37 128.19 37.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 9.2 m-85 -161.69 167.82 24.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 110.361 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.112 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -72.64 168.13 19.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 0.0 110.054 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.565 ' CE1' ' OE1' ' A' ' 46' ' ' GLU . 66.7 t60 -98.03 116.11 29.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.323 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.07 -36.45 3.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 1.112 ' CD2' HD23 ' A' ' 35' ' ' LEU . 24.8 p-80 -130.19 89.4 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -1.126 . . . . 0.0 110.29 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -178.73 -66.71 0.07 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 40' ' ' SER . 3.0 t 173.39 59.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -1.135 . . . . 0.0 110.257 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' ILE . 53.3 mt -144.68 121.85 11.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 12.6 pt -41.83 161.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.273 -0.892 . . . . 0.0 110.246 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -71.23 -37.26 72.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.206 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.708 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.78 -50.04 71.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.816 HD11 HG21 ' A' ' 134' ' ' VAL . 14.6 tp -60.02 -39.32 85.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -1.15 . . . . 0.0 110.201 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' OE1' ' CE1' ' A' ' 36' ' ' HIS . 46.4 mm-40 -50.1 -58.46 5.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.238 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -37.39 83.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.234 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -72.84 -24.34 60.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD13 ' A' ' 11' ' ' LEU . 15.9 tp -84.64 -29.22 25.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.34 -0.85 . . . . 0.0 110.183 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.593 ' HA ' HG12 ' A' ' 3' ' ' VAL . 2.1 tt0 -64.32 131.13 46.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 89.06 47.14 4.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 48' ' ' ALA . 44.1 m-70 -145.86 98.88 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -1.151 . . . . 0.0 110.25 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -53.99 -167.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.235 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 137' ' ' VAL . 31.5 t -80.85 121.68 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 3.03 31.18 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 139.58 58.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -1.175 . . . . 0.0 110.179 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -137.62 141.17 41.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 5.5 p90 -177.9 178.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 110.092 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.552 ' C ' HG23 ' A' ' 60' ' ' VAL . 13.9 p-10 -143.13 147.05 34.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 110.301 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG23 ' C ' ' A' ' 59' ' ' ASP . 28.4 t -153.35 132.62 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB2' ' HG3' ' A' ' 131' ' ' LYS . . . -84.66 113.47 21.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.946 . . . . 0.0 110.137 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.088 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.7 t -143.4 109.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 1.029 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -145.97 -80.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.946 ' HB1' ' HG3' ' A' ' 70' ' ' GLN . . . -66.74 -19.47 65.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -1.152 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 19.3 m-20 -81.15 -32.57 33.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.394 -0.816 . . . . 0.0 110.247 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 170.26 73.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.978 . . . . 0.0 110.403 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.088 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -159.52 -79.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.287 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -82.79 -11.9 57.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' GLN . . . 95.39 90.79 1.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.946 ' HG3' ' HB1' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -46.69 170.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 110.153 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' CD2' ' HB3' ' A' ' 126' ' ' ALA . 2.6 t80 -72.71 129.31 37.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.95 . . . . 0.0 110.152 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.21 104.02 8.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.13 -17.04 64.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -82.45 -10.26 59.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 122' ' ' ASN . 1.4 tp -88.58 -46.28 9.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 76' ' ' VAL . 28.4 m -56.29 119.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.26 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' HG2' ' C ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -130.45 131.76 45.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.123 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -99.72 121.32 41.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.221 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.808 ' CG1' HG21 ' A' ' 83' ' ' VAL . 21.3 t -145.75 128.62 8.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 47.5 Cg_endo -73.33 167.43 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.958 1.504 . . . . 0.0 110.425 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -15.07 8.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 110.163 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.77 -18.18 20.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 0.0 110.233 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.808 HG21 ' CG1' ' A' ' 79' ' ' VAL . 39.8 t -95.01 -14.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 86' ' ' GLY . 14.1 m-30 -95.73 74.82 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -58.71 86.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.2 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 136.18 -71.45 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.57 HG12 ' C ' ' A' ' 86' ' ' GLY . 2.8 p 33.62 82.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -1.036 . . . . 0.0 110.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -51.04 -25.09 4.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -0.89 . . . . 0.0 110.153 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 173.93 112.74 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 0.0 110.179 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 tp -99.54 129.74 45.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 0.0 110.213 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -142.91 153.4 43.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.874 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 142.03 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.46 -11.05 73.24 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.648 ' O ' HG22 ' A' ' 109' ' ' ILE . 7.0 ttt -84.2 141.77 30.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -1.106 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -90.04 142.5 27.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.636 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.3 t80 -117.67 159.41 23.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.193 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.46 HD21 ' HG2' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -120.47 140.9 50.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -113.42 117.43 31.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.332 -0.855 . . . . 0.0 110.305 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG2' HD21 ' A' ' 97' ' ' LEU . 1.4 mm-40 -98.41 82.43 2.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 110.145 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.25 155.37 19.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 110.245 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -18.57 62.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.12 16.34 7.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.6 138.8 5.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.92 128.88 13.64 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.482 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.696 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 26.8 t -139.49 118.02 8.86 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.205 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.3 Cg_endo -73.23 158.05 49.32 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.98 1.516 . . . . 0.0 110.416 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.727 ' HB ' HG22 ' A' ' 119' ' ' VAL . 6.8 m -133.92 -174.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' C ' HG23 ' A' ' 119' ' ' VAL . 13.5 tm-20 -143.84 129.53 19.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 94' ' ' MET . 5.6 tt -78.75 129.65 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.175 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -123.12 -18.28 6.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.898 . . . . 0.0 110.286 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.866 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -151.59 120.39 6.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 109' ' ' ILE . 18.6 t -110.35 105.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 110.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 4.1 mt-10 -91.17 169.66 10.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.173 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -71.04 130.03 40.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.888 . . . . 0.0 110.152 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 59.28 22.99 11.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.894 . . . . 0.0 110.13 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' A' ' 78' ' ' ARG . 13.8 t-160 -175.05 134.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 79' ' ' VAL . 3.3 p -136.41 167.76 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 111' ' ' ALA . 34.9 m -133.07 150.37 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.157 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.727 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.4 p -146.63 133.75 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.253 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 76' ' ' VAL . 9.2 m-20 -133.48 139.0 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.179 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.21 -8.45 66.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.42 ' H ' HD23 ' A' ' 75' ' ' LEU . 7.2 t30 -81.35 146.55 30.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.164 . . . . 0.0 110.211 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.73 140.54 29.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -18.86 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 1.2 mp -98.72 -84.04 0.4 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . 55.37 171.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.13 21.46 77.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 130' ' ' LEU . 4.2 tt0 -145.64 98.3 3.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -1.167 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.778 ' O ' HD22 ' A' ' 130' ' ' LEU . 9.9 t30 -54.89 159.45 2.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.174 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 129' ' ' ASN . 4.0 mm? -125.54 134.98 51.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 110.277 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.694 ' HG3' ' HB2' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -112.61 118.26 34.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.898 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLN . 35.8 p90 -147.89 146.05 28.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 12.0 p-10 -90.01 151.66 21.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.576 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.816 HG21 HD11 ' A' ' 45' ' ' LEU . 71.1 t -131.27 139.64 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.06 -1.025 . . . . 0.0 110.617 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 94.7 mt-10 -132.45 124.38 28.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 109.794 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 21.9 t -74.91 140.05 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 10' ' ' SER . 17.9 t -111.62 -37.51 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -165.57 171.07 13.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -0.97 . . . . 0.0 110.529 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.002 ' CD1' HG23 ' A' ' 3' ' ' VAL . 12.3 mt -150.73 101.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 110.058 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.77 ' O ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.42 169.85 9.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.76 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -100.61 140.41 34.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.262 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.984 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -91.94 161.46 14.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.24 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 173.96 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -56.06 -38.44 70.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.3 tt0 -71.57 -34.47 69.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.017 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.984 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.9 mm-40 -61.36 -50.07 74.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.786 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.93 HD12 ' HB3' ' A' ' 142' ' ' ALA . 1.1 mp -73.18 -22.72 60.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.83 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' A' ' 149' ' ' HIS . . . -56.34 -53.1 61.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 110.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 149' ' ' HIS . 0.8 OUTLIER -107.25 -11.07 15.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.503 -0.748 . . . . 0.0 109.67 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 82.19 68.37 1.45 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -153.48 153.09 31.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -1.118 . . . . 0.0 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.519 ' HA ' ' OE2' ' A' ' 146' ' ' GLU . 19.1 m -122.93 127.53 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 110.108 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.4 m170 46.29 71.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.243 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.88 -171.38 13.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -174.81 137.79 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -1.131 . . . . 0.0 110.198 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -66.79 -23.45 66.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 110.279 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -40.86 29.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.167 -0.958 . . . . 0.0 110.236 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 54.07 19.21 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 111.23 22.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -115.85 -51.18 2.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.616 ' O ' ' CD2' ' A' ' 162' ' ' HIS . 16.3 t0 45.93 49.97 11.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 52.52 161.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.387 -0.82 . . . . 0.0 110.465 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 164' ' ' HIS . 27.3 t70 -116.3 -70.8 0.77 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 163' ' ' ASP . 10.5 m170 -155.44 94.16 1.57 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.18 -75.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.182 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 167' ' ' CYS . . . -136.34 -177.82 15.3 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 166' ' ' GLY . 1.2 m 59.46 22.72 11.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -1.107 . . . . 0.0 110.233 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 37.0 m -65.39 -158.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.95 -105.64 1.27 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 165.85 144.2 4.0 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.61 19.59 8.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.85 83.01 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -124.02 14.63 9.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -1.192 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.41 123.64 47.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -112.2 -30.82 7.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.261 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 71.91 136.49 0.19 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -174.41 168.27 3.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.167 . . . . 0.0 110.146 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 179' ' ' HIS . 33.9 tp10 -174.52 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' A' ' 178' ' ' GLU . 6.1 p-80 -74.65 -161.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.216 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.18 -49.23 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -128.01 -157.64 9.44 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -149.25 29.92 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 110.242 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 173.74 47.68 0.05 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.88 -55.83 2.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -1.168 . . . . 0.0 110.172 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 62.21 -149.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.934 . . . . 0.0 110.188 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.38 2.95 60.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 188' ' ' LYS . . . -92.54 -136.41 7.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER 63.45 -178.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -1.155 . . . . 0.0 110.211 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.19 115.86 0.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -45.41 100.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -1.148 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.68 -35.4 1.88 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.89 38.43 0.5 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 56.7 m -104.71 74.41 1.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -1.162 . . . . 0.0 110.259 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 195' ' ' CYS . . . 170.65 55.36 0.04 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 194' ' ' GLY . 60.4 m 57.31 -160.92 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -1.16 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.566 ' CG ' ' O ' ' A' ' 196' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.238 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.236 0.541 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -92.71 -175.8 4.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.225 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.953 ' HA ' HG21 ' A' ' 139' ' ' ILE . 4.1 t -80.89 135.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.155 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -145.84 179.83 7.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HE2' ' CE1' ' A' ' 38' ' ' HIS . 0.1 OUTLIER -63.4 177.0 0.71 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 8.7 m-20 39.7 29.64 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.09 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -135.24 111.18 9.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.5 m -63.42 131.33 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.144 -0.973 . . . . 0.0 110.011 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 HG23 ' A' ' 139' ' ' ILE . 17.8 m -122.27 112.24 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.927 . . . . 0.0 110.526 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -94.39 116.75 29.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HA ' HG23 ' A' ' 137' ' ' VAL . 1.2 pp -140.61 124.06 16.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.062 -1.023 . . . . 0.0 110.684 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.917 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.38 151.33 24.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.697 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.489 ' CB ' HG12 ' A' ' 134' ' ' VAL . 37.5 p90 -156.41 149.17 23.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.068 -1.02 . . . . 0.0 110.656 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 17.1 pt20 -116.43 128.32 55.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.706 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.4 p -111.71 152.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.651 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -146.14 135.82 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.921 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.5 HG23 ' CG2' ' A' ' 23' ' ' VAL . 1.1 p -73.97 152.02 40.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -51.71 -19.83 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.392 -0.817 . . . . 0.0 110.344 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -73.18 0.07 12.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 0.0 110.137 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.68 31.32 36.78 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' C ' HD22 ' A' ' 22' ' ' LEU . 56.6 t -121.22 151.32 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.0 mm? -96.02 123.56 39.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 17' ' ' THR . 99.6 t -92.52 -53.64 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.306 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.71 ' O ' HG12 ' A' ' 15' ' ' VAL . 43.3 m-20 -142.05 150.88 41.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -148.99 132.2 16.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.938 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.917 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 57.6 p -117.34 110.63 40.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 171.69 17.0 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.012 1.532 . . . . 0.0 110.437 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 16.2 m -71.59 -15.64 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -82.85 -13.22 56.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 110.284 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . . . -152.98 51.34 0.7 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -73.01 163.11 39.23 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.942 1.496 . . . . 0.0 110.459 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mp -84.95 103.03 13.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 110.245 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.93 112.34 22.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 9' ' ' VAL . 16.2 m-85 -142.46 166.49 24.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.129 HD23 ' CD2' ' A' ' 38' ' ' HIS . 3.8 mp -67.72 155.87 38.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.726 ' CD2' HG12 ' A' ' 3' ' ' VAL . 4.5 t60 -90.42 124.68 35.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' C ' ' OE2' ' A' ' 46' ' ' GLU . . . 87.82 -37.57 3.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 1.129 ' CD2' HD23 ' A' ' 35' ' ' LEU . 38.3 p-80 -130.08 87.19 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.235 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 40' ' ' SER . . . -154.48 18.67 0.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 2.3 m 64.11 14.43 8.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.642 ' CD2' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -78.24 -141.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.122 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.844 HG21 ' HA ' ' A' ' 67' ' ' ALA . 0.8 OUTLIER -114.63 120.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 109.946 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 1.4 p -49.06 -47.05 45.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.339 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.18 -40.97 37.93 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.882 HD13 ' HZ ' ' A' ' 132' ' ' PHE . 13.1 tp -86.84 -31.23 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -1.192 . . . . 0.0 110.266 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.0 mm-40 -51.26 -59.32 4.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 110.25 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -25.63 62.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 110.262 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.76 -28.85 63.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 0.0 110.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -74.6 -45.61 44.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 40.8 tt0 -43.22 133.45 4.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.945 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.14 113.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER 175.31 -28.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.218 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 70.07 150.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 139' ' ' ILE . 17.2 t -69.15 124.84 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 109.47 3.06 30.97 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.693 ' O ' HG12 ' A' ' 136' ' ' VAL . 1.5 m-20 -102.45 134.04 46.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -1.159 . . . . 0.0 110.216 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -135.19 145.11 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.289 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 6.7 p90 -142.82 -161.61 1.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 133' ' ' ASN . 18.7 t70 -145.49 129.71 17.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -128.48 114.59 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -76.14 112.47 12.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.219 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.798 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 15.9 m -158.45 111.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -126.4 -81.06 0.37 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.698 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -84.92 -21.13 29.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.194 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' O ' ' OD2' ' A' ' 66' ' ' ASP . 3.3 t-20 -81.02 -24.28 38.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -177.71 68.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 0.0 110.27 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.844 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -155.63 -67.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.216 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 69' ' ' GLY . 38.8 m-85 -135.56 10.93 3.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.266 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' TYR . . . 44.27 89.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.698 ' HG3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -64.63 126.52 28.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.576 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -84.6 130.92 34.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 110.357 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 4.5 t0 -126.24 69.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.225 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.691 ' HA ' HG12 ' A' ' 76' ' ' VAL . 2.0 mt-10 -69.02 -7.1 32.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.403 ' OD1' HD21 ' A' ' 125' ' ' LEU . 1.3 m120 -61.75 -25.84 67.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.49 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.654 HD13 ' N ' ' A' ' 121' ' ' GLY . 0.3 OUTLIER -169.36 31.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.989 . . . . 0.0 110.595 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 76' ' ' VAL . 12.6 p -95.14 95.52 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.234 -0.916 . . . . 0.0 110.151 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 76' ' ' VAL . 4.2 mt-30 -134.25 172.58 12.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -87.65 137.67 32.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.224 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 19.3 t -147.64 110.91 3.9 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -72.85 156.66 52.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.938 1.494 . . . . 0.0 110.443 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -60.54 -14.47 20.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.877 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -19.19 62.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 83' ' ' VAL . 17.0 t -115.7 13.95 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.164 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -77.84 -48.74 15.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.2 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.7 mmt 58.6 115.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.72 72.42 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.561 HG23 HD13 ' A' ' 90' ' ' LEU . 3.4 p -139.96 79.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -1.104 . . . . 0.0 110.25 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -78.02 -3.15 40.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' O ' ' SD ' ' A' ' 94' ' ' MET . 1.2 tt0 -172.06 111.85 0.29 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD13 HG23 ' A' ' 87' ' ' VAL . 8.7 tp -109.49 84.53 1.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.161 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -104.65 132.04 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 110.199 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -47.12 141.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.49 -36.47 3.67 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 109' ' ' ILE . 14.4 ttp -57.58 145.4 33.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.178 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -89.71 126.01 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.161 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.679 ' O ' HG22 ' A' ' 107' ' ' VAL . 73.3 t80 -109.89 164.38 12.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.156 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 112.89 20.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.317 -0.864 . . . . 0.0 110.225 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.96 14.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.907 . . . . 0.0 110.204 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -106.69 135.98 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 110.192 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.37 168.84 18.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 37.1 p-10 -59.7 -25.58 64.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 3.2 pt20 -87.77 18.17 4.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.192 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.8 -175.92 26.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.02 138.68 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.044 1.549 . . . . 0.0 110.457 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.0 t -136.88 138.47 26.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 143.15 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.964 1.507 . . . . 0.0 110.467 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 119' ' ' VAL . 33.9 m -135.71 -174.61 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.186 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.788 ' C ' HD13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -136.46 -178.68 5.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -121.68 115.17 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 t -113.94 -28.02 7.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.23 145.31 30.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.958 . . . . 0.0 110.249 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HA ' HG13 ' A' ' 117' ' ' VAL . 34.8 t -137.81 104.57 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 116' ' ' HIS . 1.1 mt-10 -112.31 168.93 9.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.282 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 22.6 p-10 -76.99 145.65 37.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t0 73.69 -5.44 2.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.313 -0.867 . . . . 0.0 110.6 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 113' ' ' GLU . 14.4 p-80 -175.26 146.45 0.83 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 110.285 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.488 HG13 ' HA ' ' A' ' 112' ' ' VAL . 16.4 t -127.66 166.6 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.58 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 61.3 t -112.74 152.38 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 110.244 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.827 HG22 ' HB ' ' A' ' 107' ' ' VAL . 12.7 p -159.49 138.74 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 76' ' ' VAL . 5.7 p-10 -159.52 113.68 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.654 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -62.14 119.36 17.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' HA ' ' OD2' ' A' ' 72' ' ' ASP . 24.4 p-10 -59.03 122.8 14.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -1.116 . . . . 0.0 110.198 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -102.07 -170.15 1.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.3 mtt -77.38 -45.04 27.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.178 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.403 HD21 ' OD1' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -59.69 -30.54 68.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.664 ' HB1' ' HB3' ' A' ' 70' ' ' GLN . . . -150.41 145.31 26.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.72 21.51 6.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -123.18 84.84 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -1.166 . . . . 0.0 110.236 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 128' ' ' GLN . 4.9 t30 -42.45 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -147.0 147.54 30.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 10.5 ptpt -117.31 138.56 51.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.298 -0.876 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.882 ' HZ ' HD13 ' A' ' 45' ' ' LEU . 9.4 p90 -144.91 139.39 27.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -83.46 141.47 31.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.337 -0.852 . . . . 0.0 110.005 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.585 ' CG1' ' CE2' ' A' ' 132' ' ' PHE . 16.6 m -125.17 135.99 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.121 -0.987 . . . . 0.0 110.479 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -128.11 128.4 44.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.038 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 56' ' ' ASP . 6.9 p -75.02 142.98 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' A' ' 11' ' ' LEU . 21.4 t -111.68 -36.73 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.596 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -167.49 159.19 12.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.008 -1.058 . . . . 0.0 110.799 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.953 HG21 ' HA ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -135.63 101.75 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.623 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.901 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -118.12 158.78 24.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.155 -0.966 . . . . 0.0 110.319 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 tt0 -79.49 131.61 36.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.025 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -81.76 156.33 25.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -75.23 -175.72 2.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.132 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -41.7 88.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -43.06 74.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 110.268 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.025 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 19.8 mt-10 -55.45 -43.47 75.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.688 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.014 HD22 HD21 ' A' ' 35' ' ' LEU . 2.0 mm? -80.21 -15.23 57.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.675 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.49 -53.41 7.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 110.13 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.59 -2.62 20.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.399 -0.813 . . . . 0.0 109.418 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.499 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 96.35 -19.81 52.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.513 ' HA ' HD13 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -157.99 -178.41 7.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -1.169 . . . . 0.0 110.26 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.473 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 13.3 p -65.93 142.88 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.42 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 63.7 -158.49 0.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.853 . . . . 0.0 110.235 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -116.7 -173.85 17.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.49 ' O ' ' ND1' ' A' ' 158' ' ' HIS . . . -78.33 4.19 13.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -1.141 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -56.31 -26.99 54.09 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -76.97 -58.28 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 110.25 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 60.91 135.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -110.38 -21.59 12.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.215 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.36 -178.84 3.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.25 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -74.06 -179.6 3.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.64 -39.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -68.21 125.21 25.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.882 . . . . 0.0 110.281 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.92 163.89 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 0.0 110.17 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.06 107.18 0.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.223 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.22 109.84 2.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.05 -47.59 2.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -1.177 . . . . 0.0 110.215 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.2 p -125.14 20.37 8.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.196 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.14 -110.08 3.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 129.27 67.46 0.11 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -45.16 -28.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -168.42 -157.24 11.07 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -124.25 134.25 53.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -1.18 . . . . 0.0 110.259 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.49 60.69 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.93 . . . . 0.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.531 ' NE2' ' HB3' ' A' ' 177' ' ' HIS . 0.3 OUTLIER -78.92 5.16 12.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 137.03 -19.29 3.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.531 ' HB3' ' NE2' ' A' ' 175' ' ' HIS . 4.9 t60 -108.73 125.01 51.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -1.154 . . . . 0.0 110.189 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.34 147.94 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -0.945 . . . . 0.0 110.279 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -71.43 96.47 1.49 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -174.57 -95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.75 177.23 30.37 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.85 126.82 15.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -1.185 . . . . 0.0 110.205 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.95 -167.65 43.24 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.497 ' O ' ' C ' ' A' ' 185' ' ' CYS . 95.1 m -90.09 77.2 6.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -1.181 . . . . 0.0 110.245 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.497 ' C ' ' O ' ' A' ' 184' ' ' CYS . 14.5 p 33.8 45.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.584 -0.698 . . . . 0.0 110.518 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.34 52.14 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 188' ' ' LYS . . . -102.6 133.69 11.5 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 187' ' ' GLY . 37.3 mtpt 43.51 -153.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.82 -174.2 25.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -162.97 148.94 12.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.133 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.99 127.6 0.99 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 193' ' ' CYS . . . -110.18 15.52 30.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 192' ' ' GLY . 0.1 OUTLIER 173.05 131.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -1.15 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 159.66 -35.34 0.46 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 11.3 t -138.03 114.31 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 110.179 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.412 ' CD2' ' C ' ' A' ' 196' ' ' HIS . 7.7 p-80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.21 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.037 ' HG2' HD11 ' A' ' 139' ' ' ILE . 2.5 ttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.267 0.556 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.754 ' C ' HD12 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -129.72 158.89 38.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.891 HG13 HG21 ' A' ' 9' ' ' VAL . 30.8 t -50.98 134.18 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 110.283 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . . . -125.73 139.53 53.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.662 ' CE ' ' CE1' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -44.99 -42.11 7.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.277 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.9 ' HA ' HD11 ' A' ' 35' ' ' LEU . 64.5 m-20 -94.54 31.91 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.234 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 2.0 mp -129.31 113.13 14.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.905 . . . . 0.0 110.355 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.6 p -51.16 122.5 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.874 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 HG13 ' A' ' 3' ' ' VAL . 58.4 t -124.4 115.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.466 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.88 ' O ' HG22 ' A' ' 137' ' ' VAL . 9.1 m -92.71 105.93 17.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.2 pp -138.3 129.31 27.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 110.564 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.64 ' HB1' ' HB3' ' A' ' 26' ' ' SER . . . -84.38 149.45 26.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 109.889 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 133' ' ' ASN . 37.9 p90 -149.66 144.14 25.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.404 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -109.81 144.53 38.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.882 ' CG1' HD21 ' A' ' 130' ' ' LEU . 2.5 t -112.96 101.07 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.209 -0.932 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HG2' ' HG ' ' A' ' 22' ' ' LEU . 93.9 mtt180 -106.15 135.8 46.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.276 -0.89 . . . . 0.0 110.002 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.7 HG22 HD12 ' A' ' 130' ' ' LEU . 2.0 p -100.67 151.84 21.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.103 -0.998 . . . . 0.0 110.293 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 17' ' ' THR . 1.2 tm-20 -40.04 -30.55 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.57 -0.706 . . . . 0.0 110.411 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.4 t0 -58.89 -11.85 3.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.895 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.25 26.88 38.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.604 HG22 ' OG1' ' A' ' 17' ' ' THR . 9.6 m -121.39 151.59 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -1.124 . . . . 0.0 110.494 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HG2' ' A' ' 14' ' ' GLN . 0.6 OUTLIER -93.66 114.02 26.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 0.0 110.16 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' VAL . 6.5 t -76.11 -41.1 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.95 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.15 150.02 28.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' OE1' HD13 ' A' ' 22' ' ' LEU . 25.4 pt-20 -149.25 143.22 25.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.64 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 4.9 t -93.31 140.26 23.2 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 1.008 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.8 Cg_endo -72.55 126.27 11.37 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.019 1.536 . . . . 0.0 110.451 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.8 -35.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 110.146 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -73.31 -6.81 48.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.008 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -143.62 88.74 7.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 46.7 Cg_endo -72.99 128.66 13.35 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.003 1.528 . . . . 0.0 110.372 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.076 HD12 ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -60.76 98.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.176 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 14.9 p-10 -95.2 125.84 40.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 1.076 ' CD2' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -161.71 168.49 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD11 ' HA ' ' A' ' 6' ' ' ASP . 10.7 tp -67.36 119.72 12.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.56 ' CD2' HG11 ' A' ' 3' ' ' VAL . 36.2 t-80 -60.33 148.94 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.251 -0.905 . . . . 0.0 110.581 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 46.27 23.23 1.15 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.662 ' CE1' ' CE ' ' A' ' 5' ' ' LYS . 14.7 m80 -130.14 86.88 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -1.17 . . . . 0.0 110.222 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . 43.8 26.63 0.8 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.833 ' HB2' HD12 ' A' ' 41' ' ' LEU . 1.7 p -90.89 -72.13 0.59 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.231 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.945 HD11 ' CZ ' ' A' ' 34' ' ' TYR . 3.1 mp -130.05 -148.78 0.38 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.793 HG21 ' HA ' ' A' ' 67' ' ' ALA . 33.8 pt -93.81 146.17 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.269 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -63.39 -41.38 98.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.557 ' O ' HG22 ' A' ' 47' ' ' THR . . . -47.9 -32.44 8.77 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD13 ' HE1' ' A' ' 132' ' ' PHE . 11.3 tp -86.88 -31.76 20.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -1.125 . . . . 0.0 110.159 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 73.4 mt-10 -62.71 -37.71 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.232 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 44' ' ' GLY . 7.4 t -49.51 -41.43 40.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.885 . . . . 0.0 110.19 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' N ' HG23 ' A' ' 47' ' ' THR . . . -84.41 -39.83 18.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 3' ' ' VAL . 44.9 tp -68.3 -40.92 81.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.233 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 46' ' ' GLU . 15.3 tt0 -59.54 143.96 48.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.245 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 44.0 53.76 6.34 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.522 ' NE2' ' HB2' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -117.9 -126.44 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 110.165 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 7.9 tp10 -141.94 125.93 17.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.094 -1.004 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.695 ' HA ' HG13 ' A' ' 136' ' ' VAL . 62.1 t -77.87 120.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.519 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 109.36 3.04 31.17 Favored Glycine 0 N--CA 1.481 1.691 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' A' ' 53' ' ' GLU . 6.8 p-10 -116.61 173.36 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -1.171 . . . . 0.0 110.225 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -124.84 134.05 52.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 27.8 t80 -125.63 149.71 48.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.24 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -110.31 126.12 53.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.194 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.25 135.96 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.824 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.27 112.27 24.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.958 . . . . 0.0 110.242 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.6 t -162.94 115.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.82 . . . . 0.0 109.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 1.028 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -121.44 -82.48 0.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 128' ' ' GLN . . . -92.91 -16.46 25.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -1.138 . . . . 0.0 110.12 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.4 t-20 -81.05 -8.66 59.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER 175.38 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.062 -1.024 . . . . 0.0 110.584 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.028 ' HB3' ' O ' ' A' ' 63' ' ' GLY . . . -137.87 -145.51 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.146 -0.971 . . . . 0.0 110.153 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -80.36 -18.15 49.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 110.391 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.07 114.34 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' O ' ' CA ' ' A' ' 127' ' ' GLY . 1.3 pp0? -128.96 151.65 49.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.461 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 126' ' ' ALA . 9.2 t80 -60.22 123.63 17.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' HB2' ' HA2' ' A' ' 127' ' ' GLY . 48.8 t0 -137.11 118.71 14.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 5.5 mm-40 -68.68 -33.31 73.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -58.37 -15.63 11.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 128' ' ' GLN . 0.2 OUTLIER -65.47 -16.72 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.0 136.46 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.308 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.462 HE21 HG11 ' A' ' 79' ' ' VAL . 21.1 tp60 -126.1 130.86 51.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.656 ' CB ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.36 130.78 53.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG21 ' CZ ' ' A' ' 84' ' ' PHE . 18.7 m -156.48 133.39 6.4 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.3 Cg_endo -73.43 167.45 27.26 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.953 1.502 . . . . 0.0 110.372 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 84' ' ' PHE . 10.7 tmtt? -71.38 -13.36 61.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.324 -0.86 . . . . 0.0 110.174 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -25.3 64.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' VAL . 58.8 t -105.33 -4.1 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.219 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 2.9 m-30 -97.68 -15.18 20.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 110.237 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.4 OUTLIER 66.78 -60.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 166.39 124.89 0.74 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.646 HG11 ' HE1' ' A' ' 96' ' ' PHE . 52.8 t -133.98 74.98 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.265 -1.138 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 4.2 m-20 60.05 30.21 19.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 65.83 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.222 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB ' ' A' ' 87' ' ' VAL . 6.4 mp -98.49 136.07 39.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 109' ' ' ILE . 2.5 pt20 -144.76 -168.49 2.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 110.182 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 112' ' ' VAL . 94.8 t -86.11 143.71 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.219 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.48 -16.25 54.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.663 ' O ' HG22 ' A' ' 109' ' ' ILE . 22.5 ttt -74.49 155.24 38.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.186 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.68 129.9 54.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 110.266 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.698 ' O ' HG22 ' A' ' 107' ' ' VAL . 31.8 t80 -120.79 165.74 14.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.167 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.5 OUTLIER -136.04 140.31 43.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.24 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.97 106.4 10.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.191 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.06 133.85 33.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.232 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 p -136.24 172.85 12.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 110.067 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.59 -27.28 66.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' NE2' ' OD1' ' A' ' 129' ' ' ASN . 4.3 mt-30 -72.98 -5.73 40.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.62 161.77 11.18 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.91 130.4 15.55 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.053 1.554 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.659 HG21 ' NE2' ' A' ' 128' ' ' GLN . 75.3 t -139.4 117.71 8.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.6 Cg_endo -72.64 158.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.93 1.489 . . . . 0.0 110.42 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 96' ' ' PHE . 34.0 m -135.34 -177.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.912 . . . . 0.0 110.143 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 120' ' ' ASP . 1.9 tt0 -149.1 123.07 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.229 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 94' ' ' MET . 1.1 tt -74.4 129.54 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -113.96 -28.02 7.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.241 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.65 149.23 29.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.202 -0.936 . . . . 0.0 110.177 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.073 HG13 HG12 ' A' ' 117' ' ' VAL . 73.0 t -126.77 104.54 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.96 . . . . 0.0 110.205 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 116' ' ' HIS . 5.8 tp10 -82.82 162.32 21.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.213 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 115' ' ' ASP . 8.4 t70 -52.21 130.6 30.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 0.0 110.185 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.2 m-20 43.85 40.14 3.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.947 . . . . 0.0 110.209 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 24.8 t60 -175.11 133.46 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.96 . . . . 0.0 110.217 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.073 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -138.05 159.08 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 110.284 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.656 HG12 ' CB ' ' A' ' 78' ' ' ARG . 33.4 m -133.84 152.9 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 110.262 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.35 140.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.225 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD2' ' CD2' ' A' ' 123' ' ' HIS . 18.5 t70 -108.73 165.93 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -99.17 177.98 30.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -63.63 99.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -1.157 . . . . 0.0 110.215 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.56 ' CD2' ' OD2' ' A' ' 120' ' ' ASP . 42.9 m170 -44.04 -32.38 1.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.199 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.737 ' O ' HD12 ' A' ' 125' ' ' LEU . 5.1 ttp -57.64 -23.98 54.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.228 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 124' ' ' MET . 7.4 mp -124.63 39.54 3.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 70' ' ' GLN . . . -69.81 166.42 19.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 110.247 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' ASN . . . 91.48 21.77 33.63 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.771 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -62.95 70.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -1.163 . . . . 0.0 110.09 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 128' ' ' GLN . 1.8 m-20 164.63 71.54 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.459 -0.776 . . . . 0.0 110.397 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.882 HD21 ' CG1' ' A' ' 15' ' ' VAL . 5.7 tp -115.46 134.96 54.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.104 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -116.31 130.5 56.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.22 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.788 ' HE1' HD13 ' A' ' 45' ' ' LEU . 15.5 p90 -148.43 143.7 26.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 46.8 t-20 -95.74 161.03 14.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.21 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.649 HG11 HD21 ' A' ' 45' ' ' LEU . 12.4 m -142.83 134.31 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.536 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -124.52 105.18 9.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.168 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.695 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.4 p -77.37 136.82 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.86 -29.87 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.895 . . . . 0.0 110.751 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.4 167.02 29.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.071 . . . . 0.0 110.894 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 1' ' ' MET . 4.9 pt -153.53 108.17 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.791 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 8' ' ' VAL . 5.4 mtp85 -131.32 148.21 52.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.2 tt0 -60.76 158.06 13.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.925 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -106.24 163.52 12.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.204 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.472 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 1.9 m -73.78 169.15 17.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 110.045 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -35.21 60.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 110.152 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -73.09 -34.66 66.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.925 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 9.6 mm-40 -63.99 -49.79 71.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' CD2' ' OD1' ' A' ' 6' ' ' ASP . 1.1 mt -73.3 -9.7 58.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.659 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -74.61 -53.63 8.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.395 -0.816 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -81.18 -2.15 47.48 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.603 -0.686 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 38' ' ' HIS . . . 97.85 -16.0 60.93 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.9 p-80 -160.42 -169.48 2.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -1.176 . . . . 0.0 110.442 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 146' ' ' GLU . 1.6 p -121.54 111.47 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.893 . . . . 0.0 110.194 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.533 ' CD2' ' N ' ' A' ' 154' ' ' GLY . 69.2 t60 -169.47 -88.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.267 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.533 ' N ' ' CD2' ' A' ' 153' ' ' HIS . . . -55.0 -103.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 48.17 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 110.287 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -61.21 -13.16 16.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.05 -42.52 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.883 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.81 -161.21 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.335 -0.853 . . . . 0.0 110.236 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.25 74.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -62.08 104.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.8 -168.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 162' ' ' HIS . 7.2 p80 -166.76 137.16 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.228 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -113.29 79.62 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.257 -0.902 . . . . 0.0 110.139 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 3.8 t60 -51.84 96.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 164' ' ' HIS . 78.4 m-20 54.93 36.55 27.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.242 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 116.94 -158.49 14.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -50.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -1.14 . . . . 0.0 110.254 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 41.2 t -163.99 160.26 21.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 120.8 67.36 0.27 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 176.4 -69.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.91 176.64 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 110.208 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -98.34 -114.05 3.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 50.81 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 175' ' ' HIS . 64.9 m-20 -138.22 174.95 10.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.263 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 174' ' ' ASP . 19.8 m80 -159.59 -178.9 7.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.05 132.37 12.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 179' ' ' HIS . 1.3 t60 -111.86 65.65 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -1.155 . . . . 0.0 110.192 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 177' ' ' HIS . 11.6 tt0 54.42 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.164 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -130.79 -170.77 2.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 110.188 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.21 179.48 38.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 140.12 -88.73 0.19 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -99.46 -3.22 34.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -1.181 . . . . 0.0 110.244 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . 142.88 -168.29 26.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.35 76.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.127 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.442 ' N ' ' O ' ' A' ' 183' ' ' GLY . 63.8 m -79.97 -86.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 68.81 -109.71 3.03 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -169.1 106.56 0.25 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.63 106.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -121.72 117.25 3.34 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -120.61 8.53 10.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.244 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 192' ' ' GLY . . . -60.56 -106.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.509 ' O ' ' C ' ' A' ' 193' ' ' CYS . . . -59.95 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.509 ' C ' ' O ' ' A' ' 192' ' ' GLY . 14.9 p 33.48 -150.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.994 . . . . 0.0 110.578 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 126.74 -54.97 0.75 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.521 ' HG ' ' CE1' ' A' ' 196' ' ' HIS . 26.7 t -93.35 -87.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 195' ' ' CYS . 5.6 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.14 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HG3' ' N ' ' A' ' 2' ' ' LYS . 20.0 ptm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -155.03 173.49 16.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.167 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.836 ' HA ' HG21 ' A' ' 139' ' ' ILE . 0.5 OUTLIER -53.13 154.48 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.753 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -144.54 -177.17 5.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -70.32 -86.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.176 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.02 ' HA ' HD11 ' A' ' 35' ' ' LEU . 7.4 p-10 -68.18 61.42 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.238 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' ASP . 1.8 mp -140.66 112.31 7.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.665 HG12 HG12 ' A' ' 152' ' ' VAL . 4.0 m -56.35 123.1 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.219 -0.926 . . . . 0.0 110.029 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 9' ' ' VAL . 14.4 p -130.29 113.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 110.377 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . 4.2 p -89.12 127.5 35.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.888 . . . . 0.0 109.784 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD13 ' CG1' ' A' ' 134' ' ' VAL . 1.2 pp -146.76 113.16 5.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 110.606 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.38 139.03 39.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.803 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.787 ' HB3' HG13 ' A' ' 134' ' ' VAL . 53.3 p90 -146.24 161.7 39.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 110.502 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG2' ' OE1' ' A' ' 25' ' ' GLU . 50.9 mt-30 -127.58 137.58 52.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.422 -0.799 . . . . 0.0 110.03 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.1 p -111.44 119.98 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.531 ' CG ' ' HG ' ' A' ' 22' ' ' LEU . 4.9 mtm180 -123.73 137.07 54.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.023 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 29.1 p -90.85 151.55 21.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 110.277 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -16.45 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.523 -0.735 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.11 13.43 2.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.62 32.53 78.68 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.815 ' C ' HD12 ' A' ' 22' ' ' LEU . 22.0 t -121.34 149.28 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -1.137 . . . . 0.0 110.349 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD12 ' C ' ' A' ' 21' ' ' VAL . 9.0 mp -112.47 119.29 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.111 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 24' ' ' ASP . 57.0 t -76.09 -53.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 0.0 110.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.742 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.9 p30 -179.29 151.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -145.75 165.86 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.81 149.48 95.12 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.12 135.7 23.36 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.97 1.511 . . . . 0.0 110.44 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -62.68 -19.5 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 -6.4 59.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -161.63 110.75 1.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 10' ' ' SER . 45.3 Cg_endo -73.01 164.5 35.39 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.075 1.566 . . . . 0.0 110.406 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 41' ' ' LEU . 1.4 tp -85.96 109.72 18.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 110.255 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.683 ' O ' HG21 ' A' ' 152' ' ' VAL . 3.9 p30 -104.33 119.06 38.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.905 . . . . 0.0 110.144 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.68 158.92 43.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.02 HD11 ' HA ' ' A' ' 6' ' ' ASP . 19.1 tp -67.85 100.76 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.236 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 30.2 t-80 -63.36 133.02 53.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' C ' ' CD2' ' A' ' 38' ' ' HIS . . . 98.7 -18.1 57.39 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 37' ' ' GLY . 8.8 m-70 -129.91 87.26 2.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -1.146 . . . . 0.0 110.406 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.99 45.89 85.75 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.66 -66.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -1.077 . . . . 0.0 110.21 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HB3' HD21 ' A' ' 45' ' ' LEU . 1.1 mp -139.65 -95.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.216 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 68' ' ' TYR . 8.2 mm -128.88 132.57 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 110.127 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 47' ' ' THR . 90.1 p -49.23 -24.14 1.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -75.13 -50.93 7.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.733 ' C ' HD12 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -86.96 -33.05 19.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -1.136 . . . . 0.0 110.038 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' N ' ' HG ' ' A' ' 45' ' ' LEU . 51.1 tt0 -52.16 -39.96 60.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.082 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 43' ' ' SER . 37.9 p -65.09 -20.66 66.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -81.52 -30.46 33.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 1.5 mm? -61.53 -35.23 77.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HA ' ' CG1' ' A' ' 3' ' ' VAL . 13.7 tt0 -59.73 130.86 48.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.944 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 43.22 62.94 2.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -111.44 -71.85 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -1.211 . . . . 0.0 110.247 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 52' ' ' HIS . 2.6 pt-20 177.61 118.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 139' ' ' ILE . 38.6 t -84.97 119.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.54 3.1 78.38 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -115.52 160.42 19.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -1.129 . . . . 0.0 110.201 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -109.27 152.64 24.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.183 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.619 ' CD2' ' NE2' ' A' ' 52' ' ' HIS . 48.4 p90 -150.12 146.33 26.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.66 125.4 54.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 m -121.12 146.31 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.557 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -89.77 115.49 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.283 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 28.0 m -156.62 96.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -129.25 -81.32 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.41 -21.48 38.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -1.119 . . . . 0.0 110.186 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 98.9 m-20 -81.03 -16.03 54.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.908 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 168.85 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 0.0 110.323 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 62' ' ' VAL . . . -158.59 -138.37 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.199 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HE1' HD11 ' A' ' 42' ' ' ILE . 0.8 OUTLIER -98.32 4.62 48.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.51 -65.25 0.83 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 50.84 86.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -1.152 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 73' ' ' GLU . 1.9 t80 -74.48 126.88 31.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.168 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' CB ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -123.51 80.7 1.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.896 . . . . 0.0 110.309 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 71' ' ' TYR . 1.5 mt-10 -69.26 -7.09 33.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.2 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' C ' ' HG ' ' A' ' 75' ' ' LEU . 54.4 t-20 -64.54 -46.61 82.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 0.0 110.342 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.825 HD12 HG23 ' A' ' 76' ' ' VAL . 1.2 pp 177.98 52.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.413 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.825 HG23 HD12 ' A' ' 75' ' ' LEU . 70.0 t -139.2 110.33 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' VAL . 48.4 tt0 -150.09 147.87 28.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -124.68 139.56 53.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.279 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 83' ' ' VAL . 8.7 p -163.1 119.27 1.19 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.2 Cg_endo -73.68 165.42 32.33 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.906 1.477 . . . . 0.0 110.418 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 6.8 mttp -61.04 -14.94 26.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.17 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.29 -25.89 66.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.715 HG21 HG23 ' A' ' 79' ' ' VAL . 27.8 t -78.33 -28.38 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.195 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.676 ' CD1' ' CE2' ' A' ' 96' ' ' PHE . 15.1 m-30 -73.97 -21.22 60.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.202 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.3 ttm 44.23 53.23 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.86 100.34 2.32 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.9 m -113.52 -126.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 110.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.582 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 170.51 -49.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.153 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.669 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.3 mt-10 -157.99 103.83 1.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 89' ' ' GLU . 2.9 mp -124.17 98.53 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.241 -0.912 . . . . 0.0 110.148 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 94' ' ' MET . 4.5 pt20 -97.48 -169.71 1.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.279 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 92' ' ' VAL . 14.7 p -80.09 131.37 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 109' ' ' ILE . . . 90.41 -16.86 56.65 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.51 ' HB2' ' HG3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -56.2 144.96 27.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.261 -1.14 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -100.08 126.07 46.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 110.169 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.676 ' CE2' ' CD1' ' A' ' 84' ' ' PHE . 41.9 t80 -114.43 161.99 17.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 106' ' ' PRO . 0.3 OUTLIER -114.86 118.72 34.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -84.09 116.14 22.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.32 105.05 14.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.1 p -130.21 157.92 41.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.19 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.44 -20.64 56.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.168 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -73.39 -8.1 54.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.11 161.44 10.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.17 126.41 11.1 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.011 1.532 . . . . 0.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.852 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 86.7 t -133.58 108.72 12.11 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.706 ' HA ' HD22 ' A' ' 97' ' ' LEU . 46.0 Cg_endo -73.07 134.81 21.96 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.947 1.498 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' CG2' ' HB3' ' A' ' 96' ' ' PHE . 13.6 m -119.28 -178.99 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -137.02 128.93 29.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.058 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.75 HD13 HG12 ' A' ' 119' ' ' VAL . 11.8 mm -84.22 122.64 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 8.0 t -115.72 -6.88 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.258 -0.901 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.02 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -179.45 161.65 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.085 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.16 137.77 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.11 -179.68 4.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 115' ' ' ASP . 39.2 t0 -69.3 129.01 38.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.284 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 114' ' ' ASP . 3.8 m-20 42.57 35.83 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.224 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -173.87 144.91 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 110.198 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 118' ' ' VAL . 12.1 t -123.43 177.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.02 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -136.32 123.37 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 109' ' ' ILE . 16.6 m -127.3 138.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 108' ' ' GLU . 3.1 p30 -85.14 119.82 25.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 177.28 -97.77 0.11 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.473 ' O ' ' OD1' ' A' ' 122' ' ' ASN . 9.1 p30 -118.68 120.77 38.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.125 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 1.7 t-80 -44.99 147.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.195 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.3 tpt -77.22 -38.07 52.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.6 tt -125.67 78.11 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.185 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 123' ' ' HIS . . . -164.33 166.4 20.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.469 ' CA ' ' CD2' ' A' ' 71' ' ' TYR . . . 103.47 9.15 39.12 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 129' ' ' ASN . 1.3 mt-30 -146.38 88.99 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 110.221 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.8 p-10 -42.08 152.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD13 ' CG2' ' A' ' 15' ' ' VAL . 3.3 pp -122.7 166.16 15.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.68 138.56 31.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.307 -0.871 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.687 ' HD1' HG23 ' A' ' 15' ' ' VAL . 4.6 t80 -126.18 97.1 4.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.314 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 13.6 t30 -83.78 120.6 26.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.0 109.958 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.787 HG13 ' HB3' ' A' ' 13' ' ' TYR . 11.2 t -129.14 163.05 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 5.5 tt0 -151.06 133.28 15.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . 20.5 t -81.49 139.81 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 110.456 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 11' ' ' LEU . 61.4 t -111.68 -38.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.399 -0.813 . . . . 0.0 110.316 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -156.94 166.32 33.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.284 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.836 HG21 ' HA ' ' A' ' 3' ' ' VAL . 7.7 mt -150.63 103.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 110.125 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -128.07 159.31 35.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -75.39 153.85 37.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.244 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.972 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -97.98 159.98 14.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.429 ' OG1' ' OE2' ' A' ' 146' ' ' GLU . 56.8 p -73.97 -175.81 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.014 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.89 -37.05 86.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.178 -0.951 . . . . 0.0 110.15 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -73.0 -34.6 66.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 110.129 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.972 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -61.76 -48.55 80.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 109.867 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.954 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 3.0 mm? -74.83 -15.32 60.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.868 . . . . 0.0 109.807 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.59 -53.6 15.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.342 -0.849 . . . . 0.0 110.203 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -90.65 -3.82 57.23 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.597 -0.689 . . . . 0.0 109.394 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.59 38.57 51.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -125.63 -176.51 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.327 -1.102 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 33' ' ' ASP . 16.0 m -128.47 142.39 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 1.6 m-70 58.55 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.23 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -109.03 149.79 17.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -122.05 13.91 10.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.279 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -15.44 63.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -71.09 -60.61 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.942 . . . . 0.0 110.19 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.1 t60 62.88 164.1 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.233 -0.917 . . . . 0.0 110.165 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.515 ' C ' ' CD2' ' A' ' 159' ' ' HIS . 0.7 OUTLIER -171.99 -161.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -139.25 164.83 28.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.64 145.25 48.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 110.256 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.5 OUTLIER 178.65 -34.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.244 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 5.2 m-20 64.15 33.01 12.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.44 75.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.73 176.88 8.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -152.8 57.42 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.63 71.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -1.15 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.3 m -138.85 -44.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 110.218 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.96 66.17 1.5 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.75 8.64 59.91 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -94.77 89.44 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.229 -1.159 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.82 66.6 1.91 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.41 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.52 170.67 15.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -50.83 177.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 110.246 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -122.28 141.58 14.31 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 33.8 p80 -122.86 -162.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -1.161 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' O ' ' O ' ' A' ' 179' ' ' HIS . 0.0 OUTLIER 63.58 57.9 1.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.237 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 178' ' ' GLU . 0.1 OUTLIER 46.38 -172.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.253 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.52 -85.98 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 173.24 41.78 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -157.44 -163.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.24 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . 152.61 -19.63 0.79 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 183' ' ' GLY . 31.8 p -47.25 174.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -1.164 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 68.6 m -93.14 -15.06 26.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 110.121 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 116.67 68.79 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.42 146.93 14.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -63.77 -61.89 2.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -1.191 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 165.9 70.36 0.03 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -121.85 140.83 51.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -1.19 . . . . 0.0 110.265 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 55.42 -104.17 0.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.26 -131.39 10.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 194' ' ' GLY . 19.9 p -171.28 -144.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -1.11 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 193' ' ' CYS . . . -132.21 -80.55 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.08 102.71 5.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -1.117 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.132 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -124.13 157.38 34.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 110.185 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.08 155.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.062 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -150.54 171.54 16.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.935 . . . . 0.0 110.379 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CE ' ' HA3' ' A' ' 37' ' ' GLY . 11.1 mttt -61.54 -69.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 35' ' ' LEU . 14.5 t70 -66.57 60.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.874 HD22 HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -162.18 117.77 1.95 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.187 -0.946 . . . . 0.0 110.268 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 140' ' ' ARG . 2.3 m -67.39 137.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.663 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.911 HG12 ' CD1' ' A' ' 11' ' ' LEU . 4.8 t -135.03 117.71 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.966 . . . . 0.0 110.472 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.89 106.09 18.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.638 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.911 ' CD1' HG12 ' A' ' 9' ' ' VAL . 5.8 mp -114.51 111.97 22.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.653 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.657 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -82.76 136.68 34.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 109.341 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 1.025 ' CB ' HG22 ' A' ' 134' ' ' VAL . 17.6 p90 -152.2 150.22 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.945 -1.097 . . . . 0.0 110.965 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -99.54 144.14 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.479 -0.763 . . . . 0.0 109.509 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 24' ' ' ASP . 5.1 t -111.5 134.6 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.061 -1.024 . . . . 0.0 110.54 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' CG ' HD12 ' A' ' 22' ' ' LEU . 11.7 mtt-85 -147.34 135.67 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.91 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 20.6 p -90.59 151.92 21.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.309 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -49.33 -23.97 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -71.61 -1.52 13.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.52 37.38 23.91 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 5.9 t -121.16 151.64 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.297 -1.12 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.558 HD21 ' OE2' ' A' ' 25' ' ' GLU . 3.2 tp -106.31 119.52 39.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' CG2' ' CG1' ' A' ' 15' ' ' VAL . 4.3 m -97.66 -32.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 110.239 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.1 150.31 9.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.558 ' OE2' HD21 ' A' ' 22' ' ' LEU . 13.7 pt-20 -149.11 131.14 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.378 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.657 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -109.83 110.72 59.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.5 Cg_endo -73.31 164.95 33.87 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.019 1.536 . . . . 0.0 110.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.485 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 72.1 t -67.24 -22.93 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.133 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.47 -13.71 56.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.297 -0.877 . . . . 0.0 110.215 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -140.26 55.02 5.73 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 47.3 Cg_endo -73.07 164.47 35.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.994 1.523 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.509 ' O ' ' CD2' ' A' ' 34' ' ' TYR . 14.2 tp -103.08 102.08 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.313 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.468 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 9.5 t0 -83.04 126.99 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.075 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 41' ' ' LEU . 19.7 p90 -155.77 160.68 40.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.035 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 150' ' ' GLY . 19.7 tp -69.17 144.53 53.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.882 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 63.7 t60 -93.08 147.93 22.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA3' ' CE ' ' A' ' 5' ' ' LYS . . . 80.83 -6.01 63.57 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' GLY . 25.0 m-70 -129.97 87.9 2.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.227 -1.161 . . . . 0.0 110.362 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.2 42.66 88.49 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.624 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -76.0 -63.33 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -1.106 . . . . 0.0 110.158 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER -158.91 -72.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 110.136 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.866 HG21 ' HA ' ' A' ' 67' ' ' ALA . 12.2 mt -148.16 156.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 110.199 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -45.77 63.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 110.25 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.87 -45.69 95.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.504 HD22 ' CZ ' ' A' ' 132' ' ' PHE . 44.3 tp -68.51 -45.56 71.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.124 . . . . 0.0 110.223 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 45' ' ' LEU . 4.8 mt-10 -43.22 -31.81 0.66 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.93 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 m -56.55 -44.45 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.039 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -67.78 -23.93 65.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.181 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -69.71 -56.03 8.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 110.255 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.4 tt0 -52.74 134.39 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.253 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.24 54.06 39.94 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.94 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -111.39 -4.37 14.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -1.173 . . . . 0.0 110.243 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 65.64 147.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 54' ' ' VAL . 6.7 p -81.77 119.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.891 . . . . 0.0 110.386 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.92 -13.92 56.06 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -74.59 155.39 37.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -1.082 . . . . 0.0 110.093 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CB ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -153.53 146.65 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.039 ' CZ ' ' HB1' ' A' ' 48' ' ' ALA . 4.8 p90 -154.76 156.01 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 110.171 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -97.58 125.27 42.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.551 HG23 ' CD1' ' A' ' 58' ' ' PHE . 89.5 t -124.44 120.34 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -93.51 112.58 24.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.747 HG12 ' HB2' ' A' ' 67' ' ' ALA . 68.8 t -157.86 120.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.177 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.797 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -146.31 -79.83 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.642 ' HB1' ' CG ' ' A' ' 70' ' ' GLN . . . -77.89 -9.01 58.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -1.133 . . . . 0.0 110.212 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.03 -46.47 14.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.234 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' ALA . 0.3 OUTLIER -149.16 -39.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.294 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.866 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -41.63 -58.48 1.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 123' ' ' HIS . 20.8 m-85 -116.48 -7.08 11.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' GLN . . . 55.76 17.96 16.09 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.642 ' CG ' ' HB1' ' A' ' 64' ' ' ALA . 24.8 mt-30 60.51 81.03 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.234 -1.157 . . . . 0.0 110.466 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.617 ' N ' ' HB2' ' A' ' 126' ' ' ALA . 2.9 p90 -84.5 121.64 27.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 110.33 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 4.3 t0 -83.48 126.93 33.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -51.92 -20.14 2.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.0 4.01 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.978 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 2.0 tt -75.71 -44.41 42.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 76' ' ' VAL . 34.2 m -67.93 95.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 75' ' ' LEU . 19.2 pt20 -150.18 172.72 14.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' C ' HG13 ' A' ' 79' ' ' VAL . 47.5 mtm-85 -117.79 120.92 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.898 . . . . 0.0 110.175 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.817 ' O ' HG22 ' A' ' 117' ' ' VAL . 31.2 m -149.96 127.27 5.52 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 110.291 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.526 ' N ' ' HB2' ' A' ' 116' ' ' HIS . 46.0 Cg_endo -73.12 161.43 43.24 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.947 1.498 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HE2' HG11 ' A' ' 117' ' ' VAL . 4.8 mmtm -71.23 -30.58 66.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.943 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' VAL . 24.6 p-10 -61.83 -20.9 64.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 110.126 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 37.5 t -93.72 -4.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 110.216 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 3.3 m-30 -71.63 -32.02 67.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.63 59.59 4.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.96 . . . . 0.0 110.201 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.46 -165.8 31.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' CG1' ' CD1' ' A' ' 90' ' ' LEU . 4.9 t 58.05 96.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.158 . . . . 0.0 110.22 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.45 14.53 4.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.245 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.53 105.34 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.81 119.42 24.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.216 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 109' ' ' ILE . 6.2 tt0 -118.27 125.65 50.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.147 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 92' ' ' VAL . 11.7 p -45.06 133.36 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 110.235 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 96.04 -21.48 44.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.624 ' HB3' HD11 ' A' ' 109' ' ' ILE . 16.4 ttp -73.44 155.37 39.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 110.179 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 95' ' ' ARG . 0.8 OUTLIER -126.43 128.97 47.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.224 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 107' ' ' VAL . 48.7 p90 -141.85 165.25 27.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 110.133 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 97' ' ' LEU . 3.7 pp -83.76 146.5 28.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 110.249 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -132.38 136.22 46.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.199 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -104.74 99.01 8.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.48 164.86 11.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.164 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.63 -31.3 71.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.951 . . . . 0.0 110.179 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -73.29 -3.63 28.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.86 152.21 7.64 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.6 128.03 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.004 1.528 . . . . 0.0 110.545 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.95 147.1 43.32 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.448 -0.782 . . . . 0.0 110.226 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 45.9 Cg_endo -73.27 154.41 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 96' ' ' PHE . 15.9 m -146.08 152.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ARG . 30.2 tt0 -148.77 106.61 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.961 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -59.3 142.49 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 118' ' ' VAL . 11.9 t -129.7 -31.6 1.97 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.72 112.45 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.762 HG23 HG12 ' A' ' 117' ' ' VAL . 8.2 p -64.48 138.99 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 116' ' ' HIS . 8.2 mm-40 -131.97 151.12 51.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.235 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 3.5 t70 -46.85 155.57 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.274 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t0 69.6 -55.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.17 -0.956 . . . . 0.0 110.228 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.526 ' HB2' ' N ' ' A' ' 80' ' ' PRO . 7.3 p-80 -160.75 171.16 19.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.912 . . . . 0.0 110.3 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 79' ' ' VAL . 19.0 m -96.97 -175.66 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -0.865 . . . . 0.0 110.104 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 110' ' ' THR . 4.2 p -138.96 118.9 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' H ' HG22 ' A' ' 119' ' ' VAL . 29.7 m -98.12 141.15 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.037 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 120' ' ' ASP . 29.2 p30 -153.25 171.68 18.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.217 -0.927 . . . . 0.0 110.268 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 145.22 75.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.595 ' HA ' ' CD1' ' A' ' 71' ' ' TYR . 25.6 p-10 -108.66 107.36 17.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 0.0 110.202 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.617 ' CG ' ' HA ' ' A' ' 68' ' ' TYR . 44.4 m-70 -68.9 -167.22 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.948 . . . . 0.0 110.301 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 68' ' ' TYR . 1.6 mmt -77.58 -15.23 59.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.729 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.936 HD12 ' CB ' ' A' ' 128' ' ' GLN . 0.1 OUTLIER 178.86 116.48 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.012 -1.055 . . . . 0.0 110.313 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.617 ' HB2' ' N ' ' A' ' 71' ' ' TYR . . . -94.01 150.46 20.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.298 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.54 52.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.936 ' CB ' HD12 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -126.6 73.33 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.9 t-20 -41.34 142.91 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.676 HD12 ' HA3' ' A' ' 63' ' ' GLY . 2.5 mp -132.98 135.13 45.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.464 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -118.48 117.46 29.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 109.891 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HD22 ' A' ' 45' ' ' LEU . 52.3 p90 -143.23 138.28 29.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 0.0 110.582 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.3 t-20 -98.22 135.11 40.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.331 -0.855 . . . . 0.0 109.544 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 1.025 HG22 ' CB ' ' A' ' 13' ' ' TYR . 25.1 t -123.14 152.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.957 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 20.4 tt0 -134.16 141.15 46.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.739 . . . . 0.0 109.836 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.94 HG23 ' CD2' ' A' ' 52' ' ' HIS . 73.7 t -79.76 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.535 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' SER . 38.3 t -111.7 -51.32 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 110.332 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.66 167.17 26.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.457 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.874 HG22 HD22 ' A' ' 7' ' ' LEU . 8.3 mt -151.42 102.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.304 -0.873 . . . . 0.0 110.106 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 17.8 mtm105 -130.28 154.37 47.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.361 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -67.42 147.24 53.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.838 . . . . 0.0 110.288 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.049 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -89.7 162.96 15.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.278 -0.889 . . . . 0.0 110.169 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.94 -178.08 3.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.934 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 145' ' ' GLU . 16.2 pt-20 -60.68 -40.72 93.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.144 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -73.16 -34.65 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.324 -0.86 . . . . 0.0 110.284 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.006 ' OE2' HG23 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -62.18 -43.51 98.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.153 -0.967 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.049 HD23 ' HB3' ' A' ' 142' ' ' ALA . 1.2 mm? -78.68 -16.64 57.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.0 109.49 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.11 -53.57 9.64 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.668 0.747 . . . . 0.0 110.103 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -75.19 -2.06 26.12 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.487 0.661 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.698 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 94.53 -25.7 21.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 35' ' ' LEU . 1.7 p-80 -149.31 161.38 42.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.186 -1.184 . . . . 0.0 110.423 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.006 HG23 ' OE2' ' A' ' 146' ' ' GLU . 2.7 p -79.8 119.01 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 0.0 110.182 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.8 t60 48.82 -151.83 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 48.92 66.69 2.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.66 144.71 36.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.159 . . . . 0.0 110.233 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -78.1 -56.29 4.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.938 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.5 -48.73 7.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.268 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 55.21 50.32 15.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' CE1' ' OD1' ' A' ' 161' ' ' ASP . 3.7 t-160 -115.55 128.67 56.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.209 -0.932 . . . . 0.0 110.238 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -94.4 52.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 159' ' ' HIS . 13.5 m-20 -69.95 157.13 38.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 110.211 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -173.54 56.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.196 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -165.49 -48.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.155 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -73.29 70.61 1.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.283 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -148.06 105.01 3.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 110.24 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.0 125.89 1.26 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.94 70.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.238 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 170' ' ' GLY . 0.8 OUTLIER -62.21 -13.51 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.268 -0.895 . . . . 0.0 110.257 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.7 95.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 168' ' ' CYS . . . -152.72 -126.72 1.2 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -76.92 85.14 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -1.156 . . . . 0.0 110.216 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.67 3.74 32.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.25 147.58 14.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.206 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 p-10 -63.45 -170.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 9.9 p-80 -172.07 103.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 110.225 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.94 136.53 6.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -97.44 114.36 26.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -1.154 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.46 60.47 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -83.65 1.02 44.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.06 -98.13 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.73 -160.82 34.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -104.5 138.88 40.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -1.185 . . . . 0.0 110.215 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -100.45 103.6 2.65 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.8 t -104.62 23.49 13.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.234 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.55 74.83 1.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.22 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.75 146.56 4.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 52.43 -107.37 0.5 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -46.17 151.32 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -1.184 . . . . 0.0 110.175 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.4 151.37 5.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.75 -154.7 0.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -1.14 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 124.85 -47.67 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 161.68 -92.53 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.0 m 44.98 -159.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 110.169 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.98 -69.88 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.97 -69.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 110.131 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.189 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.222 0.534 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HE3' ' N ' ' A' ' 51' ' ' GLY . 2.8 pttt -150.0 -175.51 5.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.3 -0.875 . . . . 0.0 110.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.944 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.8 OUTLIER -80.8 132.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.08 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -162.92 165.89 24.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 39.9 tttt -49.16 167.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.532 ' OD1' ' CD1' ' A' ' 147' ' ' LEU . 66.3 m-20 57.27 21.75 7.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 110.434 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.033 HD23 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -145.98 109.63 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -0.959 . . . . 0.0 110.393 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 140' ' ' ARG . 3.1 p -61.65 136.99 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 3' ' ' VAL . 4.3 p -143.78 116.01 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 110.453 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -93.09 106.17 18.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 109.776 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.032 HD13 HG13 ' A' ' 134' ' ' VAL . 3.3 pp -135.28 133.94 39.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.58 167.44 18.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 25.1 p90 -156.37 139.6 15.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.057 -1.027 . . . . 0.0 110.495 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -110.84 164.1 13.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.769 179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.831 HG12 ' O ' ' A' ' 24' ' ' ASP . 1.7 p -137.36 109.75 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 0.0 110.427 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.18 147.65 32.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.966 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.127 HG22 HD23 ' A' ' 130' ' ' LEU . 24.2 p -102.49 151.97 21.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.184 -0.948 . . . . 0.0 110.424 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -51.32 -19.05 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.502 -0.748 . . . . 0.0 110.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 12.25 2.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.102 -0.999 . . . . 0.0 110.252 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.68 31.33 75.87 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 59.4 t -121.32 143.69 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -1.123 . . . . 0.0 110.38 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 1.6 pp -99.97 123.05 43.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' A' ' 24' ' ' ASP . 72.8 t -76.07 -40.36 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 110.168 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.831 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 172.01 164.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -149.06 161.68 41.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.903 . . . . 0.0 110.146 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -83.36 153.94 65.9 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -72.9 139.15 29.78 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.058 1.557 . . . . 0.0 110.485 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.8 t -71.9 -32.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -6.05 44.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -145.06 90.67 6.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 45.8 Cg_endo -72.95 132.97 19.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.014 1.534 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD12 ' HE2' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -69.24 96.97 0.88 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 110.337 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -83.19 135.58 34.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.062 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.616 ' OH ' HD21 ' A' ' 11' ' ' LEU . 45.5 p90 -157.83 167.8 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.318 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 147' ' ' LEU . 22.0 tp -94.07 119.36 32.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 3.3 t-80 -60.61 147.3 42.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.125 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.13 -44.01 3.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' N ' ' CD2' ' A' ' 38' ' ' HIS . 6.0 m-70 -119.72 87.19 2.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -1.126 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.83 71.87 1.27 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' C ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -140.07 50.95 1.71 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -1.136 . . . . 0.0 110.152 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 62.77 -127.47 0.61 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.226 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.646 HD12 ' CG1' ' A' ' 62' ' ' VAL . 14.3 pt -106.5 148.8 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 110.35 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.3 m -52.31 -41.38 62.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 110.18 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.86 -34.43 5.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.753 HD11 ' HD2' ' A' ' 132' ' ' PHE . 3.7 mm? -84.81 -34.18 22.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -1.126 . . . . 0.0 110.164 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 61.7 mt-10 -59.06 -51.8 68.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.248 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.4 m -61.02 -51.72 68.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.76 65.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.0 110.198 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.96 ' CD2' HD22 ' A' ' 11' ' ' LEU . 2.1 mt -84.85 -48.33 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.893 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -43.64 116.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' N ' ' HE3' ' A' ' 2' ' ' LYS . . . 74.65 40.99 36.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.508 ' CD2' HG23 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -93.0 -97.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -1.156 . . . . 0.0 110.144 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.581 ' CG ' ' CB ' ' A' ' 56' ' ' ASP . 39.2 tp10 176.04 126.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.3 p -77.64 120.03 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.92 -5.21 61.52 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.581 ' CB ' ' CG ' ' A' ' 53' ' ' GLU . 56.0 t0 -112.22 168.16 9.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -1.148 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.0 OUTLIER -126.7 151.5 48.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.296 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 59' ' ' ASP . 6.1 t80 -143.22 137.33 28.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 1.2 m-20 -90.5 148.29 22.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 132' ' ' PHE . 7.1 p -153.46 146.08 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -95.87 114.82 26.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 110.169 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 67' ' ' ALA . 7.5 t -148.7 102.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.213 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.833 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -147.9 -79.85 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HA2' ' A' ' 127' ' ' GLY . . . -87.05 -22.55 25.39 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.378 -1.072 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 19.5 t-20 -80.87 -21.24 40.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.237 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER 178.74 61.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.294 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.877 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -164.64 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 63' ' ' GLY . 9.9 m-85 -94.55 -37.95 11.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 64' ' ' ALA . . . 54.77 74.24 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.598 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 53.8 mt-30 -87.59 -146.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 110.316 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.909 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 27.2 p90 -81.99 125.87 31.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.06 -1.025 . . . . 0.0 110.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -82.98 145.42 29.35 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.911 -1.118 . . . . 0.0 110.04 179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.83 -6.84 9.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.894 . . . . 0.0 110.63 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.412 ' OD1' ' HB3' ' A' ' 72' ' ' ASP . 11.4 p-10 -48.77 -21.79 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.672 HD11 HD21 ' A' ' 122' ' ' ASN . 0.8 OUTLIER -108.81 57.76 0.61 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.221 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 120' ' ' ASP . 3.3 p -93.62 155.72 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 78' ' ' ARG . 4.9 tp60 -102.42 156.8 17.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.534 ' C ' HG23 ' A' ' 79' ' ' VAL . 2.5 mtm-85 -123.2 132.09 53.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.295 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' C ' ' A' ' 78' ' ' ARG . 17.4 t -152.29 119.72 3.18 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.111 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.1 Cg_endo -73.0 167.61 26.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.923 1.486 . . . . 0.0 110.483 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -67.64 -6.78 22.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -49.32 -22.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.997 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 83' ' ' VAL . 47.6 t -105.6 14.8 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.357 -0.839 . . . . 0.0 110.192 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.686 ' CE1' ' CZ ' ' A' ' 96' ' ' PHE . 2.7 m-85 -122.61 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.199 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.4 mtm -104.46 72.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.69 49.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 88' ' ' ASP . 34.5 m -125.77 -126.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -1.155 . . . . 0.0 110.116 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER 168.28 -54.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.175 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' OE1' ' NE2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -153.19 103.17 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 110.153 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 6.0 mp -92.59 106.82 18.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 110.29 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' NE2' ' OE1' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -100.0 174.84 5.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.263 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 92' ' ' VAL . 28.2 m -68.65 127.07 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.49 -10.12 24.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.883 ' O ' HG22 ' A' ' 109' ' ' ILE . 5.2 tmm? -77.41 153.14 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.73 159.57 17.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.899 ' HB3' HG23 ' A' ' 107' ' ' VAL . 2.9 t80 -126.43 155.56 42.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 0.0 110.209 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 97' ' ' LEU . 6.0 tp -132.57 127.86 35.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . . . -113.84 101.45 9.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.14 103.28 12.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.5 p -137.01 171.26 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -48.77 -26.21 2.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.258 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 31.0 tt0 -69.53 -6.04 28.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.97 159.99 20.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.28 112.37 3.51 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.968 1.509 . . . . 0.0 110.403 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.672 ' CG1' ' HB3' ' A' ' 98' ' ' ALA . 8.6 p -118.19 120.85 31.88 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.96 141.41 33.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.431 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.899 HG23 ' HB3' ' A' ' 96' ' ' PHE . 4.2 m -142.03 177.67 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.02 121.47 20.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 94' ' ' MET . 2.8 tt -64.72 128.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 118' ' ' VAL . 3.0 t -108.41 -19.39 13.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 110.178 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -164.67 161.12 20.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.177 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 112' ' ' VAL . 31.4 m -122.17 104.66 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 170.21 9.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.253 -0.904 . . . . 0.0 110.157 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 115' ' ' ASP . 2.2 m-20 -63.31 128.9 37.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.203 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.7 OUTLIER 42.21 36.68 0.75 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.222 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 20.0 t60 -173.91 133.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.211 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 109' ' ' ILE . 4.3 t -121.77 173.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 110' ' ' THR . 5.3 m -138.83 123.2 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 110.316 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 109' ' ' ILE . 34.2 m -129.4 150.72 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' HB3' HG23 ' A' ' 76' ' ' VAL . 7.9 p-10 -132.26 106.41 7.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.179 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -70.87 79.28 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.676 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 29.8 m120 -118.68 178.29 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -1.125 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 122' ' ' ASN . 1.6 t-160 -56.74 -142.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 110.788 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.483 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.2 ttm -77.53 -45.29 25.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.288 -0.883 . . . . 0.0 110.909 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.49 ' HA ' ' OH ' ' A' ' 71' ' ' TYR . 8.1 tp -178.21 115.88 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.013 . . . . 0.0 110.385 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 71' ' ' TYR . . . -122.58 176.73 5.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 110.131 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.59 ' HA2' ' HB1' ' A' ' 64' ' ' ALA . . . 58.94 16.47 32.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -120.23 85.95 2.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -1.16 . . . . 0.0 110.254 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' O ' ' OD1' ' A' ' 129' ' ' ASN . 16.0 p30 -42.65 140.21 1.36 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.188 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.127 HD23 HG22 ' A' ' 17' ' ' THR . 1.5 mp -105.51 171.04 7.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 8.1 mptt -90.4 112.73 24.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.178 -0.951 . . . . 0.0 110.155 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.773 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.3 t80 -105.21 112.91 26.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.4 t-20 -80.16 163.64 23.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.096 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 1.032 HG13 HD13 ' A' ' 11' ' ' LEU . 30.3 t -153.12 152.38 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.56 108.44 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -0.824 . . . . 0.0 109.88 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 139' ' ' ILE . 21.4 t -77.5 139.12 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.478 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' SER . 41.4 t -111.61 -40.79 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.389 -0.819 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -152.51 162.56 41.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.315 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.033 HG22 HD23 ' A' ' 7' ' ' LEU . 4.8 mt -148.66 101.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 110.025 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.0 148.86 43.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.135 -0.978 . . . . 0.0 110.19 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -65.38 161.68 19.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.24 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -109.14 146.9 33.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 0.0 110.301 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -175.51 2.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.105 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -33.95 76.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -73.03 -35.81 66.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 23.9 mt-10 -59.47 -48.63 80.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.69 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD13 HD21 ' A' ' 35' ' ' LEU . 4.1 mm? -74.12 -22.84 59.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.671 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -62.74 -53.49 53.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 110.045 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.555 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 14.1 m170 -83.16 -3.7 57.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.653 ' O ' HD23 ' A' ' 35' ' ' LEU . . . 98.8 -28.27 15.9 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 151' ' ' HIS . 0.3 OUTLIER -160.34 -179.89 8.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -1.154 . . . . 0.0 110.39 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 153' ' ' HIS . 7.5 p -103.15 139.21 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.296 -0.878 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 16.9 t60 57.35 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.272 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 151' ' ' HIS . . . 93.14 130.19 5.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 158' ' ' HIS . . . -125.97 155.82 40.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -1.1 . . . . 0.0 110.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -66.31 -48.89 68.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -82.28 -18.62 41.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.283 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 155' ' ' ALA . 0.2 OUTLIER -108.19 176.98 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER 61.29 140.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -102.34 88.69 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.216 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -126.9 67.04 1.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.27 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -136.14 -67.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.221 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 163' ' ' ASP . 31.5 p30 -176.32 31.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 166' ' ' GLY . 31.3 m80 -127.17 -5.48 6.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.284 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.1 t70 65.85 -67.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.23 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 168' ' ' CYS . . . 106.55 -164.22 13.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.433 ' CB ' ' O ' ' A' ' 166' ' ' GLY . 2.6 t 66.41 -60.61 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -1.175 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.522 ' N ' ' O ' ' A' ' 166' ' ' GLY . 1.7 m -152.77 43.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.14 -167.78 7.96 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 172' ' ' GLY . . . -88.61 42.79 3.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.91 89.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.22 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 170' ' ' GLY . . . -177.71 145.55 7.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -47.01 113.06 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 110.233 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.1 t70 -98.78 -63.1 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -44.96 98.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 177' ' ' HIS . . . -144.95 38.12 1.29 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 177' ' ' HIS . 0.3 OUTLIER 179.07 116.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -1.155 . . . . 0.0 110.228 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -144.89 39.5 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.508 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 21.1 m170 -80.72 -39.81 26.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.133 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.38 116.48 0.42 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 182' ' ' GLU . . . -157.18 26.7 0.49 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 181' ' ' GLY . 4.6 tm-20 54.27 104.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -1.108 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.86 31.92 4.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.51 151.7 49.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -1.176 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.7 p -120.57 -179.12 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.96 108.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -166.09 -47.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.73 118.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -1.145 . . . . 0.0 110.194 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.92 165.57 19.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.68 122.4 38.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -1.134 . . . . 0.0 110.194 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 54.42 33.94 54.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.17 -165.03 1.33 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 26.7 p -167.24 38.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -1.124 . . . . 0.0 110.167 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 195' ' ' CYS . . . -165.94 -140.25 2.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 194' ' ' GLY . 37.6 t 58.0 160.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -1.16 . . . . 0.0 110.264 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.19 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.281 0.562 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD2' ' HA2' ' A' ' 51' ' ' GLY . 10.1 mmtp -109.46 160.27 16.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.753 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -50.95 154.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -153.4 154.53 34.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.44 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.911 ' O ' HD12 ' A' ' 7' ' ' LEU . 21.2 p-10 -64.73 65.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.233 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.035 HD23 HG22 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -163.52 108.85 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 110.236 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' OD1' ' A' ' 33' ' ' ASP . 12.4 p -58.24 136.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.09 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 3' ' ' VAL . 80.9 t -143.48 121.89 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 1.1 m -88.92 111.45 22.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.563 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.47 111.89 19.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 110.586 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -90.7 139.87 30.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.566 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 134' ' ' VAL . 5.8 p90 -155.63 147.19 22.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 110.645 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' CD ' HD21 ' A' ' 22' ' ' LEU . 1.3 tt0 -104.99 135.94 45.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 132' ' ' PHE . 2.0 t -111.57 130.17 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -135.0 137.93 43.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 1.8 p -84.53 152.34 23.98 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.46 -25.6 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.337 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 20' ' ' GLY . 48.0 p-10 -66.17 -7.97 21.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 19' ' ' ASP . . . 89.05 32.08 11.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 39.3 t -121.2 151.6 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.332 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.553 HD21 ' CD ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.74 114.63 26.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' NE2' ' A' ' 102' ' ' GLN . 47.9 t -85.49 -47.41 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 110.198 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.06 150.13 40.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 110.342 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 2.0 pt-20 -149.26 124.65 10.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.846 . . . . 0.0 110.14 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.619 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -110.02 110.77 58.68 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.9 Cg_endo -72.8 161.69 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.919 1.484 . . . . 0.0 110.445 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' C ' ' HD3' ' A' ' 31' ' ' PRO . 10.8 p -71.08 -21.37 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -83.34 -17.1 43.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.246 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -141.75 50.17 1.67 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.245 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 30' ' ' ALA . 47.3 Cg_endo -73.32 164.62 34.74 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.091 1.574 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.8 mt -88.63 99.76 12.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' HG22 ' A' ' 8' ' ' VAL . 30.8 t0 -83.09 126.3 32.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 38.7 m-85 -161.28 167.93 24.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.072 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -82.16 143.06 31.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 110.126 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 66.2 t60 -61.47 140.95 57.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.75 14.48 36.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CD2' ' HD2' ' A' ' 5' ' ' LYS . 17.4 m-70 -121.77 87.2 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -1.176 . . . . 0.0 110.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . 143.19 -11.99 2.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 65.08 42.3 4.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -1.152 . . . . 0.0 110.134 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 40' ' ' SER . 9.7 tp -62.47 -137.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.115 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 67' ' ' ALA . 10.5 mt -89.65 118.14 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 110.14 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 -47.4 78.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -0.873 . . . . 0.0 110.384 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG21 ' A' ' 62' ' ' VAL . . . -57.55 -35.04 71.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.957 HD21 HG21 ' A' ' 134' ' ' VAL . 2.9 tm? -86.94 -35.37 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 8.4 mt-10 -51.2 -56.46 12.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.181 -0.949 . . . . 0.0 110.127 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.5 p -47.84 -49.55 28.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 110.069 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.1 -23.94 64.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -71.67 -39.8 70.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' A' ' 3' ' ' VAL . 18.7 tt0 -62.79 131.47 48.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 0.0 110.234 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.459 ' HA2' ' HD2' ' A' ' 2' ' ' LYS . . . 68.45 40.69 86.55 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.589 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -101.86 -124.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -1.181 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -175.44 133.95 0.3 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.177 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.5 p -66.0 119.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' C ' ' OE2' ' A' ' 135' ' ' GLU . . . 99.54 -13.19 61.33 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 9.6 t70 -88.73 136.74 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -1.106 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 3.6 pttt -101.95 145.57 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 110.196 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' O ' HG22 ' A' ' 134' ' ' VAL . 2.2 t80 -136.56 120.82 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 20.8 p-10 -87.45 125.03 34.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.196 -0.94 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.8 t -139.27 116.23 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.099 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.89 130.16 38.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 67' ' ' ALA . 7.6 p -174.69 141.21 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.22 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 129' ' ' ASN . . . -158.14 -77.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' O ' ' HA2' ' A' ' 69' ' ' GLY . . . -84.71 -7.22 59.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.377 -1.072 . . . . 0.0 110.039 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -81.17 -36.14 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 65' ' ' ASN . 57.9 m-20 -157.83 -51.41 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 110.252 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.933 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -40.41 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 110.422 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 9.4 m-85 -100.3 -11.17 20.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.255 -0.903 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 64' ' ' ALA . . . 39.4 41.5 1.6 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.598 ' HA ' ' N ' ' A' ' 127' ' ' GLY . 1.3 mt-30 63.64 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -1.156 . . . . 0.0 109.846 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.652 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.1 p90 -81.51 122.6 27.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 110.571 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' H ' HD21 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -94.49 148.05 22.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.479 -0.763 . . . . 0.0 109.478 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HB2' ' A' ' 122' ' ' ASN . 0.4 OUTLIER -66.24 -7.07 16.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 110.49 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -70.98 -30.04 66.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.564 HD21 ' H ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -108.82 79.24 1.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 109.654 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 120' ' ' ASP . 4.2 m -52.98 155.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 118' ' ' VAL . 9.2 mm-40 -119.27 172.76 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.893 . . . . 0.0 110.377 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 8.4 ptt-85 -105.82 118.41 36.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.295 -0.878 . . . . 0.0 110.218 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 117' ' ' VAL . 47.3 t -137.96 129.99 16.22 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.211 -0.931 . . . . 0.0 110.168 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.23 165.51 32.44 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.96 1.505 . . . . 0.0 110.443 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -71.46 -5.12 30.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.4 -27.5 10.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.23 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 83' ' ' VAL . 8.5 p -117.29 12.66 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.27 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 81' ' ' LYS . 1.3 m-85 -76.3 -56.4 4.67 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.454 ' CB ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 67.43 100.54 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.43 -8.33 40.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.771 HG23 ' HG ' ' A' ' 90' ' ' LEU . 1.2 p -48.56 -88.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.231 -1.159 . . . . 0.0 110.143 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.764 ' N ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 60.61 10.27 2.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.01 -1.056 . . . . 0.0 110.753 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 1.4 mt-10 167.31 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.281 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.771 ' HG ' HG23 ' A' ' 87' ' ' VAL . 23.1 mt -141.4 132.38 26.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 110.158 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' MET . 3.6 mt-30 -125.59 136.66 53.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.283 -0.886 . . . . 0.0 110.209 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 92' ' ' VAL . 36.0 m -63.03 130.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.58 -5.68 82.36 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB3' ' O ' ' A' ' 91' ' ' GLN . 0.3 OUTLIER -95.53 145.21 25.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -1.178 . . . . 0.0 110.245 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 6.3 ptp180 -89.94 127.03 35.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 107' ' ' VAL . 87.1 t80 -114.21 163.57 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.8 tp -115.08 127.59 55.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.91 . . . . 0.0 110.137 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.75 132.8 49.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -121.25 110.5 16.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -0.861 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -121.88 -179.07 4.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.193 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -72.01 -23.89 61.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.299 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' NE2' HG22 ' A' ' 23' ' ' VAL . 4.3 pt20 -87.1 18.47 3.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.179 -0.95 . . . . 0.0 110.264 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.75 138.13 10.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.12 147.49 42.9 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.022 1.538 . . . . 0.0 110.417 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 105' ' ' VAL . 2.4 m -141.9 134.76 14.02 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.395 -0.816 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 130.14 15.01 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.015 1.534 . . . . 0.0 110.366 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 119' ' ' VAL . 3.3 m -116.3 176.03 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.893 . . . . 0.0 110.316 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -134.16 114.56 13.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 110.195 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 90' ' ' LEU . 6.2 mt -77.5 127.51 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.91 . . . . 0.0 110.204 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -117.44 -20.84 8.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 110.249 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.858 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -161.35 -178.99 7.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.756 HG23 HG12 ' A' ' 117' ' ' VAL . 6.9 p -153.52 140.12 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.208 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' HIS . 2.3 mt-10 -128.41 -176.65 3.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 115' ' ' ASP . 15.2 m-20 -67.72 128.99 38.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.214 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 114' ' ' ASP . 17.1 m-20 42.72 27.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.581 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 2.8 t60 -165.95 146.87 6.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.133 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.756 HG12 HG23 ' A' ' 112' ' ' VAL . 29.3 m -148.07 170.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.251 -0.905 . . . . 0.0 110.193 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 111' ' ' ALA . 2.1 p -113.52 157.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.613 HG22 ' HB ' ' A' ' 107' ' ' VAL . 8.6 p -163.4 151.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 76' ' ' VAL . 43.3 t0 -117.28 102.17 9.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.064 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -119.09 160.81 14.03 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 3.9 t30 -117.86 142.63 47.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -1.097 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.55 ' N ' ' OH ' ' A' ' 71' ' ' TYR . 5.7 m170 -102.37 177.62 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.971 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.521 ' O ' ' CD2' ' A' ' 125' ' ' LEU . 3.6 ttt -47.11 -28.79 1.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.993 . . . . 0.0 109.851 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER 174.23 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.862 . . . . 0.0 110.14 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -40.48 131.69 2.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 109.866 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.598 ' N ' ' HA ' ' A' ' 70' ' ' GLN . . . 113.1 21.82 5.81 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 129' ' ' ASN . 20.8 mm-40 -87.24 75.18 9.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -1.095 . . . . 0.0 109.825 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' A' ' 128' ' ' GLN . 1.8 p-10 -26.27 139.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.803 -0.561 . . . . 0.0 111.261 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 130' ' ' LEU . 2.8 mp -136.54 157.19 47.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.237 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -116.45 134.5 54.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 110.025 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 8.5 p90 -148.41 148.91 30.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.977 . . . . 0.0 110.586 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 7.7 t-20 -100.04 131.58 45.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.924 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.957 HG21 HD21 ' A' ' 45' ' ' LEU . 17.2 m -107.58 150.12 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.272 -0.892 . . . . 0.0 110.554 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -136.23 124.75 23.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.96 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 3.7 t -74.88 138.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -0.953 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 54' ' ' VAL . 63.8 t -111.58 -46.89 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.379 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -155.58 166.68 32.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.526 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.035 HG22 HD23 ' A' ' 7' ' ' LEU . 7.9 mt -150.61 101.97 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.044 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 6.9 mtt180 -121.15 155.27 34.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 62.8 tt0 -81.6 162.19 23.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.201 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.012 ' HB3' HD12 ' A' ' 147' ' ' LEU . . . -123.58 153.57 40.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 144' ' ' GLU . 1.4 m -73.99 -175.49 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 143' ' ' THR . 0.8 OUTLIER -57.18 -44.3 83.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.939 . . . . 0.0 110.055 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 3.7 tt0 -72.49 -39.45 67.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 109.883 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.007 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 62.7 mm-40 -56.74 -40.79 76.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.012 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -75.11 -15.86 60.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.431 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -78.36 -53.49 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.487 -0.758 . . . . 0.0 110.072 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.605 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 14.9 m170 -78.95 -0.94 32.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.507 -0.745 . . . . 0.0 109.318 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.8 46.5 82.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -160.4 179.42 8.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 110.254 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.637 ' CG1' HG21 ' A' ' 8' ' ' VAL . 7.5 p -130.6 139.29 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.935 . . . . 0.0 110.212 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.438 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 65.01 80.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.927 . . . . 0.0 110.202 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.57 -44.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -48.59 124.46 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -1.126 . . . . 0.0 110.143 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -62.65 -34.36 76.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 110.194 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.405 ' HB2' ' OE1' ' A' ' 145' ' ' GLU . 5.0 m-20 -48.06 -60.45 2.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 47.1 67.21 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.225 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 161' ' ' ASP . 53.9 p-80 -96.34 158.61 15.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.245 -0.91 . . . . 0.0 110.221 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' HIS . 11.6 m-70 42.33 -96.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 110.173 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 41.46 -155.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 162' ' ' HIS . 7.3 t60 -115.11 64.25 0.68 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.4 t0 -119.21 50.17 1.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 166' ' ' GLY . 10.2 p80 178.05 -39.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 164' ' ' HIS . 2.4 t70 65.86 -65.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.879 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 164' ' ' HIS . . . 143.56 -123.81 2.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 166' ' ' GLY . 26.6 t 58.47 87.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.276 -1.132 . . . . 0.0 110.248 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.68 -65.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 135.13 137.45 3.74 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -168.75 71.26 0.15 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 171' ' ' HIS . 0.5 OUTLIER -49.04 158.49 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.172 . . . . 0.0 110.176 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.4 151.47 35.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -78.61 -154.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -1.152 . . . . 0.0 110.196 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 175' ' ' HIS . 1.6 t70 -151.69 158.44 43.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.161 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.405 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 58.2 m-70 -138.34 -88.39 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.3 128.51 1.94 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -132.05 160.31 36.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -1.148 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.28 90.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -146.28 -49.32 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.915 . . . . 0.0 110.2 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.86 -107.54 2.97 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -160.96 172.94 37.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -45.06 123.6 4.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.97 83.58 1.63 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 27.4 p -124.36 28.54 6.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.241 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.92 44.31 2.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.41 -80.51 1.32 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.2 69.6 1.29 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 50.86 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.147 . . . . 0.0 110.287 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -53.63 -85.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -172.63 38.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -1.157 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.54 -21.75 2.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.08 174.54 51.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 4.8 m -150.79 57.08 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.13 . . . . 0.0 110.196 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 130.3 57.94 0.1 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 21.6 p -115.89 4.2 13.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -1.122 . . . . 0.0 110.232 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.056 -0.974 . . . . 0.0 110.169 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 ttp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.208 0.527 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -97.34 171.48 8.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.946 ' HA ' HG21 ' A' ' 139' ' ' ILE . 37.2 t -85.16 142.39 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -106.86 159.15 16.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.35 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 18.6 tttt -58.67 -34.86 71.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.247 -0.908 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.851 ' HA ' HD11 ' A' ' 35' ' ' LEU . 2.1 p-10 -113.36 49.21 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.249 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 4' ' ' ALA . 2.6 mp -130.66 111.82 12.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 110.126 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 8' ' ' VAL . 4.3 m -51.25 126.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.037 ' CG2' HG23 ' A' ' 139' ' ' ILE . 52.5 t -128.52 110.67 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 110.239 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.954 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.7 t -88.83 122.42 32.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.711 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.985 ' CD2' HD21 ' A' ' 49' ' ' LEU . 3.7 pp -142.7 126.46 17.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.079 -1.013 . . . . 0.0 110.713 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -80.66 152.55 28.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.385 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.568 ' HB3' HG22 ' A' ' 134' ' ' VAL . 45.2 p90 -154.92 144.97 21.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.936 -1.102 . . . . 0.0 110.826 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -113.28 134.5 54.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 24' ' ' ASP . 3.6 m -113.59 152.73 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.0 110.9 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.9 ptp180 -149.71 135.84 18.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 26.8 p -77.81 152.06 33.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 110.33 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.13 -18.85 4.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -2.15 17.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.57 28.05 30.79 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 42.1 t -121.27 151.67 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 110.239 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 5.2 mp -103.3 123.59 47.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 110.269 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG2' HG23 ' A' ' 17' ' ' THR . 48.8 t -81.25 -53.02 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.231 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.841 ' O ' HG22 ' A' ' 15' ' ' VAL . 21.4 t70 -166.58 164.39 16.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.352 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.49 -178.31 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.143 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -129.99 121.48 19.83 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.38 155.36 50.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.443 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.6 -11.85 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.243 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 t -83.31 -10.81 58.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.49 60.04 2.66 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 46.3 Cg_endo -72.86 156.31 52.78 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.985 1.519 . . . . 0.0 110.468 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -99.23 148.44 24.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.177 -0.952 . . . . 0.0 110.136 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.512 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 1.4 m-20 -89.8 151.85 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 110.166 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 1.131 ' CD2' HD13 ' A' ' 41' ' ' LEU . 24.0 m-85 -132.96 148.18 52.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.851 HD11 ' HA ' ' A' ' 6' ' ' ASP . 13.3 tp -112.06 109.46 19.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 109.988 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 50' ' ' GLU . 7.6 t-80 -64.73 149.19 49.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.88 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 61.72 21.85 61.21 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.642 ' CG ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -129.99 -150.13 0.42 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.188 -1.183 . . . . 0.0 108.828 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.84 36.04 1.07 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 41.7 t -69.13 -20.11 64.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -1.158 . . . . 0.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.131 HD13 ' CD2' ' A' ' 34' ' ' TYR . 1.2 mp -140.58 -86.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.152 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.971 HD11 ' CZ ' ' A' ' 68' ' ' TYR . 9.0 mt -137.6 135.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 110.189 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 t -68.81 -24.15 64.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 110.086 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.42 -33.6 52.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 22.0 tp -83.78 -32.0 25.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -1.158 . . . . 0.0 110.22 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -61.48 -35.42 77.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.314 -0.866 . . . . 0.0 110.256 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.1 m -54.97 -34.48 63.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.253 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 52' ' ' HIS . . . -84.59 -23.73 29.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.274 -0.891 . . . . 0.0 110.288 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.985 HD21 ' CD2' ' A' ' 11' ' ' LEU . 2.1 mt -60.85 -48.13 83.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.315 -0.865 . . . . 0.0 110.186 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 77.8 tt0 -59.15 132.05 52.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 52' ' ' HIS . . . 86.58 72.42 1.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.677 ' CD2' ' CE1' ' A' ' 58' ' ' PHE . 5.0 m-70 -164.18 107.13 0.92 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -1.155 . . . . 0.0 110.157 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.9 mt-10 -64.47 165.29 10.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 36.0 t -67.11 119.14 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.55 2.7 50.25 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -86.68 137.2 32.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -1.172 . . . . 0.0 110.236 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 36.8 pttt -129.83 133.06 46.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.94 . . . . 0.0 110.244 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CE1' ' CD2' ' A' ' 52' ' ' HIS . 9.6 p90 -137.24 154.13 50.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.169 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 18.3 t0 -106.7 129.68 54.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.195 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -141.68 141.93 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.225 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 131' ' ' LYS . . . -92.69 133.27 36.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.769 HG22 ' HB2' ' A' ' 67' ' ' ALA . 7.4 p -164.6 102.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.137 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.94 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -143.47 -80.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' C ' ' A' ' 69' ' ' GLY . . . -66.35 -8.45 25.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -1.112 . . . . 0.0 109.987 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 33.2 t-20 -81.15 -32.44 33.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.875 . . . . 0.0 110.331 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 23.1 t70 178.92 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -0.926 . . . . 0.0 110.95 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.94 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -58.22 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.068 -1.02 . . . . 0.0 110.348 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.971 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 13.0 m-85 -135.79 13.86 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.969 . . . . 0.0 110.157 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' HA ' ' A' ' 64' ' ' ALA . . . -93.58 -19.5 34.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.59 -25.15 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.31 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 5.7 t80 -43.26 143.32 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 0.0 110.161 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' N ' ' CD1' ' A' ' 71' ' ' TYR . 1.2 t70 -130.8 148.26 52.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.231 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -24.14 64.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.223 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -50.8 -20.94 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.82 59.35 5.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 110.203 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.5 p -56.69 153.82 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.46 154.12 21.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 110.23 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 117' ' ' VAL . 1.1 ttm180 -119.69 126.46 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 47.4 t -142.06 138.89 17.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.156 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HD3' ' CE1' ' A' ' 116' ' ' HIS . 45.8 Cg_endo -73.01 158.0 50.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.436 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.8 pttp -67.86 -7.81 31.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.196 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -63.76 -34.85 78.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 83' ' ' VAL . 92.8 t -94.48 19.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.181 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 1.2 m-85 -97.08 75.41 2.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tmm? -48.4 -59.51 3.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.217 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.88 71.41 3.01 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.594 HG23 HD23 ' A' ' 90' ' ' LEU . 6.3 p -101.04 70.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -1.132 . . . . 0.0 110.257 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 89' ' ' GLU . 22.8 t70 -76.56 -0.84 24.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 172.74 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.186 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD23 HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -108.11 89.68 3.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 110.167 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.438 ' O ' HG21 ' A' ' 109' ' ' ILE . 36.4 tt0 -124.75 158.88 32.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.271 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' H ' HG12 ' A' ' 92' ' ' VAL . 7.2 p -79.2 134.49 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 109' ' ' ILE . . . 91.64 -4.65 79.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.843 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.9 ttp -83.16 144.73 29.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.3 -1.117 . . . . 0.0 110.269 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.89 143.83 26.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.211 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 107' ' ' VAL . 28.0 t80 -122.37 165.85 15.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 110.254 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.9 pp -139.18 113.62 8.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.186 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -90.98 111.09 22.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.98 68.1 4.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 110.331 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.9 p -75.29 175.28 8.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 0.0 110.21 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.87 -30.98 62.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' OE1' ' A' ' 102' ' ' GLN . 3.2 tp60 -67.49 -6.91 21.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 110.2 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 134.69 171.55 12.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 45.6 Cg_endo -73.24 114.5 4.05 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.007 1.53 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 98' ' ' ALA . 53.7 t -102.49 101.63 21.13 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.196 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 104' ' ' PRO . 45.5 Cg_endo -72.7 133.23 19.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.381 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.848 HG23 ' HB3' ' A' ' 96' ' ' PHE . 6.4 m -136.35 172.16 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.908 . . . . 0.0 110.155 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB3' ' OD2' ' A' ' 120' ' ' ASP . 27.6 tt0 -145.53 120.18 9.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.138 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -70.34 131.78 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.16 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.751 HG23 HG13 ' A' ' 118' ' ' VAL . 1.5 t -114.18 -26.07 8.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG11 ' A' ' 118' ' ' VAL . . . -160.0 166.49 29.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.226 -0.921 . . . . 0.0 110.243 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.5 t -128.4 104.54 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.373 -0.829 . . . . 0.0 110.112 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.01 169.15 12.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.91 129.42 40.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 47.19 31.32 1.65 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.185 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.492 ' CE1' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -173.19 143.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.781 HG11 HD11 ' A' ' 109' ' ' ILE . 5.9 t -128.67 173.08 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -0.866 . . . . 0.0 110.222 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.751 HG13 HG23 ' A' ' 110' ' ' THR . 2.8 p -133.8 125.4 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 110.253 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 109' ' ' ILE . 35.1 m -139.14 135.3 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.893 . . . . 0.0 110.139 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 2.0 p30 -88.23 155.8 19.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.36 96.74 0.16 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -62.96 137.93 58.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -1.123 . . . . 0.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.27 164.57 14.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 110.17 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.1 mtm -71.4 -12.92 61.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.269 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 130' ' ' LEU . 1.4 mm? -89.22 -66.24 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -47.82 117.89 2.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -136.99 81.2 1.86 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -1.155 . . . . 0.0 110.19 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -58.44 172.0 0.53 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.249 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.745 HD23 ' H ' ' A' ' 130' ' ' LEU . 1.8 pt? -136.57 148.78 47.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.202 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -111.39 138.58 47.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.821 ' CB ' HG12 ' A' ' 15' ' ' VAL . 7.4 p90 -143.04 151.03 40.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.6 m120 -90.0 150.7 22.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.938 ' CG1' HD13 ' A' ' 11' ' ' LEU . 10.1 t -133.7 129.45 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.975 . . . . 0.0 110.58 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.7 121.28 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.368 -0.833 . . . . 0.0 109.994 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 9' ' ' VAL . 54.4 t -77.27 138.66 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 110.441 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 10' ' ' SER . 3.1 m -111.76 -27.02 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -163.22 165.26 24.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 110.511 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.037 HG23 ' CG2' ' A' ' 9' ' ' VAL . 4.7 mt -151.18 101.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.905 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -121.4 145.5 47.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.245 -0.909 . . . . 0.0 110.218 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 7' ' ' LEU . 2.4 pt-20 -62.23 137.42 58.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.055 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . . . -83.29 163.44 20.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.242 -0.911 . . . . 0.0 110.13 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 144' ' ' GLU . 23.2 m -73.91 177.09 5.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 143' ' ' THR . 0.6 OUTLIER -55.93 -41.02 73.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.908 . . . . 0.0 110.113 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -72.51 -39.73 67.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 110.028 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.985 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 47.6 mt-10 -57.9 -43.06 85.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.0 . . . . 0.0 109.77 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.055 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -82.09 -20.85 37.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.862 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -72.95 -53.42 11.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.0 m170 -88.66 -5.23 58.27 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.421 -0.799 . . . . 0.0 109.223 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.575 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 72.11 56.36 6.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 66.2 m-70 -159.09 -176.04 5.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -1.126 . . . . 0.0 110.315 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 152' ' ' VAL . 4.8 m -130.56 119.67 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 110.185 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.471 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 81.6 t60 57.93 96.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.912 . . . . 0.0 110.205 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 155' ' ' ALA . . . 75.61 158.78 7.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 158' ' ' HIS . . . -175.89 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -1.166 . . . . 0.0 110.244 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -83.98 5.46 25.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 110.269 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -76.53 -31.51 57.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.413 ' O ' ' CB ' ' A' ' 159' ' ' HIS . 1.9 p80 -118.84 170.36 9.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 158' ' ' HIS . 0.5 OUTLIER 63.27 77.12 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 110.175 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -157.99 48.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.193 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.32 45.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -99.48 -52.01 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.267 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -44.62 123.98 3.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 110.207 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.475 ' CE1' ' OD1' ' A' ' 165' ' ' ASP . 26.8 t-80 -151.97 152.99 33.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.189 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' OD1' ' CE1' ' A' ' 164' ' ' HIS . 9.6 p-10 -60.55 -177.56 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.09 135.83 1.89 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.447 ' HG ' ' CE1' ' A' ' 173' ' ' HIS . 0.5 OUTLIER -151.83 41.14 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -1.149 . . . . 0.0 110.144 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 22.2 p -62.07 178.8 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.47 41.17 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 174.86 37.67 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -91.08 67.4 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -1.157 . . . . 0.0 110.152 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -62.04 -31.26 78.08 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 172' ' ' GLY . 4.6 m-70 -60.58 -128.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 110.133 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 173' ' ' HIS . 1.9 t70 -41.66 136.57 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 110.264 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -102.46 152.47 21.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.44 80.63 0.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -63.16 -69.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.1 114.58 2.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -171.96 169.14 5.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 110.24 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 107.59 -15.2 38.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 182' ' ' GLU . . . 64.12 173.06 2.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 181' ' ' GLY . 10.6 pt-20 38.0 35.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.44 -1.036 . . . . 0.0 110.385 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.72 -31.58 2.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.6 t -101.46 -5.91 24.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -1.143 . . . . 0.0 110.11 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -138.54 104.55 5.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -172.45 70.56 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -82.45 -31.68 29.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 162.92 6.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -1.16 . . . . 0.0 110.188 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -98.72 -159.16 29.67 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -90.44 -43.78 10.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.0 110.23 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -177.75 134.08 2.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.19 24.77 3.95 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 49.1 t -110.06 59.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -1.146 . . . . 0.0 110.173 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -108.91 -10.62 24.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 29.3 p -114.88 -15.06 11.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -1.135 . . . . 0.0 110.192 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 17.7 ptm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.81 -175.45 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG22 HG21 ' A' ' 9' ' ' VAL . 1.1 t -77.7 129.6 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 110.19 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -147.93 -174.52 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -0.816 . . . . 0.0 110.226 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HE2' ' CD2' ' A' ' 38' ' ' HIS . 1.0 OUTLIER -68.53 153.96 42.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.863 ' O ' HD22 ' A' ' 7' ' ' LEU . 1.3 m-20 59.13 32.06 21.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.863 HD22 ' O ' ' A' ' 6' ' ' ASP . 1.7 mm? -132.32 100.08 4.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.331 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 152' ' ' VAL . 3.9 m -51.5 126.33 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.0 109.721 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.079 HG21 HG22 ' A' ' 3' ' ' VAL . 69.2 t -134.05 115.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 0.0 110.53 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.461 ' C ' ' HB2' ' A' ' 31' ' ' PRO . 5.3 p -94.8 105.94 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.687 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.77 HD21 ' OH ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -127.24 115.77 19.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 110.592 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.52 36.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CB ' HG12 ' A' ' 134' ' ' VAL . 33.3 p90 -156.16 149.82 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.522 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 3.3 tt0 -115.88 129.96 56.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 109.777 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.031 HG12 ' O ' ' A' ' 24' ' ' ASP . 11.4 p -111.5 152.63 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 110.559 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.87 140.36 19.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 109.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 18.8 p -87.23 151.98 22.7 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 110.25 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -50.14 -20.99 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 110.242 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -74.12 -0.48 16.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.34 31.44 34.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 24.1 t -121.24 143.12 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -1.169 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -100.07 113.76 26.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -76.02 -34.08 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.122 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.031 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -165.55 150.26 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 0.0 110.193 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.12 136.77 20.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.25 143.89 27.11 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.156 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.83 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.3 Cg_endo -73.18 136.63 24.81 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.014 1.534 . . . . 0.0 110.485 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 28' ' ' VAL . 19.9 m -63.57 -30.82 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.2 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.9 t -78.98 -17.59 55.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.166 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.83 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -136.15 91.1 17.33 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' ' C ' ' A' ' 10' ' ' SER . 45.2 Cg_endo -73.1 164.54 35.16 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.075 1.566 . . . . 0.0 110.401 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 tp -94.83 95.83 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.361 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 3.7 p30 -82.99 126.54 32.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.236 -0.915 . . . . 0.0 109.903 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.834 ' CZ ' HD23 ' A' ' 41' ' ' LEU . 7.3 p90 -159.87 168.29 26.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.447 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.899 HD21 ' HG ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -67.32 110.36 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.616 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 18.4 t-80 -79.17 142.48 36.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.327 -0.858 . . . . 0.0 110.765 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.76 -28.65 5.81 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.767 ' CE1' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -130.42 87.25 2.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -1.023 . . . . 0.0 110.251 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.52 63.62 2.44 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.661 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -123.6 -80.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 0.0 110.224 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.834 HD23 ' CZ ' ' A' ' 34' ' ' TYR . 3.3 mm? -122.66 -89.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.068 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.899 HG21 ' HA ' ' A' ' 67' ' ' ALA . 10.0 mt -144.94 161.44 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.252 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -58.15 -23.83 56.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.719 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -87.03 -29.69 22.28 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.641 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 3.4 tt -84.87 -54.97 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' LEU . 27.3 mt-10 -42.33 -48.26 5.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 p -64.58 -27.89 69.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.164 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 58' ' ' PHE . . . -81.22 -23.84 37.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.201 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD21 HD22 ' A' ' 11' ' ' LEU . 4.9 mt -74.15 -33.0 63.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.193 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.527 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -42.56 135.52 2.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.195 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.87 110.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.568 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.1 OUTLIER 176.77 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -1.105 . . . . 0.0 110.19 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 54' ' ' VAL . 9.2 tp10 -82.65 139.77 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.237 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 137' ' ' VAL . 50.4 t -43.33 119.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.3 2.11 33.35 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.78 140.78 34.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -1.153 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' HB3' ' CG ' ' A' ' 135' ' ' GLU . 10.0 pttt -148.82 157.2 43.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CE1' HG23 ' A' ' 134' ' ' VAL . 7.3 p90 -158.41 165.03 35.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.244 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.425 ' OD2' ' HE3' ' A' ' 131' ' ' LYS . 32.0 t70 -97.08 128.24 43.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.311 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 132' ' ' PHE . 9.3 p -123.09 123.06 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 110.242 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.572 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -92.94 113.45 25.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.257 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG11 ' HA3' ' A' ' 44' ' ' GLY . 38.8 t -153.35 101.73 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -125.17 -74.54 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.822 ' HB3' ' H ' ' A' ' 127' ' ' GLY . . . -86.11 -17.87 33.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -1.138 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.16 -26.69 35.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.897 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.654 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -174.01 67.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.121 -0.987 . . . . 0.0 110.311 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.899 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -171.2 -139.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.887 . . . . 0.0 110.224 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HE2' HD11 ' A' ' 42' ' ' ILE . 24.1 m-85 -106.95 35.88 2.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.16 -113.35 0.97 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 71' ' ' TYR . 8.6 pt20 -157.23 -114.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 110.137 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.907 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 12.1 p90 -84.73 143.91 28.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 25.7 p30 -104.93 69.76 0.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' H ' ' HB3' ' A' ' 126' ' ' ALA . 43.7 mt-10 -67.33 -6.62 19.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 2.5 p-10 -67.3 4.05 1.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.304 -0.872 . . . . 0.0 110.761 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -10.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.109 -0.995 . . . . 0.0 110.548 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 119' ' ' VAL . 1.4 p -53.14 153.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -128.81 152.25 48.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.244 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -102.75 114.04 27.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 117' ' ' VAL . 8.3 m -138.47 124.19 12.43 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 110.225 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 46.6 Cg_endo -73.13 167.84 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.901 1.474 . . . . 0.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 1.6 ttpt -65.59 -8.57 20.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.86 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.78 9.08 12.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 83' ' ' VAL . 90.8 t -117.27 -5.4 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.918 . . . . 0.0 110.245 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 14.6 m-85 -77.8 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.225 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' PHE . 3.2 ttp 176.61 -57.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 110.22 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -121.94 -14.9 4.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 86' ' ' GLY . 4.8 m 37.82 36.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.415 -1.05 . . . . 0.0 110.416 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -80.35 -5.48 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.254 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.08 40.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.298 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' HG3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -87.19 116.15 25.08 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.631 -0.668 . . . . 0.0 110.175 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.23 141.39 0.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.173 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -45.02 139.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.56 -9.56 35.23 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.43 ' HB3' HD12 ' A' ' 109' ' ' ILE . 3.9 ttp -105.42 141.75 36.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.148 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -98.01 131.91 44.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 107' ' ' VAL . 31.5 t80 -108.1 156.16 19.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 110.163 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -113.72 146.84 39.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.27 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -131.37 129.38 41.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 2.0 mt-10 -112.84 75.64 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.0 p -70.57 163.35 27.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.26 -15.98 63.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 12.85 18.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.145 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 125.55 150.32 7.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 46.9 Cg_endo -72.94 127.31 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.034 1.544 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.764 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 14.6 p -141.22 113.91 6.85 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.893 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 44.9 Cg_endo -72.73 162.95 39.85 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.046 1.55 . . . . 0.0 110.456 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 96' ' ' PHE . 12.7 m -133.64 -179.57 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.164 -0.96 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 120' ' ' ASP . 0.1 OUTLIER -136.03 129.02 31.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.92 . . . . 0.0 110.144 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 94' ' ' MET . 21.8 mt -80.52 101.08 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.9 t -89.47 -31.39 17.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.56 141.6 20.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.69 HG13 HG22 ' A' ' 117' ' ' VAL . 39.6 t -122.53 119.78 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' HIS . 0.7 OUTLIER -105.04 165.0 11.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.01 131.37 49.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 110.162 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 46.3 t0 50.69 20.91 0.81 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 14.4 t60 -164.34 133.55 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.288 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.69 HG22 HG13 ' A' ' 112' ' ' VAL . 80.0 t -141.56 163.15 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' VAL . 71.2 t -138.57 118.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.168 -0.957 . . . . 0.0 110.203 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.3 m -112.8 133.59 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.023 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.543 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 8.1 p-10 -148.81 146.75 28.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.456 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.74 -20.17 8.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 8.3 m120 -118.71 177.52 4.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -1.127 . . . . 0.0 110.184 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 26.1 m80 -71.19 142.13 50.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 110.309 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.6 mtm -77.44 -11.21 59.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.964 . . . . 0.0 110.078 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 126' ' ' ALA . 0.3 OUTLIER -51.92 -68.28 0.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 0.0 110.533 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 71' ' ' TYR . . . -47.14 176.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.822 ' H ' ' HB3' ' A' ' 64' ' ' ALA . . . 100.01 -34.12 5.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.423 ' HG3' ' C ' ' A' ' 127' ' ' GLY . 6.6 mt-30 -135.23 71.55 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.042 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -94.34 -21.33 19.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.441 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.487 ' HB2' ' HA2' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -132.72 135.19 45.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.424 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 13.2 tttp -133.76 122.17 22.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.32 -0.862 . . . . 0.0 109.903 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.643 ' CE1' ' CG1' ' A' ' 60' ' ' VAL . 18.8 p90 -147.89 141.37 25.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.507 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 58' ' ' PHE . 4.2 t30 -96.31 127.14 42.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.592 HG12 ' CB ' ' A' ' 13' ' ' TYR . 17.5 m -110.98 139.97 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.622 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tm-20 -126.68 123.41 37.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -0.788 . . . . 0.0 109.842 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 52' ' ' HIS . 86.9 t -77.17 137.62 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 110.427 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.801 ' O ' HG13 ' A' ' 54' ' ' VAL . 43.9 t -111.67 -28.62 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 110.373 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 54' ' ' VAL . . . -164.34 165.73 21.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.542 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 7' ' ' LEU . 5.8 mt -149.7 101.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.346 -0.846 . . . . 0.0 110.041 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.854 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -117.46 152.32 35.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.157 -0.965 . . . . 0.0 110.114 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.3 tt0 -79.64 132.65 36.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 110.366 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -88.3 145.69 25.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 144' ' ' GLU . 10.7 m -73.98 171.89 12.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.291 -0.881 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.45 -33.41 44.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.573 ' O ' ' CE1' ' A' ' 149' ' ' HIS . 2.0 tp10 -69.0 -43.0 75.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.872 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 0.6 OUTLIER -58.45 -46.92 85.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.899 ' HG ' HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -81.99 -10.02 59.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 0.0 110.102 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -66.68 -53.08 37.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 145' ' ' GLU . 1.8 p80 -112.05 -12.68 13.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 109.99 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' HIS . . . 100.55 73.56 1.05 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 21.1 m-70 -160.43 176.71 11.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -1.174 . . . . 0.0 110.195 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 8' ' ' VAL . 57.6 t -123.63 142.45 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 110.252 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.44 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 65.75 13.23 8.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.231 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 155' ' ' ALA . . . 89.92 78.45 1.33 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HA ' ' CG ' ' A' ' 151' ' ' HIS . . . 54.14 106.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.255 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.46 -72.14 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.27 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -92.02 -58.2 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 0.2 OUTLIER 176.7 -60.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 26.5 p80 -176.94 -165.31 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.426 ' O ' ' CB ' ' A' ' 161' ' ' ASP . 0.1 OUTLIER 63.04 104.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 110.17 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 160' ' ' HIS . 3.7 t0 63.84 -146.51 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.237 -0.914 . . . . 0.0 110.26 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -91.18 -67.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -174.46 149.26 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.32 101.47 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.53 107.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.65 -164.36 1.8 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 1.7 t -122.75 57.25 1.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.32 -1.106 . . . . 0.0 110.192 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 46.22 -166.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.02 -162.57 11.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.89 140.31 14.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -165.79 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -1.138 . . . . 0.0 110.183 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.89 -71.1 2.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.37 -47.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.298 -1.119 . . . . 0.0 110.217 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -113.53 101.83 9.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.0 110.231 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 53.5 -153.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -92.14 -133.52 6.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -163.21 55.87 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.24 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.11 13.63 4.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.155 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -95.19 -30.88 13.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.15 45.44 73.18 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 152.6 115.63 0.63 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.47 117.22 4.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 184' ' ' CYS . . . 160.7 125.32 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 1.1 m 59.04 57.46 3.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.239 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 149.36 1.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 178.24 93.61 0.09 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.55 -129.66 3.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.57 -2.59 6.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -1.196 . . . . 0.0 110.18 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -99.9 -53.71 1.09 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 12.2 m120 51.42 46.14 26.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -1.168 . . . . 0.0 110.183 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.69 116.43 3.95 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 152.24 61.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 61.5 m -85.03 114.54 22.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 117.09 136.48 5.69 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 9.6 p -139.35 158.22 44.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -1.113 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.151 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 13.5 ptt? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -97.33 154.33 17.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.164 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -51.06 151.92 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.079 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HB3' HD22 ' A' ' 7' ' ' LEU . . . -154.45 165.3 36.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 110.302 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' CG ' ' A' ' 6' ' ' ASP . 8.8 tttt -58.39 174.29 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.86 . . . . 0.0 110.226 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.976 ' CB ' HD21 ' A' ' 147' ' ' LEU . 3.1 p30 36.91 42.47 0.23 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.44 -0.788 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.795 HD22 ' HB3' ' A' ' 4' ' ' ALA . 5.1 tp -134.5 104.42 6.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.254 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 152' ' ' VAL . 1.4 p -51.24 129.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.977 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.637 ' CG2' HG23 ' A' ' 139' ' ' ILE . 48.0 t -143.5 120.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 137' ' ' VAL . 66.3 m -96.07 106.18 18.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.245 -0.91 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 49' ' ' LEU . 2.8 pp -135.4 127.47 29.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.51 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.004 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -85.73 154.79 21.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.877 . . . . 0.0 109.874 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' CB ' HG12 ' A' ' 134' ' ' VAL . 4.9 p90 -155.33 137.83 15.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 110.425 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -106.44 138.46 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.889 . . . . 0.0 109.979 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.972 HG12 ' O ' ' A' ' 24' ' ' ASP . 8.7 p -124.23 139.01 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.141 -0.974 . . . . 0.0 110.582 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -140.62 138.11 34.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.84 . . . . 0.0 109.915 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 130' ' ' LEU . 36.7 p -87.36 151.97 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 110.394 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.5 -17.37 1.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.419 -0.801 . . . . 0.0 110.472 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -77.15 8.2 4.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.5 29.04 64.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 54.1 t -121.21 141.66 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -1.104 . . . . 0.0 110.177 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 15' ' ' VAL . 4.9 tt -103.75 121.36 42.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 110.356 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' N ' HD23 ' A' ' 22' ' ' LEU . 22.7 t -77.68 -46.77 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.009 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.972 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -171.8 150.33 2.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 110.251 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -148.95 169.74 19.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 0.0 110.212 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 1.004 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -133.7 111.69 12.5 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.172 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' OE2' ' A' ' 25' ' ' GLU . 46.7 Cg_endo -73.37 165.42 32.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.012 1.533 . . . . 0.0 110.446 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.421 ' H ' HG12 ' A' ' 28' ' ' VAL . 3.9 p -60.75 -25.25 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.8 9.1 17.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.122 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -160.13 63.4 2.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.217 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.87 162.26 41.54 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.513 . . . . 0.0 110.313 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.67 99.93 9.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.3 m-20 -84.79 125.04 32.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.994 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -161.02 162.51 31.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 38' ' ' HIS . 12.9 tp -68.7 108.07 3.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 110.128 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -60.56 144.53 51.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' OE2' ' A' ' 46' ' ' GLU . . . 97.38 -81.35 0.68 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.703 ' O ' HD23 ' A' ' 35' ' ' LEU . 6.7 p80 -130.0 87.75 2.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -1.091 . . . . 0.0 110.217 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -148.57 -51.99 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 0.5 OUTLIER 173.29 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.323 -1.104 . . . . 0.0 110.174 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.41 -172.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 110.146 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.91 HG21 ' HA ' ' A' ' 67' ' ' ALA . 7.6 mt -98.54 149.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.097 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.36 -47.16 83.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 110.355 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.08 -46.35 85.23 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD21 HG11 ' A' ' 134' ' ' VAL . 1.2 tt -66.58 -37.21 84.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -1.151 . . . . 0.0 110.238 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 37' ' ' GLY . 2.2 tt0 -55.37 -45.21 76.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.71 -58.97 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -51.58 -23.89 4.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 11' ' ' LEU . 4.7 mt -72.75 -28.1 62.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.3 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -49.01 135.55 15.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.2 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.9 91.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.538 ' HB3' HG11 ' A' ' 136' ' ' VAL . 2.6 t-80 -149.4 101.04 3.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -1.133 . . . . 0.0 110.243 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 2.6 tp10 -43.02 111.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.151 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -42.12 123.99 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 110.477 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 136' ' ' VAL . . . 92.57 2.97 67.06 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 23.5 t0 -102.39 152.98 20.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -1.132 . . . . 0.0 110.27 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -121.79 138.11 54.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.06 158.76 37.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.66 127.84 49.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.938 HG21 ' HB1' ' A' ' 48' ' ' ALA . 38.2 t -133.58 139.34 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -111.09 116.62 31.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.261 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 61' ' ' ALA . 55.7 t -158.65 120.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.753 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -140.41 -81.58 0.07 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' CB ' ' HA2' ' A' ' 127' ' ' GLY . . . -62.73 -16.58 58.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -1.089 . . . . 0.0 109.897 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 1.4 m-20 -81.16 -33.23 33.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.367 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 167.94 73.89 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.058 -1.026 . . . . 0.0 110.517 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -143.07 -64.74 0.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 67' ' ' ALA . 22.6 m-85 -144.88 -38.97 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.248 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.605 ' HA2' ' CD2' ' A' ' 123' ' ' HIS . . . -83.81 -80.16 1.04 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER 68.68 125.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.267 -1.137 . . . . 0.0 110.436 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -43.44 144.36 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CG ' ' CB ' ' A' ' 122' ' ' ASN . 1.0 OUTLIER -82.75 79.14 9.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 0.0 110.005 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 2.2 mt-10 -69.35 -26.87 64.9 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.025 -1.047 . . . . 0.0 109.646 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 2.6 t-20 -63.12 -3.95 2.08 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 74' ' ' ASN . 33.4 mt 61.32 65.14 1.0 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.891 0.853 . . . . 0.0 109.778 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.913 HG23 ' HA ' ' A' ' 120' ' ' ASP . 1.4 p -52.75 95.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.77 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' LEU . 1.4 tt0 -151.29 173.04 14.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.358 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG2' ' CG1' ' A' ' 118' ' ' VAL . 63.5 mtm180 -77.02 129.23 35.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.861 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.676 HG23 ' HD2' ' A' ' 80' ' ' PRO . 7.7 p -161.76 147.32 10.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.0 110.214 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.676 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.0 Cg_endo -73.37 167.72 26.6 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.94 1.495 . . . . 0.0 110.389 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -68.43 -6.44 24.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.22 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -51.62 -24.47 5.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.7 t -97.53 11.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HB2' ' HD3' ' A' ' 81' ' ' LYS . 3.3 m-30 -101.9 77.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 110.201 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 mtm -56.1 -40.78 74.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.281 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 100' ' ' THR . . . -106.58 149.74 16.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.719 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -171.29 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -1.139 . . . . 0.0 110.166 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.719 ' H ' HG13 ' A' ' 87' ' ' VAL . 0.5 OUTLIER 57.12 14.3 1.94 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.133 -0.98 . . . . 0.0 110.346 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 167.65 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -149.9 64.34 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 94' ' ' MET . 0.0 OUTLIER -62.33 125.77 25.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.124 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 91' ' ' GLN . 2.1 p -42.14 119.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.83 -21.59 45.26 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 1.028 ' O ' HD11 ' A' ' 109' ' ' ILE . 1.7 ttp -81.03 125.24 29.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -1.183 . . . . 0.0 110.247 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.18 143.77 32.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.855 . . . . 0.0 110.106 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE1' ' HG ' ' A' ' 90' ' ' LEU . 1.5 p90 -168.12 165.74 13.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 110.303 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD21 ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -82.67 111.36 18.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.116 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -65.27 158.86 25.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.163 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.99 106.66 9.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 0.0 110.193 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLY . 1.6 p -119.92 160.58 22.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.928 . . . . 0.0 110.243 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -24.96 10.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 21.01 2.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 0.0 110.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.63 157.01 30.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.883 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 Cg_endo -72.68 154.0 54.31 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.052 1.554 . . . . 0.0 110.508 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 98' ' ' ALA . 3.2 m -141.93 124.58 9.35 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.468 -0.77 . . . . 0.0 110.277 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.6 Cg_endo -73.37 119.25 5.88 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.925 1.487 . . . . 0.0 110.466 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.639 ' HB ' HG21 ' A' ' 119' ' ' VAL . 2.8 m -144.28 157.64 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' C ' HD13 ' A' ' 109' ' ' ILE . 16.2 mp0 -132.91 166.77 21.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.247 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.028 HD11 ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -127.09 120.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.0 110.122 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 t -104.53 -22.66 13.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.323 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -162.01 163.38 28.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 117' ' ' VAL . 5.8 p -147.48 109.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.29 -0.881 . . . . 0.0 110.151 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.62 171.67 14.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 110.174 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' CD2' ' A' ' 116' ' ' HIS . 2.3 t0 -49.91 129.02 19.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.92 . . . . 0.0 110.078 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 19.5 t70 45.9 33.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.953 . . . . 0.0 110.159 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.639 ' O ' HG23 ' A' ' 112' ' ' VAL . 60.9 m-70 -154.14 152.49 30.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.223 -0.923 . . . . 0.0 110.262 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 112' ' ' VAL . 91.4 t -133.71 172.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 117' ' ' VAL . 55.6 t -139.23 133.2 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.639 HG21 ' HB ' ' A' ' 107' ' ' VAL . 2.9 p -133.64 133.71 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.185 -0.947 . . . . 0.0 110.027 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.913 ' HA ' HG23 ' A' ' 76' ' ' VAL . 15.8 p-10 -137.39 171.76 14.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.247 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.74 34.01 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.65 ' OD1' HG21 ' A' ' 76' ' ' VAL . 2.5 p-10 -115.0 171.89 7.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 110.325 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.605 ' CD2' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-70 -102.44 176.86 5.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.121 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.6 ptp -49.13 -22.08 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' A' ' 125' ' ' LEU . 7.8 tp -174.11 104.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.45 146.9 52.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.155 -0.966 . . . . 0.0 110.213 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.404 ' HA2' ' CB ' ' A' ' 64' ' ' ALA . . . 112.57 14.71 10.18 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.611 ' O ' HD12 ' A' ' 130' ' ' LEU . 30.6 tt0 -96.29 71.03 2.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -1.153 . . . . 0.0 110.19 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -44.88 128.95 7.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 128' ' ' GLN . 5.2 mp -106.66 140.38 39.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -102.34 127.86 49.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -0.912 . . . . 0.0 110.086 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 32.1 p90 -148.04 146.72 28.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.446 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 6.3 m-20 -100.36 156.52 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.568 HG11 HD21 ' A' ' 45' ' ' LEU . 11.9 m -136.61 136.04 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.425 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' LYS . 47.6 tt0 -126.04 118.77 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.08 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 9' ' ' VAL . 7.3 p -84.57 139.73 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 110.225 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 10' ' ' SER . 2.9 m -111.69 -30.58 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB1' ' NE ' ' A' ' 140' ' ' ARG . . . -156.31 161.31 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.98 . . . . 0.0 110.35 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.781 HG22 HD23 ' A' ' 7' ' ' LEU . 7.8 mt -147.09 101.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.079 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.67 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -125.98 170.7 11.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.215 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.558 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.8 pt-20 -98.1 141.71 30.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.211 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.063 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -82.81 160.38 22.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.318 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.487 ' N ' ' HB2' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -73.97 -175.57 2.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 110.161 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -59.23 -46.44 88.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 110.222 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -36.5 72.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.063 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.4 OUTLIER -61.79 -42.6 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.151 -0.968 . . . . 0.0 109.745 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -81.85 -23.34 36.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.39 -53.46 44.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 110.196 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 1.8 m-70 -97.34 -6.38 34.36 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.632 -0.667 . . . . 0.0 109.418 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 80.39 62.39 2.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.507 ' CD2' ' HB2' ' A' ' 149' ' ' HIS . 8.9 p80 -160.42 153.46 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -1.162 . . . . 0.0 110.35 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.813 HG21 HG21 ' A' ' 8' ' ' VAL . 4.9 p -128.02 127.31 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.185 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER 53.9 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 154.22 -103.12 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' A' ' 158' ' ' HIS . . . 56.24 79.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -1.164 . . . . 0.0 110.13 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -66.73 -39.59 88.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.895 . . . . 0.0 110.244 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 160' ' ' HIS . 0.2 OUTLIER -75.57 -25.95 57.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 110.273 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.867 ' HB2' ' HB1' ' A' ' 155' ' ' ALA . 15.9 t60 -46.78 -62.47 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -47.22 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 45.6 t60 43.49 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.217 -0.927 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.02 -44.73 13.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.4 26.96 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -134.69 -56.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.18 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -112.62 93.33 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.209 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -151.73 129.61 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 110.225 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.71 42.96 1.17 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 168' ' ' CYS . 26.0 t -85.88 164.45 17.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -1.095 . . . . 0.0 110.207 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 4.2 t 64.94 169.17 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 110.142 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.52 -120.88 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.12 47.18 0.03 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -132.63 121.48 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -1.176 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.52 -144.99 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.9 56.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -1.145 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -146.23 36.6 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -0.874 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -126.46 151.29 47.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.25 147.78 12.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -91.32 121.28 32.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.203 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.8 116.25 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 110.123 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -143.62 144.27 31.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.14 -153.95 20.97 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.82 11.24 5.16 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -49.62 157.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -1.149 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 185' ' ' CYS . . . -174.77 49.72 0.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 185' ' ' CYS . 53.3 m 54.32 -86.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.515 ' N ' ' O ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER 65.53 154.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 174.12 -108.33 0.27 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.98 -144.18 10.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.75 -15.64 10.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -1.161 . . . . 0.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.07 -80.69 0.09 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.99 176.64 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 110.195 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.38 -124.57 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.0 -102.89 0.56 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 10.1 m -64.62 171.1 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -1.094 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 103.38 21.85 9.59 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.91 115.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -1.163 . . . . 0.0 110.206 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.222 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LYS . 14.2 ttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.293 0.568 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' HG21 ' A' ' 139' ' ' ILE . 10.2 ptpt -140.61 -175.52 4.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.928 HG23 ' CD1' ' A' ' 139' ' ' ILE . 1.2 t -85.34 136.28 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.105 -0.997 . . . . 0.0 110.321 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -138.94 -176.74 4.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 7' ' ' LEU . 76.5 tttt -69.45 148.11 50.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.844 ' O ' HD22 ' A' ' 7' ' ' LEU . 5.8 m-20 63.05 32.36 15.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.844 HD22 ' O ' ' A' ' 6' ' ' ASP . 2.6 mm? -128.63 120.92 27.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 110.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.4 m -68.53 124.18 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.793 HG21 HG21 ' A' ' 3' ' ' VAL . 7.6 p -134.6 112.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.291 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -88.97 106.08 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.848 HD21 ' HE1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -131.83 132.61 43.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 110.444 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.93 159.53 21.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.924 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 133' ' ' ASN . 40.4 p90 -156.4 138.27 14.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.133 -0.98 . . . . 0.0 110.434 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.3 OUTLIER -106.74 158.24 17.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.902 HG13 ' CE1' ' A' ' 132' ' ' PHE . 3.1 t -127.9 100.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 110.315 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 131' ' ' LYS . 3.7 ptm180 -114.67 135.83 53.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.946 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.829 HG22 HD23 ' A' ' 130' ' ' LEU . 33.0 p -95.33 151.93 18.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 110.323 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -34.17 12.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.25 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -13.41 7.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.0 33.0 7.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 71.1 t -121.24 150.75 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -1.109 . . . . 0.0 110.306 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.29 121.82 42.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.125 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' HB ' ' CG1' ' A' ' 15' ' ' VAL . 3.6 t -86.57 -27.96 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.351 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 t0 -178.03 150.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 25' ' ' GLU . 2.1 pp20? -149.0 126.69 11.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 110.115 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.2 m -78.16 152.23 79.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.35 131.98 17.13 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.021 1.537 . . . . 0.0 110.5 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.9 -31.34 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.23 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.5 p -74.62 0.23 15.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.918 . . . . 0.0 110.222 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -158.06 89.29 2.33 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' HG21 ' A' ' 137' ' ' VAL . 46.1 Cg_endo -73.31 142.12 33.1 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.99 1.521 . . . . 0.0 110.405 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.52 108.79 17.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -90.0 112.69 24.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 110.088 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.958 ' CD1' HD13 ' A' ' 41' ' ' LEU . 32.9 p90 -123.39 167.71 13.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 110.202 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.785 HD23 ' CE1' ' A' ' 38' ' ' HIS . 2.3 tp -71.9 109.43 5.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.118 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.561 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 47.9 t60 -60.5 148.6 37.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.1 -65.17 3.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.785 ' CE1' HD23 ' A' ' 35' ' ' LEU . 4.6 p80 -130.16 87.22 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -1.177 . . . . 0.0 110.241 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -147.62 -52.22 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 1.6 t 171.39 -47.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -1.124 . . . . 0.0 110.238 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -41.91 130.26 3.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.336 -0.853 . . . . 0.0 110.185 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' C ' ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -30.48 141.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.508 -0.745 . . . . 0.0 110.379 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 22.4 p -60.67 -44.03 96.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.246 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 66' ' ' ASP . . . -60.12 -40.46 97.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 41' ' ' LEU . 16.2 tp -60.76 -40.46 92.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' SER . 86.7 mt-10 -45.88 -35.61 4.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.222 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 44' ' ' GLY . 43.9 p -58.67 -53.65 55.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.163 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' HB1' ' HZ ' ' A' ' 58' ' ' PHE . . . -56.5 -24.47 46.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 11' ' ' LEU . 1.3 mm? -90.8 -31.89 16.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' HA ' HG12 ' A' ' 3' ' ' VAL . 32.3 tt0 -63.3 131.47 48.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 60.65 58.28 14.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -116.4 -125.89 0.29 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -1.116 . . . . 0.0 110.166 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.2 tp10 -172.95 128.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 110.217 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG12 HG13 ' A' ' 139' ' ' ILE . 19.4 m -64.51 119.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.473 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.71 -0.6 56.64 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -94.54 136.69 34.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -1.132 . . . . 0.0 110.236 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CG ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER -121.25 143.29 49.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 110.133 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CE1' ' NE2' ' A' ' 52' ' ' HIS . 10.3 p90 -165.24 156.51 14.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 110.366 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.16 149.56 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.123 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 132' ' ' PHE . 9.5 p -144.41 152.67 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.317 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -101.63 117.06 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 0.0 110.186 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.858 HG12 ' HB2' ' A' ' 67' ' ' ALA . 12.2 t -150.21 94.55 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.252 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.685 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -137.02 -81.15 0.1 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.8 -18.29 26.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -1.072 . . . . 0.0 110.106 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -80.97 -15.32 56.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.274 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 177.71 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.311 -0.868 . . . . 0.0 110.421 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.858 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.79 -151.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.585 ' HH ' ' HE1' ' A' ' 132' ' ' PHE . 42.2 p90 -110.94 48.82 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.073 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 70' ' ' GLN . . . -46.64 -99.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.566 ' HB2' ' CA ' ' A' ' 126' ' ' ALA . 6.2 mt-30 -141.7 -106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 110.232 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.084 ' N ' ' HB2' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -76.77 120.31 21.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.1 -1.0 . . . . 0.0 110.405 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.23 113.6 10.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.954 ' O ' HG13 ' A' ' 76' ' ' VAL . 2.5 mm-40 -66.2 -8.63 25.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.264 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.97 -14.49 54.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -124.24 33.19 5.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.954 HG13 ' O ' ' A' ' 73' ' ' GLU . 18.4 m -66.64 149.95 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 110.119 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 5.1 mm-40 -118.7 128.91 54.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' C ' ' CG2' ' A' ' 79' ' ' VAL . 1.8 ptt180 -114.37 121.11 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.097 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 83' ' ' VAL . 2.3 t -148.62 139.36 13.49 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.239 -0.913 . . . . 0.0 110.107 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 45.4 Cg_endo -72.55 165.46 32.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.001 1.527 . . . . 0.0 110.482 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -63.52 -28.62 70.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.238 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.85 -18.39 8.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.26 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' HB ' HG12 ' A' ' 79' ' ' VAL . 47.6 t -111.56 -17.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' HD2' HD11 ' A' ' 90' ' ' LEU . 1.9 m-85 -56.59 -19.07 14.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.237 -0.914 . . . . 0.0 110.209 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 43.41 82.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.144 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' C ' HG12 ' A' ' 87' ' ' VAL . . . 104.94 151.83 21.2 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.744 HG13 ' H ' ' A' ' 88' ' ' ASP . 0.6 OUTLIER 175.07 -80.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -1.144 . . . . 0.0 110.186 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.744 ' H ' HG13 ' A' ' 87' ' ' VAL . 3.1 t0 63.24 8.57 3.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.991 -1.068 . . . . 0.0 110.522 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 168.3 105.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.966 . . . . 0.0 110.134 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -138.37 92.39 2.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.1 170.92 9.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.947 . . . . 0.0 110.203 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 92' ' ' VAL . 9.9 p -84.53 119.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.2 -0.937 . . . . 0.0 110.177 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.55 -33.39 6.24 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.524 ' O ' HD11 ' A' ' 109' ' ' ILE . 13.9 ttp -63.34 131.94 49.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.144 . . . . 0.0 110.174 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 1.6 ttm180 -97.88 126.17 43.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.18 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CE1' ' CG2' ' A' ' 107' ' ' VAL . 14.0 p90 -122.33 151.49 41.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.225 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -79.54 98.93 7.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 110.171 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 105.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 110.233 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.26 86.48 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.83 154.14 17.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -55.62 -17.79 6.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.477 ' OE1' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -89.48 14.13 12.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 110.265 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.99 162.24 18.94 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.13 138.69 28.38 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.103 1.581 . . . . 0.0 110.485 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG21 ' OE1' ' A' ' 102' ' ' GLN . 82.9 t -139.16 127.8 13.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 0.0 110.172 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.18 128.82 13.35 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.968 1.509 . . . . 0.0 110.425 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.846 ' HB ' HG22 ' A' ' 119' ' ' VAL . 13.5 m -143.17 167.83 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.132 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.872 ' C ' HD13 ' A' ' 109' ' ' ILE . 11.1 tt0 -132.34 173.83 10.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.238 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' C ' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -121.38 114.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.039 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 110' ' ' THR . 2.0 t -109.86 -27.59 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 110.216 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.598 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -146.07 158.22 43.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.231 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.64 104.59 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.913 . . . . 0.0 110.187 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 116' ' ' HIS . 5.0 mm-40 -82.35 168.34 17.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' OD1' ' A' ' 115' ' ' ASP . 20.0 t0 -63.29 132.45 51.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.226 -0.922 . . . . 0.0 110.166 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 1.2 m-20 49.22 26.39 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.284 -0.885 . . . . 0.0 110.17 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' NE2' ' HB2' ' A' ' 78' ' ' ARG . 11.2 t-80 -173.55 136.8 0.6 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 111' ' ' ALA . 1.8 p -129.4 162.6 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.201 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 10.7 m -113.62 131.85 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.222 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 108' ' ' GLU . 9.7 p -130.05 135.12 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.184 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -135.95 130.13 33.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 107' ' ' VAL . . . -73.26 137.12 23.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.447 ' O ' ' OD1' ' A' ' 122' ' ' ASN . 19.2 p30 -118.5 121.67 40.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -1.177 . . . . 0.0 110.302 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.473 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 16.5 m-70 -76.45 -162.23 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 ttp -62.98 -41.02 99.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.493 ' N ' ' OE1' ' A' ' 70' ' ' GLN . 17.3 tp 174.4 109.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.084 ' HB2' ' N ' ' A' ' 71' ' ' TYR . . . -96.39 -167.52 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.2 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.27 -17.52 53.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' ASN . 24.4 tt0 -105.96 79.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -1.114 . . . . 0.0 110.104 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 128' ' ' GLN . 15.3 p30 -41.23 149.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.321 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.829 HD23 HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -105.66 171.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.963 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -90.56 137.7 32.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.902 ' CE1' HG13 ' A' ' 15' ' ' VAL . 43.4 m-85 -134.88 100.0 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.379 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -65.88 155.16 37.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 49' ' ' LEU . 16.1 t -146.9 139.08 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 110.404 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.542 ' CG ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 mt-10 -140.9 107.72 5.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.934 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.626 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 20.7 t -74.91 137.14 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 10' ' ' SER . 21.7 t -111.69 -47.53 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -148.6 170.98 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.923 . . . . 0.0 110.51 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.928 ' CD1' HG23 ' A' ' 3' ' ' VAL . 6.7 mt -152.89 102.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.684 ' O ' HD13 ' A' ' 7' ' ' LEU . 4.7 mmm180 -129.64 167.52 17.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.169 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 2.0 pt-20 -90.82 152.08 20.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.969 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -99.53 159.59 14.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 147' ' ' LEU . 80.9 p -74.25 -175.69 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 110.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -36.78 85.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 110.249 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 7.7 tt0 -71.6 -38.79 70.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.969 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 5.2 mt-10 -60.3 -47.62 85.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.983 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 143' ' ' THR . 1.1 mt -78.01 -7.59 57.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.878 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -72.23 -53.67 11.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.857 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 155' ' ' ALA . 14.6 m-70 -81.47 0.08 39.4 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.514 0.673 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.733 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 100.52 -29.47 12.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.492 ' CD2' ' O ' ' A' ' 151' ' ' HIS . 0.5 OUTLIER -160.55 163.64 32.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -1.193 . . . . 0.0 110.293 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 146' ' ' GLU . 2.3 p -64.91 114.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.159 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 156' ' ' HIS . 57.3 t60 -158.04 -66.12 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 110.197 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 136.66 37.75 0.17 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 149' ' ' HIS . . . 46.41 41.2 9.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -1.129 . . . . 0.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 153' ' ' HIS . 1.4 t-80 -82.65 -63.25 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -32.53 73.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.912 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 51.03 -143.61 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -148.68 0.34 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -87.05 179.95 6.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 48.95 -174.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 48.13 54.91 9.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -130.16 125.93 36.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.06 5.79 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.92 2.8 53.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 110.269 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -120.05 60.36 0.52 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 28.1 p -131.58 7.26 4.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 24.8 p -167.02 132.66 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.234 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.22 -81.23 0.22 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 171' ' ' HIS . . . 88.31 178.93 46.94 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 170' ' ' GLY . 0.1 OUTLIER 63.07 61.48 1.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.172 . . . . 0.0 110.199 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 173' ' ' HIS . . . -103.61 -32.34 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 172' ' ' GLY . 5.7 m-70 55.03 165.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.198 -1.178 . . . . 0.0 110.256 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -70.75 -60.75 2.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.84 48.04 1.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 63.38 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.406 ' ND1' ' C ' ' A' ' 177' ' ' HIS . 0.0 OUTLIER -71.34 -153.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 110.223 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.449 ' OE2' ' N ' ' A' ' 179' ' ' HIS . 1.5 tm-20 -103.5 140.13 37.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.449 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -67.14 -158.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -136.02 -135.77 3.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.411 ' O ' ' CB ' ' A' ' 182' ' ' GLU . . . 114.57 -62.61 0.33 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 181' ' ' GLY . 17.4 tt0 62.75 38.6 11.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -1.14 . . . . 0.0 110.225 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.11 171.61 42.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 185' ' ' CYS . 48.8 t -108.74 -32.89 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -1.192 . . . . 0.0 110.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 184' ' ' CYS . 8.7 t 61.12 164.96 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.6 52.0 2.23 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.54 -152.71 14.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -60.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -155.1 171.3 33.33 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -175.56 168.32 3.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -1.135 . . . . 0.0 110.196 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 130.96 87.76 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 97.98 82.51 1.66 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 39.1 t -173.98 149.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -1.121 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -152.36 69.22 0.31 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 46.9 m -130.88 7.4 4.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 110.207 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.243 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.281 0.563 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -124.53 139.3 54.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.686 HG23 HD13 ' A' ' 139' ' ' ILE . 0.4 OUTLIER -66.19 155.14 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.946 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -145.87 156.45 43.56 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.451 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -46.72 -74.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.305 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 7' ' ' LEU . 33.9 p-10 -73.24 67.46 0.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.975 ' CD2' HG22 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -155.63 101.53 2.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 140' ' ' ARG . 5.6 p -51.14 138.99 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -0.896 . . . . 0.0 110.035 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.676 HG12 HD22 ' A' ' 11' ' ' LEU . 49.3 t -135.41 108.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 110.369 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -88.97 108.04 19.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.921 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 11' ' ' LEU . 1.8 pt? -135.71 146.37 47.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.932 . . . . 0.0 110.59 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 135' ' ' GLU . . . -106.02 154.34 20.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.877 ' CB ' HG12 ' A' ' 134' ' ' VAL . 29.5 p90 -156.39 151.71 26.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.08 -1.012 . . . . 0.0 110.563 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 33.7 mt-30 -115.91 150.71 36.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.381 -0.825 . . . . 0.0 109.796 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 24' ' ' ASP . 4.7 t -111.54 138.95 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.0 110.456 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -142.0 135.73 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.835 . . . . 0.0 109.925 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 36.1 p -98.87 151.71 20.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.52 -35.69 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 0.0 110.429 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -64.82 -6.1 7.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.15 27.37 33.87 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.2 t -121.33 125.46 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.356 -1.085 . . . . 0.0 110.219 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.106 HD13 ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.94 159.15 30.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.36 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.039 ' N ' HD22 ' A' ' 22' ' ' LEU . 25.6 t -120.53 -24.41 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.031 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 15' ' ' VAL . 23.2 t0 -170.43 151.43 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 13.1 pt-20 -149.0 134.59 18.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 13' ' ' TYR . 57.5 m -66.82 142.83 97.71 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.268 -0.895 . . . . 0.0 110.197 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' ALA . 46.2 Cg_endo -72.89 121.85 7.67 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.963 1.507 . . . . 0.0 110.379 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 28' ' ' VAL . 5.2 m -60.16 -18.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.125 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.77 2.1 55.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.217 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -164.52 95.28 0.94 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.252 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 45.4 Cg_endo -72.63 146.19 43.15 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.974 1.513 . . . . 0.0 110.358 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -77.26 111.89 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -99.81 126.86 45.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 110.197 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 1.025 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.4 p90 -161.27 167.85 25.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.988 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.728 HD22 ' HD2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -71.63 168.23 18.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 9.6 t60 -101.09 121.33 41.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.604 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.87 -26.66 5.25 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.728 ' HD2' HD22 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.08 92.43 3.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -1.124 . . . . 0.0 109.854 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 150' ' ' GLY . . . -171.65 -73.39 0.04 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 t -178.5 -37.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -1.184 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.025 HD12 ' CZ ' ' A' ' 34' ' ' TYR . 20.2 mt -51.66 145.44 9.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 7.4 pt -55.88 157.26 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -74.5 -42.02 59.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 110.176 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' SER . . . -43.99 -36.13 3.71 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD13 ' HE1' ' A' ' 132' ' ' PHE . 21.6 tp -86.74 -32.84 20.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -1.135 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 42' ' ' ILE . 3.4 mm-40 -64.31 -44.55 91.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.136 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -35.59 61.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 110.226 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 58' ' ' PHE . . . -70.21 -28.05 64.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD23 ' CD2' ' A' ' 52' ' ' HIS . 2.1 mt -64.4 -37.97 89.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.575 ' HA ' HG12 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -42.48 118.66 1.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.302 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA2' ' CD ' ' A' ' 2' ' ' LYS . . . 54.81 56.87 20.56 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 1.034 ' NE2' HD11 ' A' ' 139' ' ' ILE . 13.2 p80 -102.1 4.72 39.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -1.158 . . . . 0.0 110.209 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER 60.82 119.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.627 HG22 HG13 ' A' ' 139' ' ' ILE . 36.0 t -65.99 119.06 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 110.427 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.839 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 108.37 0.69 33.07 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -103.74 176.17 5.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.148 -1.207 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -150.01 121.96 8.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.302 -0.873 . . . . 0.0 110.206 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 134' ' ' VAL . 11.7 p90 -114.68 169.6 8.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.211 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.7 p30 -130.8 136.11 48.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.79 133.61 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' C ' HG23 ' A' ' 62' ' ' VAL . . . -79.51 113.22 17.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -0.874 . . . . 0.0 110.194 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.108 HG12 ' HB2' ' A' ' 67' ' ' ALA . 57.4 t -152.22 113.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' A' ' 67' ' ' ALA . . . -141.91 -78.01 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.89 -20.28 21.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.201 -1.176 . . . . 0.0 110.229 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -79.74 -22.89 42.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.268 -0.895 . . . . 0.0 110.238 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' HB3' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -172.21 39.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.108 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -157.19 -158.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 110.199 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 69' ' ' GLY . 22.6 p90 -104.48 45.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.667 ' HA2' HD13 ' A' ' 130' ' ' LEU . . . -42.97 -90.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -177.65 58.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -1.182 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 6.6 t80 -78.74 134.79 37.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.148 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' HB2' HD21 ' A' ' 125' ' ' LEU . 0.3 OUTLIER -83.88 74.09 10.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.269 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.946 ' O ' HG12 ' A' ' 76' ' ' VAL . 22.3 mp0 -69.31 -16.39 63.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.173 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' OD1' ' OD1' ' A' ' 72' ' ' ASP . 24.2 p-10 -56.5 -16.53 6.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -91.64 -25.44 19.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.197 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.045 HG23 ' HB2' ' A' ' 120' ' ' ASP . 7.2 p -55.53 140.3 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.893 . . . . 0.0 110.161 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -108.58 123.65 49.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.701 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.8 ptm180 -104.62 116.78 32.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.834 ' CG1' HG11 ' A' ' 83' ' ' VAL . 25.7 t -159.09 135.78 6.62 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.935 . . . . 0.0 110.065 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 83' ' ' VAL . 44.4 Cg_endo -72.04 160.02 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.988 1.52 . . . . 0.0 110.487 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.667 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 4.9 mptp? -71.49 -1.81 14.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.472 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.76 -1.08 12.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.834 HG11 ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -117.55 23.54 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.907 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.917 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -120.29 54.85 1.03 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.891 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.02 -24.3 1.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.914 . . . . 0.0 110.46 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 87' ' ' VAL . . . -81.07 -106.47 0.32 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' A' ' 84' ' ' PHE . 6.9 t 66.99 114.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.436 -1.037 . . . . 0.0 110.571 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 22.4 p30 -101.1 -21.77 14.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -171.73 41.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -0.818 . . . . 0.0 110.101 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.909 ' HB2' HG13 ' A' ' 87' ' ' VAL . 2.2 tp -67.24 132.4 47.69 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.357 0.598 . . . . 0.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.443 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 0.1 OUTLIER -150.59 149.25 29.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.078 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.1 t -44.87 119.52 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.47 -4.59 69.89 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' ' N ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -88.67 136.37 33.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -1.161 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' N ' ' HE3' ' A' ' 94' ' ' MET . 0.1 OUTLIER -130.96 155.03 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.097 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 107' ' ' VAL . 4.6 p90 -167.89 165.54 13.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.96 . . . . 0.0 110.266 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 0.4 OUTLIER -89.27 134.91 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.217 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.63 153.4 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.135 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -109.76 96.47 6.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.09 177.52 6.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 0.0 110.213 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.29 -26.62 38.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.271 -0.893 . . . . 0.0 110.225 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -82.76 10.54 7.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 110.287 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.18 179.87 15.92 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.21 130.26 15.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.007 1.53 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.94 104.12 23.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.276 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 45.8 Cg_endo -73.01 146.01 40.83 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.392 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 96' ' ' PHE . 32.9 m -143.83 146.31 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 110.263 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 95' ' ' ARG . 24.7 mt-10 -132.76 107.18 8.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.163 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.907 ' HA ' HG12 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -64.28 127.11 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.117 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 111' ' ' ALA . 4.1 t -116.57 -34.96 4.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 110' ' ' THR . . . -156.95 -179.73 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 0.0 110.181 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 112' ' ' VAL . 14.6 p -131.83 104.81 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 2.3 mm-40 -73.68 -176.45 2.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 115' ' ' ASP . 29.3 t0 -70.38 128.9 37.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER 41.99 30.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 78' ' ' ARG . 10.0 t-80 -175.05 152.63 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.716 HG12 HG23 ' A' ' 112' ' ' VAL . 17.9 m -136.3 170.36 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.182 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 76' ' ' VAL . 8.0 p -139.08 143.21 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 109' ' ' ILE . 24.0 m -132.12 133.71 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 110.046 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 1.045 ' HB2' HG23 ' A' ' 76' ' ' VAL . 15.6 t0 -150.02 165.86 31.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.99 -162.54 23.89 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 37.1 p-10 -118.11 96.02 5.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.157 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 125' ' ' LEU . 8.0 m-70 -74.48 151.75 39.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.422 ' O ' ' C ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -75.49 -39.32 58.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -0.928 . . . . 0.0 110.175 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 72' ' ' ASP . 3.0 pp -42.98 -29.83 0.37 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 71' ' ' TYR . . . -98.15 157.39 16.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 110.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.95 -6.83 29.24 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -97.91 76.17 2.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -1.13 . . . . 0.0 110.225 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -44.05 150.88 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.211 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.667 HD13 ' HA2' ' A' ' 69' ' ' GLY . 6.0 mp -105.7 135.2 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.957 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 129.65 38.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.933 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.556 ' HE1' HD13 ' A' ' 45' ' ' LEU . 28.9 p90 -148.44 142.76 26.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.323 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 133' ' ' ASN . 1.8 m-20 -104.37 148.03 26.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.059 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.877 HG12 ' CB ' ' A' ' 13' ' ' TYR . 4.1 m -129.97 162.74 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.937 . . . . 0.0 110.422 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.9 121.85 15.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.969 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.987 HG21 ' ND1' ' A' ' 52' ' ' HIS . 22.5 m -78.52 143.71 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 10' ' ' SER . 25.3 t -111.73 -35.49 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.343 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' HG12 ' A' ' 139' ' ' ILE . . . -161.66 172.2 16.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.034 HD11 ' NE2' ' A' ' 52' ' ' HIS . 9.8 mt -152.96 104.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.341 -0.85 . . . . 0.0 110.016 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.616 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -138.94 147.64 42.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.207 -0.933 . . . . 0.0 110.322 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 28.4 tt0 -55.73 141.06 39.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.032 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -89.08 157.28 18.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -0.949 . . . . 0.0 110.207 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.6 p -74.02 -176.79 2.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -0.956 . . . . 0.0 110.07 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.38 -41.33 89.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 110.261 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -69.97 -42.27 73.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.032 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 42.0 mt-10 -55.59 -42.83 75.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.77 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.961 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -81.99 -21.58 37.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.869 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.73 -53.47 50.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 110.107 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 15.7 m170 -78.61 -1.26 33.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.432 -0.793 . . . . 0.0 109.393 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 38' ' ' HIS . . . 94.96 -23.67 32.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 35' ' ' LEU . 1.5 p-80 -159.94 -171.33 3.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.339 -1.095 . . . . 0.0 110.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 146' ' ' GLU . 25.3 t -85.4 136.32 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 12.6 t60 58.4 154.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.187 -0.946 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.82 32.38 2.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.16 -26.57 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -1.195 . . . . 0.0 110.25 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.99 -16.76 62.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -56.73 -18.84 13.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -103.37 132.66 49.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 110.13 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.449 ' HB3' ' OD1' ' A' ' 161' ' ' ASP . 4.1 t60 -140.58 19.56 2.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 50.88 75.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 161' ' ' ASP . 1.2 m-20 -125.16 172.07 9.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 163' ' ' ASP . 79.4 m80 -58.27 -94.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 162' ' ' HIS . 1.3 t0 59.56 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.242 -0.911 . . . . 0.0 110.23 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 165' ' ' ASP . 32.9 m80 -91.25 -4.31 56.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.188 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 164' ' ' HIS . 0.9 OUTLIER 42.53 -163.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 110.336 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 170.13 116.06 0.36 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.53 53.72 0.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.255 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 15.9 m -79.43 135.82 36.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 0.0 110.218 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.61 -76.28 1.08 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.48 145.62 26.65 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -129.71 128.16 41.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -1.181 . . . . 0.0 110.229 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -51.24 166.89 0.64 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 173' ' ' HIS . 0.0 OUTLIER -165.83 140.46 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.223 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -167.33 69.83 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 110.172 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.63 63.62 1.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -56.07 -38.07 74.4 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.26 69.71 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -1.152 . . . . 0.0 110.216 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -78.11 137.06 38.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.425 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 0.5 OUTLIER -69.27 -158.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.211 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.91 170.91 0.31 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 169.96 -33.2 0.17 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 46.16 26.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -1.158 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 74.34 154.2 3.54 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.7 t -142.36 -52.19 0.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 94.5 m -133.82 167.99 19.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.927 . . . . 0.0 110.21 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 89.33 89.53 1.22 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -134.24 -51.12 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.0 -168.21 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.397 -1.061 . . . . 0.0 110.259 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 144.13 145.84 4.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 48.96 -173.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -1.18 . . . . 0.0 110.255 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -129.82 157.76 21.99 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 90.43 102.24 1.18 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.48 134.97 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -1.184 . . . . 0.0 110.177 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.92 111.01 1.61 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 30.5 t -95.58 -5.4 42.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 110.222 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.252 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' O ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.32 0.581 . . . . 0.0 110.255 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -147.57 158.5 44.02 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.288 -0.882 . . . . 0.0 110.074 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 50' ' ' GLU . 0.4 OUTLIER -51.11 155.06 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.153 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.862 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -156.33 178.45 10.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HE2' ' CG ' ' A' ' 38' ' ' HIS . 1.2 tttt -82.36 44.29 0.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.953 ' HA ' HD11 ' A' ' 35' ' ' LEU . 28.3 p-10 177.51 35.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.855 . . . . 0.0 110.105 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.863 HD21 ' OE2' ' A' ' 141' ' ' GLU . 0.7 OUTLIER -135.97 109.03 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.672 HG13 ' HB3' ' A' ' 140' ' ' ARG . 1.6 p -51.53 127.32 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.867 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 138' ' ' ALA . 1.6 p -142.98 130.29 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 110.334 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -95.52 113.38 25.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -0.856 . . . . 0.0 109.827 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.876 HD13 HD21 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -132.54 111.98 11.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 110.286 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.791 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -78.41 154.76 30.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.893 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' HB3' HG12 ' A' ' 134' ' ' VAL . 42.4 p90 -156.52 137.57 13.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.105 -0.997 . . . . 0.0 110.582 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.6 tt0 -105.77 129.68 53.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.84 . . . . 0.0 109.737 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 24' ' ' ASP . 10.3 p -117.92 153.08 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.075 -1.016 . . . . 0.0 110.795 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -154.37 141.23 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.45 -0.781 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.486 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 21.2 p -85.87 151.85 23.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 110.346 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -32.3 62.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 0.0 110.318 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -59.28 -13.18 6.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.121 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.81 31.14 7.16 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 2.9 t -121.25 145.06 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -1.117 . . . . 0.0 110.178 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HD12 ' A' ' 22' ' ' LEU . 1.9 mp -100.71 118.27 36.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.259 -0.901 . . . . 0.0 110.27 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 130' ' ' LEU . 12.4 t -78.19 -44.6 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.157 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.858 ' O ' HG12 ' A' ' 15' ' ' VAL . 37.4 t0 -162.05 158.65 25.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -148.93 128.81 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.264 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.791 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -106.42 112.25 63.88 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.98 158.62 49.45 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.998 1.525 . . . . 0.0 110.4 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.6 t -58.85 -26.78 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -78.42 -0.68 30.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 110.287 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.38 61.93 2.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 110.286 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 46.9 Cg_endo -73.26 163.82 36.92 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.315 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -74.79 90.51 2.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 110.182 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.37 105.06 17.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.165 -0.959 . . . . 0.0 110.028 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.25 168.38 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.258 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.953 HD11 ' HA ' ' A' ' 6' ' ' ASP . 12.7 tp -67.26 94.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.953 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.792 ' CD2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -60.51 145.42 48.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.847 . . . . 0.0 110.484 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' C ' ' HG2' ' A' ' 5' ' ' LYS . . . 75.66 -50.2 2.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.621 ' CG ' ' HE2' ' A' ' 5' ' ' LYS . 2.1 t-160 -115.19 86.44 2.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -1.192 . . . . 0.0 110.023 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.85 -67.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.636 ' O ' ' C ' ' A' ' 41' ' ' LEU . 47.4 t -174.86 -72.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.167 . . . . 0.0 110.032 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.636 ' C ' ' O ' ' A' ' 40' ' ' SER . 4.5 mt 19.05 -126.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.703 -0.623 . . . . 0.0 110.867 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -151.92 136.24 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.99 . . . . 0.0 110.072 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -65.58 -46.78 78.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 47' ' ' THR . . . -48.66 -46.67 30.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 62' ' ' VAL . 19.0 tp -79.62 -27.27 41.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -1.183 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -51.31 -55.46 18.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 44' ' ' GLY . 4.3 t -47.61 -38.76 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' THR . . . -73.64 -23.88 59.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 110.197 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.876 HD21 HD13 ' A' ' 11' ' ' LEU . 4.7 mt -84.93 -28.89 25.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 3' ' ' VAL . 3.1 mt-10 -53.18 129.32 30.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 110.396 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 63.41 109.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' NE2' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -164.44 -39.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -1.183 . . . . 0.0 110.235 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 2.5 tt0 69.72 147.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 110.251 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 54' ' ' VAL . 33.3 m -63.2 123.78 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.46 3.0 31.0 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 37.7 t0 -105.96 93.79 4.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -1.177 . . . . 0.0 110.246 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.09 144.87 30.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 110.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 134' ' ' VAL . 6.8 p90 -147.15 -156.59 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.106 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -145.16 133.41 21.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.177 -0.952 . . . . 0.0 110.41 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG12 HG13 ' A' ' 62' ' ' VAL . 24.1 t -144.01 147.42 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.103 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.768 ' HB2' ' HD3' ' A' ' 131' ' ' LYS . . . -111.31 116.55 31.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 110.122 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.682 HG13 HG12 ' A' ' 60' ' ' VAL . 4.5 m -151.91 118.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.126 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 1.021 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -161.67 -64.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' GLN . . . -77.65 -21.9 51.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.384 -1.068 . . . . 0.0 110.062 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 2.6 t30 -81.1 -28.75 35.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.24 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER 169.95 73.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.414 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' HA2' ' A' ' 63' ' ' GLY . . . -167.33 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.27 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.401 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 17.3 m-30 -110.16 -29.06 8.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 110.321 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.23 -121.45 0.91 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HA ' ' NE2' ' A' ' 70' ' ' GLN . 4.4 mm-40 54.94 68.09 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -1.182 . . . . 0.0 110.148 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.867 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 1.4 p90 -43.39 143.39 0.91 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.59 90.51 3.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 110.31 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -52.09 -21.07 2.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.962 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -78.63 4.26 14.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 110.121 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.544 ' C ' ' O ' ' A' ' 74' ' ' ASN . 1.3 tt -31.4 -58.66 0.25 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.52 -0.738 . . . . 0.0 110.578 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 120' ' ' ASP . 21.4 t -83.62 95.48 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 110.108 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.61 163.21 13.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.295 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.66 16.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 110.261 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 p -141.21 123.33 9.34 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.248 -0.907 . . . . 0.0 110.108 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.8 Cg_endo -72.94 157.19 51.68 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.976 1.514 . . . . 0.0 110.516 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 23.5 pttt -71.43 -2.18 15.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -50.48 -26.2 4.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.896 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' O ' ' C ' ' A' ' 84' ' ' PHE . 29.7 t -108.64 -75.72 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.845 ' CE2' HD11 ' A' ' 90' ' ' LEU . 1.5 m-85 33.32 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 109.68 2.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.235 -0.916 . . . . 0.0 110.238 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.719 ' O ' HG13 ' A' ' 87' ' ' VAL . . . 73.27 123.57 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG11 ' HB3' ' A' ' 84' ' ' PHE . 4.5 m -159.87 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.31 -1.112 . . . . 0.0 110.278 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.68 -42.01 18.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.148 -0.97 . . . . 0.0 110.049 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 3.9 pm0 -134.03 69.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 110.186 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD11 ' CE2' ' A' ' 84' ' ' PHE . 15.1 tp -60.03 99.2 0.07 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.783 -0.573 . . . . 0.0 110.314 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -98.79 154.65 17.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 92' ' ' VAL . 10.3 p -91.07 121.79 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 110.187 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.63 -36.39 4.39 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.675 ' HG3' HD11 ' A' ' 109' ' ' ILE . 21.0 ptt? -50.37 155.39 1.04 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -1.172 . . . . 0.0 110.3 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' CG ' ' CG ' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -111.97 136.04 51.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.298 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 13.3 p90 -153.74 162.63 41.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.15 139.46 30.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.365 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 96' ' ' PHE . . . -121.77 109.88 15.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.32 107.91 8.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.185 -0.947 . . . . 0.0 110.136 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.35 162.43 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 110.296 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.7 -23.42 1.03 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 110.19 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.02 15.42 5.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.71 174.17 35.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.75 129.13 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.004 1.528 . . . . 0.0 110.308 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG23 ' HD2' ' A' ' 106' ' ' PRO . 7.1 p -139.1 139.26 22.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.935 . . . . 0.0 110.239 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 45.6 Cg_endo -72.81 136.41 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.985 1.518 . . . . 0.0 110.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.841 ' HB ' HG21 ' A' ' 119' ' ' VAL . 1.4 m -145.31 149.93 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.579 ' CG ' ' CG ' ' A' ' 95' ' ' ARG . 1.5 tt0 -134.89 106.46 6.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.117 -0.989 . . . . 0.0 110.359 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.675 HD11 ' HG3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -49.11 127.66 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -0.901 . . . . 0.0 110.194 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.705 HG21 ' OD1' ' A' ' 120' ' ' ASP . 4.3 t -123.72 -23.55 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -0.863 . . . . 0.0 110.132 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.053 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -155.87 113.39 3.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 117' ' ' VAL . 7.9 t -86.33 147.08 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 110.226 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.646 ' OE1' HG13 ' A' ' 118' ' ' VAL . 0.2 OUTLIER -134.67 -179.36 5.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 115' ' ' ASP . 3.7 m-20 -72.42 129.7 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' ASP . 4.1 m-20 42.48 26.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 3.3 t-160 -166.09 142.1 4.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.189 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 112' ' ' VAL . 15.5 t -136.09 152.86 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.299 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.053 HG22 ' O ' ' A' ' 111' ' ' ALA . 25.0 m -111.4 157.27 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.841 HG21 ' HB ' ' A' ' 107' ' ' VAL . 3.9 p -147.31 134.1 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.705 ' OD1' HG21 ' A' ' 110' ' ' THR . 30.7 p-10 -167.63 99.18 0.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -165.97 68.04 0.2 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.518 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -118.61 177.45 4.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 110.033 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 122' ' ' ASN . 1.2 m-70 -43.89 128.49 5.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.137 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.463 ' O ' HD12 ' A' ' 125' ' ' LEU . 6.1 mtp -76.58 -19.85 57.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -147.93 100.1 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.867 ' HB3' ' HB3' ' A' ' 71' ' ' TYR . . . -98.03 -176.12 3.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.172 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.38 18.0 27.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.55 81.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -1.161 . . . . 0.0 110.244 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.414 ' C ' ' HG ' ' A' ' 130' ' ' LEU . 10.6 p30 -60.69 157.41 14.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.905 . . . . 0.0 110.147 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 130' ' ' LEU . 1.3 mp -136.44 146.08 45.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.768 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -105.4 127.27 52.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 110.267 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 132' ' ' PHE . 15.2 p90 -146.18 144.08 29.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 134' ' ' VAL . 8.7 t-20 -90.99 150.55 21.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.753 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 m -134.98 135.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -1.0 . . . . 0.0 110.503 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -127.86 127.9 44.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 109.99 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' HD12 ' A' ' 11' ' ' LEU . 51.8 t -78.75 137.24 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.168 -0.958 . . . . 0.0 110.271 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 10' ' ' SER . 13.2 t -111.59 -33.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -156.75 164.73 37.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.475 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.66 ' CD1' HG23 ' A' ' 3' ' ' VAL . 5.6 mt -154.32 101.82 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -0.823 . . . . 0.0 109.823 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.672 ' HB3' HG13 ' A' ' 8' ' ' VAL . 13.1 tpt180 -121.57 154.11 37.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.863 ' OE2' HD21 ' A' ' 7' ' ' LEU . 51.4 mp0 -78.99 157.72 28.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -108.16 158.33 17.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.172 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.583 HG23 ' OE1' ' A' ' 146' ' ' GLU . 59.1 p -74.06 179.94 4.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -57.18 -39.78 76.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.22 -46.32 64.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.158 -0.964 . . . . 0.0 110.244 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -56.01 -41.83 75.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.921 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 0.5 OUTLIER -81.98 -24.03 35.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.41 -53.15 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.86 -12.27 13.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.528 -0.732 . . . . 0.0 109.749 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.563 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 89.39 70.56 1.25 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 150' ' ' GLY . 11.0 m-70 -153.6 161.7 41.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -1.144 . . . . 0.0 110.226 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.635 HG21 ' HB ' ' A' ' 8' ' ' VAL . 32.8 t -130.23 111.61 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 0.0 110.163 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.485 ' CB ' ' O ' ' A' ' 152' ' ' VAL . 0.3 OUTLIER 67.22 -58.49 0.41 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 110.206 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 152' ' ' VAL . . . -73.08 150.6 44.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.6 114.5 4.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -1.113 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -83.14 -32.44 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.293 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -78.85 -15.13 58.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.548 ' CD2' ' NE2' ' A' ' 162' ' ' HIS . 16.3 t-80 -108.75 15.5 23.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.196 -0.94 . . . . 0.0 110.156 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -127.17 -66.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 110.232 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' A' ' 161' ' ' ASP . 0.3 OUTLIER -66.97 101.83 0.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.282 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 61.89 124.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.283 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.548 ' NE2' ' CD2' ' A' ' 158' ' ' HIS . 1.1 t-160 -114.69 -21.09 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.142 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -167.58 -158.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.162 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -97.67 99.01 10.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.171 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.38 40.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.914 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.73 -47.48 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 31.5 m 50.19 85.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -1.127 . . . . 0.0 110.204 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 26.3 p -81.91 5.89 17.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.173 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -55.37 170.64 1.73 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.9 -24.5 20.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.24 14.1 32.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -1.154 . . . . 0.0 110.18 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -138.01 -177.32 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 175' ' ' HIS . 2.2 t-80 -106.79 -3.36 20.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -1.151 . . . . 0.0 110.226 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 173' ' ' HIS . 11.5 t0 66.28 -63.67 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 0.0 110.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' A' ' 175' ' ' HIS . 21.4 p-80 -149.47 132.58 16.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 110.24 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 178' ' ' GLU . . . 178.55 52.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.446 ' HB2' ' OE2' ' A' ' 178' ' ' GLU . 31.5 m-70 54.54 -87.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.154 . . . . 0.0 110.158 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -125.05 152.7 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 110.296 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 179' ' ' HIS . 20.2 m170 -74.72 -8.51 56.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.213 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.88 130.11 2.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.23 -97.55 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.67 159.76 31.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.07 -99.66 2.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 185' ' ' CYS . 53.9 t -75.11 116.51 15.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -1.152 . . . . 0.0 110.214 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 184' ' ' CYS . 8.2 m 54.91 -171.3 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.78 -160.85 24.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.0 157.2 35.11 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 146.33 27.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -1.169 . . . . 0.0 110.137 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.35 95.07 0.94 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -129.06 105.75 8.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -1.155 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.35 -48.63 85.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.27 131.85 5.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 48.5 t -110.09 -51.0 2.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -1.177 . . . . 0.0 110.233 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.02 46.7 0.66 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 20.2 p -176.18 154.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -1.111 . . . . 0.0 110.275 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.226 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' CE ' ' HG ' ' A' ' 7' ' ' LEU . 7.5 ttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.232 0.539 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' HA2' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -124.28 154.21 40.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.157 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.918 ' HA ' HG21 ' A' ' 139' ' ' ILE . 6.1 t -58.12 133.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.138 -0.977 . . . . 0.0 110.157 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -152.71 -178.21 6.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.347 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.613 ' HG2' ' CE1' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -60.59 177.04 0.32 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.232 -0.918 . . . . 0.0 110.148 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.869 ' O ' HD22 ' A' ' 7' ' ' LEU . 24.2 t0 40.88 32.49 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.896 HD13 ' C ' ' A' ' 140' ' ' ARG . 0.5 OUTLIER -141.99 109.42 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.357 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 140' ' ' ARG . 3.4 m -63.42 129.18 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 HG23 ' A' ' 139' ' ' ILE . 32.3 m -123.18 115.44 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.383 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.4 m -88.79 106.07 18.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.486 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.774 HD21 ' CB ' ' A' ' 134' ' ' VAL . 2.8 tt -132.96 119.37 20.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 110.705 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 145.82 24.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.814 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.701 ' HB3' HG12 ' A' ' 134' ' ' VAL . 50.0 p90 -147.22 154.51 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 110.683 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 1.2 pm0 -121.57 126.92 50.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.438 -0.789 . . . . 0.0 109.704 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.2 p -111.68 148.11 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -147.96 141.34 25.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.583 HG21 HD21 ' A' ' 125' ' ' LEU . 38.3 p -83.25 151.83 25.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -55.76 -29.63 59.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.417 -0.802 . . . . 0.0 110.253 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 1.3 m-20 -59.08 -13.59 7.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 110.034 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.82 30.2 7.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 76.8 t -121.29 151.13 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -100.81 118.45 36.91 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.271 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 17' ' ' THR . 25.3 t -76.09 -46.07 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.921 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -175.49 150.2 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.942 . . . . 0.0 110.366 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 5.1 pm0 -149.05 142.91 25.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.421 -0.799 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -79.45 149.6 72.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.937 . . . . 0.0 110.19 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.751 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.67 134.84 22.8 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.993 1.523 . . . . 0.0 110.369 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 m -61.98 -24.04 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.88 -0.15 55.99 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -158.26 93.03 2.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' SER . 46.5 Cg_endo -73.08 156.69 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.014 1.534 . . . . 0.0 110.365 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.489 ' HG ' ' CE2' ' A' ' 34' ' ' TYR . 3.1 tp -73.84 108.31 6.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 4.4 m-20 -88.06 104.42 16.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 110.238 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 9' ' ' VAL . 15.1 m-85 -141.65 164.5 30.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.156 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.152 HD23 ' CD2' ' A' ' 38' ' ' HIS . 0.9 OUTLIER -68.43 167.98 13.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.096 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 50' ' ' GLU . 31.9 t60 -97.42 113.66 25.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA2' ' CG ' ' A' ' 46' ' ' GLU . . . 87.01 -33.39 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 1.152 ' CD2' HD23 ' A' ' 35' ' ' LEU . 41.7 p-80 -130.07 87.67 2.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 40' ' ' SER . . . -170.93 -50.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.6 OUTLIER 170.4 -26.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -1.143 . . . . 0.0 110.271 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 2.4 tp -48.57 179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.22 -0.925 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 67' ' ' ALA . 9.9 mt -97.22 158.43 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.345 -0.847 . . . . 0.0 110.205 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -68.72 -38.39 80.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 110.085 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.43 -42.41 99.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.854 HD11 ' CE1' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -72.35 -34.32 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -1.139 . . . . 0.0 109.986 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' CG ' ' HA2' ' A' ' 37' ' ' GLY . 2.4 mt-10 -42.54 -55.28 3.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.046 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.2 p -51.85 -33.27 35.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.537 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -83.64 -28.46 28.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.138 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -72.61 -44.97 61.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 110.187 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 16.9 tt0 -53.35 137.26 35.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.215 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 2' ' ' LYS . . . 43.13 81.93 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 52' ' ' HIS . 1.3 t60 -127.02 13.3 7.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -1.091 . . . . 0.0 110.157 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.7 tt0 53.9 94.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 110.16 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.823 HG13 HD11 ' A' ' 139' ' ' ILE . 6.5 m -43.64 118.97 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 110.399 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 108.24 2.82 33.54 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -108.53 166.86 10.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -1.169 . . . . 0.0 110.273 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -128.59 129.59 46.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.301 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 7.3 t80 -114.57 142.16 46.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.908 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -99.42 128.38 45.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.945 . . . . 0.0 110.206 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 48' ' ' ALA . 11.9 t -139.76 127.87 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.326 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.35 125.06 50.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 110.181 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.9 p -173.63 123.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.924 ' CA ' HD12 ' A' ' 130' ' ' LEU . . . -133.09 -81.75 0.19 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -71.63 -5.89 36.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -1.123 . . . . 0.0 110.046 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -80.86 -18.28 47.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.502 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER 172.63 -25.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.098 -1.001 . . . . 0.0 110.738 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -42.03 -90.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 3.6 m-30 -112.6 10.17 19.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.139 -0.976 . . . . 0.0 110.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 70' ' ' GLN . . . 72.3 2.49 54.36 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 8.0 mm100 41.61 77.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -1.156 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.631 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 21.3 p90 -54.13 124.28 15.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 110.259 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.665 ' O ' HD23 ' A' ' 75' ' ' LEU . 15.8 m-20 -83.28 126.4 32.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -52.16 -19.78 2.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 110.308 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -76.14 2.75 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.882 HD11 ' ND2' ' A' ' 122' ' ' ASN . 2.7 pp -88.2 -7.83 56.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 110.356 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 73' ' ' GLU . 28.4 m -53.67 122.97 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.91 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -150.27 172.94 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.509 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.945 ' HG2' HG23 ' A' ' 118' ' ' VAL . 45.2 mtm-85 -131.98 133.55 44.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.143 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 78' ' ' ARG . 7.2 m -159.63 146.31 12.4 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.276 -0.89 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 46.4 Cg_endo -73.74 167.08 28.14 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.015 1.534 . . . . 0.0 110.445 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -19.03 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -49.52 -22.59 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.84 -6.31 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.238 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HD21 ' A' ' 90' ' ' LEU . 11.4 m-85 -82.83 62.29 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.172 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.47 ' O ' ' O ' ' A' ' 86' ' ' GLY . 13.9 mtt -50.21 119.62 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 110.299 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 85' ' ' MET . . . 58.37 154.25 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.882 HG22 ' H ' ' A' ' 89' ' ' GLU . 2.6 p -176.82 -50.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.232 -1.158 . . . . 0.0 110.37 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.617 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.7 m-20 49.86 20.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.882 ' H ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 166.35 115.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.797 HD21 ' CD2' ' A' ' 84' ' ' PHE . 6.5 tp -145.65 122.9 11.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -121.38 168.16 11.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 110.07 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 112' ' ' VAL . 49.6 t -81.7 130.6 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.139 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 109' ' ' ILE . . . 93.94 -29.6 8.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 109' ' ' ILE . 6.0 ttt -45.95 155.41 0.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -1.101 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 2.0 ttt180 -130.32 126.52 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 107' ' ' VAL . 33.2 p90 -142.63 163.96 31.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.247 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 1.3 pp -87.0 106.12 17.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 105' ' ' VAL . . . -76.22 134.02 39.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.22 72.29 5.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 0.0 110.235 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.485 ' OG1' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -79.05 -176.5 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -69.33 -29.72 67.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -73.67 -4.48 34.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.08 -152.21 18.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.69 118.25 5.5 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' CG2' ' OG1' ' A' ' 100' ' ' THR . 48.8 t -125.08 118.58 25.42 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 46.8 Cg_endo -73.5 128.91 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.013 1.533 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 18.9 m -135.66 179.9 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 93' ' ' GLY . 15.1 tt0 -153.4 106.52 2.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.17 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 94' ' ' MET . 0.0 OUTLIER -48.54 122.7 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.19 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 118' ' ' VAL . 13.7 t -106.94 -21.59 12.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 110.02 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.798 ' HB3' ' CG1' ' A' ' 118' ' ' VAL . . . -149.06 178.89 8.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.853 . . . . 0.0 110.113 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 92' ' ' VAL . 48.3 t -152.58 107.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.185 -0.947 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 -179.24 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 115' ' ' ASP . 0.1 OUTLIER -65.46 128.95 37.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' ASP . 29.2 m-20 42.11 41.61 2.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.249 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -161.66 162.72 30.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 110.324 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 116' ' ' HIS . 11.8 t -150.92 153.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.037 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.945 HG23 ' HG2' ' A' ' 78' ' ' ARG . 1.9 p -139.05 134.41 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -112.61 133.56 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.355 -0.841 . . . . 0.0 110.027 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -167.72 171.81 9.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.82 60.66 0.84 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.882 ' ND2' HD11 ' A' ' 75' ' ' LEU . 74.4 m-20 -118.79 144.22 46.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -1.202 . . . . 0.0 110.198 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.522 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 2.3 m-70 -76.24 139.5 41.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.259 -0.901 . . . . 0.0 110.277 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.554 ' CA ' ' HG3' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -77.45 -11.35 59.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 110.051 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.583 HD21 HG21 ' A' ' 17' ' ' THR . 10.0 tp -54.39 -36.63 64.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 110.349 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.603 ' CB ' ' O ' ' A' ' 71' ' ' TYR . . . -42.1 143.53 0.57 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.76 21.68 5.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 129' ' ' ASN . 68.2 mt-30 -148.47 101.81 3.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.103 . . . . 0.0 109.994 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 128' ' ' GLN . 2.8 p30 -37.85 140.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.381 -0.824 . . . . 0.0 110.354 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.924 HD12 ' CA ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -110.76 135.55 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.314 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -103.7 133.83 48.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.142 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.854 ' CE1' HD11 ' A' ' 45' ' ' LEU . 6.3 p90 -148.38 154.05 39.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 13' ' ' TYR . 1.1 t30 -107.47 138.67 43.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.868 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.774 ' CB ' HD21 ' A' ' 11' ' ' LEU . 3.0 m -120.13 134.12 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.584 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.552 ' C ' HD12 ' A' ' 11' ' ' LEU . 14.1 tt0 -122.66 120.21 33.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.969 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.748 ' N ' HD12 ' A' ' 11' ' ' LEU . 4.9 p -74.8 141.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.358 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 10' ' ' SER . 40.1 t -111.71 -48.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.6 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -150.47 171.16 17.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.027 -1.046 . . . . 0.0 110.776 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.94 HG23 HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -145.08 101.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 109.623 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.896 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.6 150.38 35.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.222 -0.924 . . . . 0.0 110.344 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.6 OUTLIER -77.49 124.35 27.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.267 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.031 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -76.71 157.61 31.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.396 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -76.64 -177.01 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.998 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.29 95.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.8 -35.89 77.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 110.265 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.031 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 18.5 mp0 -59.23 -50.45 73.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.069 -1.02 . . . . 0.0 109.39 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.903 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.0 mm? -67.99 -22.07 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.407 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.25 -53.49 8.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.497 -0.752 . . . . 0.0 109.955 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -75.41 -3.08 31.71 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.456 -0.777 . . . . 0.0 109.177 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.63 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 89.62 -18.7 45.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.561 ' CE1' ' O ' ' A' ' 153' ' ' HIS . 0.6 OUTLIER -159.49 -169.56 2.64 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.135 -1.215 . . . . 0.0 110.407 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.859 HG12 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -99.85 123.67 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.355 -0.84 . . . . 0.0 110.335 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.561 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 0.2 OUTLIER 47.77 -163.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -0.904 . . . . 0.0 110.306 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 85.19 -52.95 4.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 154' ' ' GLY . . . 54.73 72.25 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 110.207 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -53.77 -29.59 40.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 158' ' ' HIS . 19.0 p-10 -75.51 -32.72 60.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -0.956 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 160' ' ' HIS . 0.7 OUTLIER 52.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 110.166 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -114.12 23.59 12.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 110.224 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -76.58 -170.14 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.253 -0.904 . . . . 0.0 110.214 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 163' ' ' ASP . 3.6 m-20 -150.71 103.09 3.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.178 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 80.4 m-70 55.31 -85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.176 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 161' ' ' ASP . 11.6 t0 -111.0 -145.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.246 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -121.25 2.61 10.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.217 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.83 146.89 29.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.222 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.26 53.07 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 30.3 p -78.77 1.74 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -1.117 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.26 127.87 55.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.186 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -118.02 -164.67 13.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.45 147.56 22.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.68 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -1.13 . . . . 0.0 110.142 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.85 -178.36 50.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -164.75 62.01 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.5 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.206 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 92.11 1.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 157.93 -74.85 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.82 83.88 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -1.179 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 179' ' ' HIS . 1.3 tp10 -66.24 -63.95 0.97 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.128 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 178' ' ' GLU . 2.8 m80 47.49 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -129.85 148.27 18.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -106.86 -107.05 3.17 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -176.66 168.34 2.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -1.094 . . . . 0.0 110.238 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 46.18 -124.6 7.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 52.9 t -100.36 126.76 46.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -1.149 . . . . 0.0 110.172 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.95 61.44 0.73 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.154 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -135.7 10.9 4.29 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -151.73 58.26 0.43 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -25.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -1.199 . . . . 0.0 110.192 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.81 125.46 3.33 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.57 135.24 54.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -1.193 . . . . 0.0 110.167 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.91 75.57 1.93 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.22 173.66 3.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.99 169.93 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -1.176 . . . . 0.0 110.202 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 195' ' ' CYS . . . -126.81 -33.92 0.62 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.543 ' O ' ' CG ' ' A' ' 196' ' ' HIS . 36.4 m 58.71 153.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -1.174 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 195' ' ' CYS . 73.9 m80 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.214 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' HD11 ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 139' ' ' ILE . 5.6 ttmt -129.75 149.67 51.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 110.259 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 HD22 ' A' ' 49' ' ' LEU . 29.8 t -69.21 134.13 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.211 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.015 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -117.96 178.76 4.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 0.0 110.313 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -87.03 -6.27 58.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 110.21 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.932 ' CB ' HD21 ' A' ' 147' ' ' LEU . 6.6 p-10 -127.27 39.17 3.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD13 ' HB3' ' A' ' 4' ' ' ALA . 3.7 mp -138.32 139.06 38.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.208 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 8' ' ' VAL . 2.5 m -65.99 118.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 3' ' ' VAL . 43.6 t -117.14 113.77 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 110.344 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.2 OUTLIER -88.97 106.14 18.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.986 HD13 ' CG1' ' A' ' 134' ' ' VAL . 2.8 pp -138.74 122.01 17.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.886 ' HB1' ' OG ' ' A' ' 26' ' ' SER . . . -81.26 160.11 24.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.876 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' N ' ' OG ' ' A' ' 26' ' ' SER . 8.0 p90 -156.32 138.51 14.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.063 -1.023 . . . . 0.0 110.568 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -113.76 125.8 54.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CB ' ' HB3' ' A' ' 132' ' ' PHE . 11.3 p -111.5 147.62 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.086 -1.009 . . . . 0.0 110.711 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 3.4 ptt-85 -145.63 145.89 31.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.552 -0.718 . . . . 0.0 109.784 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 27.5 p -92.98 151.89 19.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.403 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 17' ' ' THR . 15.5 mp0 -41.17 -27.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.511 -0.743 . . . . 0.0 110.49 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -58.87 -12.64 4.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.46 23.98 35.1 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.534 ' CG1' ' OG1' ' A' ' 17' ' ' THR . 9.3 p -121.38 150.34 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.286 -1.126 . . . . 0.0 110.318 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -96.21 117.86 31.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' CG2' HG23 ' A' ' 17' ' ' THR . 5.2 t -76.03 -41.3 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.451 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -147.82 150.39 34.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.282 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -149.0 123.01 9.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.886 ' OG ' ' HB1' ' A' ' 12' ' ' ALA . 77.3 p -65.72 147.61 98.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.149 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 45.4 Cg_endo -72.9 128.99 13.77 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.971 1.511 . . . . 0.0 110.408 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.0 -13.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 t -106.37 14.17 27.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.195 -0.941 . . . . 0.0 110.228 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.821 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -162.61 88.48 1.36 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.16 147.73 43.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.971 1.511 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 90.53 6.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 110.271 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 8.4 t70 -86.87 104.38 16.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 110.038 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HA ' HG11 ' A' ' 152' ' ' VAL . 6.8 t80 -134.6 167.5 20.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.73 HD21 ' HG ' ' A' ' 147' ' ' LEU . 21.5 tp -67.77 86.73 0.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 10.0 t-80 -60.49 141.73 56.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.1 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 5' ' ' LYS . . . 94.11 -19.68 51.86 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.492 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 27.7 m-70 -121.73 86.98 2.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 110.2 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 50.76 38.65 37.29 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.603 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.7 t -78.72 -65.21 1.02 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.319 -1.106 . . . . 0.0 110.323 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.603 HD12 ' CB ' ' A' ' 40' ' ' SER . 5.2 mp -139.74 -90.19 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG13 ' CB ' ' A' ' 45' ' ' LEU . 3.8 pt -131.86 158.62 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -73.32 -37.19 66.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 110.251 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' THR . . . -56.38 -37.57 74.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 134' ' ' VAL . 15.7 tp -86.74 -30.15 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.0 110.183 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HA ' ' NE2' ' A' ' 36' ' ' HIS . 4.5 mt-10 -56.45 -38.13 71.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 44' ' ' GLY . 14.1 t -75.83 -28.63 58.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.04 -24.78 40.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.265 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -80.95 -52.75 7.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.93 . . . . 0.0 110.261 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -47.76 121.36 4.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.253 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 76.02 64.69 2.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 58' ' ' PHE . 1.5 t-80 -137.52 4.73 2.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.282 -1.128 . . . . 0.0 110.3 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 136' ' ' VAL . 0.0 OUTLIER 66.03 151.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.0 110.306 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 1' ' ' MET . 38.5 t -85.13 119.77 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.873 . . . . 0.0 110.411 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.88 ' H ' HG23 ' A' ' 136' ' ' VAL . . . 109.37 3.1 31.12 Favored Glycine 0 N--CA 1.482 1.715 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.897 ' O ' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -105.04 157.34 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -1.139 . . . . 0.0 110.171 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CB ' ' HG2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -134.94 174.26 10.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.316 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CD1' ' NE2' ' A' ' 52' ' ' HIS . 10.6 p90 -164.66 154.52 13.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 133' ' ' ASN . 10.7 p-10 -121.61 125.37 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.142 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.08 139.18 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . . . -85.94 113.86 22.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 62' ' ' VAL . 22.0 m -155.67 98.68 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 110.116 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.552 ' HA3' HD12 ' A' ' 130' ' ' LEU . . . -123.9 -81.23 0.5 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' N ' ' HA3' ' A' ' 69' ' ' GLY . . . -86.13 -18.76 31.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -1.091 . . . . 0.0 110.258 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' OD1' ' A' ' 129' ' ' ASN . 9.4 t-20 -81.12 -27.3 35.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -170.91 63.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.283 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' VAL . . . -179.11 -136.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.11 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -110.52 34.5 3.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' HA3' ' N ' ' A' ' 64' ' ' ALA . . . -78.97 -33.7 36.0 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 69' ' ' GLY . 3.1 mm-40 -41.6 163.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -1.089 . . . . 0.0 109.943 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.675 ' CD2' ' HB3' ' A' ' 126' ' ' ALA . 1.8 t80 -84.68 120.47 26.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.121 -0.987 . . . . 0.0 110.576 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -137.75 122.45 18.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 44.0 mt-10 -69.5 -6.42 30.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 111.162 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' C ' ' A' ' 75' ' ' LEU . 5.1 m-80 -82.3 -46.98 12.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.875 -1.14 . . . . 0.0 112.146 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -40.56 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.698 ' H ' HD12 ' A' ' 75' ' ' LEU . 1.6 m -146.06 156.3 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.33 -0.856 . . . . 0.0 110.991 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HB2' ' CA ' ' A' ' 121' ' ' GLY . 18.2 tt0 -132.59 160.83 35.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.857 . . . . 0.0 110.055 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 77' ' ' GLN . 28.3 mtm180 -132.07 130.06 40.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.236 -0.915 . . . . 0.0 110.191 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 79' ' ' VAL . 8.7 p -162.96 117.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.271 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 47.1 Cg_endo -74.62 167.47 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.86 1.452 . . . . 0.0 110.51 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HD3' ' CG2' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -58.65 -16.02 14.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 110.25 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.96 -21.54 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.65 -9.28 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.096 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CZ ' ' CE2' ' A' ' 96' ' ' PHE . 4.0 m-30 -88.35 -60.25 2.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtm 47.98 34.61 4.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 110.162 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 87' ' ' VAL . . . -176.39 77.46 0.07 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.009 ' HB ' HD23 ' A' ' 90' ' ' LEU . 13.7 m -157.84 105.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 89' ' ' GLU . 11.2 t0 -58.06 -26.65 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER 173.78 117.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.009 HD23 ' HB ' ' A' ' 87' ' ' VAL . 2.3 pp -141.67 132.91 26.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -130.69 -167.72 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.9 146.75 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 110.185 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.85 68.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.436 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 4.4 ttt -103.31 149.8 24.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.232 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -94.93 138.59 32.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.678 ' CE2' ' CZ ' ' A' ' 84' ' ' PHE . 45.9 t80 -109.73 146.18 35.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 110.224 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.17 131.13 55.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -116.72 139.04 51.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.0 110.186 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -113.11 62.16 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 110.173 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.8 p -59.99 170.4 1.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 110.271 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.8 m-20 -70.84 -28.91 64.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.168 -0.957 . . . . 0.0 110.178 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -69.85 -7.68 42.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 135.13 171.79 12.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.0 114.62 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.918 1.483 . . . . 0.0 110.368 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 95.4 t -118.41 116.28 35.35 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 146.29 42.2 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.967 1.509 . . . . 0.0 110.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.905 HG12 ' HB ' ' A' ' 119' ' ' VAL . 1.5 t -116.4 171.2 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.899 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' CG ' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -135.66 106.67 6.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 94' ' ' MET . 8.4 mt -65.82 122.51 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -110.57 -16.42 13.65 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.342 -0.849 . . . . 0.0 110.169 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.03 ' HB3' HG21 ' A' ' 118' ' ' VAL . . . -164.96 -178.99 5.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.81 147.5 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.257 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.5 155.27 45.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.227 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -52.27 129.23 27.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 9.5 t70 45.34 44.1 8.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.185 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.538 ' CD2' ' HB3' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -174.7 150.68 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.194 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 79' ' ' VAL . 22.7 t -135.06 166.49 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.785 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.03 HG21 ' HB3' ' A' ' 111' ' ' ALA . 27.7 m -139.1 118.66 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.666 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.905 ' HB ' HG12 ' A' ' 107' ' ' VAL . 3.6 m -119.36 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.401 -0.812 . . . . 0.0 109.539 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 108' ' ' GLU . 24.1 p-10 -97.59 105.61 17.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 110.168 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.619 ' CA ' ' HB2' ' A' ' 77' ' ' GLN . . . -160.88 -141.08 3.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 40.8 p30 -53.76 168.27 0.2 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.151 . . . . 0.0 110.248 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.814 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -102.0 -161.3 0.84 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 110.334 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.431 ' O ' ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -77.47 -29.14 52.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 110.299 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 126' ' ' ALA . 0.5 OUTLIER 179.14 -29.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.91 . . . . 0.0 110.423 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . . . 61.64 174.48 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.8 21.61 69.46 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' ASN . 7.7 tp-100 -125.2 89.58 3.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -1.119 . . . . 0.0 110.123 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -39.34 129.95 1.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 110.285 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.552 HD12 ' HA3' ' A' ' 63' ' ' GLY . 1.8 mp -108.76 137.2 47.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 61' ' ' ALA . 1.3 ttpm? -99.03 129.18 45.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.025 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.508 ' HB3' ' CB ' ' A' ' 15' ' ' VAL . 45.3 p90 -148.42 146.6 28.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.497 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 59' ' ' ASP . 2.0 t-20 -92.09 162.86 14.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.884 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.986 ' CG1' HD13 ' A' ' 11' ' ' LEU . 8.3 t -144.31 132.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 0.0 110.58 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 22.1 mt-10 -122.83 124.78 44.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.83 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 56' ' ' ASP . 19.5 m -80.94 142.08 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.541 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 10' ' ' SER . 38.9 t -111.73 -44.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.851 . . . . 0.0 110.475 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' C ' HG23 ' A' ' 139' ' ' ILE . . . -159.03 170.86 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.097 -1.002 . . . . 0.0 110.581 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 2' ' ' LYS . 9.4 pt -152.29 116.63 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 109.973 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -124.08 -179.91 4.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.275 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.36 142.83 32.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.348 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 1.01 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -95.59 159.88 14.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.83 177.29 5.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.967 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 12.7 pt-20 -57.12 -42.6 81.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -69.36 -34.71 74.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.344 -0.847 . . . . 0.0 110.134 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.01 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt-10 -60.52 -48.59 81.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.929 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.932 HD21 ' CB ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -82.06 -16.47 50.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -76.16 -53.4 8.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 149' ' ' HIS . 12.9 m170 -93.83 -8.48 40.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.493 -0.754 . . . . 0.0 109.331 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.09 45.3 11.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 155' ' ' ALA . 2.3 m-70 -122.9 146.65 47.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.31 -1.112 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 34' ' ' TYR . 2.9 p -130.1 116.49 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.227 -0.921 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 52.12 41.06 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.246 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 155' ' ' ALA . . . -174.42 -174.62 41.34 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 154' ' ' GLY . . . -179.79 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -1.099 . . . . 0.0 110.242 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -63.29 -23.59 67.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.28 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.06 4.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 102.14 4.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.98 54.33 1.92 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.311 -0.868 . . . . 0.0 110.243 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.51 78.8 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.66 5.67 2.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 110.238 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -81.49 141.92 33.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 110.236 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 164' ' ' HIS . 6.7 t70 -175.01 121.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.578 ' O ' ' CG ' ' A' ' 164' ' ' HIS . 0.4 OUTLIER -178.27 95.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 30.4 p30 -44.77 157.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 110.199 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.68 -76.5 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.252 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 58.63 74.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -163.15 -79.77 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -148.95 119.62 1.08 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -91.77 -86.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -1.13 . . . . 0.0 110.18 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 173' ' ' HIS . . . -155.67 -160.22 9.84 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.485 ' O ' ' CD2' ' A' ' 175' ' ' HIS . 3.4 t60 63.75 130.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -1.181 . . . . 0.0 110.222 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.36 127.82 18.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 173' ' ' HIS . 55.8 m-70 -103.73 164.95 11.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.12 144.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 178' ' ' GLU . 0.7 OUTLIER -173.92 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.125 . . . . 0.0 110.12 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 179' ' ' HIS . 2.1 tm-20 65.15 136.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 180' ' ' GLY . 19.5 p-80 -59.21 -146.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' ' CG ' ' A' ' 179' ' ' HIS . . . -123.77 88.46 0.39 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.14 143.85 47.2 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -150.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.096 . . . . 0.0 110.241 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.13 -143.19 0.42 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.89 130.72 36.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -1.135 . . . . 0.0 110.244 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.36 26.11 6.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.221 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 126.16 106.4 1.5 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.43 49.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.201 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 90.98 -179.89 42.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.67 -175.22 4.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -1.16 . . . . 0.0 110.166 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -123.12 -148.18 7.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 164.38 21.98 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.12 85.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -1.14 . . . . 0.0 110.215 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -121.95 -63.18 0.22 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 196' ' ' HIS . 31.2 p -127.52 151.15 49.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 110.252 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 195' ' ' CYS . 18.9 t60 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.163 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HE2' HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.8 tttt -148.74 156.12 41.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.222 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.904 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -50.89 139.27 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 110.009 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.868 ' N ' HD21 ' A' ' 7' ' ' LEU . . . -146.89 171.3 15.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 110.268 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HE3' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -78.98 47.63 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 110.01 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -169.15 14.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.543 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.043 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.7 pp -136.18 147.59 47.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.063 . . . . 0.0 110.381 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.881 HG11 ' CG2' ' A' ' 152' ' ' VAL . 7.0 m -77.76 140.48 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.367 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.877 HG21 HG22 ' A' ' 3' ' ' VAL . 17.4 t -136.52 108.78 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.307 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 0.6 OUTLIER -89.06 106.29 18.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.907 HD12 HG13 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -132.75 135.29 45.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.1 -1.0 . . . . 0.0 110.534 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -84.12 168.05 16.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 109.741 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 20.0 p90 -156.49 144.37 19.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.631 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 133' ' ' ASN . 2.4 mt-30 -120.53 126.36 50.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.882 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.884 HG12 ' O ' ' A' ' 24' ' ' ASP . 3.4 p -111.47 128.86 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.444 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -132.39 135.83 46.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.029 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 21' ' ' VAL . 25.5 p -87.68 152.02 22.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 -14.48 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 0.0 110.525 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.97 13.6 2.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 28.54 71.19 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 3.8 t -121.27 151.1 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -1.136 . . . . 0.0 110.263 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' OE1' ' A' ' 25' ' ' GLU . 2.0 pp -110.65 122.58 48.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 89.3 t -78.86 -27.65 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.884 ' O ' HG12 ' A' ' 15' ' ' VAL . 3.4 t70 175.09 151.44 0.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -148.96 145.08 27.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.316 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 1.035 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.9 m -122.9 112.74 30.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.201 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.62 175.22 11.0 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.981 1.516 . . . . 0.0 110.504 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 21.7 t -71.76 -11.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.25 -0.906 . . . . 0.0 110.204 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.2 p -78.06 -9.69 59.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 110.166 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.13 60.79 3.06 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.27 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' VAL . 44.7 Cg_endo -72.87 141.81 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.941 1.495 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.64 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 13.7 p-10 -93.45 104.47 16.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.835 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 8.7 p90 -133.6 166.88 21.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.189 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.739 HD22 ' HA2' ' A' ' 150' ' ' GLY . 7.9 tp -78.52 140.12 38.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.489 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 49' ' ' LEU . 52.8 t-80 -83.45 149.06 26.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' CG ' ' A' ' 5' ' ' LYS . . . 88.02 -50.0 3.86 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.675 ' NE2' HD23 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -130.08 87.28 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -1.093 . . . . 0.0 110.032 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . . . 117.91 62.83 0.3 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' LEU . 24.6 t -145.03 53.54 1.21 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -1.114 . . . . 0.0 110.285 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.802 HD12 ' C ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 67.19 -70.17 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.278 -0.889 . . . . 0.0 110.306 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 41' ' ' LEU . 4.5 pt -151.36 162.85 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.269 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.443 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 1.7 p -75.71 -42.7 50.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 110.194 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -45.35 -43.55 10.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -79.12 -33.67 44.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 110.213 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 40' ' ' SER . 58.6 mt-10 -53.77 -50.08 66.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.188 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 p -48.53 -30.69 5.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 110.253 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -23.79 42.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.14 -28.36 42.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 110.1 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' HA ' HG12 ' A' ' 3' ' ' VAL . 21.9 tt0 -65.0 139.05 58.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 0.0 110.203 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' HA2' ' HG2' ' A' ' 2' ' ' LYS . . . 58.56 63.72 4.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.592 ' CD2' ' CG2' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -121.45 -126.85 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.172 . . . . 0.0 110.044 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -178.5 152.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.29 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 137' ' ' VAL . 90.9 t -75.19 119.08 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 110.395 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.22 1.11 61.16 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 23.4 t0 -89.62 126.22 35.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -1.175 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 135' ' ' GLU . 33.9 mtmt -115.26 137.78 51.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.225 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 134' ' ' VAL . 35.4 p90 -141.38 176.72 8.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.889 . . . . 0.0 110.088 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 3.4 p-10 -132.2 132.58 43.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.69 151.78 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 112.95 25.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.054 HG12 ' HB2' ' A' ' 67' ' ' ALA . 16.7 t -143.95 115.45 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.95 . . . . 0.0 110.216 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.98 ' HA2' ' HB3' ' A' ' 67' ' ' ALA . . . -158.47 -70.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 71' ' ' TYR . . . -83.41 -26.03 30.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -1.107 . . . . 0.0 110.16 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 t30 -81.02 -25.99 36.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 62' ' ' VAL . 0.3 OUTLIER 176.89 70.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 1.054 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -174.07 156.48 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.234 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.34 56.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.207 -0.933 . . . . 0.0 110.431 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -150.9 87.08 0.14 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.809 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 88.1 mm-40 57.08 47.71 16.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -1.095 . . . . 0.0 110.171 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 1.5 p90 -70.18 127.19 31.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.0 110.388 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.813 ' CG ' ' HB3' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -135.41 69.36 1.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.124 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.85 -34.14 73.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.895 . . . . 0.0 110.396 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' CG ' ' CG1' ' A' ' 105' ' ' VAL . 63.7 t30 -79.24 -15.48 57.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.282 -0.886 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -44.07 -30.06 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.056 -1.027 . . . . 0.0 110.086 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 ' N ' ' HG ' ' A' ' 75' ' ' LEU . 7.4 p -144.02 126.66 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 110.203 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' C ' ' HG2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -150.09 141.85 23.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.143 -0.973 . . . . 0.0 110.301 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -127.35 122.47 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.174 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 83' ' ' VAL . 5.8 m -138.04 129.15 15.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.276 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 116' ' ' HIS . 46.7 Cg_endo -73.29 167.72 26.59 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.984 1.518 . . . . 0.0 110.409 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' HG21 ' A' ' 87' ' ' VAL . 1.3 pttp -50.61 -26.28 5.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 110.265 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.35 -21.91 64.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.941 . . . . 0.0 110.26 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 83' ' ' VAL . 25.3 t -79.63 5.82 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 12.1 m-85 -119.18 -126.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.11 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.62 -80.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 110.134 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.82 80.74 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 81' ' ' LYS . 27.7 m -78.67 56.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.246 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -18.68 58.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 110.217 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.99 106.25 1.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.145 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.58 137.74 51.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.242 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -134.2 178.06 7.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 110.133 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 92' ' ' VAL . 31.3 m -89.69 140.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.43 39.95 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.651 ' O ' HG22 ' A' ' 109' ' ' ILE . 2.1 ttp -81.65 121.47 26.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -1.111 . . . . 0.0 110.211 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -110.21 133.2 53.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p90 -147.57 165.06 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.21 140.59 36.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' CB ' HG11 ' A' ' 107' ' ' VAL . . . -108.74 112.58 24.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -71.88 95.25 1.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.259 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.68 162.65 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.15 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -57.86 -28.34 64.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 110.227 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -72.44 -5.7 38.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.16 -166.25 14.13 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.89 116.94 4.91 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.931 1.49 . . . . 0.0 110.473 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG1' ' CG ' ' A' ' 74' ' ' ASN . 69.9 t -129.05 126.08 23.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 146.28 40.09 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.013 1.533 . . . . 0.0 110.46 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 96' ' ' PHE . 14.1 m -143.48 158.83 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.147 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.636 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.3 mt-10 -128.16 108.65 10.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.195 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' HG23 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -56.34 125.79 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.0 110.171 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.2 t -113.26 -20.18 11.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 110' ' ' THR . . . 178.58 142.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 112' ' ' VAL . 10.7 p -88.31 110.84 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.548 ' HB3' ' NE2' ' A' ' 116' ' ' HIS . 1.9 mm-40 -83.76 170.27 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 115' ' ' ASP . 4.8 m-20 -78.64 135.3 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 114' ' ' ASP . 1.2 t70 73.95 -5.58 2.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.828 . . . . 0.0 110.559 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.548 ' NE2' ' HB3' ' A' ' 113' ' ' GLU . 9.0 p-80 -175.24 158.72 2.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 109' ' ' ILE . 6.3 t -99.76 174.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 78' ' ' ARG . 97.5 t -126.15 142.7 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 110.179 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.654 HG23 ' N ' ' A' ' 109' ' ' ILE . 2.8 p -162.86 133.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.22 171.67 7.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 110.317 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . -167.66 63.08 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.35 162.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -1.177 . . . . 0.0 110.24 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.424 ' CE1' ' OH ' ' A' ' 71' ' ' TYR . 1.9 t-80 -102.28 -140.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.6 ' O ' HD12 ' A' ' 125' ' ' LEU . 3.4 mtm -63.97 -45.12 90.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER 176.64 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.195 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.813 ' HB3' ' CG ' ' A' ' 72' ' ' ASP . . . -66.93 -177.31 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.315 -0.866 . . . . 0.0 110.226 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.57 21.76 6.0 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.536 ' CB ' ' HG3' ' A' ' 70' ' ' GLN . 6.0 tt0 -121.18 87.06 2.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 64' ' ' ALA . 8.7 m120 -72.19 142.7 49.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -0.894 . . . . 0.0 110.383 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.838 HD12 HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -128.04 171.04 12.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.211 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -90.55 138.45 31.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 15' ' ' VAL . 14.2 t80 -134.15 108.6 8.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.547 ' C ' HG23 ' A' ' 134' ' ' VAL . 7.5 m120 -87.32 159.9 18.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.947 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.907 HG13 HD12 ' A' ' 11' ' ' LEU . 82.2 t -153.18 158.99 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.545 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 58.0 mt-10 -150.22 124.11 9.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 109.855 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.592 ' CG2' ' CD2' ' A' ' 52' ' ' HIS . 15.2 t -82.06 138.8 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 10' ' ' SER . 20.5 t -111.69 -37.17 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' CG1' ' A' ' 139' ' ' ILE . . . -159.05 172.74 17.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.144 -0.972 . . . . 0.0 110.466 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.999 HG23 HD13 ' A' ' 7' ' ' LEU . 4.5 mt -157.36 102.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 110.101 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 8' ' ' VAL . 10.4 tpt180 -123.22 161.26 24.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.292 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.517 ' N ' ' HG3' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -85.05 140.79 30.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.996 ' HB1' ' HB3' ' A' ' 146' ' ' GLU . . . -92.42 162.99 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.478 ' CB ' ' OE1' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -78.45 -175.77 4.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.197 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.71 -43.62 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 110.416 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 33.1 tt0 -67.42 -44.26 79.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.996 ' HB3' ' HB1' ' A' ' 142' ' ' ALA . 4.0 mp0 -57.78 -45.73 85.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.881 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.818 HD12 ' HB3' ' A' ' 142' ' ' ALA . 0.8 OUTLIER -72.98 -17.7 61.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 109.7 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -59.09 -53.06 62.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.476 -0.765 . . . . 0.0 110.001 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 -10.17 14.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.542 -0.724 . . . . 0.0 109.634 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.739 ' HA2' HD22 ' A' ' 35' ' ' LEU . . . 84.95 64.54 1.53 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 150' ' ' GLY . 79.5 m-70 -160.23 178.55 9.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -1.152 . . . . 0.0 110.263 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.881 ' CG2' HG11 ' A' ' 8' ' ' VAL . 16.7 t -130.48 111.08 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 110.174 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.464 ' C ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 39.03 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 155' ' ' ALA . . . 148.31 -61.66 0.44 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 154' ' ' GLY . . . 66.31 115.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -1.108 . . . . 0.0 110.215 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 151' ' ' HIS . 11.0 m170 -64.22 -26.5 68.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 110.216 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 158' ' ' HIS . 0.1 OUTLIER -78.54 -24.4 45.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 110.257 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' HIS . 1.4 t60 60.07 145.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.222 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 159' ' ' HIS . 2.1 p80 -178.49 156.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.506 ' CD2' ' C ' ' A' ' 160' ' ' HIS . 3.4 p-80 -53.02 -175.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -155.3 -178.49 7.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 162' ' ' HIS . 2.1 p-80 -135.09 -158.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 110.16 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -146.87 -176.8 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -0.881 . . . . 0.0 110.208 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 165' ' ' ASP . 8.6 m80 -57.29 -168.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 110.224 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 164' ' ' HIS . 11.5 m-20 -156.81 -52.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.951 . . . . 0.0 110.222 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 167' ' ' CYS . . . 161.59 -37.0 0.39 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.522 ' C ' ' O ' ' A' ' 166' ' ' GLY . 15.2 p 33.45 44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.5 -1.0 . . . . 0.0 110.562 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 43.4 t -113.2 89.88 3.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.87 71.48 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.64 87.79 1.81 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.23 56.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.157 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.47 -71.48 0.72 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -172.73 133.11 0.57 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -1.134 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 176' ' ' GLY . 28.4 t0 -100.79 150.34 22.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.448 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 19.0 t-80 -103.58 -15.23 15.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.189 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 174' ' ' ASP . . . -168.8 -169.01 31.67 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 177' ' ' HIS . 6.3 p80 -148.1 18.11 1.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -1.148 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -77.48 139.53 39.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -70.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.167 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 135.72 135.43 3.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 182' ' ' GLU . . . -45.97 -81.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' GLY . 14.6 mt-10 43.49 -148.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -1.142 . . . . 0.0 110.227 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 184' ' ' CYS . . . -101.59 -22.76 10.0 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' GLY . 0.8 OUTLIER 60.24 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.159 . . . . 0.0 110.24 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 29.9 m 44.84 -145.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 127.62 114.69 1.86 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.71 -49.81 0.23 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -176.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.179 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 98.12 -116.43 5.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -173.13 171.04 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.183 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.81 176.48 6.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.26 15.8 57.45 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -179.48 8.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -1.155 . . . . 0.0 110.209 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.439 ' O ' ' SG ' ' A' ' 195' ' ' CYS . . . -93.84 41.92 2.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 194' ' ' GLY . 1.7 m -160.61 173.62 15.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -1.154 . . . . 0.0 110.223 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.614 ' HE2' HG22 ' A' ' 139' ' ' ILE . 2.0 ttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.3 0.571 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' CG ' ' HA2' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -143.93 172.16 13.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.994 HG23 ' CD1' ' A' ' 139' ' ' ILE . 0.5 OUTLIER -72.21 145.93 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 7' ' ' LEU . . . -153.94 172.03 18.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.275 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HG2' ' HA3' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -61.1 171.64 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.092 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.886 ' HB3' HD21 ' A' ' 147' ' ' LEU . 2.8 m-20 42.69 47.02 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.101 ' CD2' HG23 ' A' ' 139' ' ' ILE . 0.7 OUTLIER -142.54 116.19 9.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.286 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 140' ' ' ARG . 2.3 p -63.5 123.8 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.145 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.927 ' CG1' HD23 ' A' ' 7' ' ' LEU . 13.2 m -140.37 119.83 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.296 -0.877 . . . . 0.0 110.196 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -90.14 129.52 36.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.016 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -136.29 112.07 9.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -91.12 142.69 27.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.788 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 134' ' ' VAL . 2.8 p90 -156.45 149.0 23.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 110.641 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HG2' ' CD2' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -106.41 131.53 53.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.86 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 24' ' ' ASP . 7.4 p -111.67 146.11 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.555 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 18.2 ttp180 -146.95 136.42 22.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.906 HG22 HD22 ' A' ' 130' ' ' LEU . 35.1 p -94.2 151.84 19.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -39.38 -32.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.563 -0.71 . . . . 0.0 110.489 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' THR . 1.4 t0 -59.01 -11.95 4.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 22.3 45.33 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.573 HG22 ' OG1' ' A' ' 17' ' ' THR . 17.2 m -121.49 151.62 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.4 -1.059 . . . . 0.0 110.333 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' CD2' ' HG2' ' A' ' 14' ' ' GLN . 1.7 mp -102.2 126.39 49.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.341 -0.849 . . . . 0.0 110.255 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.0 -30.28 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.789 ' O ' HG12 ' A' ' 15' ' ' VAL . 1.1 t0 176.97 151.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -148.97 155.87 41.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.237 -0.914 . . . . 0.0 110.229 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.622 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 t -106.6 110.67 63.92 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.575 ' HG2' ' HB3' ' A' ' 30' ' ' ALA . 46.4 Cg_endo -73.25 -179.5 4.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.999 1.526 . . . . 0.0 110.412 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.69 -38.88 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.229 -0.919 . . . . 0.0 110.177 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -73.48 -3.54 28.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . . . -146.78 68.67 11.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.91 164.41 35.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.109 1.584 . . . . 0.0 110.35 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' SER . 15.6 mt -98.88 90.58 4.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.262 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 34' ' ' TYR . 12.3 t0 -95.2 127.28 41.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.108 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 33' ' ' ASP . 34.5 m-85 -161.11 167.98 25.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 110.302 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 38' ' ' HIS . 5.9 tp -68.58 159.75 31.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 38.1 t60 -105.53 148.98 26.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.187 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 83.19 -50.91 4.49 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.809 ' CD2' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -130.0 87.21 2.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -1.138 . . . . 0.0 110.306 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 34' ' ' TYR . . . 104.9 56.78 0.7 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.592 ' C ' HD12 ' A' ' 41' ' ' LEU . 88.2 p -123.58 -80.22 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 40' ' ' SER . 4.5 mp -144.59 -90.33 0.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.151 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.906 HG21 ' HA ' ' A' ' 67' ' ' ALA . 17.0 mt -141.66 147.71 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 110.195 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.68 -23.42 51.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.919 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.06 -45.89 11.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 134' ' ' VAL . 55.1 tp -85.42 -10.9 55.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -1.211 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -64.71 -33.74 76.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -71.1 -26.25 62.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.269 -0.894 . . . . 0.0 110.177 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 45' ' ' LEU . . . -77.16 -24.27 51.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 110.249 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.869 HD11 HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.8 -47.05 67.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 3' ' ' VAL . 1.8 mt-10 -48.44 111.27 0.43 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' CG ' ' A' ' 2' ' ' LYS . . . 76.75 64.38 2.15 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 1.029 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -118.62 -24.83 6.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -1.172 . . . . 0.0 110.12 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 4.7 tt0 64.47 154.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.187 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 54' ' ' VAL . 11.0 m -84.52 119.02 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.92 2.92 36.61 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 52' ' ' HIS . 16.2 t0 -96.66 116.88 29.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 158.51 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.345 -0.847 . . . . 0.0 110.141 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.85 ' CE2' HG22 ' A' ' 60' ' ' VAL . 8.9 t80 -170.89 140.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 2.1 p30 -101.28 129.38 47.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 0.0 110.26 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG22 ' CE2' ' A' ' 58' ' ' PHE . 64.5 t -122.42 112.07 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.202 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -75.93 112.39 12.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.134 -0.979 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.771 HG12 ' HB2' ' A' ' 67' ' ' ALA . 24.6 t -160.26 111.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 110.182 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' O ' ' HB3' ' A' ' 67' ' ' ALA . . . -135.15 -81.19 0.13 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.7 -17.71 43.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -1.137 . . . . 0.0 110.137 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -81.02 -18.55 46.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 110.243 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.3 OUTLIER 175.06 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.906 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -153.72 -136.61 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.2 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.742 ' CE1' HD11 ' A' ' 42' ' ' ILE . 2.6 m-30 -65.44 -36.03 82.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.159 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.07 105.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.849 ' HB2' HD22 ' A' ' 125' ' ' LEU . 0.8 OUTLIER -106.15 -45.26 4.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -1.114 . . . . 0.0 110.096 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.147 ' CB ' ' HB2' ' A' ' 126' ' ' ALA . 1.5 p90 -43.16 144.89 0.59 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -125.75 116.97 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.614 -0.679 . . . . 0.0 110.181 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -53.03 -21.84 5.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -15.17 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.194 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 72' ' ' ASP . 2.6 pp -46.99 -27.19 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.895 . . . . 0.0 110.162 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -55.82 136.27 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.22 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -133.03 131.72 40.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 110.247 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -99.89 117.15 33.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 110.289 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' HD2' ' A' ' 80' ' ' PRO . 11.9 p -146.87 145.18 21.69 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.2 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 79' ' ' VAL . 46.3 Cg_endo -72.76 167.84 26.13 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.022 1.538 . . . . 0.0 110.404 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -55.77 -16.22 4.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -49.51 -22.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.075 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 84' ' ' PHE . 10.9 p -78.33 -17.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' CD1' HG13 ' A' ' 83' ' ' VAL . 21.7 m-85 -117.43 77.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' CG ' ' A' ' 85' ' ' MET . 2.0 ptt? -62.53 82.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.199 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' PHE . . . 121.28 24.34 2.45 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.972 HG21 ' CD2' ' A' ' 90' ' ' LEU . 3.0 p -42.71 -38.45 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -1.167 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 9.0 t0 70.28 3.89 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 109.853 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.678 ' H ' HG22 ' A' ' 87' ' ' VAL . 1.4 mt-10 167.14 103.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.444 -0.785 . . . . 0.0 109.878 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.972 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.77 98.85 5.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.0 110.215 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -140.46 162.52 35.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.249 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 4.3 p -73.28 142.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.32 -7.79 64.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.7 ttp -106.46 138.13 43.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 32.2 mtm180 -94.34 126.52 39.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' VAL . 50.5 t80 -112.7 161.47 16.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 96' ' ' PHE . 2.6 mp -124.34 124.57 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.47 159.15 15.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.147 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -137.26 85.9 2.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.09 174.58 7.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -68.59 -16.79 63.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.202 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -90.93 23.06 3.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.265 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.84 156.72 25.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.11 125.38 10.28 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 124.026 1.54 . . . . 0.0 110.46 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.59 116.98 36.45 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.888 . . . . 0.0 110.195 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 146.26 41.55 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.981 1.516 . . . . 0.0 110.441 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 96' ' ' PHE . 31.6 m -132.09 136.87 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 110.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 120' ' ' ASP . 6.8 mm-40 -106.23 109.34 21.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 92' ' ' VAL . 9.5 mt -71.29 105.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 110.198 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 92' ' ' VAL . 8.8 t -99.12 -32.31 11.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 110.202 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.777 ' HB3' ' CG2' ' A' ' 118' ' ' VAL . . . -131.65 175.83 8.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 117' ' ' VAL . 8.8 p -154.91 127.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.235 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -122.76 -176.91 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.177 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -69.55 128.99 38.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.29 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 80' ' ' PRO . 77.2 m-20 42.95 38.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 135.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 112' ' ' VAL . 17.8 m -143.07 143.52 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.26 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.777 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 29.4 m -101.32 154.56 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.517 HG13 ' C ' ' A' ' 118' ' ' VAL . 29.7 m -150.89 142.08 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 110.303 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 108' ' ' GLU . 3.7 t0 -120.98 162.87 19.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -163.36 -174.38 33.16 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.61 133.25 54.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -1.129 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.74 -171.62 0.87 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -28.91 63.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.849 HD22 ' HB2' ' A' ' 70' ' ' GLN . 3.7 tp -110.88 -125.47 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.888 . . . . 0.0 110.007 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.147 ' HB2' ' CB ' ' A' ' 71' ' ' TYR . . . 45.86 96.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.131 -0.981 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.14 -5.28 27.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 81.36 1.9 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -1.162 . . . . 0.0 110.134 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HB2' ' N ' ' A' ' 63' ' ' GLY . 3.4 p30 -51.07 178.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.268 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.906 HD22 HG22 ' A' ' 17' ' ' THR . 17.1 mt -105.65 143.69 33.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.17 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.37 126.39 49.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 11.0 p90 -148.5 147.92 29.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.453 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -100.33 129.5 46.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.842 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 HD21 ' A' ' 45' ' ' LEU . 25.3 t -109.02 154.15 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.905 . . . . 0.0 110.599 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -141.78 130.02 22.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.903 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 1.029 HG21 ' HB3' ' A' ' 52' ' ' HIS . 74.4 t -74.93 142.49 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.333 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 10' ' ' SER . 61.0 t -111.61 -49.49 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' VAL . . . -158.88 157.26 31.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.965 . . . . 0.0 110.459 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.101 HG23 ' CD2' ' A' ' 7' ' ' LEU . 4.2 mt -136.6 107.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.738 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -144.38 160.61 40.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.219 -0.925 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 4.0 mt-10 -81.24 128.57 33.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.988 ' HB1' ' CB ' ' A' ' 146' ' ' GLU . . . -69.23 161.49 29.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.236 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.96 -176.06 2.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.94 . . . . 0.0 110.032 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -37.86 88.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 2.2 tt0 -71.19 -34.7 71.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.215 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.988 ' CB ' ' HB1' ' A' ' 142' ' ' ALA . 3.4 mm-40 -62.97 -49.88 72.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.912 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -73.77 -15.68 61.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.935 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 145' ' ' GLU . . . -66.54 -53.69 32.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.427 -0.796 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -78.26 1.22 22.34 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.438 0.637 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 35' ' ' LEU . . . 94.77 -18.04 57.98 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' A' ' 146' ' ' GLU . 1.9 p-80 -157.11 -177.86 6.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.253 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.938 HG13 ' OE2' ' A' ' 146' ' ' GLU . 74.7 t -70.8 140.8 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 154' ' ' GLY . 0.1 OUTLIER 61.01 129.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 153' ' ' HIS . . . -48.57 175.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.12 15.7 11.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -1.183 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -83.93 -7.06 59.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 110.121 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.7 m-20 -44.18 -58.55 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 160' ' ' HIS . 0.3 OUTLIER -167.09 -70.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 158' ' ' HIS . 19.7 t-160 58.58 -78.68 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.285 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' HIS . 43.8 p-80 -133.27 176.39 8.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.175 -0.953 . . . . 0.0 110.225 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 162' ' ' HIS . 23.2 m-20 -70.9 137.58 49.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.237 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 161' ' ' ASP . 4.2 t-160 58.24 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.217 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -84.3 56.41 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -120.06 -0.22 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.87 -172.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 110.244 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' SG ' ' A' ' 167' ' ' CYS . . . 87.18 -143.14 18.62 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 166' ' ' GLY . 0.5 OUTLIER 176.97 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -1.153 . . . . 0.0 110.186 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 168' ' ' CYS . 24.7 p -144.27 110.85 5.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -110.78 -40.75 1.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 158.8 -136.41 4.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.23 111.73 3.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -92.98 -136.97 7.97 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.54 -65.43 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -1.138 . . . . 0.0 110.227 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -175.63 -68.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 179.05 4.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 110.268 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 136.43 108.13 0.89 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.31 -159.31 0.63 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -1.163 . . . . 0.0 110.267 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.51 -28.94 7.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 110.223 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.91 94.53 7.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -108.2 147.49 16.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -56.28 120.72 21.03 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -151.67 113.23 4.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.166 . . . . 0.0 110.217 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.65 135.58 9.28 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 11.8 p -168.05 101.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 12.5 t -133.02 101.44 5.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.211 -0.931 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.86 0.84 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.41 0.94 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.64 107.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -1.096 . . . . 0.0 110.227 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.78 160.86 27.87 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -45.9 115.34 0.95 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.301 -1.117 . . . . 0.0 110.161 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.79 -165.38 0.24 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 166.38 129.97 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' CYS . . . . . . . . . . . . . 12.0 t -102.85 -3.66 25.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -1.069 . . . . 0.0 110.126 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 169.5 169.16 32.45 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 8.8 t 46.91 54.97 8.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -1.137 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.151 179.966 . . . . . . . . 0 0 . 1 stop_ save_